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Abstract 
 
Frailty affects 10% of adults aged 65 years and older. It denotes loss of an individual’s body 
reserves, which increases vulnerability to developing adverse health outcomes such as death, 
disability, and institutionalization. Consequently, frailty has been described as the most 
problematic expression of ageing. Having good understanding of specific conditions influencing 
development of frailty and its effects holds the key to slowing its progression and mitigating its 
adverse outcomes. To this end, pathways to frailty and its adverse outcomes are the focus of 
my thesis. I begin with a literature review to assemble evidence on frailty pathways and 
instruments. Guided by this evidence and using the working framework of the Canadian 
Initiative on Frailty and Aging as the template, frailty pathways incorporating physical, 
psychological, and social conditions are conceptualized. Arguing that narrower physical frailty 
specifications are more suitable for investigating these pathways, I develop them based on the 
frailty phenotype. In my first two papers, I use data of 4,638 respondents aged 65 to 89 years 
from the English Longitudinal Study of Ageing to demonstrate construct, concurrent, and 
predictive validity of two physical frailty specifications. Adopting the specification with three 
indicators for latent growth curve analysis in my third paper, I show that chronic disease, 
allostatic load, low physical activity, cognitive impairment, depressive symptoms, poor social 
support, and poor social integration are predictors, mediators, or moderators on pathways to 
physical frailty. In my fourth paper, discrete time survival analysis reveals that low physical 
activity and cognitive impairment are mediators on pathways from physical frailty to death. In 
my fifth paper, autoregressive cross-lagged analyses demonstrate that these two conditions 
and depressive symptoms are mediators on pathways from physical frailty to activity limitation. 
All these conditions represent potentially modifiable targets for population-level interventions to 
address physical frailty in older people.  
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Part One 
 
Frailty Pathways: Defining the Issues and Charting the Course Ahead 
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1 Background 
 
Most of us have used the word “frail” to describe some older people we know. Although it 
means different things to different people, frailty is most commonly equated to being old and 
weak. Indeed, the Oxford Dictionary defines frailty as “the condition of being weak and 
delicate”. 
 
However, to the scientific community, frailty has two different albeit related meanings. The first 
has its roots in demography and refers to the unobservable heterogeneity distribution in 
mathematical models for survival (Hogan, 2003), which have come to be known as frailty 
models. That these models have been applied to mortality and ageing establishes the common 
ground it shares with the second meaning, which is the subject of this thesis. Here, frailty 
denotes the multidimensional loss of an individual’s reserves that occurs with greater 
probability in the face of advancing age. This loss results in the vulnerability to developing 
adverse outcomes such as hospitalization, functional dependency, and death (Espinoza & 
Walston, 2005; Lally & Crome, 2007; Mohandas et al., 2011; Pel-Littel et al., 2009). Within 
medical circles, frailty is widely considered as a clinical syndrome with an underlying biological 
basis, and is thought to be a transitional state that lies between robustness and functional 
decline (P. O. Lang et al., 2009b). A key underlying concept is that multiple body systems are 
involved (Strawbridge et al., 1998). Historically, frailty was first conceptualized as involving 
multiple domains by Strawbridge almost two decades ago in his seminal work on older 
respondents in the Alameda County study. He proposed viewing frailty as a syndrome involving 
deficiencies in two or more of physical, nutritive, cognitive, and sensory domains (Strawbridge 
et al., 1998). 
 
Despite the existence of frailty being generally accepted in most quarters, its concept has yet to 
be widely agreed upon by researchers and practitioners alike. For a long time, a broad 
consensus on its precise definition was lacking (Bergman et al., 2007; Crome & Lally, 2011). 
Although many health care professionals encounter frailty among older patients they care for 
on a daily basis, a single and universally accepted definition for its clinical diagnosis has long 
remained elusive (Conroy, 2009). Indeed, a well-known Canadian geriatrician declared that for 
clinicians, “frailty is like pornography: it is hard to define but easy to recognize when seen” 
(Rockwood & Bergman, 2012). However, a recent conference involving experts representing 
six major international bodies involved in ageing issues achieved some degree of consensus in 
conceptualizing frailty. Frailty was defined as "a medical syndrome with multiple causes and 
contributions that is characterized by diminished strength, endurance, and reduced physiologic 
function that increases an individual's vulnerability for developing increased dependency and/or 
death". More significantly, it was agreed that the diagnosis of frailty can be made on the basis 
of existing well-validated models that are operationalized as screening instruments (Morley et 
al., 2013). 
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Aside from formal definitions of frailty, knowing its opposite meaning can assist in achieving a 
better understanding of this seemingly vague concept. In this case, an antonym of frail is 
“robust”, which has been adopted in the categorization of health states (Fried et al., 2001). 
Alternatively, “resilience” is at one end of the spectrum of well-being and is characterized by the 
capacity for adaptation when confronted with challenges, whereas at the opposite end, frailty 
represents a reduced capacity to respond to these challenges due to loss of physiologic 
reserves (Kuh, 2007). Finally, the idea of “fitness” has also been used in contrast to frailty (A. 
Mitnitski et al., 2005; Rockwood et al., 2004). 
 
Not surprisingly, common physical states have often been confused with and mistaken for 
frailty. Particularly, it is worth highlighting that while there is some degree of overlap of frailty 
with co-morbidity and disability, all three are distinct concepts (Fried et al., 2004). Co-morbidity 
refers to the presence of chronic medical illnesses, while disability describes impairments, 
activity limitations, and participation restrictions (ICF, 2002). 
 
Another key condition related to frailty is sarcopenia. This has been defined as the age-
associated loss of skeletal muscle mass and function (Fielding et al., 2011). While frailty and 
sarcopenia are linked, they are considered as distinct entities, but with overlapping causes 
(Cooper et al., 2012; Reijnierse et al., 2016). Alternatively, sarcopenia has been viewed as a 
component of frailty, but that the latter is more multifaceted than sarcopenia alone (Morley et 
al., 2013). More crucially, I will argue that sarcopenia is the biological process underpinning the 
concept of physical frailty, which is a key domain of frailty. Beyond this, frailty is the subject of 
interest in this document and therefore, the focal point for analyses and conclusions that follow. 
 
In investigating frailty, one cannot help but be impressed by the rapid growth of the emerging 
literature on this condition over the past two decades (Karunananthan, 2009). There are a 
number of possible reasons for this. Firstly, the size of the problem needs to be considered. 
Precise estimation of the prevalence of frailty among older adults living in the community is a 
challenging task due to the lack of a universally accepted definition of frailty (Lally & Crome, 
2007). Nevertheless, a laudable attempt at obtaining a weighted average of its prevalence from 
different studies yielded an estimate of 10.7% among adults aged 65 years and older. The data 
was drawn from multiple individual studies that contributed prevalence estimates ranging from 
4 to 59% (Collard et al., 2012). Given this, we can infer that one out of every 10 community-
dwelling older people is likely to be frail. In 2015, the proportion of the population aged 65 years 
or older in the United Kingdom was 17.8 per cent, or 11.6 million people (ONS, 2016). In other 
words, frail older people comprised approximately 1.2 million in absolute numbers. Across the 
world where about 8.3% of the almost 7.4 billion people were aged 65 years or older in that 
same year (World Bank, 2016), we can expect about 65 million of them to be frail. To say that 
this is an enormous number of people would still be an understatement. Yet beyond size, its 
potential consequences bring about its true impact. On this count, there is overwhelming 
evidence that frailty confers increased risk of adverse health-related outcomes that matter to 
older people and their families. As mentioned, these include death (Buchman et al., 2009; 
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Cawthon et al., 2009; Gu et al., 2009; A. B. Mitnitski et al., 2004; Rockwood et al., 2011), 
disability (Avila-Funes et al., 2008; Romero-Ortuno et al., 2011; Woo et al., 2006), falls (Bilotta 
et al., 2012a; Samper-Ternent et al., 2012), fractures, cognitive impairment and dementia 
(Auyeung et al., 2011; Boyle et al., 2010; Woo et al., 2006), lower health-related quality of life 
(Kanauchi et al., 2008), hospitalization (Bilotta et al., 2012a), greater health services utilization 
(Rockwood et al., 2011), and institutionalization in long term care facilities (Jones et al., 2005). 
In view of these consequences, frailty plays a significant role in the well-being of older people at 
the individual and societal levels, and therefore has major public health importance. Moreover, 
with the projection of rapid growth in the number of older people across the world, frailty 
presents a rapidly escalating societal challenge on a global scale (Conroy, 2009). Finally, given 
its impact, frailty has been summarily described as the most problematic expression of ageing 
(Clegg et al., 2013). 
 
On a more positive note, there is accumulating evidence suggesting that frailty is an 
addressable issue from both health and social viewpoints. Using the metaphor of a frail older 
person as a car running out of petrol, there now appears to be measures that can be applied as 
it were to "fill up the tank" (Jeffery et al., 2013). Targeted interventions such as exercise have 
shown promise in reducing incident frailty (Mohandas et al., 2011). Moreover, the adverse 
outcomes of frailty may be modifiable to a certain extent. In this light, a good understanding of 
determinants of frailty and factors influencing the development of its adverse outcomes holds 
the key to its successful management (Bergman et al., 2004; Espinoza & Walston, 2005; Ho et 
al., 2011; Walston et al., 2006). With this knowledge, appropriate solutions can be better 
formulated and implemented in rational, effective, and efficient ways. To this end, pathways to 
frailty and from frailty to its adverse outcomes will be the focus of this thesis. 
 
With these in mind, the overarching research aim is to achieve a good understanding of the 
physical, psychological, and social conditions influencing the development of frailty and its 
adverse outcomes. 
 
A brief outline of this document is as follows: 
1) Literature review: A critical review will assemble current evidence, discuss its 
implications, and identify important gaps in the understanding of the predictors of frailty 
and its effects. The definition of frailty and instruments for its identification will be the 
secondary focus. 
2) Research plan: Based on evidence gathered from the literature review, further research 
will be proposed to address important knowledge gaps and gather additional evidence 
that can inform the development of interventions and policies aimed at improving the 
health and well-being of older people. 
3) Data: A brief discussion on the choice of secondary data set and its feasibility for the 
proposed research will follow. 
4) First paper: I will discuss the process of selecting suitable frailty specifications for 
investigating frailty pathways, which specify relationships between frailty and its 
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multidimensional predictors, as well as its outcomes. I will argue that a narrower 
physical frailty specification is more suitable for this task. Evaluation of construct and 
concurrent validity of candidate physical frailty specifications will be the focus. 
5) Second paper: I will complete the selection of candidate physical frailty specifications 
by evaluating their predictive validity with respect to key outcomes relevant to older 
people. 
6) Third paper: I will proceed with implementing one of these candidate physical frailty 
specifications in examining pathways to physical frailty. 
7) Fourth paper: I will shift the focus to examining pathways from physical frailty to death. 
8) Fifth paper: Finally, I will explore pathways from physical frailty to activity limitation. 
9) Closing discussion and final conclusions: I will summarize the key findings of my thesis, 
and then suggest directions for further work. 
 
The five papers (found in sections 5.2, 6.2, 8.2, 9.2, and 10.2) are written in the format required 
for submission to peer-reviewed journals that impose word limits. Thus, they are necessarily 
brief in keeping with length restrictions for original research articles, which are typically in the 
range of 6000 to 8000 words. Furthermore, this document is written in United States English to 
maintain consistency throughout, and to keep in mind the submission to journals. Given that 
these papers are self-contained articles, their texts inevitably contain repetitions of points made 
elsewhere in the thesis. Finally, the specific references for the five papers are listed near their 
end just before their respective Supplementary Materials sections. On the other hand, 
references for the rest of the document are compiled at the end of the thesis (pages 226 to 
243) just before the Appendix. 
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2 Literature Review: Pathways to Frailty and its Adverse Outcomes in Older People 
 
2.1 Abstract 
 
Pathways to frailty and to its adverse outcomes hold the key to the translation of research on 
frailty into successful health and social care strategies for older people. Physical, psychological, 
and social conditions that operate as individual determinants of frailty or as mediators and 
moderators of its effects are best integrated in a framework of pathways that takes into account 
their inter-relationships. A suitable frailty specification is needed at the heart of this framework. 
 
In view of these points, the primary aim of this critical review is to identify conditions on 
pathways to frailty and to its adverse outcomes. The secondary aim is to identify frailty 
specifications that could be suitable to be operationalized in the investigation of these 
pathways. This review focuses on conceptual development, and then develops hypotheses for 
further research. Sources of literature include electronic databases and hand searched 
documents. Papers are selected on the basis of their relevance and contribution. The narrative 
form of synthesis is adopted rather than attempting a systematic review. 
 
Conditions on pathways to frailty are largely those in the physical domain. They include older 
age, female gender, genetic influences, chronic disease, taking multiple medications, health 
events requiring hospitalization or activity restriction, allostatic load or physiological 
dysregulation, chronic systemic inflammation, physical inactivity, being underweight or 
overweight, specific diet compositions, smoking, and heavy drinking. Conditions in the 
psychological domain are impaired cognition and depression. The social domain is represented 
by less education, lower income, living alone, and social isolation. A number of exposures on 
pathways from frailty to its adverse outcomes decrease the risk of adverse outcomes such as 
hospitalization, functional dependency, and death. They are largely in the physical domain and 
include exercise, protein-energy supplementation, multidimensional intervention programs, and 
somewhat unexpectedly, being overweight. Conversely, low blood vitamin D levels increase 
this risk. To integrate the multiple physical, psychological, and social conditions on frailty 
pathways, the working framework of the Canadian Initiative for Frailty and Aging provides a 
useful frame of reference to build on. 
 
A wide array of frailty identifiers are available and they reflect different, albeit overlapping 
constructs. Given that key conditions on frailty pathways include those in the psychological and 
social domains, narrower physical frailty specifications may be more suitable for investigation of 
these pathways. The Cardiovascular Health Study (CHS) frailty phenotype is the prototype for 
physical frailty. It has five components, namely slowness, weakness, exhaustion, weight loss, 
and low physical activity. In developing physical frailty specifications to investigate frailty 
pathways based on the CHS frailty phenotype, the item on low physical inactivity should ideally 
be omitted from the list of indicators since it is a predictor of frailty. Since exhaustion might also 
be a manifestation of depression, which is in the psychological domain and also a predictor of 
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frailty, omitting this component may need to be considered. Therefore, candidate physical frailty 
specifications could be based on the CHS frailty phenotype, but exclude the component of 
physical inactivity and perhaps, exhaustion. The feasibility and validity of these specifications 
will need to be evaluated. 
 
The findings of this literature review offer guidance for further research on candidate frailty 
specifications and effects of physical, psychological, and social conditions on frailty pathways. 
They also provide a useful conceptual framework for understanding how these conditions may 
be related to frailty. 
 
2.2 Introduction 
 
To begin with, it is worth reiterating the key features of frailty that explain the amount of 
attention it has received in recent years, and which also constitute the basis for its choice as 
the subject for this research. Firstly, frailty is a common problem for older people, which is set 
to grow rapidly in terms of numbers affected. Secondly, frailty bears adverse consequences, 
which are significant at both the individual and societal levels. Finally, frailty may be prevented 
or have its adverse impact mitigated at least in part by appropriate interventions. 
 
Given that the ultimate purpose for studying frailty is to understand how we may influence its 
development and effects, a detailed examination of its pathways is an essential step. Early 
attempts to create graphical representations focused largely on biological pathways. Fried 
proposed a cycle of frailty that assembles physiological and clinical factors in a feedback loop 
(Fried et al., 2001). The effects of ageing, disease, and under-nutrition are linked to loss of 
muscle mass known as sarcopenia. This in turn manifests as decreased strength, physical 
inactivity, and low energy expenditure, which then leads back to under-nutrition. The cycle is 
then repeated as a feedback loop. 
 
Subsequently, a life course epidemiological approach was proposed to offer a more 
comprehensive framework for investigating predictors and effects of frailty in older people. Life 
course epidemiology can be best understood as the study of longer term physical and social 
exposures on health across life stages. It attempts to integrate rather than dichotomize 
biological and social risk factors for a given condition (Kuh et al., 2003). In doing so, this 
approach can be valuable in conceptualizing multiple predictors that exert their dynamic effects 
across different time periods (Kuh, 2007). Typically, there is explicit temporal ordering of 
exposures with inter-relationships among themselves. Their links with outcomes are either 
direct or indirectly through intermediate conditions known as a mediators (Ben-Shlomo & Kuh, 
2002). A tangible and desirable output is the diagrammatic representation of these factors that 
serves as a suitable framework for the application of statistical modeling techniques such as 
path analysis and structural equation modeling (Ben-Shlomo & Kuh, 2002). Kuh argues that the 
ability to study lifetime determinants of frailty including its early life origins is an advantage of 
adopting this approach. Moreover, it affords opportunities to examine separate components of 
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the frailty syndrome prior to their clustering, dynamic relationships between different domains of 
frailty, and conditions promoting resilience in contrast to frailty (Kuh, 2007). 
 
Adopting this line of thought, Bergman used the life-course approach for chronic disease (Ben-
Shlomo & Kuh, 2002) to develop the working framework of the Canadian Initiative on Frailty 
and Aging. A graphical representation of biological and social exposures across the life span 
with their explicit relationship with frailty and its adverse outcomes is constructed (Bergman et 
al., 2004). An adapted version of these relationships across the life course is shown in Figure 
2.1. 
 
 
Figure 2.1. A life course approach to exposures in relation to frailty and its adverse 
outcomes by the Canadian Initiative on Frailty and Aging (Bergman et al., 2004) 
(adapted) 
 
 
Pathways to frailty including their inter-relationships 
Pathways to adverse outcomes including moderators 
 
 
 
Here, conditions on pathways to frailty include increasing age, genetic influences, pre-birth 
growth, chronic diseases, environment influences, lifestyle habits, education, socioeconomic 
status, personal resources, social interaction and support, preventative measures, and access 
to medical and social services. While some of these conditions may have direct effects on 
frailty, others have their effects filtered through mediators on alternative pathways. Yet some 
others influence pathways from frailty to its adverse outcomes as moderators (Hendricks, 2012) 
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by increasing or decreasing the strength of relationships between frailty and these conditions. 
For simplicity, possible feedback loops are not illustrated. Individual conditions in the framework 
were selected on the basis of empirical evidence, theoretical grounds, or expert opinion. 
 
The relationship between frailty and adverse outcomes has attracted increasing interest in 
recent years. Indeed, the consistent ability of frailty to predict adverse outcomes is perhaps the 
most prominent finding in this area of research. A wide array of instruments to identify frailty 
have been developed and validated over the past decade (Pialoux et al., 2012), with different 
tools probably best suited for different purposes (Martin & Brighton, 2008). Direct comparative 
studies of several of these instruments have demonstrated largely equivalent predictive ability 
(Pilotto et al., 2012). However, beyond mere prediction, it is important to explain how frailty 
actually leads to these outcomes. In other words, a more precise understanding of pathways 
from frailty to these outcomes is desirable. This requires the unpacking of the "black box" of 
these pathways since underlying mechanisms offer plausibility for interventions designed to 
modify the adverse effects of frailty. More specifically, conditions along these pathways 
represent potential points for effective interventions (Rockwood et al., 2011). 
 
Thus, pathways from predictors to frailty and from frailty to its adverse outcomes hold the key to 
the translation of frailty research into effective health and social care interventions. Questions 
on what multidimensional conditions operate as predictors of frailty or as mediators and 
moderators of its effects, and how they relate to each other and to frailty are of interest. In 
addition, the direct and indirect pathways to adverse outcomes need to be understood better.  
Furthermore, knowledge of how individual conditions may be integrated in a common set of 
pathways that considers their inter-relationships is needed. 
 
For the study of these pathways, it is essential to have a suitable specification of frailty. 
However, deciding on the definition of frailty is challenging given that this condition is not 
directly observed (Kamaruzzaman et al., 2010). Moreover, the absence of universal agreement 
among researchers on one dominant frailty construct, and the resulting multitude of instruments 
developed for its identification (Pialoux et al., 2012) makes this task a most challenging and at 
the same time, an intriguing one (Heuberger, 2011). In fact, the search for an optimal definition 
of frailty has been likened to the holy grail of geriatric medicine (Conroy, 2009). Meaningful 
specifications of frailty for the purpose of investigating pathways are needed. A key emerging 
question is whether a narrower definition such as physical frailty would be more suitable given 
that important psychological and social conditions that are possible frailty indicators may 
already be represented along these frailty pathways. 
 
With all these questions in mind, the aims of this literature review are twofold. Firstly, it seeks to 
identify multidimensional conditions on pathways to frailty and to its adverse outcomes. 
Secondly, it attempts to review available frailty specifications and then propose one or more of 
these as candidates for implementation in the investigation of frailty pathways. 
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Therefore, the objectives of this review are: 
1) To examine pathways to frailty and its adverse outcomes, which include physical, 
psychological, and social conditions that operate as direct agents, mediators, and 
moderators. 
2) To identify frailty specifications that have a more parsimonious set of indicators, while 
retaining good predictive ability with respect to adverse outcomes of frailty. 
 
 
2.3  Methods 
 
2.3.1 Strategy 
 
The underlying approach I will adopt is that of a critical review, according to terminology 
proposed in the recent past (Grant & Booth, 2009). This type of review starts with wide search, 
analysis, and synthesis of the literature, progresses on to conceptual development, and then 
arrives at hypotheses or models as its end. While a systematic approach to search, appraisal, 
synthesis and analysis is utilized, this is nevertheless not a systematic review. The latter 
constitutes a secondary analysis that focuses on the collation of all empirical evidence that fits 
pre-specified criteria to answer a specific research question, and uses explicit and reproducible 
methods to minimize bias (Higgins & Green, 2011). Nevertheless, this review will have an 
aggregative intent in the sense that the principal focus is on the average overall result (Booth et 
al., 2012). 
 
2.3.2 Scope 
 
The scope of this review is defined by the research question, which has two parts: 
1) For community-dwelling older adults: 
a) What conditions are physical, psychological, and social predictors of frailty? 
b) Which of these conditions influence the progression from frailty to its adverse 
health-related outcomes? 
2) For the purpose of examining the relationship of frailty with its predictors and 
outcomes, what are suitable specifications of frailty? 
 
2.3.3 Search 
 
Two separate sets of search strategies and terms for the two parts of the research question are 
used. The sources of literature include electronic databases such as MEDLINE and hand 
searched documents. The search strategies and list of these sources are provided in the 
Appendix (pages 244 and 245). The final search was conducted on 2 June 2016. 
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2.3.4 Selection 
 
Rather than focusing on quality of evidence, I evaluate and select papers on the basis of their 
relevance and contribution to answering the research question. To do this, I employ a two-
stage approach. Firstly, titles of papers are screened for short-listing. Then from these, 
abstracts are examined to decide on the final list of papers for inclusion. This sequential 
strategy was previously found to be more efficient than the combined titles and abstract 
screening approach (Mateen et al., 2013). 
 
2.3.5 Synthesis 
 
I adopt the narrative form of synthesis. The purpose is to identify conceptual contribution 
towards suitable frailty specifications and theoretical frameworks that define pathways to frailty 
and its adverse outcomes. 
 
 
2.4 Results 
 
2.4.1 Search 
 
Using the search strategy for frailty identifiers through MEDLINE with PubMed, 3,157 papers 
are found. Similarly, for frailty pathways, 2,995 papers are identified. From Web of Science, 
2,485 and 1,220 titles including journal articles and conference proceedings are found for frailty 
indicators and pathways respectively. From the Cochrane Library, use of the title, abstract, and 
keywords search term “frailty” yields 4 reviews. No relevant papers are identified in title and 
keywords search term “frailty” of the Campbell Library. 
 
2.4.2 Selection 
 
From MEDLINE with PubMed and Web of Science, 209 papers on frailty identifiers and 283 for 
frailty pathways are selected from sequential screening of titles and abstracts. Of the 
systematic reviews identified in the Cochrane Library, no reviews are selected on account of 
relevance. 
 
2.4.3 Synthesis 
 
 
Frailty pathways 
 
Concerning the literature on pathways to frailty and from frailty to adverse outcomes, most 
available evidence has been generated in the past two decades. Much of the empirical work 
has focused on investigation of the relationship between single conditions and frailty. However, 
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conceptual frameworks that take into account the simultaneous and sequential effects of a 
range of individual health and social conditions have also been proposed. These frameworks 
provide a more complete picture of predictors and effects of frailty. Nevertheless, it is the 
evidence on individual conditions that constitute the building blocks for the construction of these 
frameworks, and offers plausibility for the existence of these pathways in the first place. It is 
worth noting that different studies use different definitions of frailty. While this may have 
implications on understanding pathways, I will put this issue aside for the moment in the bid to 
maintain focus on conditions related to frailty. 
 
For clarity, individual conditions may be classified into those on pathways to frailty, and others 
on pathways from frailty to its adverse outcomes. Evidence on these conditions emanate from 
longitudinal studies, which may have randomized controlled trial (RCT) or cohort designs. 
RCTs provide stronger evidence than cohort studies do. Conditions only found to be associated 
with frailty in cross-sectional studies offer additional evidence albeit with uncertain direction of 
effect. The relative positions of these categories of conditions in a conceptual framework of 
frailty are illustrated in Figure 2.2.  
 
 
 
Figure 2.2. Conditions along pathways to frailty (C1), and from frailty to adverse 
outcomes (C2) based on evidence from longitudinal studies and those only found to be 
associated with frailty (C3) from cross-sectional studies 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
These categories can be further sub-divided into conditions in the physical, psychological, and 
social domains. In this classification, no distinction is made on whether these conditions 
operate as effects, mediators, or moderators. 
 
 
 
C3 
Frailty 
Adverse 
outcomes 
C1 C2 
Longitudinal studies 
Cross-sectional 
studies 
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Conditions on pathways to frailty 
 
There are multiple conditions (Levers et al., 2006; Strawbridge et al., 1998) on pathways to 
frailty, and they are represented by C1 in Figure 2.2. Most of the available evidence concerns 
those of the physical domain. Both older age (Fallah et al., 2011; Ottenbacher et al., 2009) and 
female gender increase the likelihood of frailty (Etman et al., 2012; Peek et al., 2012; Woods et 
al., 2005). That frailty is attributable in part to genetic influences is expected. Data from multi-
generational families suggest that for frailty, the variance components due to genetic and 
shared environmental influences are comparable (Garibotti et al., 2006). Chronic disease has 
also been found to be a predictor of frailty (Ottenbacher et al., 2009; Strawbridge et al., 1998; 
Syddall et al., 2010; Woods et al., 2005). Cardiovascular risk scores were associated with 
higher risk of developing frailty (Bouillon et al., 2013a). Polypharmacy defined as the concurrent 
prescription of five or more medications has also been shown to increase the likelihood of 
incident frailty (Gnjidic et al., 2012). Heath events such as illness requiring hospitalization or 
restriction of activities also increased this risk (Peek et al., 2012). Poorer mobility measured by 
walking speed was also associated with development of frailty (Fallah et al., 2011). Sleep 
disturbances were independently associated with higher future odds of frailty (Ensrud et al., 
2012). 
 
Allostatic load or multiple physiological dysregulation is a more complex physical condition. 
This entity refers to alterations in the molecular, cellular, and physiological mechanisms of 
cardiovascular, neuroendocrine, metabolic, immune, and nervous systems (Gruenewald et al., 
2009). Typically, multiple biomarkers are employed to assess and measure allostatic load. In a 
study of 803 adults aged 70 years and older, Gruenewald and co-investigators assigned a 
value of one for each of 13 selected biomarkers when their scores fell into the quartile of 
highest clinical risk, thus obtaining total scores ranging from 0 to 13. They demonstrated that 
for each one-unit increase in the allostatic load score at baseline, there was 10% increase in 
the likelihood of frailty at 3 years (Gruenewald et al., 2009). 
  
Chronic systemic inflammation is also an important underlying mechanism for the development 
of frailty. Higher blood levels of C-reactive protein (CRP) (Puts et al., 2005), a marker of 
inflammation were associated with incident frailty in a sub-cohort of participants of the 
Cardiovascular Health Study (Barzilay et al., 2007). Similarly, immune-endocrine biomarkers 
predicted development of frailty. Lower baseline blood levels of insulin-like growth factor-1 
(IGF-1) predicted new-onset frailty (Yeap et al., 2013). Higher baseline white blood cell count 
and lower levels of dehydroepiandrosterone (DHEAS) were associated with increased odds of 
incident frailty (Baylis et al., 2013). Lower blood testosterone levels were associated with 
incident frailty (Cawthon et al., 2009; Hyde et al., 2010). Finally, low vitamin D levels (Puts et 
al., 2005; Shardell et al., 2012; Y. Y. Wong et al., 2013b) also increase the risk of frailty. 
 
Exercise is by far the most prominent factor shown to prevent or minimize frailty. Convincing 
evidence comes from randomized controlled trials and observational studies of exercise 
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programs in community-dwelling frail older adults (Brown et al., 2000b; Faber et al., 2006; 
Yamada et al., 2012). Moreover, higher midlife leisure time physical activity was associated 
with lower prevalence of frailty in old age among Finnish men (Savela et al., 2013). Similarly, 
participation in self-selected exercise by frail older people was associated with delay in onset 
and progression of frailty (Peterson et al., 2009). Sedentary individuals had higher odds of 
developing frailty compared with the exercise active participants in the Health, Aging and Body 
Composition (ABC) study (Peterson et al., 2009). Poor mobility (Fallah et al., 2011), physical 
inactivity (Strawbridge et al., 1998), and life-space restriction (Xue et al., 2008b) are predictors 
of frailty.  
 
In nutrition, findings from the Women’s Health Initiative Observational Study indicate that being 
underweight, overweight, or obese are positively associated with incident frailty compared with 
having normal weight (Woods et al., 2005). In older men, weight loss was associated with 
incident frailty, compared with normal weight (Strandberg et al., 2013). On the other hand, 
midlife obesity and overweight state was associated with higher risk of developing frailty in old 
age among Finnish adults (Stenholm et al., 2014; Strandberg et al., 2012). In contrast, higher 
dietary protein intake (Beasley et al., 2010) and greater adherence to a Mediterranean-style 
diet led to reduced risk of developing frailty (Talegawkar et al., 2012). Among other lifestyle 
habits, smoking (Ottenbacher et al., 2009; Woods et al., 2005) and heavy drinking (Strawbridge 
et al., 1998) are positively associated with incident frailty, while moderate drinking has a 
negative association (Woods et al., 2005). 
 
In the psychological domain, poorer cognition such as indicated by lower Mini-Mental State 
Examination (MMSE) scores confers higher risk of developing frailty (Ottenbacher et al., 2009; 
Raji et al., 2010). Similarly, depression is associated with higher risk of incident frailty (Lakey et 
al., 2012; Ottenbacher et al., 2009; Park-Lee et al., 2009; Strawbridge et al., 1998; Woods et 
al., 2005). Conversely, having positive affect was protective against the risk of developing frailty 
(Ostir et al., 2004). 
 
In the social domain, having less education (Alvarado et al., 2008), lower income, non-white 
collar occupation (Alvarado et al., 2008), living alone, and being social isolated are associated 
with higher risk of developing frailty or worsening of frailty (Etman et al., 2012; Peek et al., 
2012; Strawbridge et al., 1998; Syddall et al., 2010; Woods et al., 2005). Financial strain also 
increases this risk (Alvarado et al., 2008; Peek et al., 2012). These findings are likely to reflect 
the effect of chronic stressors on older people. From a life course perspective, poor social 
conditions in childhood in the form of experiencing hunger and having challenging 
socioeconomic circumstances was also associated with developing frailty in older persons 
(Alvarado et al., 2008). On the other hand, social support characterized by perceived emotional 
support from family or friends protects against increasing degrees of frailty (Peek et al., 2012). 
Risk of incident frailty was also lower for older persons who participated in group cultural 
activities (Fushiki et al., 2012). 
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Finally, multidimensional interventional programs can influence frailty. In a randomized 
controlled trial (RCT) of frail community-dwelling older adults in Australia, the intervention group 
received multi-factorial, inter-disciplinary measures, which included a home exercise program 
focusing on mobility and coordinated management of medical and psychological conditions. 
Frailty was reduced in them compared with the control group (Cameron et al., 2013). 
 
 
Conditions on pathways from frailty to its adverse outcomes 
 
Conditions on pathways from frailty to its adverse outcomes are represented by C2 in Figure 
2.2 (page 25). These influence outcomes of older people who are already frail. It is worth noting 
that these conditions operate either as moderators, mediators, or both. To a large extent, 
existing theory will inform the appropriate categorization of the effect of individual conditions 
into one of these three possible roles. 
 
Here again, most conditions are in the physical domain. Exercise is the most prominent among 
them. An RCT of exercise training yielded improved physical performance measures and 
functional status among participants (Binder et al., 2002). Similarly, an RCT on Tai Chi training 
demonstrated improved physical performance and reduced fall occurrence (Wolf et al., 2006). 
Another RCT on functional circuit training improved basic activities of daily living (BADL) among 
frail older people (Gine-Garriga et al., 2010). On a broader scale, the findings of a systematic 
review of 20 selected studies on physical exercise training suggested that older people with 
varying degrees of frailty can still improve their functional performance with regular exercise 
training programs. The majority of these programs studied were facility-based and based on 
group exercise of 45 to 60 minutes in duration performed 3 times per week (Chin et al., 2008). 
Yet another systematic review found that long-lasting and high-intensive multi-component 
exercise programs had a positive effect on ability in activities of daily living (ADL) in moderately 
frail community-dwelling older people (Daniels et al., 2008). Then, a meta-analysis of studies 
on exercise in frail older adults revealed that performance in ADL was improved in addition to 
better physical performance (Chou et al., 2012). However, the clearest indication on the 
benefits of exercise at the population level comes from the Canadian Study of Health and 
Aging.  Death rates for those aged over 75 years who exercised were similar to those aged 
from 65 to 75 years who did not exercise. This effect was seen across gender and different 
degrees of frailty. Of note, the largest health benefits of exercise were found among those 
participants who were more frail at baseline (Hubbard et al., 2009a). In another study, exercise 
training improved physical capacity (functional capacities and physical endurance), cognitive 
performance, and quality of life in frail older people (Langlois et al., 2013). Overall, several 
studies on exercise intervention composed of strength, endurance and balance training 
reduced falls, enhanced gait ability and balance, and increased muscle strength among 
physically frail older people (Cadore et al., 2013). 
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Other physical conditions on these pathways include those related to nutrition. In an RCT 
examining the effect of protein-energy supplementation for frail older adults with low 
socioeconomic status, the intervention group had reduced progression of functional decline 
measured by physical performance measures (Kim & Lee, 2013). In another RCT, combined 
amino acid supplementation and a self-administered exercise program under the supervision of 
home helpers resulted in less worsening of instrumental activities of daily living (IADL) of older 
persons at risk for frailty (Bonnefoy et al., 2012). Quite unexpectedly, frail overweight and 
obese respondents have reduced rate of functional limitations and disability in the Health and 
Retirement Study (Bowen, 2012). While suggesting that some excess body weight may be 
beneficial, these findings appear to contradict those of studies mentioned earlier where being 
overweight or obese was associated with the development of frailty. Finally, low vitamin D 
levels conferred added risk of mortality among frail non-institutionalized older people (Smit et 
al., 2012). 
 
Among psychological conditions, only cognitive impairment was found to increase the likelihood 
of incident disability among frail older persons (Avila-Funes et al., 2009). 
 
Yet again, multidimensional interventional programs influence the outcomes in frail older 
people. Three RCT's provide supporting evidence. The first involved frail community-dwelling 
older adults in Australia that was mentioned earlier. The intervention group received measures 
that included a home exercise program focusing on mobility and coordinated management of 
medical and psychological conditions. At 12 months, benefit was seen in the attainment of 
individualized goals on participation and in mobility measured by Life Space Assessment 
among those who received the intervention compared with controls (Fairhall et al., 2012). The 
second is the Elderly Persons in the Risk Zone study conducted in Sweden where the 
intervention was either a preventative home visit or four-weekly multi-professional senior group 
meetings with one follow-up home visit. Compared with the control group, both these health-
promoting interventions delayed deterioration in self-rated health and dependence in activities 
of daily living (ADL) at three months among adults aged 80 years or older (Gustafsson et al., 
2012). The third implemented a six-month program that included measures focused on 
improving physical function impairments in moderately physically frail older people living in their 
homes in the United States of America. The intervention group had reduced functional decline 
compared with those in the control group. However, this benefit was not observed in those with 
severe frailty (Gill et al., 2002). 
 
 
Conditions associated with frailty but with uncertain position on pathways 
 
There are a host of conditions associated with frailty where the evidence is from cross-sectional 
studies. These conditions are represented as C3 in Figure 2.2. Lack of temporal ordering of 
conditions and outcomes imposes limits in the confidence we can have in placing them on 
frailty pathways, since the direction of effect would be uncertain. Nevertheless, most of them 
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have also been studied in longitudinal studies and are already categorized as belonging to C1, 
C2, or both.  
 
Among these conditions in the physical domain are older age (Avila-Funes et al., 2008; Cramm 
& Nieboer, 2013; A. B. Mitnitski et al., 2004), chronic co-morbidity (Chen et al., 2010) especially 
cardiovascular disease (Danon-Hersch et al., 2012) and multi-morbidity (Avila-Funes et al., 
2008; Gobbens et al., 2010c), cardio-metabolic disorders (Tang et al., 2013), higher blood 
pressure and other cardiovascular risk factors (Bastos-Barbosa et al., 2012), inflammatory-
related disease (S. S. Chang et al., 2012), disability such as impairment in performing BADL 
and instrumental activities of daily living (IADL) (Bilotta et al., 2010; Chen et al., 2010; C. H. 
Wong et al., 2010), falls (Fhon et al., 2013), walking impairment (Nishi et al., 2012), urinary 
incontinence (Bilotta et al., 2010; Nishi et al., 2012), hearing impairment (Nishi et al., 2012), 
poor visual function (Klein et al., 2003), sleep disturbances (Ensrud et al., 2009; Vaz Fragoso et 
al., 2009), specific medications, and unhealthy lifestyle that includes smoking and alcohol use 
(Gobbens et al., 2010c; Woo et al., 2010). Constricted life space manifesting as leaving the 
neighborhood less frequently was associated with frailty (Xue et al., 2008b). 
 
In addition, inflammatory markers were associated with frailty. Among these, higher levels of 
blood protein biomarkers such as transferrin, fibrinogen, and interleukin-6 are associated with 
frailty even after adjustment for age and sex (Darvin et al., 2014). In addition, blood levels of 
interleukin-6 (IL-6) (Leng et al., 2007), tumor necrosis factor alpha (TNF-alpha), C-reactive 
protein (CRP) (Walston et al., 2002) were associated with frailty in very old people (Collerton et 
al., 2012; Hubbard et al., 2009b) as were neutrophils (Collerton et al., 2012; Leng et al., 2007) 
and albumin (Hubbard et al., 2009b). Interestingly, the combination of elevated white blood cell 
(WBC) counts and low insulin-like growth factor-1 (IGF-1) is associated with frailty (Leng et al., 
2009). Higher D-dimer and tissue plasminogen activator (t-PA) levels in the blood were also 
associated with frailty (Reiner et al., 2009). Similarly, higher blood adiponectin levels were 
associated with increasing number of frailty components (Tsai et al., 2013). Higher blood 
neopterin levels were associated with frailty (Leng et al., 2011). Lower levels of vitamin D were 
associated with frailty (C. I. Chang et al., 2010; Hirani et al., 2013; Tajar et al., 2013; Wilhelm-
Leen et al., 2010) with one study showing this relationship in men, but not in women (Shardell 
et al., 2009). Higher levels of blood cystatin C, a precise marker of kidney function were 
associated with greater odds of being frail rather than robust in older men (Hart et al., 2013). 
Higher levels of blood homocysteine levels were associated with frailty (Y. Y. Wong et al., 
2013a), as were higher estrogen levels (Carcaillon et al., 2012). On the other hand, low blood 
testosterone (Wu et al., 2010) and dehydroepiandosterone (DHEAS) levels (Voznesensky et 
al., 2009) were associated with frailty. Another interesting observation is that absolute burden 
of hormonal deficiencies manifested as low levels of two or more of IGF-1, DHEAS, and 
testosterone has a much stronger association with being frail than the individual hormonal 
deficiency. This suggests that a more generalized hormonal disorder is involved in frailty 
(Cappola et al., 2009). Moreover, frailty was also associated with higher blood inflammatory 
markers and lower blood esterase activity (Hubbard et al., 2008). Low levels of vitamin E, which 
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is a component of the human anti-oxidant system, was associated with frailty (Ble et al., 2006). 
Finally, heavier allostatic load was associated with increasing degrees of frailty (Szanton et al., 
2009). 
 
Among other conditions in the physical domain, common brain abnormalities such as those of 
Alzheimer's Disease at autopsy showed association with more rapid progression of frailty 
beyond that explained by demographic factors (Buchman et al., 2008). Further, malnutrition risk 
using anthropometric and dietary measures was associated with frailty in community dwelling 
older adults (Bollwein et al., 2013b). The Mediterranean-type of diet was associated with 
reduced frailty (Bollwein et al., 2013a). Smoking was associated with presence of frailty 
(Hubbard et al., 2009c; Wang et al., 2013). 
 
Among conditions in the psychological domain, mild cognitive impairment was associated with 
higher odds of being frail (Nishi et al., 2012; Shimada et al., 2013). Depression was also 
associated with frailty (Bilotta et al., 2010; Nishi et al., 2012) as were mere depressive 
symptoms (Chen et al., 2010; Ni Mhaolain et al., 2012a; Ni Mhaolain et al., 2012b; St John et 
al., 2013). Higher emotional reliance on another person and less self-efficacy were found 
among frail older people compared with those who were not frail (Imuta et al., 2001). In 
addition, lower levels of psychological well-being were also associated with frailty (Andrew et 
al., 2012). 
 
Concerning conditions in the social domain, singlehood (Chen et al., 2010; Cramm & Nieboer, 
2013), less education (Avila-Funes et al., 2008; Chen et al., 2010; Szanton et al., 2010), lower 
income (Avila-Funes et al., 2008; Szanton et al., 2010), non-white collar occupation (Woo et al., 
2005), low social participation (Woo et al., 2005), living alone (Bilotta et al., 2010), social 
vulnerability (Andrew et al., 2008), and neighborhood deprivation (I. A. Lang et al., 2009a) were 
all associated with frailty. On the other hand, stronger sense of social cohesion and 
neighborhood belonging was associated with reduced frailty (Cramm & Nieboer, 2013). 
 
A summary of the evidence on conditions on pathways to frailty (C1) and from frailty to its 
adverse outcomes (C2), or merely associated with frailty (C3) is presented in Table 2.1. It is 
again clear that there is much more evidence available on pathways to frailty (first column) than 
from frailty to adverse outcomes (second column). 
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Table 2.1. Summary of evidence on conditions on pathways related to frailty 
 
Condition Pathways 
to frailty 
(C1) 
Pathways 
from frailty 
to adverse 
outcomes 
(C2) 
Uncertain 
position 
on 
pathways 
(C3) 
Physical: 
Older age 
Female gender 
Singlehood 
Non-white collar occupation 
Less education 
Genetic factors 
Chronic disease 
Polypharmacy (>=5 concurrent medications) 
Health-related events 
Allostatic load 
Chronic systemic inflammation 
Low blood vitamin D level 
Low blood vitamin E level 
Low blood estrogens level 
Low blood testosterone level 
Overweight  
Underweight 
Disability in activities of daily living (ADL) 
Sleep disturbances 
Impaired mobility 
Urinary incontinence 
Impaired vision 
Impaired hearing  
Lifestyle factors 
o   Exercise (or physical activity) 
o   Smoking 
o   Increased protein /amino acid in diet 
o   Mediterranean-type diet 
o   Heavy drinking 
o   Moderate drinking 
 
+ 
+ 
 
 
+ 
+/- 
+ 
+ 
+ 
+ 
+ 
+ 
 
 
+ 
+ 
+ 
 
+ 
+ 
 
 
 
 
- 
+ 
- 
- 
+ 
- 
 
 
 
 
 
 
 
 
 
 
 
 
+ 
 
 
 
- 
 
 
 
 
 
 
 
 
- 
 
- 
 
 
 
+ 
+ 
 
 
 
 
 
 
 
 
+ 
+ 
 
 
 
+ 
 
 
+ 
+ 
+ 
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Table 2.1 (continued). Summary of evidence on conditions on pathways related frailty 
 
Condition Pathways 
to frailty 
(C1) 
Pathways 
from frailty 
to adverse 
outcomes 
(C2) 
Uncertain 
position 
on 
pathways 
(C3) 
Psychological: 
Poor cognition 
Depression 
High emotional reliance 
Less self-efficacy 
Lower psychological well-being 
 
+ 
+ 
 
+ 
 
 
 
+ 
+ 
+ 
Social: 
Lower education 
Non-white collar occupation 
Lower income 
Financial strain 
Living alone 
Social isolation 
Social support 
Low social participation 
Social vulnerability 
Neighborhood deprivation 
Stronger social cohesion 
Poor social conditions in childhood 
 
+ 
+ 
+ 
+ 
+ 
+ 
- 
+ 
 
 
 
+ 
 
 
 
 
 
 
 
 
 
 
 
+ 
+ 
- 
 
Multidimensional: 
Interdisciplinary intervention program 
 
- 
 
- 
 
 
 
Note: + positive effect; - negative effect; 
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Frailty frameworks 
 
Conceptual frameworks that integrate multidimensional conditions and define their relationship 
with frailty and with each other have been proposed and reported in the literature by several 
research groups. However, empirical studies of such frameworks are not identified. 
Nevertheless, examination of these frameworks is worthwhile as they provide the basis for 
construction of frailty models for further research. 
 
The best known frailty framework is that proposed by the Canadian Initiative on Frailty and 
Aging (Bergman et al., 2004). This is shown in Figure 2.3. It acknowledges the influence of 
advancing age on transitions from pre-frailty to frailty. Life-course conditions from the biological, 
psychological, social, and societal spheres influence age-related declines in physiological 
reserves and disease. These in turn promote the onset of frailty in later life. Frailty leads to 
adverse outcomes ranging from disability to hospitalization and death. Its effects are modified 
by the same conditions. Emphasis on multidimensional conditions and the distinction it makes 
between pathways leading to frailty, and those from frailty to adverse outcomes are valuable 
features of this framework. 
 
 
 
Figure 2.3. Working framework of the Canadian Initiative on Frailty and Aging (Bergman 
et al., 2004) (adapted with modifications) 
 
 
 
 
This working framework was adapted and modified in the development of the integral 
conceptual model of frailty (Gobbens et al., 2010b). While most elements are retained, this 
model accommodates physical, psychological, and social components of frailty rather than the 
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original seven candidate components. For physical frailty, its components are decline in 
nutrition, mobility, physical activity, strength, endurance, balance, and sensory functions. For 
psychological frailty, decline in cognition, mood, and coping are specified, while for social frailty, 
decline in social relations and social support are included as components. 
 
While other frailty models have been proposed, most are restricted to biological aspects or 
have a heavy mathematical emphasis. Given that these do not contribute to a multidimensional 
approach to frailty, they will not be discussed. 
 
 
Frailty identifiers 
 
For the study of frailty pathways, an appropriate specification of frailty is needed. The wide 
array of screening instruments developed and validated over the past decade (Pialoux et al., 
2012) attests to the absence of a universally accepted definition of frailty (Rodriguez-Manas et 
al., 2013). Closer examination reveals that these instruments reflect different yet overlapping 
concepts of frailty. What is strikingly common among these concepts is their consistent ability to 
predict adverse outcomes such as mortality, disability, falls, hospitalization, and nursing home 
placement (Ensrud et al., 2008; Jones et al., 2005; Kiely et al., 2009; Woo et al., 2012). The 
purpose of this section is to survey these various frailty concepts and to compare them. At the 
close, one or more candidate frailty specifications judged to be more suitable for the study of 
frailty pathways will be discussed. 
 
To start with, the Cardiovascular Health Study (CHS) frailty phenotype proposed by Fried is 
arguably the most widely adopted among existing concepts (Bouillon et al., 2013b). It 
conceptualizes frailty as being a geriatric syndrome resulting from decline in multiple 
physiologic systems and operationalized by requiring the presence of at least three of its five 
components: 
1) Shrinking: unintentional weight loss of at least 10 pounds or 5% in the prior year 
2) Weakness: hand grip strength in the lowest quintile adjusting for gender and body 
mass index 
3) Poor endurance and energy: self-reported exhaustion 
4) Slowness: slowest quintile of the population based on 15-feet walk adjusting for gender 
and standing height 
5) Low physical activity level: lowest gender-specific quintile of weighted score of 
kilocalories expended per week based on self-report 
This specification of frailty predicted mortality at three years with an adjusted hazard ratio (HR) 
of 2.24. Worsening activities of daily living disability and falls over three years could also be 
predicted with adjusted HR of 1.98 and 1.29 respectively (Fried et al., 2001). The frailty 
phenotype has subsequently been adapted to measure frailty in specific populations (Avila-
Funes et al., 2009; Avila-Funes et al., 2008; Graham et al., 2009; Woods et al., 2005; Xue et 
al., 2008a). In addition, it has also been modified while retaining the same phenotypic concept, 
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and then applied using the data of specific populations (Romero-Ortuno, 2013; Romero-Ortuno 
et al., 2010; Santos-Eggimann et al., 2009). A variant of the original definition used sarcopenia 
(low skeletal muscle mass) in place of hand grip strength (Cawthon et al., 2007). Yet another 
modification of the frailty phenotype developed by Buchman has four of the five components 
represented. It omitted physical activity and replaced weight loss with body mass index. Of 
note, this frailty specification retained the ability to predict death, dementia, and disability in the 
future (Boyle et al., 2010; Buchman et al., 2007; Buchman et al., 2011; Buchman et al., 2009). 
 
In the aforementioned working framework of the Canadian Initiative on Frailty and Aging, frailty 
is defined by seven components. Of these, five items are of the CHS frailty phenotype with 
cognitive decline and depressive symptoms as additional ones (Bergman et al., 2004). Of 
these, slow walking speed, low physical activity, weight loss, and cognitive impairment were 
individually associated with mortality, disability, and nursing home residence over the following 
7.5 years with HR ranging from 1.4 to 3.9 controlling for other frailty components (Rothman et 
al., 2008). 
 
As mentioned, the integral conceptual model of frailty builds on the Canadian framework and 
explicitly recognizes its multidimensional nature (Gobbens et al., 2012a). Here, frailty is defined 
by losses in one of more of the physical, psychological and social domains of functioning 
(Gobbens et al., 2010a). Based on this model, the Tilburg Frailty Indicator (TFI) comprising 15 
items representing the three domains was developed (Gobbens et al., 2010d). The TFI 
predicted disability, higher health care utilization including hospitalization and use of residential 
care facilities, as well as poorer quality of life at two years. Using Cohen’s f2 for continuous 
outcomes, all effect sizes were categorized as small to medium (f2 between 0.02 and 0.15) 
(Gobbens et al., 2012b).  
 
Next, the Frailty Index (FI) based on a deficit accumulation approach proposed by Rockwood is 
arguably the second most widely adopted concept for the measurement of frailty (Bouillon et 
al., 2013b; Rockwood & Mitnitski, 2007). The FI is constructed by taking a simple count of 
deficits, which are a collection of symptoms, signs, diseases, disabilities, or test abnormalities. 
The simple idea is that increasing number of deficits increased the likelihood of being frail. The 
FI is expressed as the ratio of actual deficits to total possible number of deficits, and is 
therefore a scalar measure from 0 to 1. Typically, at least 30 variables reflecting a wide range 
of deficits are used to construct the FI (Searle et al., 2008). Indicators used varied across 
studies. When FI was dichotomized to scores less than 0.25 (robust group) and scores equal to 
or higher than 0.25 (frail group), Kaplan-Meier 5-year survival curves indicated that probabilities 
of survival and institutional care avoidance were significantly higher for the robust group 
(Rockwood et al., 2007). The FI also identified frail people at risk of death and 
institutionalization over the following 10 years (Song et al., 2010). When the FI was based on 
elements of clinical examination that were part of a standard comprehensive geriatric 
assessment (CGA) of older people, it was designated as FI-CGA (Jones et al., 2005). Aside 
from this, the FI has been applied populations around the world using locally available data to 
37 
 
construct its required set of variables (Garcia-Gonzalez et al., 2009; Romero-Ortuno et al., 
2011; Woo et al., 2006; Yu et al., 2012). In fact, the anthropological approach to operationalize 
the FI by using deficits selected at the local level was advocated in contrast to prevailing efforts 
to obtain a standardized version to be applied across different populations (de Souto Barreto, 
2011). The FI has also been applied in specific settings such as primary health care (Drubbel et 
al., 2013). An interesting variant of the FI uses the deficit accumulation approach to define 
disability-free physical frailty phenotype (PFP), mental frailty phenotype (MFP), and social frailty 
phenotype (SFP). The combination of these three deficit-defined entities was able to predict 
mortality (Garre-Olmo et al., 2013). 
 
An emerging frailty identifier is the five-item FRAIL scale, which assesses fatigue, resistance, 
ambulation, illness, and loss of weight. (Abellan van Kan et al., 2010; Morley et al., 2012). This 
instrument relies solely on self-report. It was listed as one of a few suitable tools to screen for 
frailty at the recent landmark consensus meeting on frailty (Morley et al., 2013). 
 
Other frailty indicators described in the literature comprise an extremely lengthy list. In a review 
of the definition and measurement of the frailty concept, existing instruments were categorized 
as either multi-component or single component (Pel-Littel et al., 2009). It is worth highlighting 
that frailty instruments reviewed so far are multi-component with most being multidimensional 
as well. Others in this category but not mentioned yet include two related instruments, the 
Frailty Scale, which is based on the Geriatric Status Scale (GSS) that focused on several 
functional domains (Rockwood et al., 1999), and Canadian Study of Health and Aging (CSHA) 
Clinical Frailty Index, which is a seven-point scale based on activity and illness (Rockwood et 
al., 2005). Going further back in time, the Frailty Measure proposed by Strawbridge was the 
earliest of multidimensional instruments. It is a 16-item tool that defined frailty based on 
features in at least two out of four domains, which are physical function, nutritional status, 
cognition, and sensory function (Matthews et al., 2004; Strawbridge et al., 1998). The 
Groningen Frailty Indicator (GFI) identifies loss of function in four domains, namely physical, 
cognitive, social, and mental, using a total of 15 questions (Steverink, 2001). It feasibility, 
reliability, and validity were demonstrated (Peters et al., 2012). Others that make the list include 
the Edmonton Frail Scale (EFS), which samples 10 domains (cognition, balance and mobility, 
mood, functional independence, medication use, social support, nutrition, general health, 
continence, and burden of medical illness) (Rolfson et al., 2006), Study of Osteoporotic 
Fractures (SOF) frailty index, which consists of three items (weight loss, chair rise inability, and 
reduced energy) (Bilotta et al., 2012a; Bilotta et al., 2012b; Ensrud et al., 2008) , and 
Sherbrooke Postal Questionnaire (SPQ), which has six items that cover the physical, cognitive, 
and social domains (Hebert, 1996). As expected, these instruments have demonstrated similar 
ability to predict a range of adverse outcomes. 
 
Meanwhile, other multi-component instruments have continued to be developed and proposed 
for various settings. These include the Gerontopole Frailty Screening Tool (GFST) which is 
designed for general practitioners and consists of two sections. The first is an initial 
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questionnaire to detect symptoms and signs suggestive of frailty, whereas the second allows 
the practitioner to exercise clinical judgment on the presence or otherwise of frailty (Vellas et 
al., 2013). The Comprehensive Frailty Assessment Instrument (CFAI) is a self-reporting 
instrument that includes physical, psychological, social, and environmental domains (De Witte 
et al., 2013). The frailty identifier derived from data of the Beaver Dam Eye Study uses frailty 
markers that included walking time, handgrip strength, peak respiratory flow rate, ability to 
stand from a sitting position without using arms, and best corrected visual acuity (Klein et al., 
2003, 2005). The Conselice Study of Brain Aging Score (CSBAS) consists of seven variables 
was also used as a frailty measure (Lucicesare et al., 2010). The Identification of Seniors at 
Risk (ISAR) screening tool utilizes a comprehensive geriatric assessment based approach to 
define frailty and risk of adverse outcomes, albeit in older people after an Emergence 
Department (ED) visit (Salvi et al., 2012). Definition of frailty using four items based on 
information from the RAND-36/SF-36 tool was also proposed and used in a Finnish population 
of older men (Sirola et al., 2011). The combination of five frailty markers concerning physical 
activity, strength, cognition, energy, and mobility has been investigated (Au et al., 2011).  Frailty 
was also operationalized using four criteria, namely low body mass index (BMI), low physical 
activity level, and dissatisfaction with both muscle strength and endurance, which was based 
on self-report in a French population (Barreto et al., 2012). The "Kihon Checklist" and "Kaigo-
Yobo Checklist" were developed and validated for use in the Japanese population (Ogawa et 
al., 2011; Shinkai et al., 2010). The Elders Risk Assessment (ERS) index based on information 
gleaned from electronic medical records was developed to measure frailty and future risk of hip 
fracture (Albaba et al., 2012). The Evaluative Frailty Index for Physical Activity (EFIP) was 
based on deficit accumulation and designed to evaluate the effect of physical activity on frailty 
(de Vries et al., 2013). Weight loss and physical activity were proposed as effective criteria to 
identify frail older people (Chin et al., 2003). In a similar vein, two self-report measures on self-
perception of one`s health and whether health troubles prevent one from doing things were 
used to predict frailty (Gutman et al., 2001). The Short Physical Performance Battery (SPPB) is 
an assessment tool that evaluates physical performance and frailty (Berkova et al., 2013). The 
Vienna Frailty Questionnaire for Persons with Intellectual Disabilities (VFQ-ID) and its revised 
version (VFQ-ID-R) were developed specifically to assess frailty in persons with existing 
intellectual disabilities (Brehmer-Rinderer et al., 2013). 
 
The long list of single component instruments includes functional measures such as ADL and 
IADL scales (Chin et al., 1999; Weiner, 1992), individual tests of musculoskeletal function such 
as grip strength (Syddall et al., 2003), and 30-second chair stand test (Millor et al., 2013), 
mobility tests such as the walking speed (Abellan van Kan et al., 2009; Brown et al., 2000a; 
Chin et al., 1999) and Timed Up and Go (TUG) test (Savva et al., 2013), balance tests such as 
functional reach (Weiner, 1992) and Berg balance test (Brown et al., 2000a), and tests of 
cognitive function such as the Mini-Mental State Examination (MMSE) (Chin et al., 1999). The 
Adjusted Clinical Groups (ACG) frailty tag extracted from the ACG-diagnoses based 
computerized predictive model (ACG-DX-PM) suite for administrative data was able to identify 
older people who were frail (Sternberg et al., 2012). Generally, most single component 
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instruments are not likely to be suitable for the identification of frailty when used alone. 
Nevertheless, an interesting instrument that could show promise in predicting frailty is the 
Walking While Talking Test (WWT). This is a performed mobility stress test that utilizes dual-
tasking ability. Its predictive validity with respect to disability and death was demonstrated 
(Verghese et al., 2012). Another potentially promising tool for identifying frailty was gait 
variability. Walking stride time variability under fast walking conditions was prominently 
associated with frailty (Montero-Odasso et al., 2011). Further development of these two 
measures is awaited. 
 
Finally, other practice-based tools for identifying older people with frailty have been developed 
and reported. These include the EASY-Care Two-step Older Persons Screening (EASY-Care 
TOS) (van Kempen et al., 2013; van Kempen et al., 2014). The Clinical Global Impression of 
Change in Physical Frailty (CGIC-PF) instrument includes six intrinsic domains (mobility, 
balance, strength, endurance, nutrition, and neuromuscular performance) as well as seven 
consequence domains (medical complexity, healthcare utilization, appearance, self-perceived 
health, activities of daily living, emotional status, and social status). Each of these domains had 
two to four clinical indicators scored on a seven-point scale (Studenski et al., 2004). Although 
announced as having strong face validity, and being reliable and feasible, its subsequent 
application has been limited. 
 
Developers of individual instruments tend also to be their strongest proponents. Consequently, 
reasonably objective reviews are few and far between. In a systematic review that possibly 
possesses this attribute, the CHS frailty phenotype was acknowledged as having attracted the 
most attention from researchers, given the appeal of its physiological basis and semi-
quantifiable components. However, the intuitive feeling was that this definition does an 
incomplete job in describing frailty. The authors note that in response, more recent studies 
have added mood and cognition to augment the Fried components. They also offer their 
opinion that walking speed as a single item may in the future prove to be a feasible early 
identifier of frailty among non-disabled older people. Nevertheless, they conclude that the 
choice of instrument is best determined by the purpose at hand. For researchers who desire a 
biologically plausible model may want to consider the CHS frailty phenotype. Others such as 
policy makers and administrators whose focus is on planning health services may opt for the 
Frailty Index given that information on its deficit items may be extracted from administrative 
databases and clinical records (Sternberg et al., 2011). In another yet more recent systematic 
review of frailty assessment instruments, the authors recommend careful selection of 
instrument based on its intended purpose, domains captured, and past use (Buta et al., 2016). 
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2.5 Discussion 
 
From this literature review, I found a rewarding amount of evidence concerning individual 
conditions on pathways to frailty. These span the physical, psychological, and social domains, 
and include relevant medical illnesses and other life course determinants. However, I found 
less evidence concerning conditions on pathways from frailty to adverse outcomes.  Although 
several conditions were found to be associated with frailty in cross-sectional studies, the 
direction of these relationships are unclear, particularly when they are not also represented in 
longitudinal studies. To provide a summary of these factors, the working framework of the 
Canadian Initiative on Frailty and Aging (Bergman et al., 2004) provides an excellent template 
to position these individual pieces of evidence on in the attempt to construct the whole picture. 
Figure 2.4 illustrates how the available evidence from the literature review relates to this 
framework. 
 
 
 
Figure 2.4. Evidence on frailty pathways using the working framework of the Canadian 
Initiative on Frailty and Aging (Bergman et al., 2004) as the template 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(+) positive moderating effect 
(-) negative moderating effect 
 
Age 
Life course 
determinants: 
PHYSICAL: genetic 
factors, physical 
inactivity, 
over/underweight, 
Mediterranean diet, 
smoking, heavy 
drinking, sleep 
disturbances   
PSYCHOLOGICAL: 
impaired cognition, 
depression      
SOCIAL: living 
alone, low income, 
low education, poor 
social support, 
social isolation, 
socioeconomic 
adversity during 
childhood 
Adverse 
outcomes:     
death, 
institutionalization, 
disability, falls, 
poor quality of life, 
hospitalization 
 
FRAILTY  
Disease:    
chronic disease, 
health events 
Physiological 
dysregulation:         
allostatic load, 
systemic 
inflammation, 
hormonal 
abnormalities 
 
 
 
Multidimensional 
intervention programs (-) 
Exercise (-), nutritional 
supplementation (protein, 
amino acids) (-), 
overweight (-), low blood 
vitamin D level (+), 
impaired cognition (+) 
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It is important to note that age is designated as having effect on frailty and its adverse 
outcomes apart from or in combination with the other sets of conditions. It is also worth pointing 
out that the sequential relationship between life course determinants and both disease and 
physiological dysregulation may be more complex than represented in this graph. Life course 
determinants would have direct effects on frailty that are not mediated by the latter two 
conditions. Moreover, disease and physiological dysregulation may have a bidirectional 
relationship. 
 
Similarly, the graph implies that multidimensional interventional programs, exercise, nutritional 
supplementation, and other factors listed have moderating effects. However, it might be 
possible that these factors, particularly low blood vitamin D levels and impaired cognition may 
operate as mediators in the relationship between frailty and its adverse outcomes. 
Nevertheless, this simplified framework of evidence constitutes a reasonable foundation on to 
build more complex hypothesized pathways for frailty in further work.  
 
Continuing the focus on the relationship between frailty and its adverse outcomes, I note that 
the working framework of the Canadian Initiative on Frailty and Aging (Bergman et al., 2004) 
hypothesizes that biological, psychological, social, and societal conditions may have 
moderating effects on them. However, there is paucity of available evidence on these possible 
conditions from the literature review, particularly those in non-physical domains. Clearly, it is a 
subject that requires further investigation given the implications on the search for effective 
interventions and policies for frail older people. It would be important to investigate whether 
other medical-related conditions, depression, and social support have their effects on these 
pathways either as moderators, mediators, or both. The likelihood that frailty pathways may be 
more complex than is apparent on the surface could also explain in part the apparently 
contradictory findings that being overweight increases risk of incident frailty, but conversely 
reduces risk of some adverse outcomes among older people who are already frail. 
 
Moving on to frailty identifiers, the striking picture arising from the literature review is the 
plethora of instruments which have been developed, applied, and in some cases validated over 
time. It is also clear that there is significant overlap of the underlying constructs of many of 
them. For the purpose of selecting a suitable frailty specification for investigation of frailty 
pathways, the list of potential candidates will be shortened. 
 
The most important consideration is whether a suitable frailty specification should be limited to 
a single dimension such as the physical domain, or should include multiple dimensions such as 
also incorporating the psychological and social domains. The concept that frailty represents a 
multidimensional entity was first mooted by Strawbridge (Strawbridge et al., 1998). Since then, 
the definition of frailty has been dominated by the CHS frailty phenotype, which is limited to 
representing its physical domain, and the FI, which attempts to represent more than one 
domain. Further along the way, the multidimensional construct has been reemphasized by the 
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integral conceptual model of frailty, which makes reference to physical, psychological, and 
social frailty (Gobbens et al., 2010b), with these dimensions represented as items in the Tilburg 
Frailty Indicator (TFI) (Metzelthin, 2010). Moreover, the concept of frailty proposed in the 
working framework of the Canadian Initiative on Frailty and Aging encompasses the physical 
domain by including components of the CHS frailty phenotype, and the psychological domain 
by also incorporating cognitive impairment and depression to complete the set of candidate 
components (Bergman et al., 2004). Indeed, in the recent frailty consensus conference 
mentioned earlier, frailty was described as either physical, psychological, or a combination of 
the two components, at least in concept. However, the collective discourse proceeded to focus 
on physical frailty and screening for this entity with recommended instruments (Morley et al., 
2013). It is important to note that the purpose of that consensus conference was to propose 
ways of identifying frail older people and offer effective interventions to them. For that purpose, 
limiting the frailty concept to its physical dimension seems justified. This brings me back to the 
aforementioned assertion that different frailty instruments best serve different purposes (Martin 
& Brighton, 2008). In this spirit, I return to the purpose of selecting frailty identifiers for the 
investigation of frailty pathways that I had set out with. 
 
If the framework in Figure 2.4 is adopted as the conceptual model for investigating the 
relationship between frailty and the multiple multidimensional conditions, then it is clear that 
some key components of the multidimensional concept of frailty would be represented on 
pathways to frailty itself, and from frailty to its adverse outcomes. The theoretical argument on 
which conditions are predictors or effects, and which conditions should rightfully be considered 
integral components of the frailty construct is beyond the scope of this review. Rather, I will 
take the pragmatic view that key conditions which appear to operate as key predictors or 
effects with respect to frailty are best excluded from its definition when investigating frailty 
pathways. This will be the general approach adopted in formulating hypotheses on frailty 
pathways in this review and further research that follows. 
 
In doing so, it becomes immediately clear that the psychological and social domains are 
represented as predictors, effects, or both in the framework in Figure 2.4. Therefore, candidate 
specifications for the purpose of investigating frailty pathways will necessarily be those 
representing physical frailty. Among physical conditions found in this framework, physical 
inactivity and chronic disease are components of more prominent physical frailty identifiers 
such as the CHS frailty phenotype (Fried et al., 2001) and FRAIL tool (Abellan van Kan et al., 
2010) respectively. Two less prominent physical frailty identifiers manage to avoid this situation 
by not having either of these two conditions as their components. The first is the Buchman 
modification of the CHS frailty phenotype, which in omits the physical inactivity as a component 
(Buchman et al., 2009). The second is Study of Osteoporotic Fractures (SOF) frailty index, 
which has three components, namely weight loss, chair rise inability, and reduced energy 
(Ensrud et al., 2007). Of significance is the finding that the SOF had equivalent ability to predict 
adverse outcomes as the CHS frailty phenotype, at least in women (Ensrud et al., 2008). It 
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could be that these two frailty specifications are also suitable for investigation of frailty 
pathways hypothesized in Figure 2.4. 
 
An extreme interpretation of the adopted approach would be to consider physical frailty 
identifiers that are single component instruments. Grip strength (Syddall et al., 2003), walking 
speed (Abellan van Kan et al., 2009), Timed Up and Go (TUG) test (Savva et al., 2013), 
Walking While Talking Test (WWT) (Verghese et al., 2012), and walking stride time variability 
under fast walking conditions (Montero-Odasso et al., 2011) are some examples. Of these, only 
the first two have been more widely measured in research studies, thereby limiting the 
application of the last three instruments. Interestingly, walking speed was the strongest 
predictor of hospitalization among the five subcomponents of the CHS frailty phenotype while 
grip strength was not a significant predictor after adjusting for age, sex and other 
subcomponents in the Whitehall II study cohort (Bouillon et al., 2013c). However, it is quite 
likely that the combination of more than one subcomponent predicts adverse outcomes better 
than just a single subcomponent. Indeed, three to five components together predicted 
hospitalization much better than one or two components did, thereby confirming the existence 
of a dose-response relationship where their number is concerned in the same study (Bouillon et 
al., 2013c). This supports the idea that frailty identifiers with multiple components are likely to 
have stronger predictive validity than those with a single component. Moreover, those with 
multiple components have better face validity with respect to representing the frailty construct. 
 
Beyond their purpose and performance, it is important that frailty identifiers have strong 
theoretical justification. Notably, the concept of physical frailty is underpinned by the process of 
sarcopenia which is characterized by age-associated loss in skeletal muscle mass and function 
(Fielding et al., 2011). In fact, sarcopenia has been described as the biological substrate of 
physical frailty (Landi et al., 2015), thereby providing the latter with a strong conceptual basis. 
 
Given all these points, I argue that physical frailty is the most logical point at which to begin in 
specifying frailty for investigation of frailty pathways. The CHS frailty phenotype remains the 
preeminent prototype for physical frailty. For the reasons already stated, the component of low 
physical activity is best omitted. As mentioned, the Buchman modification of the frailty 
phenotype meets this requirement. Next, exhaustion may also be a symptom of depression. In 
fact, two out of eight items of the Center for Epidemiologic Studies Depression (CES-D) scale 
for depression were used to operationalize exhaustion for the development of frailty phenotype 
in the original study (Fried et al., 2001). Depression belongs to the psychological domain and 
may itself be a target for interventions to reduce frailty and its effects. If we also omit this 
component, then there are three remaining indicators for physical frailty, which are slow walking 
speed, reduced grip strength, and weight loss. On the other hand, if weight loss is omitted 
rather than exhaustion, then we obtain another physical frailty specification with three 
indicators. Thus far, there are no published reports on the validity of such specifications of 
frailty. In addition, the three-item SOF frailty index may also be a suitable alternative but a 
potential drawback is information needed on performance of chair rise, which may not be 
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available in secondary data sources. Ultimately, availability of data to create variables 
representing these components may be an important consideration in selection of candidate 
specifications of physical frailty. 
 
From this review, important gaps in the understanding of frailty specifications and pathways are 
uncovered. Firstly, the validity of frailty pathways in a comprehensive framework has not yet 
been investigated. As such, they remain at best plausible, and at worst, merely hypothetical. 
Moreover, simultaneous effects of conditions on these pathways have received less attention. 
In other words, the question arises as to whether these individual conditions would still exert 
significant effects when controlled for other conditions which exert parallel effects. In addition, 
inter-relationships between these conditions including moderated and mediated effects need to 
be identified and quantified to identify additional yet unrecognized effects, which may be as 
important as known main effects. Where possible, the direction of effect of associations with 
frailty from cross-sectional studies requires clarification. Finally, the feasibility and validity of 
candidate physical frailty specifications discussed are uncertain. Further study to address these 
knowledge gaps in the pursuit of understanding frailty pathways is clearly merited. 
 
The strengths of this review lie in its broad literature search and focus on synthesis of concepts, 
as well as its critical analysis. On the other hand, its main limitation is the lack of emphasis on 
the quality of available evidence, though this is justified given that providing critical review is the 
main objective here. Moreover, in view of the numerous relevant papers identified, detailed 
discussion of each predictor or instrument is not attempted. 
 
 
2.6 Conclusion 
 
Evidence from this literature review confirms that physical, psychological, and social conditions 
including those in the domains are represented on frailty pathways. They largely concern 
predictors of frailty, while there is less information on conditions that influence its impact on 
adverse outcomes. A few suitable candidate specifications of frailty are available for 
investigation of frailty pathways, but they may need to be modified for purpose. Further 
empirical work to evaluate the validity of frailty specifications and to estimate predictive, 
moderated, and mediated effects of multidimensional conditions on frailty pathways is 
warranted to gain better understanding of the development of frailty and its outcomes. 
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3 Research Outline 
 
3.1 Objectives 
 
The proposed research will address suitable physical frailty specifications for the investigation 
of frailty pathways. It will also examine pathways to frailty and to its adverse outcomes. 
 
Therefore, the specific research aims are: 
1) To evaluate physical frailty specifications with respect to their validity and relationship 
with psychological and social frailty 
2) To explore the validity of a framework of pathways to frailty and to its adverse 
outcomes by quantifying the relationship of physical frailty with physical, psychological, 
and social conditions on these pathways 
 
There are three key research questions which I will seek to answer. They are: 
1) Do physical frailty specifications based on three or four of the components of the CHS 
frailty phenotype have construct, concurrent, and predictive validity? 
2) What conditions are physical, psychological, and social predictors of physical frailty, 
and what are the moderators, and mediators of their effects in older people? 
3) What conditions are moderators and mediators of the effect of physical frailty on death 
and activity limitation in older people? 
 
I will adopt two conceptual models for this research. The first is the working framework of the 
Canadian Initiative on Frailty and Aging. It provides the basis for developing a set of 
hypothesized frailty pathways. The second is the integral conceptual model of frailty. This offers 
a useful way of thinking about the three dimensions of frailty; namely, physical, psychological, 
and social frailty. 
 
3.2 Methods 
 
The study design is secondary analysis of longitudinal survey data conducted in two stages. In 
the first stage, I will explore candidate physical frailty specifications deemed suitable for use in 
investigating frailty pathways. Their validity will be evaluated and compared. The desired end 
will be the selection of one or two physical frailty specifications from these candidates. In the 
second stage, I will use the selected physical frailty specification to investigate the relationship 
of physical frailty with multidimensional conditions on frailty pathways. In doing so, I will 
advance beyond mere prediction of physical frailty and its adverse outcomes to examine 
moderation and mediation of these effects. 
 
Thus, there are five sub-studies in my thesis. Their scope will be: 
1) Identification of candidate physical frailty specifications and evaluation of their construct 
and concurrent validity 
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2) Evaluation of predictive validity of candidate physical frailty specifications 
3) Examination of the effects of predictors of physical frailty including moderated and 
mediated effects using latent growth curve analysis 
4) Examination of the effect of physical frailty on death with focus on moderated and 
mediated effects using discrete time survival analysis 
5) Examination of the effect of physical frailty on activity limitation with focus on 
moderated and mediated effects using autoregressive cross-lagged analysis. 
The subjects for the last two sub-studies are chosen because of their relevance of longevity 
(lifespan) and healthy living (healthspan) of older people. 
 
I will use data from the English Longitudinal Study of Ageing (ELSA) to conduct these five sub-
studies. Before that, a description of the main features of ELSA, and discussion of its feasibility 
and limitations for the research purpose will be provided in the next section. 
 
3.3 Contribution 
 
This research will build on the existing knowledge base on predictors and effects of frailty in 
older people, and will expand on it in two key areas. In the first, suitable specifications of frailty 
for study of frailty pathways will be identified, and their feasibility and validity carefully 
examined. For the second, potentially modifiable conditions on hypothesized frailty pathways 
will be identified and the magnitude of their effects estimated. I expect that the findings will 
contribute to informing health and social policies on target conditions to focus on for population-
level strategies that address the prevention and management of frailty in older people. At the 
very least, they can serve as a springboard from which future research on frailty pathways may 
be conducted. 
 
3.4 Originality 
 
The research will critically review and further develop theoretical concepts related to frailty 
specification and pathways. The novelty of this work lies in its: 
1) specification of frailty in a form that permits its relationship with potentially remediable 
physical, psychological, and social conditions to be examined as distinct and separate 
elements on frailty pathways 
2) investigation of frailty in a single frailty framework, based on the working framework of 
the Canadian Initiative on Frailty and Aging, which integrates health and social 
conditions seamlessly, while considering their simultaneous effects  
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4 Data Feasibility 
 
4.1 Description of the English Longitudinal Study of Ageing 
 
The English Longitudinal Study of Ageing (ELSA) is sponsored by various government 
departments of the United Kingdom, and the National Institutes on Aging (NIA) of the United 
States of America. Data collection and processing is coordinated by University College London 
(UCL) Research Department of Epidemiology and Public Health, Institute for Fiscal Studies 
(IFS), National Centre for Social Research (NATCEN), and The University of Manchester, 
School of Social Sciences. 
 
ELSA was started in 2002 and is still ongoing. It is a panel study with successive biennial 
waves. The primary objective is to collect longitudinal data from a representative sample of the 
English population aged 50 years and older to observe change in their health, economic and 
social circumstances over time. Its primary aim is to provide high-quality multidisciplinary data 
that can inform on the causes and consequences of outcomes relevant to older people. A 
secondary aim is to assist in planning for an ageing population, while ensuring that the 
healthcare and pension systems will meet emerging needs. 
 
ELSA surveys residents of England aged 50 years and older who live in private residential 
addresses, thereby excluding those living in institutions and the homeless. Its sampling frame 
comprised adults aged 50 years and older who responded in 3 years of the Health Survey for 
England (HSE): 1998, 1999 and 2001. This sampling design had two phases. 
 
Phase One: The Health Survey for England (HSE) is a survey of people living in private 
households who are nationally representative in terms of their age, gender, geographic area 
and socio-demographic characteristics. Each year, a new random sample is selected using the 
Postcode Address File (PAF) as the sampling frame, and a two-stage stratified random 
sampling process (Taylor et al., 2007). 
 
1st stage: Random sample of primary sampling units (PSUs) based on postcode 
sectors, with probability proportional to total number of addresses within the PSU was 
carried out. Stratification was achieved through ordering of the PSUs as per local 
authority and percentage of households with a household head in a non-manual 
occupation, to facilitate representativeness by local health authority and socio-
economic group. Systematic sampling of the list at fixed intervals from a random 
starting point was performed. 
 
2nd stage: Simple random sampling of a fixed number of addresses from the PAF was 
drawn from each selected postcode. Eligible individuals from each household were 
invited to participate in HSE. The total number of households for HSE in these three 
survey years was 31,051. 
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Phase Two: The ELSA wave 1 (2002) sample was selected from the 31,051 households of the 
HSE sample based on the following eligibility criteria: 
1) households that responded to HSE 
2) households that included at least one individual born on or before 29 February 1952, 
who remained alive according to administrative records, and gave permission to be 
contacted in the future. 
The final number of households for ELSA was 11,578. These yielded 18,813 individuals, who 
also included cohabitating spouses or partners who were living within the household at the time 
of the HSE interview and born after 29 February 1952. 
 
The sample was refreshed at wave 3 (2006) with individuals aged 50 to 52 years on 1 March 
2006, and at wave 4 (2008) with those aged 50 to 74 years on 1 March 2008, using the same 
eligibility criteria as those for wave 1. 
 
There were two modes of data collection. The first mode is face-to-face Computer-Assisted 
Personal Interviewing (CAPI) plus a self-completion paper questionnaire for waves 1 to 7 
(2002, 2004, 2006, 2008, 2010, 2012, and 2014). The second mode is additional nurse visit 
and assessment only for waves 2 (2004), 4 (2008), and 6 (2012). Overall, the response rate at 
wave 2 for eligible core members (successfully interviewed in wave 1) was 82% (Scholes et al., 
2008). 
 
4.2 Data availability 
 
The key data elements required and available for this research can be categorized as follows: 
1) Demographic information: age, gender 
2) Physical frailty indicators: walking speed, hand grip strength, weight, report of 
exhaustion, and physical activity level 
3) Multidimensional conditions on frailty pathways: 
a. Physical: chronic disease (hypertension, angina, myocardial infarction, heart 
failure, arrhythmia, diabetes mellitus, stroke, asthma, arthritis, osteoporosis, 
cancer, Parkinson’s disease, psychiatric condition, and dementia), allostatic 
load (systolic blood pressure, diastolic blood pressure, blood total cholesterol-
HDL-cholesterol ratio, blood triglyceride level, blood C-reactive protein level, 
blood glycosylated hemoglobin level, blood fibrinogen level, waist-hip ratio, and 
peak flow rate), body mass index (BMI), smoking habit, alcohol consumption, 
and physical activity level 
b. Psychological: depressive symptoms (CES-D: Center for Epidemiologic 
Studies Depression Scale) (Radloff, 1977), and cognitive performance 
(memory and executive function tests) 
c. Social: educational attainment (qualifications), wealth (total non-pension 
wealth), social support indicators (children, other family member, and friends: 
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"criticizes the respondent", "lets the respondent down", "gets on the nerves of 
respondent", “understand the way you feel”, “can rely on if you had a serious 
problem”, “can open up to them if you need to talk”), and social integration 
indicators (living without spouse or partner, contact with children, other family 
members, and friends, membership of any organization, club, or society) 
4) Outcomes of physical frailty: death (year), activities of daily living, self-reported health, 
and quality of life (CASP: Control, Autonomy, Self-realization, and Pleasure measure) 
(Howel, 2012) 
 
Most of these data elements are available across waves 1, 2, 4, and 6. Notable exceptions are 
cognitive performance and waist-hip ratio (a component of allostatic load) at wave 6. In 
addition, death data is only available till February 2012, and so is incomplete for wave 6. Data 
on childhood event history is available in the Life History Interview conducted at wave 3, but are 
not considered, given that this information would not be available for wave 2 respondents who 
died or dropped out by then. Although available, genetic information is not the focus of the 
intended research. 
 
As expected with longitudinal data, missing values are encountered for all variables except for 
age, gender, and death. With successive waves, missing values due to loss to follow up and 
death increase. For the subset of respondents aged 65 to 89 years, these occur in up 10% for 
most variables, but up to approximately 50% for certain variables such those constituting 
allostatic load at wave 6. Methods for handling these missing values in a principled and explicit 
manner with appropriate assumptions will be employed. 
 
 
4.3 Summary 
 
Overall, data availability is adequate for the research. The major challenge is missing values for 
most variables sought, and this will necessitate appropriate handling. In addition, missing 
information on specific parameters, such as cognitive performance and waist-hip ratio at wave 
6, would need to be borne in mind when constructing variables for the statistical analyses. 
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Part Two 
 
Frailty Pathways:  Developing Suitable Frailty Specifications for Their Investigation 
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5 First Paper 
 
5.1 Introduction 
 
The need to develop a physical frailty specification for investigation of frailty pathways has 
already been alluded to. This section comprises two papers that address this task. 
 
To recap, the preceding literature review assembled evidence on a wide range of frailty 
instruments that have been developed to identify frailty in older people. It takes the view that 
different instruments are best suited for different purposes. Thus far, the issue of the suitable 
instruments for investigating frailty pathways has not received much attention in the literature. 
An argument is made to adopt a narrower concept of physical frailty when considering 
instruments for this purpose. This contrasts with prevailing efforts to conceptualize frailty as a 
broader concept that extends across physical, psychological, and social domains. The main 
reason is that some key components of the multidimensional concept of frailty would 
themselves be included on pathways to frailty and its adverse outcomes. This renders the 
investigation of the relationships of frailty with its potential predictors and effects even more 
challenging. Moreover, physical frailty is a concept that is underpinned by the biological 
process of sarcopenia, which is age-associated loss of skeletal muscle mass and function. 
When physical frailty is the adopted concept for frailty instruments for investigating frailty 
pathways, then the Cardiovascular Health Study (CHS) frailty phenotype (Fried et al., 2001) is 
an excellent choice among others to consider. Its conceptual framework is represented by the 
cycle of frailty (Xue et al., 2008a). Here, sarcopenia holds a key position in the sense that 
pathways emanating from it lead to slowness, weakness, and exhaustion which are positioned 
immediately downstream. In turn, these conditions eventually result in important health-related 
outcomes, such as falls, disability, and dependency. Indeed, sarcopenia has been summarily 
described as the biological substrate of physical frailty (Landi et al., 2015). 
 
For the CHS frailty phenotype, the component of physical inactivity is problematic as it is a key 
predictor of frailty that needs to be included on frailty pathways. The Buchman modification of 
the CHS frailty phenotype omits this component while retaining the other four. In addition, the 
component of exhaustion could also prove to be problematic. Besides having physical causes, 
it may also be a manifestation of depression, which lies in the psychological domain. 
Depression is a key condition on frailty pathways and has clear association with frailty, although 
the direction of the relationship is unclear (Collard & Oude Voshaar, 2012). Therefore, the 
decision to retain or omit this component from candidate physical frailty specifications needs to 
be carefully made. 
 
At this point, it is worthwhile reviewing other frailty instruments that focus on physical frailty 
alone, and which may also be reasonable alternatives to the CHS frailty phenotype. Besides 
the Buchman modification of the CHS frailty phenotype mentioned, three other instruments 
merit consideration. The first is the FRAIL tool, which consists of five self-reported items, 
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namely fatigue, resistance, ambulation, illnesses, and loss of weight. While physical inactivity 
is not included as an item, the presence of more than five chronic illnesses defines the item on 
“illnesses”. This presents a similar problem in that chronic illness is another key condition on 
frailty pathways, and its relationship with frailty needs to be evaluated. Indeed, the prevailing 
notion is that frailty is an entity that is distinct from chronic illness or comorbidity, although they 
overlap in concept (Fried et al., 2004). The second is the Study of Osteoporotic Fractures 
(SOF) frailty index, which has three components, namely weight loss, chair rise inability, and 
reduced energy (Bilotta et al., 2012b). The SOF frailty index predicts adverse outcomes such 
as falls, disability, hospitalization, and death with accuracy similar to that of the CHS frailty 
phenotype  (Bouillon et al., 2013b). Of concern, inability to rise from the chair may not be a 
common assessment item in longitudinal studies of ageing. The third is walking speed alone, 
which a good predictor of adverse outcomes (Abellan van Kan et al., 2009). It also performed 
best among the five components of the CHS frailty phenotype in predicting future 
hospitalizations (Bouillon et al., 2013c). However, it suffers from being a single item and 
arguably does not capture the wider concept of even just physical frailty. Thus, its face validity 
with respect to reflecting the concept of physical frailty is compromised. Given these issues, the 
three alternative frailty instruments are probably not as suitable as three or four items of the 
original CHS frailty phenotype for investigating frailty pathways. 
 
Returning to the CHS frailty phenotype, a candidate physical frailty specification comprising 
four indicators, which are slowness, weakness, exhaustion, and weight loss is obtained when 
only physical inactivity is omitted. As mentioned, this specification parallels the Buchman 
modification of the CHS frailty phenotype. If weight loss is additionally dropped, then a 
specification with three items comprising slowness, weakness, and exhaustion is obtained. On 
the other hand, if exhaustion is dropped instead due to concerns on its relationship with 
depression, then an alternative specification with three items comprising slowness, weakness, 
and weight loss is obtained. At this point, these three physical frailty specifications appear to be 
equally promising, and will be have their validity evaluated. For the validation process, I will 
adopt a previously proposed approach to defining frailty (Rockwood, 2005). 
 
Before that, I will consider the face validity of these candidate specifications. The picture of an 
older person walking slowly, having decreased strength, being easily fatigued, and having 
unintentional loss of weight reflects what is commonly understood of as frailty among health 
care professionals and researchers. Secondly, content validity is arguably almost assured since 
the four indicators of candidate specifications are drawn from the five components of the CHS 
frailty phenotype. Moreover, these indicators parallel some of the components of other physical 
frailty instruments, namely FRAIL tool and SOF frailty index. Indeed, weakness, exhaustion, 
and weight loss are included as indictors across these three frailty instruments, whereas 
slowness is included by two of them. 
 
A version of the following paper is published in the journal, AGE (Ding, 2016). Here, I evaluate 
construct validity, which comprises convergent and discriminant validity, as well as concurrent 
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validity, which is an important aspect of criterion validity. Some of the foregoing key points are 
unavoidably repeated as this is a self-contained journal article. References are in a separate list 
just before the Supplementary Materials (page 71). 
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5.2 Developing Physical Frailty Specifications for Investigation of Frailty Pathways 
in Older People 
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Abstract 
 
Different frailty definitions are suitable for different purposes. When investigating its key 
multidimensional predictors and effects, narrower definitions of frailty that exclude these 
elements may be more desirable. For this purpose, candidate physical frailty specifications are 
developed, and then evaluated on their construct and concurrent validity. For 4638 participants 
aged 65 to 89 years from wave 2 (2004) of the English Longitudinal Study of Ageing, 
confirmatory factor analysis is performed to create physical frailty specifications with four 
indicators (slowness, weakness, exhaustion, and weight loss) and with three indicators 
(slowness, weakness, and either exhaustion or weight loss). Using derived factor scores, their 
convergent, discriminant, and concurrent validity are compared. For specifications with four 
indicators and with three indicators including exhaustion, slowness contributes dominantly to 
the physical frailty factor. However, with three indicators including weight loss, weakness 
contributes most. Where represented, weight loss only contributes minimally. Higher factor 
scores are significantly associated with chronic diseases, functional impairment, and 
poor self-rated health, although less so for the third specification. Factor scores for the first two 
specifications have low correlation with psychological and social frailty while those for the third 
have negligible correlation. Factor scores increase with higher Frailty Index, although again 
less so for the third specification. Minor differences are seen across gender. On account of their 
convergent, discriminatory, and concurrent validity, physical frailty specifications with four 
indicators and with three indicators including exhaustion hold promise for use in investigation of 
frailty pathways involving multidimensional predictors and effects. 
 
 
 
Keywords 
Frailty, specification, aged, frailty pathways, validity
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Introduction 
 
Frailty is widely regarded as the multidimensional loss of an individual’s reserves that results in 
vulnerability to developing adverse health-related outcomes (Espinoza & Walston, 2005; Lally & 
Crome, 2007; Pel-Littel et al., 2009). It is conceptualized as the transitional state between 
robustness and functional decline (Lang et al., 2009). The estimated prevalence of frailty is 
about 10% among people aged 65 years living in the community (Collard et al., 2012). Beyond 
mere numbers of affected people in any population, frailty is unfortunately associated with 
increased risk of death, disability, falls, hospitalization, and institutionalization (Daniels et al., 
2008; Ensrud et al., 2009; Ensrud et al., 2008; Jones et al., 2005; Kiely et al., 2009; Pilotto et 
al., 2012; Woo et al., 2012). Consequently, frailty plays a central role in determining the well-
being of older people, and has major public health importance (Woo et al., 2006). 
 
Over the past decade, the wide array of frailty instruments available (Pialoux et al., 2012) 
attests to the absence of a universally accepted concept. Nevertheless, recent efforts to forge 
consensus among international experts have achieved some degree of agreement on suitable 
instruments for the recognition of frailty in older persons (Morley et al., 2013). These 
instruments reflect different albeit overlapping concepts. Among them, two have gained greater 
prominence. The Cardiovascular Health Study (CHS) frailty phenotype is probably the most 
widely adopted. It conceptualizes frailty as a geriatric syndrome resulting from decline in 
multiple physiologic systems, and is operationalized by requiring presence of at least three of 
its five components: shrinking (unintentional weight loss), weakness (low hand grip strength), 
poor endurance and energy (self-reported exhaustion), slowness (slow walking speed), and low 
physical activity level (based on self-report) (Fried et al., 2001). The Frailty Index (FI) is 
possibly the second most widely applied instrument, and is based on a deficit accumulation 
approach (Rockwood & Mitnitski, 2007; Rockwood et al., 2004). A count is taken of deficits, 
which are a collection of symptoms, signs, diseases, disabilities, or test abnormalities. Selected 
deficits should be associated with poorer health status, should increase with age, but not 
saturate too early, must as a group cover a range of systems, and must be the same for a 
group of people followed serially (Searle et al., 2008). An increasing number of deficits raise the 
likelihood of being frail. It is expressed as the ratio of actual number of deficits to total possible 
number of deficits, and is therefore a scalar measure ranging from 0 to 1. Besides these two 
instruments, the FRAIL tool was developed to identify older persons who are at risk for frailty. It 
consists of five self-reported items, which are fatigue, resistance, ambulation, illnesses, and 
loss of weight. Presence of three or more items defines frailty (Abellan van Kan et al., 2008; 
Morley et al., 2013). In addition, the Tilburg Frailty Indicator (TFI) is based on an integral 
conceptual model of frailty, which explicitly recognizes its multidimensional nature by defining 
losses in one of more of physical, psychological, and social functioning domains through its 15 
items (Gobbens et al., 2010a). It is scored from 0 to 15, with higher scores representing higher 
levels of frailty (Gobbens et al., 2010b). While CHS frailty phenotype and FRAIL focus on the 
physical domain, FI and TFI attempt to measure frailty across more than a single domain. 
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Not surprisingly, all these four instruments predict future adverse outcomes in older people 
reasonably well (Abellan van Kan et al., 2008; Fried et al., 2001; Gobbens et al., 2012; 
Rockwood et al., 2007). Moreover, where head-to-head comparisons are available, their 
predictive performance were shown to be approximately equivalent (Ravindrarajah et al., 2013; 
Woo et al., 2012). Past debate on which instrument is best among them appears to have run 
out its course over recent years and may now be less relevant in moving frailty research and 
public policy agendas forward. Rather, there is a growing sense that different instruments are 
best suited for different purposes (Cesari et al., 2014; Martin & Brighton, 2008). 
 
Mapping of different frailty instruments to specific roles such as clinical screening, population 
studies, and biomedical research has been proposed (Bouillon et al., 2013; Cesari et al., 2014; 
Morley et al., 2013). However, less work has been done in developing suitable specifications 
for investigating frailty pathways, which represent relationships between frailty and its 
multidimensional predictors and effects. The working framework proposed by the Canadian 
Initiative on Frailty and Aging Frailty provides an excellent reference for this endeavor, and is 
illustrated in Figure 1.  
 
 
Figure 1. Working framework proposed by the Canadian Initiative on Frailty and Aging 
Frailty (adapted from Bergman, 2004 with modifications)  
 
 
 
 
It conceptualizes frailty as having seven components including five items of the Frailty 
Phenotype and two additional items, namely depression and impaired cognition (Bergman et 
al., 2004). However, both depression and impaired cognition are psychological factors that 
could very well be represented as predictors and effects of frailty on its pathways. Having these 
as components of the frailty specification and at the same time as predictors or effects renders 
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the task of teasing out their relationship with frailty very challenging. More recently, the integral 
concept of frailty proposed by Gobbens was built on the Canadian framework. Here, frailty is 
explicitly specified as having separate physical, psychological, and social domains (Gobbens et 
al., 2010a). Doing so allows physical frailty to be disaggregated from the other two frailty 
domains, and in turn facilitates less constrained exploration of the relationship of frailty with its 
multidimensional predictors and effects. The adoption of this latter approach holds promise for 
developing frailty specifications that can be usefully applied when investigating relationships on 
these frailty pathways. 
 
In developing candidate physical frailty specifications for investigating frailty pathways, the CHS 
frailty phenotype provides a good starting point particularly as it is widely considered the 
prototype for physical frailty. Its conceptual framework is represented by the cycle of frailty in 
which its five components are positioned in a set of pathways (Xue et al., 2008) as illustrated in 
Figure 2.  
 
 
Figure 2. Modified representation of the cycle of frailty (adapted from Xue 2008) 
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In this framework, sarcopenia holds a key position in the cycle of frailty in the sense that it is on 
the main pathway loop that includes weight loss, decreased total energy expenditure, and 
chronic undernutrition. Moreover, pathways emanating from it eventually lead to important 
health-related endpoints, namely impaired balance, falls and injuries, immobilization, disability, 
and dependency. In these pathways to adverse outcomes, weakness and exhaustion are 
positioned immediately downstream to sarcopenia and slowness immediately follows 
weakness. Given this framework, it may be argued that among the five components of the CHS 
frailty phenotype, the cluster of exhaustion, weakness, and slowness appears central to the 
physical frailty concept and closest in proximity to its adverse outcomes. In addition, two of 
these five components pose interesting challenges. Firstly, low physical activity is considered a 
predictor of frailty while its counter, exercise is a modifier of frailty’s effect (Daniels et al., 2008; 
Strawbridge et al., 1998). On this account, it might be best excluded from the set of physical 
frailty indicators. Indeed, Buchman used the remaining four items to construct a composite 
measure of physical frailty albeit using body mass index instead of weight loss (Buchman et al., 
2009). Secondly, exhaustion may at times be a manifestation of depression in older people. In 
fact, two out of eight items of the Center for Epidemiologic Studies Depression (CES-D) scale 
were used to operationalize the component of exhaustion in the original study on the CHS 
frailty phenotype (Fried et al., 2001). Moreover, depression resides within the psychological 
dimension, and could itself be a potential target for interventions to reduce frailty and its effects. 
However, given that exhaustion is more typically related to physical conditions, it is unclear 
whether dropping it from the set of frailty indicators is necessary. With these points in mind, 
candidate physical frailty specifications based on the CHS frailty phenotype could omit physical 
inactivity and possibly exhaustion, thereby retaining three or four of the five original indicators. 
 
Over this backdrop, the aims of this study are twofold. The first is to develop physical frailty 
specifications that are suitable for investigation of frailty pathways. These will be based on 
three or four components of the CHS frailty phenotype. The second is to evaluate and compare 
candidate specifications on their convergent, discriminant, and concurrent validity. The ultimate 
purpose is to obtain a frailty specification that can be used to quantify the relationships of frailty 
with its multidimensional predictors and effects. Ultimately, knowledge on these elements can 
inform broad strategies employing population-level interventions that seek to reduce frailty and 
its adverse effects in older people.
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Methods 
 
Data 
 
Panel data from wave 2 (2004) of the English Longitudinal Study of Ageing (ELSA) (Marmot et 
al., 2015) provides the requisite information. This is longitudinal survey of a representative 
sample of the English population aged 50 years and older living in their homes at baseline 
(Steptoe et al., 2013a). ELSA respondents aged 65 to 89 years at wave 2 are included. Those 
aged 90 years and older have their age merely coded as “90”, and are thus excluded. All 
participants gave informed consent. Ethical approval for ELSA was granted by the Multicenter 
Research and Ethics Committee. Ethical oversight for this study is provided by procedures of 
the London School of Economics Ethics Policy. 
 
Measures 
 
Indicators for physical frailty are based on four components of the CHS frailty phenotype (Fried 
et al., 2001). Slowness is the average gait speed (in m/s) of two attempts at walking a distance 
of 2.4 m multiplied by -1. Weakness is the dominant hand grip strength in kg, which is multiplied 
by 1.5 for women. The difference in expectation of grip strength mirrors population-independent 
cut-off values proposed for the CHS frailty phenotype criteria (Saum et al., 2012). After that, 
values are reversed through multiplying them by -1. Weight loss is a binary variable for 
decrease in weight of more than 5 kg from wave 0 to 2. Weight at wave 0 is used as the 
reference because this was not measured at wave 1. Exhaustion is also a binary variable 
based on a positive reply to either or both of two items of the CES-D scale on whether the 
respondent “felt everything they did during the past week was an effort” and “could not get 
going much of the time in the past week” (Radloff, 1977). 
 
Using three permutations of these indicators, candidate physical frailty specifications are 
developed. The first specification has all four indicators namely slowness, weakness, 
exhaustion, and weight loss. Using latent class analysis of the CHS frailty phenotype, estimated 
probabilities of individual components for frail and non-frail states suggests that slowness and 
weakness discriminated best between them (Bandeen-Roche et al., 2006). Thus, these two 
indicators are retained for remaining specifications. The second specification drops weight loss 
leaving the other three indicators. For the third, exhaustion instead of weight loss is dropped in 
view of the potential concerns already alluded to. 
 
For psychological frailty, three indicators adapted from the TFI are constructed. Firstly, impaired 
cognition is based on total cognitive index, which combines test scores for memory, and 
executive function, which are recoded (0 to 49) so that higher scores indicate poorer function. 
Secondly, depressive symptoms are measured by number of positive items in the CES-D scale. 
Given that the physical frailty indicator of exhaustion is based on two of its eight items, only the 
remaining six are used. Thirdly, low resilience is measured in relation to three facets of 
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adversity previously proposed (Demakakos et al., 2008). Objective financial adversity is defined 
as being in the lowest quintile of total non-pension wealth. Self-perceived financial adversity is 
the report of sometimes or more often having too little money to spend on needs. Widowhood is 
the change of marital status from being married or single in wave 1 to being widowed in wave 
2. The criterion for establishing resilience under these three facets of adversity is a CES-D 
score of three or less. Each facet is scored in an ordinal manner with “-1” if both adversity and 
resilience criteria are satisfied, “1” if only the criterion for adversity is satisfied, and “0” if only 
the criterion for resilience is satisfied or if neither criterion is satisfied. Summing up those for the 
three facets, a total score ranging from -3 to 3 is obtained where higher scores indicate lower 
resilience. 
 
For social frailty, three indicators adapted from the TFI and based on previous work on social 
isolation (Steptoe et al., 2013b) are constructed. Firstly, loneliness is measures by the Revised 
UCLA Loneliness Score, which comprises three items and scored from 3 to 9 (Hughes et al., 
2004). Secondly, poor social integration is a combination of 5 items (scored 0 to 14) on whether 
participants have no spouse and partner living with them, had little contact with children, had 
little contact with other family members, had little contact with friends, and were not a member 
of any organization, club or society. Little contact was defined as less than monthly contact by 
meeting, phoning, or writing or email. Thirdly, poor social support is the combined scores on 
three items (score 0 to 54) on whether there is lack positive support, and occurrence of 
negative support. Lack of positive support is measured by negative answers to questions on 
“understand the way you feel”, “can rely on if you had a serious problem”, and “can open up to 
them if you need to talk” with respect to children, other family members, and friends.  Negative 
support is measured by positive answers to questions on whether children, other family 
members, and friends "criticizes the respondent", "lets the respondent down", and "gets on the 
nerves of respondent". 
 
The FI (Rockwood & Mitnitski, 2007; Rockwood et al., 2004) is computed as the number of 
positive items out of 30 illnesses and functional impairments divided by 30, thereby deriving a 
scalar value of 0 to 1 (Searle et al., 2008). In line with previously proposed cut-off values, 
people with FI of 0.08 or less are categorized as not frail, those with FI of 0.25 or more are frail, 
while the remaining are pre-frail (Song et al., 2010). 
  
Statistical Analyses 
 
Confirmatory factor analysis (CFA) is performed in turn for the three candidate physical frailty 
specifications. Unique factor scores for each participant are obtained for each specification. 
CFA is then repeated for subgroups defined by gender. Construct validity is assessed by 
considering convergent and discriminant validity. For convergent validity, functional impairment 
(number of basic activities of daily living (BADL) and instrumental activities of daily living (IADL) 
performed with difficulty), comorbidity (number of chronic illnesses), and poor self-rated health 
are regressed in turn on physical frailty factor scores (Rockwood, 2005). Coefficients of the 
62 
 
latter adjusting for age are obtained. For discriminant validity, Pearson's coefficient is used to 
quantify the correlation of physical frailty factor scores with those of psychological and social 
frailty factors. Factor scores for the latter two were also derived from CFA using their respective 
indicators. Pearson's coefficient higher than 0.90 indicates very high correlation, 0.71 to 0.90 
indicates high correlation, 0.51 to 0.70 indicates moderate correlation, 0.31 to 0.50 indicates 
low correlation, and 0.30 indicates negligible correlation (Hinkle, 2003). To assess concurrent 
validity, FI is regressed on physical frailty factor scores and their coefficients adjusting for age 
are examined. For all validity checks, analyses are performed for the whole group and then in 
subgroups defined by gender. 
 
CFA is performed with Mplus version 7.4 (Muthén & Muthén, 1998-2012) using maximum 
likelihood estimation with robust standard errors (MLR), which handles missing values by 
implementing full information maximum likelihood (FIML). MLR is selected over WLSMV 
(weighted least squares with mean- and variance-adjustment) because of better handling of 
missing values. For other regression analyses, missing values are handled by multiple 
imputation using chained equations to generate 20 sets. In using FIML and multiple imputation, 
the assumption of missing at random (MAR) is held. All other data analyses are performed with 
Stata version 13.1. Statistical significance is taken at p-value of less than 0.05.  
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Results 
 
Data of 4,638 people (2,070 male and 2,568 female) aged from 65 to 89 years are analyzed. 
Their characteristics are summarized in Table 1. They have on average two chronic illnesses. 
More than one a quarter of them has some degree of functional impairment measured by basic 
activities of daily living. As expected, physical performance measured by walking speed and 
hand grip strength is worse among female participants. Frailty measured by both modified CHS 
frailty phenotype and Frailty Index is more common among them too. Thus, a significant 
proportion of participants have health issues and functional limitations. Among psychological 
measures, female participants display less resilience. Somewhat surprisingly, there were only 
minimal differences in social measures across gender. 
 
 
Table 1. Characteristics of English Longitudinal Study of Ageing (ELSA) wave 2 
respondents aged 65 to 89 years included for analyses  
 
Variables All By gender 
Male Female 
General: 
Mean age, years (SD) 
Female, n/N (%) 
Mean chronic disease count (SD)               
Number of basic activities of daily 
living (BADL) items with difficulty,  
n (%) 
- 0 
- 1 or 2 
- 3 or 4 
- 5 or 6 
Number of instrumental activities of 
daily living (IADL) items with 
difficulty, n/N (%) 
- 0 
- 1 or 2 
- 3 or 4 
- 5 or 6 or 7 
Self-rated health, n/N (%) 
- excellent or very good 
- good 
- fair or poor 
 
74.0 (6.3) 
2,568/4,638 (55.4) 
1.9 (1.4)1 
 
 
 
3,389/4,635 (73.1) 
948/4,635 (20.5) 
220/4,635 (4.8) 
78/4,635 (1.7) 
 
 
 
3,308/4,635 (71.4) 
991/4,635 (21.4) 
236/4,635 (5.1) 
100/4,635 (2.2) 
 
1,554/4565 (34.0) 
1,528/4,565 (33.5) 
1,483/4,565 (32.5) 
 
73.5 (6.2) 
- 
1.8 (1.4)2 
 
 
 
1,560/2,070 (75.4) 
389/2070 (18.8) 
95/2,070 (4.6) 
26/2,070 (1.3) 
 
 
 
1,593/2,070 (77.0) 
358/2,070 (17.3) 
77/2,070 (3.7) 
42/2,070 (2.0) 
 
674/2,029 (33.2) 
686/2,029 (33.8) 
669/2,029 (33.0) 
 
74.3 (6.4) 
- 
2.0 (1.4)3 
 
 
 
1,829/2,565 (71.3) 
559/2,565 (21.8) 
125/2,565 (4.9) 
52/2,565 (2.0)  
 
 
 
1,715/2,565 (66.9) 
633/2,565 (24.7) 
159/2,565 (6.2) 
58/2,565 (2.3) 
 
880/2,536 (34.7) 
842/2,536 (33.2) 
814/2,536 (32.1) 
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Physical: 
Mean average walking speed,  
m/sec (SD) 
Hand grip strength (dominant hand), 
kg (SD) 
Exhaustion, n/N (%) 
Weight loss >5 kg from waves 0 to 
2, n/N (%) 
Frailty status by modified CHS frailty 
phenotype, n/N (%) 
- Not frail 
- Pre-frail 
- Frail 
Frailty status by Frailty Index a,  
n/N (%) 
- Not frail 
- Pre-frail 
- Frail 
 
 
0.82 (0.28)4 
 
25.9 (10.2)7 
1,490/4,510 (33.0) 
 
587/3,590 (16.4) 
 
 
866/3,242 (26.7)  
1,758/3,242 (54.2)  
618/3,242 (19.1)  
 
 
1,444/3,647 (39.6) 
1,486/3,647 (40.8) 
717/3,647 (20.7) 
 
 
0.86 (0.27)5 
 
33.4 (8.9)8 
568/1,997 (33.0) 
 
255/1,608 (15.9) 
 
 
485/1,462 (33.2) 
775/1,462 (53.0) 
202/1,462 (13.8) 
 
 
774/1,639 (47.2) 
629/1,639 (38.4) 
236/1,639 (24.4) 
 
 
0.78 (0.28)6 
 
19.6 (6.1)9 
992/2,5103(33.0) 
 
332/1,982 (16.8) 
 
 
381/1,780 (21.4) 
983/1,780 (55.2) 
416/1,780 (33.4) 
 
 
670/2,008 (33.4) 
857/2,008 (42.7) 
481/2,008 (33.9) 
Psychological: 
Mean cognitive impairment score 
(SD)   
Mean CESD-8 c score (SD) 
Mean low resilience score d (SD) 
 
 
18.9 (6.5)10 
1.7 (2.0)13 
0.20 (0.83)16 
 
 
19.3 (6.4)11 
1.3 (1.7)14 
0.13 (0.80)17 
 
 
18.5 (6.5)12 
1.9 (2.1)15 
0.26 (0.84)18 
Social: 
Loneliness score e (SD) 
Mean poor social support score f 
(SD) 
Mean poor social integration score g 
(SD) 
 
4.2 (1.5)19 
 
13.7 (7.0)22 
 
6.6 (2.5)25 
 
4.0 (1.4)20 
 
14.7 (7.0)23  
 
6.7 (2.6)26 
 
4.3 (1.6)21 
 
12.9 (6.8)24 
 
6.5 (2.5)27 
Outcome: 
Two-year mortality, n/N (%) 
 
278/4,638 (6.0) 
 
147/2,070 (7.1) 
 
131/2,568 (5.1) 
 
a Frailty Index: 30 items (score 0 to 1) 
b Cognitive impairment score: score 0 to 49 
c CESD-8: Center for Epidemiologic Studies Depression Scale - 8 items (score 0 to8) 
d Low resilience score: 3 items (score 3 to 12) 
e Loneliness score: Revised UCLA Loneliness Score - 3 items (score 3 to 9) 
f Low social support score: 18 items (score 0 to 54) 
g Poor social integration score: 6 items (score 0 to 15) 
Unless indicated otherwise, N = 4,638 for all, 2,070 for male, and 2,568 for female.  
N = 14,608 22,052 32,556 44,092 51,826 62,266 73,869 81,760 92,109 104,348 111,945 122,403 134,479 141,987 
152,492 163,854 171,946 182,460 193,854 201,746 212,106 223,339 231,529 241,810 253,267 261,506 271,761 
 
 
Table 2 summarizes the results of CFA for the three physical frailty specifications. For four 
indicators, slowness contributes most to the physical frailty factor whereas weakness and 
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exhaustion do so to a lesser extent. Weight loss contributes much less. Similarly, for three 
indicators including exhaustion, slowness contributes more than weakness and exhaustion do. 
On the other hand, for three indicators including weight loss, weakness contributes most with 
slowness doing so less. Here again, weight loss contributes minimally. These patterns are 
generally consistent across gender with only minor differences seen. 
 
 
Table 2. Measurement model for three specifications of physical frailty using 
confirmatory factor analysis (CFA) with full information maximum likelihood (FIML)  
 
 
Physical frailty specification 
 
Standardized coefficient (standard error) 
All By gender 
Male Female 
Four indicators: 
   Slowness a 
   Weakness b 
   Exhaustion c 
   Weight loss d 
 
0.76 (0.03) 
0.54 (0.02) 
0.55 (0.02) 
0.28 (0.03) 
 
0.73 (0.05) 
0.47 (0.04) 
0.56 (0.04) 
0.24 (0.06) 
 
0.77 (0.03) 
0.56 (0.03) 
0.54 (0.03) 
0.31 (0.04) 
Three indicators including 
exhaustion: 
   Slowness a 
   Weakness b 
   Exhaustion c 
 
 
0.78 (0.03) 
0.52 (0.02) 
0.54 (0.03) 
 
 
0.79 (0.05) 
0.43 (0.04) 
0.53 (0.04) 
 
 
0.78 (0.04) 
0.55 (0.03) 
0.54 (0.03) 
Three indicators including 
weight loss:   
   Slowness a 
   Weakness b 
   Weight loss d 
 
 
0.60 (0.05) 
0.68 (0.05) 
0.30 (0.03) 
 
 
0.45 (0.08) 
0.76 (0.13) 
0.26 (0.06) 
 
 
0.68 (0.06) 
0.63 (0.06) 
0.33 (0.04) 
 
p-values are <0.05 for all coefficients 
a Slowness: mean gait speed multiplied by a factor of -1 
b Weakness: dominant hand grip strength multiplied by a factor of -1 (males) or -1.5 (females) 
c Exhaustion: positive response to either or both of two items of CES-D scale on “could not get going 
much of the time in the past week” and “felt everything they did during the past week was an effort” 
d Weight loss: decrease in weight of more than 5 kg from wave 0 to wave 2 
N = 4,547 (all) 2,019 (male) 2,528 (female) for first two specifications; N=4,440 (all) 1,985 (male) 2,455 
(female) for the third specification 
 
 
Factor loading patterns reflect stronger correlation among slowness, weakness, and 
exhaustion, compared with their correlation with weight loss. These differences are supported 
by tetrachoric correlation coefficients of weight loss with the other three indicators (0.16 to 0.19) 
being much lower than those between the other three (0.29 to 0.43) for the whole group as 
shown in Table 6 of the Supplementary Materials. Histograms showing approximately normal 
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distribution of derived factor scores for the three physical frailty specifications are provided in 
Figure 3 of the Supplementary Materials. 
 
In terms of convergent validity, Table 3 shows that for one standard deviation (SD) increase in 
the physical frailty factor score, the number of chronic diseases increases by 0.28 to 0.35 
across specifications and gender after adjusting for age. Similarly, for one SD increase in 
physical frailty factor score, the combined number of items of BADL and IADL performed with 
difficulty increases by 0.36 to 0.51. Finally, for one SD increase in physical frailty factor score, 
the number of categories of poor self-rated health increase by 0.38 to 0.54.  
 
 
Table 3. Linear regression of chronic disease, functional status, and self-rated health on 
factor scores for three physical frailty specifications adjusted for age: standardized 
coefficients (95% confidence interval)  
 
 All By gender 
Male Female 
Number of chronic diseases: 
4 indicators 0.35 (0.32 to 0.38) a  0.34 (0.29 to 0.38) 0.34 (0.30 to 0.39) 
3 indicators (including exhaustion) 0.34 (0.31 to 0.37) b 0.33 (0.29 to 0.38) 0.34 (0.30 to 0.38) 
3 indicators (including weight loss) 0.30 (0.27 to 0.33) c 0.28 (0.23 to 0.33) 0.29 (0.25 to 0.34) 
Number of basic and instrumental activities of daily living items performed with difficulty: 
4 indicators 0.49 (0.46 to 0.52) d 0.46 (0.42 to 0.50) 0.51 (0.47 to 0.55) 
3 indicators (including exhaustion) 0.48 (0.46 to 0.51) e 0.45 (0.41 to 0.50) 0.50 (0.46 to 0.54) 
3 indicators (including weight loss) 0.39 (0.36 to 0.43) f 0.36 (0.31 to 0.41) 0.41 (0.37 to 0.45) 
Categories of poor self-rated health: 
4 indicators 0.51 (0.48 to 0.53) g 0.48 (0.43 to 0.52) 0.54 (0.51 to 0.58) 
3 indicators (including exhaustion) 0.50 (0.47 to 0.53) h 0.47 (0.43 to 0.51) 0.53 (0.50 to 0.57) 
3 indicators (including weight loss) 0.40 (0.37 to 0.43) i 0.38 (0.33 to 0.43) 0.44 (0.40 to 0.48) 
 
P-values are <0.05 for all coefficients. 
a AIC/BIC = 15,902/15,922 r2 = 0.12; b AIC/BIC = 15,917/15,935 r2 = 0.12; c AIC/BIC = 16,071/16,090 r2 = 
0.09; d AIC/BIC = 18,572/18,591 r2 = 0.25; e AIC/BIC = 18,600/18,620 r2 = 0.25; f AIC/BIC = 19,048/19,067 
r2 = 0.17; g AIC/BIC = 13,018/13,038 r2 = 0.23; h AIC/BIC = 13,047/13,066 r2 = 0.22; 
i AIC/BIC = 13,483/13,503; r2 = 0.14; 
N = 4,638 for all, 2,070 for male, and 2,568 for female 
 
 
Regression coefficients are of similar magnitude across gender except for the specification with 
three indicators including weight loss where they are clearly higher for female participants. 
Overall, regression coefficients for physical frailty factor scores with four indicators and with 
three indicators including exhaustion are very similar. However, their coefficients are higher 
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than those with three indicators including weight loss, particularly for prediction of BADL and 
ADL difficulties, as well as poor self-rated health where there is minimal or no overlap of 
confidence intervals. The likely explanation is that as individual indicators, slowness, weakness, 
and exhaustion predict these outcomes better than weight loss does. This is supported by the 
results of linear regression analyses shown in Table 7 of the Supplementary Materials, which 
show that slowness and exhaustion predict these three outcomes best, followed distantly by 
weakness, and finally, weight loss. Notably, Akaike Information Criteria (AIC) and Bayesian 
Information Criteria (BIC) values for models with the first two specifications are similar, while 
those with the third specification are higher (see footnote of Table 3). This means that the 
goodness-of-fit of models with the first two specifications are similar but better than those with 
the third specification. In addition, r-squared values and therefore, the variance explained for 
models with the first two specifications are also very similar but higher than those with the third 
specification (see footnote of Table 3). Overall, these findings indicate that the first two physical 
frailty specifications have higher convergent validity than the third. 
 
For discriminant validity, Table 4 shows that physical frailty factor scores for the first two 
specifications have low correlation with psychological frailty and negligible correlation with 
social frailty. In contrast, physical frailty factor score for the third specification has negligible 
correlation with the other frailty domains, suggesting higher discriminant validity. Nevertheless, 
all Pearson's coefficients are well below the arbitrary 0.85 cut-off level where greater values are 
regarded as indicating low discriminant validity. Equally important, the correlation coefficients 
between the three different physical frailty specifications (“multi-method”) are in the region of 
0.88 to 1.00 and therefore much larger than those between physical frailty and psychological 
frailty or social frailty (“multi-trait”), which are from 0.12 to 0.41. This further supports 
discriminant validity. The corresponding Modified Multi-trait Multi-Method (MTMM) Matrix is 
provided in Table 8 of the Supplementary Materials. 
 
Where concurrent validity is concerned, multiple linear regression analyses obtained 
statistically significant coefficients for all three physical frailty specifications as shown in Table 
5. For one SD increase physical frailty factor scores, the FI increases by 0.61 to 0.76 SD. There 
are minor variations of regression coefficients across gender. Overall, regression coefficients 
are higher for specifications with four indicators and with three indicators including exhaustion, 
than those for the third specification. Yet again, AIC and BIC values for models with the first two 
specifications are similar while those with the third specification are higher. R-squared values 
are almost equivalent for the first two specifications and higher than those of the third (see 
footnote of Table 5). This means that the goodness-of-fit of models and variance explained by 
models with the first two specifications are similar but better or higher than those with the third 
specification. Together, these findings indicate that concurrent validity for the first two 
specifications is higher than that for the third. 
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Table 4. Correlation of factor scores for three physical frailty specifications with those 
for psychological and social frailty, and between factor scores for three physical frailty 
specifications (modified multi-trait multi-method analysis): Pearson’s coefficient (95% 
confidence interval)  
 
 Pearson's correlation coefficient (Standard  
error) 
All 
 
By gender 
Male Female 
Between physical and psychological frailty: 
4 indicators 0.41 
(0.38 to 0.43) 
0.38 
(0.34 to 0.42) 
0.40 
(0.36 to 0.43) 
3 indicators (including exhaustion) 0.40 
(0.37 to 0.43) 
0.38 
(0.34 to 0.42) 
0.39 
(0.35 to 0.43) 
3 indicators (including weight loss) 0.29 
(0.26 to 0.32) 
0.26 
(0.22 to 0.30) 
0.28 
(0.24 to 0.32) 
Between physical and social frailty: 
4 indicators 0.16 
(0.13 to 0.20) 
0.18 
(0.14 to 0.23) 
0.17 
(0.12 to 0.22) 
3 indicators (including exhaustion) 0.16 
(0.13 to 0.19) 
0.18 
(0.13 to 0.23) 
0.17 
(0.12 to 0.21) 
3 indicators (including weight loss) 0.12 
(0.08 to 0.15) 
0.13 
(0.08 to 0.18) 
0.14 
(0.09 to 0.18) 
Between specifications of physical frailty: 
3 indicators (including exhaustion) and 3 
indicators (including weight loss) 
0.89 
(0.87 to 0.90) 
0.88 
(0.86 to 0.90) 
0.89 
(0.87 to 0.90) 
4 indicators and 3 indicators (including 
exhaustion) 
1.00 
(0.99 to 1.00) 
1.00 
(0.99 to 1.00) 
1.00 
(0.99 to 1.00) 
3 indicators (including weight loss) and 4 
indicators 
0.90 
(0.89 to 0.91) 
0.90 
(0.88 to 0.91) 
0.90 
(0.89 to 0.92) 
 
P-values are <0.05 for all correlation coefficients. 
N = 4,638 for all, 2,070 for male, and 2,568 for female 
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Table 5. Linear regression of Frailty Index on factor scores for three physical frailty 
specifications adjusted for age with multiple imputation: standardized coefficients  
 
 All By gender 
Male Female 
4 indicators 0.76 (0.73 to 0.79) a 0.76 (0.71 to 0.80) 0.76 (0.72 to 0.79) 
3 indicators (including exhaustion) 0.75 (0.72 to 0.78) b 0.74 (0.70 to 0.79) 0.74 (0.71 to 0.78) 
3 indicators (including weight loss) 0.62 (0.59 to 0.65) c 0.61 (0.55 to 0.66) 0.61 (0.57 to 0.65) 
 
P-values are <0.05 for all physical frailty factor score coefficients. 
a AIC/BIC = -6,998/-6,978 r2 = 0.44; b AIC/BIC = -6,918/-6,899 r2 = 0.43; c AIC/BIC = -5,977/-5,957 r2 = 
0.30; 
N = 4,638 for all, 2,070 for male, and 2,568 for female 
 
 
As sensitivity analysis, the CFA for physical frailty and regressions for evaluating convergent 
and concurrent validity are repeated using the WLSMV estimator. Comparison of coefficients 
obtained using MLR and WLSMV estimators are provided in Table 9 to 11 in the 
Supplementary Materials. Overall, only trivial differences are observed in the coefficients, which 
do not change the interpretation of the results. 
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Discussion 
 
This study reports the development of frailty specifications for investigating multidimensional 
predictors and effects of frailty such as those proposed by the working framework of the 
Canadian Initiative on Frailty and Aging. Rather than adopting a broad definition, narrower 
focus on physical frailty is employed to enhance prospective application when investigating its 
relationship with multidimensional elements on frailty pathways. In addition, physical frailty is 
viewed as a construct and is thus developed as a factor. Unlike the case with established frailty 
instruments including the CHS frailty phenotype where contribution of separate components is 
arbitrarily assumed and then fixed, latent variable analysis through CFA is performed to 
empirically derive the relationship of each indicator with the physical frailty factor. Furthermore, 
CFA allows measurement error to be accounted for, which is particularly relevant as 
performance measures are used as indicators This combined approach represents an advance 
on the frailty specification proposed in the working framework of the Canadian Initiative on 
Frailty and Aging and further builds on the that put forth in the integral concept of frailty 
(Bergman et al., 2004; Gobbens et al., 2010a). 
 
To begin with, content validity is retained given that the selected indicators used are drawn 
from the original components of the CHS frailty phenotype, which is still widely regarded as the 
prototype of physical frailty. Higher weightage is accorded to slowness, weakness, and 
exhaustion given the relative importance of their positions in the cycle of frailty. Thus, the 
physical frailty specification with three indicators including exhaustion could be considered as 
having the essential set of indicators. Furthermore, for candidate specifications examined, 
slowness is central to the physical frailty factor except for the case with three indicators 
including weight loss. Weight loss clearly contributes little and an argument may be made for its 
exclusion as an indicator at least based on the findings from this study. It is notable that our 
results are generally consistent across gender. More crucially, higher convergent and 
concurrent validity with four indicators and with three indicators including exhaustion are 
demonstrated over the third specification.  Although the latter performs better on discriminant 
validity, the first two specifications have sufficiently low correlation with psychological and social 
frailty to suggest that overlap of their constructs is probably not large enough to be of practical 
concern. This is important when examining the relationship of physical frailty with 
multidimensional elements including those which are closely related to or are themselves 
deployed as indicators of psychological and social frailty. 
 
Given these findings, physical frailty specifications with four indicators and that with three 
indicators including exhaustion appear to be suitable candidates for use in investigation of 
frailty pathways. Minimal contribution of weight loss as the fourth indicator suggests that three 
indicators, namely slowness, weakness, and fatigue may be sufficient to represent physical 
frailty. However, the performance of these physical frailty specifications in predicting adverse 
health-related outcomes needs to be separately evaluated. This is an issue that is addressed in 
further research. 
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Although encouraging, these findings should to be viewed in the context of the study limitations. 
Firstly, data from only one population is used and therefore there is uncertainty on the extent to 
which these findings may be generalized to other populations. To address this issue, the 
measurement model from this study needs to be applied to data from other populations in 
future work. Next, secondary data is used. The consequence is that choice of variables 
representing physical frailty is inevitably restricted. Nevertheless, selected variables arguably 
have face validity. The major challenge is the quantification of weight loss, which is by 
necessity across the span of four years due to weight measurements not being available in 
wave 1. It remains to be seen whether weight loss may perform better as an indicator when 
change is measured across a shorter period such as two years. Thirdly, missing data may 
introduce bias in our analyses. Multiple imputation is used to handle this issue here and 
requires the missing at random (MAR) assumption. Notwithstanding the inevitable uncertainty 
on the extent of bias introduced, this is not likely to be large enough to change the conclusions 
on the validity of physical frailty specifications evaluated here. 
 
On the other hand, the strengths of this study include the use of ELSA, which offers 
representative, reliable and high quality data that has produced a wealth of information on how 
older people age in England. Moreover, the relatively large sample size allows greater precision 
in estimation. Lastly, availability of physical performance measures for two physical frailty 
indicators provides more detailed information than questionnaire data alone would. 
 
In conclusion, narrowing of the frailty specification to that of physical frailty is argued on the 
grounds that multidimensional elements on frailty pathways are best excluded from the set of 
its indicators. Suitable indicators are drawn from components of the CHS frailty phenotype and 
include slowness, weakness, and exhaustion with or without weight loss. In addition to retaining 
face and content validity, these two physical frailty specifications have demonstrated 
reasonable convergent, discriminatory, and concurrent validity using the data of older people 
living in England. Together, they hold promise as physical frailty specifications to be applied in 
the investigation of frailty pathways. 
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Table 6. Tetrachoric correlations between indicators for physical frailty specified as 
binary variables: coefficients (N) 
 
 Slowness Weakness Exhaustion Weight loss 
All 
Slowness 1.00 (4,092)    
Weakness 0.43 (3,530) 1.00 (3,869)   
Exhaustion 0.43 (4,067) 0.29 (3,844) 1.00 (4,510)  
Weight loss 0.18 (3,325) 0.19 (3,509) 0.16 (3,572) 1.00 (3,590) 
Male 
Slowness 1.00 (1,826)    
Weakness 0.43 (1,604) 1.00 (1,760)   
Exhaustion 0.41 (1,812) 0.24 (1,742) 1.00 (1,997)  
Weight loss 0.13 (1,484) 0.22 (1,591) 0.17 (1,595) 1.00 (1,608) 
Female 
Slowness 1.00 (2,266)    
Weakness 0.41 (1,926) 1.00 (2,109)   
Exhaustion 0.43 (2,255) 0.31 (2,102) 1.00 (2,513)  
Weight loss 0.22 (1,841) 0.17 (1,918) 0.15 (1,977) 1.00 (1,982) 
 
P-values are <0.05 for all coefficients 
 
Binary variables for slowness and weakness are created by adopting a proposed modification of the Fried 
frailty criteria that uses population-independent cutpoints (Saum et al., 2012).  
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Table 7. Linear regression of chronic disease, functional status, and self-rated health on 
four binary components of the CHS frailty phenotype adjusted for age with multiple 
imputation: standardized coefficients (95% confidence interval)  
 
 All By gender 
Male Female 
Number of chronic diseases: 
Slowness 0.71 (0.62 to 0.79) 0.68 (0.55 to 0.82) 0.70 (0.58 to 0.82) 
Weakness 0.37 (0.28 to 0.46) 0.31 (0.16 to 0.46) 0.38 (0.25 to 0.50) 
Exhaustion 0.74 (0.66 to 0.83) 0.83 (0.69 to 0.96) 0.66 (0.55 to 0.77) 
Weight loss 0.29 (0.16 to 0.42) 0.32 (0.12 to 0.51) 0.26 (0.55 to 0.77) 
Number of basic and instrumental activities of daily living items performed with difficulty: 
Slowness 1.40 (1.27 to 1.52) 1.34 (1.16 to 1.52) 1.42 (1.24 to 1.59) 
Weakness 0.78 (0.63 to 0.93) 0.72 (0.52 to 0.93) 0.79 (0.59 to 0.98) 
Exhaustion 1.65 (1.53 to 1.77) 1.60 (1.43 to 1.78) 1.66 (1.51 to 1.82) 
Weight loss 0.54 (0.29 to 0.79) 0.48 (0.08 to 0.88) 0.57 (0.30 to 0.84) 
Categories of poor self-rated health: 
Slowness 0.79 (0.72 to 0.86) 0.81 (0.71 to 0.91) 0.79 (0.70 to 0.88) 
Weakness 0.44 (0.37 to 0.52) 0.42 (0.30 to 0.53) 0.50 (0.40 to 0.60) 
Exhaustion 0.92 (0.86 to 0.99) 0.94 (0.85 to 1.05) 0.92 (0.84 to 1.00) 
Weight loss 0.34 (0.24 to 0.44) 0.35 (0.19 to 0.50) 0.33 (0.20 to 0.47) 
 
P-values are <0.05 for all coefficients. 
N = 4,638 for all, 2,070 for male, and 2,568 for female  
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Table 8. Modified Multi-trait Multimethod Matrix for physical, psychological, and social 
frailty: Pearson’s coefficients for the whole group  
 
 Physical frailty Psychological 
frailty 
Social frailty 
4 indicators 3 indicators 
including 
exhaustion 
3 indicators 
including 
weight loss 
Physical 
frailty 
4 indicators 
 
 
1.00 1.00 0.90 0.41 0.16 
3 indicators 
including 
exhaustion 
1.00 1.00 0.89 0.40 0.16 
3 indicators 
including 
weight loss 
0.90 0.89 1.00 0.29 0.12 
Psychological frailty 
 
 
0.41 0.40 0.29 1.00 - 
Social frailty 
 
 
0.16 0.16 0.12 - 1.00 
 
N = 4,638  
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Table 9. Measurement model for three specifications of physical frailty with confirmatory 
factor analysis (CFA) using maximum likelihood with robust standard errors (MLR) 
compared with weighted least squares with mean- and variance-adjustment (WLSMV)  
 
 
Physical frailty specification 
Standardized coefficient (standard error) 
MLR WLSMV 
Four indicators: 
   Slowness a 
   Weakness b 
   Exhaustion c 
   Weight loss d 
 
0.76 (0.03) 
0.54 (0.02) 
0.55 (0.02) 
0.28 (0.03) 
 
0.74 (0.02) 
0.54 (0.02) 
0.58 (0.02) 
0.28 (0.03) 
Three indicators including exhaustion: 
   Slowness a 
   Weakness b 
   Exhaustion c 
 
0.78 (0.03) 
0.52 (0.02) 
0.54 (0.03) 
 
0.76 (0.02) 
0.53 (0.02) 
0.57 (0.02) 
Three indicators including weight loss:   
   Slowness a 
   Weakness b 
   Weight loss d 
 
0.60 (0.05) 
0.68 (0.05) 
0.30 (0.03) 
 
0.58 (0.05) 
0.70 (0.05) 
0.29 (0.03) 
 
P-values are <0.05 for all coefficients. 
a Slowness: mean gait speed multiplied by a factor of -1 
b Weakness: dominant hand grip strength multiplied by a factor of -1 (males) or -1.5 (females) 
c Exhaustion: positive response to either or both of two items of CES-D scale on “could not get going 
much of the time in the past week” and “felt everything they did during the past week was an effort” 
d Weight loss: decrease in weight of more than 5 kg from wave 0 to wave 2 
N = 4,547 for first two specifications; N = 4,440 for the third specification  
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Table 10. Linear regression of chronic disease, functional status, self-rated health on 
factor scores, and Frailty Index for three physical frailty specifications adjusted for age 
using maximum likelihood with robust standard errors (MLR) compared with weighted 
least squares with mean- and variance-adjustment (WLSMV): standardized coefficients 
(95% confidence interval)  
 
Physical 
frailty 
specifications 
Number of chronic 
diseases 
Number of basic 
and instrumental 
activities of daily 
living items 
performed with 
difficulty 
Categories of poor 
self-rated health 
Frailty Index 
MLR WLSMV MLR WLSMV MLR WLSMV MLR WLSMV 
4 indicators 
 
 
0.35 
(0.32 to 
0.38) 
0.35 
(0.32 to 
0.38) 
0.49 
(0.46 to 
0.52) 
0.49 
(0.46 to 
0.52) 
0.51 
(0.48 to 
0.53) 
0.50 
(0.48 to 
0.53) 
0.76 
(0.73 to 
0.79) 
0.76 
(0.73 to 
0.79) 
3 indicators 
(including 
exhaustion) 
0.34 
(0.31 to 
0.37) 
0.34 
(0.31 to 
0.37) 
0.48 
(o.46 to 
0.51) 
0.48 
(0.45 to 
0.51) 
0.50 
(0.47 to 
0.53) 
0.50 
(0.47 to 
0.53) 
0.75 
(0.72 to 
0.78) 
0.75 
(0.72 to 
0.78) 
3 indicators 
(including 
weight loss) 
0.30 
(0.27 to 
0.33) 
0.29 
(0.26 to 
0.32) 
0.39 
(0.36 to 
0.43) 
0.38 
(0.35 to 
0.41) 
0.40 
(0.37 to 
0.43) 
0.39 
(0.36 to 
0.42) 
0.62 
(0.59 to 
0.65) 
0.61 
(0.57 to 
0.64) 
 
N = 4,638 for all, 2,070 for male, and 2,568 for female  
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Table 11. Correlation of factor scores for three physical frailty specifications with those 
for psychological and social frailty using maximum likelihood with robust standard 
errors (MLR) compared with weighted least squares with mean- and variance-adjustment 
(WLSMV): Pearson’s coefficient (95% confidence interval)  
 
Physical frailty 
specifications 
Psychological frailty Social frailty 
MLR WLSMV MLR WLSMV 
4 indicators 
 
 
0.41 
(0.38 to 0.43) 
0.41 
(0.38 to 0.43) 
0.16 
(0.13 to 0.20) 
0.16 
(0.13 to 0.20) 
3 indicators 
(including 
exhaustion) 
0.40 
(0.37 to 0.43) 
0.40 
(0.37 to 0.43) 
0.16 
(0.13 to 0.19) 
0.16 
(0.13 to 0.19) 
3 indicators 
(including weight 
loss) 
0.29 
(0.26 to 0.32) 
0.29 
(0.26 to 0.31) 
0.12 
(0.08 to 0.15) 
0.12 
(0.08 to 0.15) 
 
N = 4,638 for all, 2,070 for male, and 2,568 for female  
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Figure 3. Distribution of factor scores for the three physical frailty specifications  
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N = 4,547 for first two specifications; N = 4,440 for the third specification 
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5.3 Further thoughts 
 
I have argued in favor of a narrower physical frailty specification for investigation of frailty 
pathways to avoid overlap of its construct with psychological and social conditions on these 
pathways. I have also discussed the face and content validity of two physical frailty 
specifications based on the original CHS frailty phenotype, which has five components. The 
first specification has three indicators namely, slowness, weakness, and exhaustion, while the 
second has four indicators with the addition of weight loss.  
 
Following that, I demonstrate construct validity of these two physical frailty specifications 
through the findings on convergent and discriminant validity. Convergent validity is shown by 
higher physical frailty factor scores being significantly associated with chronic diseases, 
functional impairment, and poor self-rated health. These conditions are expected to present or 
be more severe with increasing physical frailty. On the other hand, discriminant validity is 
shown by their factor scores having low correlation with psychological and social frailty. This 
lends support to physical frailty as specified, being a distinct construct in relation to the other 
two domains of frailty. Furthermore, concurrent validity is shown in that their factor scores 
increase with higher Frailty Index (FI) values. The latter is another established instrument for 
measuring frailty, but based on the different concept of deficit accumulation. 
 
With these conclusions, I will now proceed with evaluating predictive validity of the two 
candidate specifications for physical frailty. 
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6 Second Paper 
 
6.1 Introduction 
 
Having demonstrated construct and concurrent validity of the two candidate physical frailty 
specifications, one with four indicators and the other with three indicators including exhaustion, 
I now turn the attention to the question of their predictive validity. While prediction by no means 
implies causation, it is nevertheless an important attribute that should be possessed by any 
candidate physical frailty specification. The preceding literature review revealed that the 
majority of frailty instruments available are strong predictors of future adverse outcomes such 
as death and disability, and that the most prominent instruments have approximately equivalent 
ability to do so. This sets the stage for the task at hand. 
 
Beyond merely demonstrating that the two candidate physical frailty specifications can predict 
these adverse outcomes, I will focus on two additional issues. Firstly, these candidate 
specifications with three or four indicators should ideally have equivalent or almost equivalent 
predictive ability as the specification with five indicators, which fully represents the CHS frailty 
phenotype (Fried et al., 2001). If so, this lends further support for the use of these subsets of 
the five indicators. Secondly, the candidate specifications should have predictive ability similar 
to that of another established frailty instrument, namely the Frailty Index (FI) (Rockwood & 
Mitnitski, 2007) . Having predictive ability that approximates that of FI certainly makes a 
stronger case for the suitability of candidate specifications. 
 
To assess their predictive ability, data from consecutive waves of the English Longitudinal 
Study of Ageing (ELSA) will again be used. Predicted adverse outcomes that are important to 
older people, their families, and wider society are selected. They are death, functional 
impairment, poor self-rated health, and poor quality of life. A special challenge faced concerns 
death being a joint outcome or competing risk with the other three outcomes. Predicting the last 
three outcomes without considering the possibility of death occurring may introduce bias. 
Although there are sophisticated methods of handling this situation, I will for now opt for the 
simpler approach of restricting analyses to survivors when evaluating prediction of these three 
outcomes. This facilitates ease of interpreting the results. Moreover, this is a reasonable 
approximation of the truth if the mortality rate for respondents of ELSA is relatively low, as 
anticipated. 
 
In the following paper, some of the foregoing key points are unavoidably repeated as this is a 
self-contained journal article. References specifically for this paper are in a separate list just 
before the Supplementary Materials (pages 102 and 103). Relevant Mplus input files are 
provided in the Appendix. At the time of writing, a version of this paper is being considered for 
publication in a gerontology journal. 
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6.2 Predictive Validity of Two Physical Frailty Specifications Developed for 
Investigation of Frailty Pathways in Older People 
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Abstract 
 
This study evaluates the predictive validity of two physical frailty specifications with three 
indicators, namely slowness, weakness, and exhaustion, and four indicators with addition of 
weight loss, which were developed for investigating frailty pathways. For 4,368 respondents 
aged 65 to 89 years from wave 2 of the English Longitudinal Study of Ageing, prediction of 
death, basic and instrumental activities of daily living (BADL and IADL) difficulty, and poor 
quality of life (reverse of Control, Autonomy, Self-realization, and Pleasure or CASP-19) at 
wave 3 by factor scores for these two candidate specifications is compared with those of 
alternative specifications with three and five indicators, and Frailty Index (FI), using c-statistics, 
standardized coefficients, and r-squared values. The candidate specifications predict these 
outcomes as well or better than the alternative with three indicators, but marginally worse than 
that with five indicators. Compared with FI, they predict death and poor quality of life similarly, 
but perform worse for functional impairment. Minor differences are observed across gender. 
Predictive validity of the two candidate physical frailty specifications with three and four 
indicators is demonstrated for death, functional impairment, and poor quality of life two years 
later. These findings offer evidence to support their suitability for investigating frailty pathways. 
 
 
Keywords 
Death, functional impairment, quality of life, frailty phenotype, frailty index 
88 
 
Introduction 
 
Frailty is defined as a state where there is increased vulnerability to developing increased 
dependency and mortality with exposure to stressors (Morley et al., 2013). It is estimated that 
one out of every 10 community-dwelling older people is frail. While a plethora of instruments 
developed to identify frailty in older people are available (Sternberg et al., 2011), different 
instruments are thought to be best suited for different purposes (Martin & Brighton, 2008). The 
choice of instruments for investigation of frailty pathways that incorporate predictors and effects 
has received some degree of attention in recent years. In developing a working framework for 
understanding frailty, the Canadian Initiative on Frailty and Aging incorporated biological, 
psychological, social, and environmental factors across the life course as predictors of frailty, 
and as modifiers along pathways from frailty to its adverse outcomes. In this framework, seven 
core components of frailty were proposed. They are weakness, poor endurance, reduced 
physical activity, slow gait, unintentional weight loss, cognitive decline, and depressive 
symptoms (Bergman et al., 2004). Of these components, five represent the physical while two 
represent the psychological dimensions of frailty. Furthermore, conditions represented by these 
components may be on frailty pathways, and thereby exacerbating the challenges of examining 
the relationship of frailty with these very elements. On the basis of the Canadian framework, the 
integral conceptual model of frailty was subsequently proposed with the main difference being 
that frailty is explicitly specified as having distinct physical, psychological, and social domains 
(Gobbens et al., 2010a). This allows physical frailty to be disaggregated from the other two 
frailty domains. This in turn permits less constrained exploration of the relationship of frailty with 
its multidimensional predictors and effects. The Tilburg Frailty Indicator (TFI) operationalizes 
this frailty concept (Gobbens et al., 2010b). The adoption of this approach holds promise for 
developing frailty specifications that can be applied when investigating relationships along 
these frailty pathways. 
 
In developing frailty specifications restricted to the physical domain, the Cardiovascular Health 
Study (CHS) frailty phenotype (Fried et al., 2001) is an excellent point of reference. The frailty 
phenotype is arguably the most widely adopted among existing frailty concepts (Buta et al., 
2016). It conceptualizes frailty as being a geriatric syndrome resulting from decline in multiple 
physiologic systems, and operationalized by requiring the presence of at least three of its five 
components: shrinking (unintentional weight loss of at least 5% in the prior year), weakness 
(hand grip strength in the lowest quintile adjusting for gender and body mass index), poor 
endurance and energy (self-reported exhaustion), slowness (slowest quintile of the population 
on the basis of 15-feet walk adjusting for gender and standing height), and low physical activity 
level (lowest gender-specific quintile of weighted score of kilocalories expended per week 
based on self-report). Sarcopenia, which is the loss of muscle mass and function that occurs 
with increasing age (Rolland et al., 2008), is closely related to the frailty phenotype (Mijnarends 
et al., 2015), and considered the biological substrate of physical frailty (Landi et al., 2015). It is 
the condition underpinning the frailty phenotype concept, and holds a key position on the cycle 
of frailty (Xue et al., 2008). In the latter, pathways emanating from sarcopenia lead to 
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manifestations of the frailty phenotype, namely slowness, weakness, and exhaustion, which 
may in turn lead to adverse health-related outcomes including functional dependency. This 
frailty specification predicted mortality at three years with an adjusted hazard ratio (HR) of 2.24. 
Worsening activities of daily living disability over three years could also predicted with adjusted 
HR of 1.98 (Fried et al., 2001). A modification of the frailty phenotype developed by Buchman 
comprises four out of the five components of the frailty phenotype. Physical activity is omitted 
and weight loss is replaced by body mass index. The ability to predict death, and future 
disability was retained (Buchman et al., 2011; Buchman et al., 2009). 
 
Thus, physical frailty specifications with their indicators based on different permutations of the 
five components of the frailty phenotype are developed. In selecting the appropriate 
combinations of these indicators for candidate physical frailty specifications, physical inactivity 
is excluded as it represents a predictor of physical frailty that is amenable to interventions, and 
that could also potentially reduce its adverse effects, prevent or delay its onset, and slow its 
progression (Landi et al., 2010). Using the remaining components, specifications with either 
three indicators, namely slowness, weakness, and exhaustion, or four indicators with the 
addition of weight loss had their construct and concurrent validity demonstrated (Ding, 2016). 
Of note, the second specification is analogous to the modification of the frailty phenotype using 
four measures (Buchman et al., 2011). 
 
As the next step, the predictive validity of these two candidate physical frailty specifications is 
assessed to further evaluate their suitability for application in the investigation of relationships 
on frailty pathways. It is important for candidate physical frailty specifications to be able to 
predict important adverse outcomes reasonably well, and if possible, to the extent that 
established frailty instruments do. Only then can we be confident that these specifications 
represent suitable concepts of physical frailty for investigating frailty pathways. 
 
Therefore, the primary aim of this study is to evaluate the predictive validity of these two 
candidate physical frailty specifications with respect to four selected outcomes. More 
specifically, the first research question asks: how well do the two candidate physical frailty 
specifications with three indicators including exhaustion, and with four indicators with the 
addition of weight loss predict death, functional impairment measured by basic and 
instrumental activities of daily living (BADL and IADL) difficulties, and quality of life two years 
later? The secondary aims are twofold. To begin with, the predictive ability of these two 
specifications is quantified to evaluate how well they compare with alternative specifications 
with five indicators mirroring the CHS frailty phenotype, and three indicators where weight loss 
substitutes exhaustion, as well as Frailty Index (FI), which is another established frailty 
instrument (Rockwood & Mitnitski, 2007). Thus, the second research question asks: how well 
do these two candidate physical frailty specifications predict these four adverse outcomes, 
compared with the specification with five indicators, the alternative with three indicators 
including weight loss, and FI? Next, predictive ability is evaluated across gender to determine if 
there are any important differences. Thus, the third research question asks: do the two 
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candidate physical frailty specifications predict these four adverse outcomes differently across 
gender? To achieve these aims and answer these questions, panel data from the English 
Longitudinal Study of Ageing (ELSA) is used. ELSA is a longitudinal survey of a representative 
sample of the English population aged 50 years and older living in their homes at baseline 
(Steptoe et al., 2013), and is still ongoing.   
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Methods 
 
Data 
 
Panel data from waves 2 and 3 (2004 and 2006) of the English ELSA (Marmot et al., 2015) is 
used. All participants gave informed consent. Ethical approval for ELSA was granted from the 
Multicentre Research and Ethics Committee. Ethical oversight for this analysis is provided by 
procedures of the London School of Economics Ethics Policy. 
 
Measures 
 
Physical frailty is measured at wave 2 (2004). Its indicators are based on the five components 
of the CHS frailty phenotype (Fried et al., 2001). Slowness is the average gait speed (in m/s) of 
two attempts at walking a distance of 2.4 m multiplied by -1. Weakness is measured by the 
dominant hand grip strength in kg, which is multiplied by 1.5 for women. The differential 
handling of raw grip strength values in men and women mirrors the relative differences in 
gender-specific and population-independent values for grip strength proposed for the CHS 
frailty phenotype criteria (Saum et al., 2012). After that, values are reversed through multiplying 
them by -1. Weight loss is a binary variable for decrease in weight of 5 kg or more from waves 
0 to 2. Exhaustion is also a binary variable based on a positive reply to either or both of two 
items of the CES-D scale on whether the respondent “felt everything they did during the past 
week was an effort” and “could not get going much of the time in the past week” (Radloff, 
1977). Low physical activity is a binary variable for whether the respondent had the lowest of 
four categories of physical activity (sedentary). 
 
The two candidate physical frailty specifications have indicators that are based on four 
(slowness, weakness, exhaustion, and weight loss) and three (slowness, weakness, and 
exhaustion) out of the five components of the CHS frailty phenotype. The two alternative 
specifications are based on further permutations of these components with five (slowness, 
weakness, exhaustion, weight loss, and low physical activity) and three (slowness, weakness, 
and weight loss) indicators. Confirmatory factor analysis (CFA) is performed for each of these 
four specifications to obtain their respective factor scores for each participant. For this, full 
information maximum likelihood (FIML), which is analogous to multiple imputation, but without 
actual creation of imputed datasets, is implemented to handle missing values under the missing 
at random (MAR) assumption. FI (Rockwood & Mitnitski, 2007) is computed as the number of 
positive items out of 30 illnesses and functional impairments, which is then divided by 30 to 
obtain a score of 0 to 1 (Searle et al., 2008). For descriptive purposes, and in line with 
proposed cut-off values, the respondent is not frail if FI is 0.08 or less, frail if FI is 0.25 or more 
if frail, and pre-frail if FI is in between these values (Song et al., 2010). 
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Four outcome variables are measured at wave 3 (2006), namely: death, number of six items of 
basic activity of daily living (BADL: eating, transferring, walking, toileting, dressing, and bathing) 
performed with difficulty, number of seven items of instrumental activity of daily living (IADL: 
using a map to get around, preparing meals, shopping for groceries, making telephone calls, 
taking medications, doing housework, managing money) performed with difficulty, and reverse 
of CASP-19 (Control, autonomy, self-realization, and pleasure) quality of life score (Howel, 
2012). 
 
Statistical Analyses 
 
For regression analyses, multiple imputation with chained equations is implemented to handle 
missing values while holding the MAR assumption. The mi set of commands of Stata statistical 
package is used to generate 20 sets of imputed values for estimation procedures that follow. 
 
Predictive validity of the four physical frailty specifications is assessed in two ways depending 
on whether the outcome measure is binary or continuous. For death at two years, which is a 
binary measure, logistic regression is performed with the factor scores for the four 
specifications and FI in turn as predictors while holding age constant. This is repeated for two 
separate groups according to gender. Estimates of odds ratio and c-statistics, which is a 
measure of model discrimination, are compared across specifications. For BADL difficulty, IADL 
difficulty, and poor quality of life (reverse of CASP-19 score) as outcomes among survivors at 
two years, linear regression is performed with the factor scores for the four specifications and 
FI as predictors in turn, while holding their corresponding values at wave 2 (2004) and age 
constant. Estimates of standardized coefficients and r2, which is a measure of variance 
explained, are compared across specifications. To construct these models and perform 
estimation, mi estimate, mibeta and lroc Stata commands are used. 
 
CFA is performed using Mplus version 7.4 (Muthén & Muthén, 1998-2012). All other analyses 
are performed with Stata version 14.1. Statistical significance is assessed at the 5% level.  
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Results 
 
Table 1 summarizes the characteristics of 4,638 respondents aged 65 to 89 years or older 
included for analyses at wave 2 (2004). Respondents assessed to be pre-frail and frail 
according to their Frailty Index (FI) scores accounted for 41 and 20 percent respectively. These 
proportions are higher for women. Physical performance on walking and hand grip strength is 
worse, and exhaustion is more common among women. Significant weight loss of more than 5 
kg over the previous 4 years is experienced by one out of every seven participants, and is 
marginally more common in women. More than 25 percent of respondents have functional 
impairment defined as having difficulty in performing any item of basic activities of daily living 
(BADL), with this impairment being more common among women. A similar pattern is seen for 
instrumental activities of daily living (IADL). On the other hand, quality of life levels assessed by 
mean CASP-19 scores are almost identical across gender. 
 
 
Table 1. Description of English Longitudinal Study of Ageing (ELSA) wave 2 
respondents aged 65 to 89 years included for analyses  
 
Variables All By gender 
Male Female 
Baseline characteristics (wave 2): 
Mean age, years (SD) 
Female, n/N (%) 
Mean average walking speed,  
m/sec (SD) 
Grip strength (dominant hand),  
kg (SD) 
Weight loss > 5kg (waves 0 to 2), 
n/N (%) 
Exhaustion, n/N (%) 
Frailty status by Frailty Index a,  
n/N (%) 
- Not frail 
- Pre-frail 
- Frail 
Number of basic activities of daily 
living (BADL) items performed with 
difficulty, n/N (%):              0 
                                          1 or 2 
                                          3 or 4 
                                          5 or 6 
                                     mean, (SD) 
 
74.0 (6.3) 
2,568/4,638 (55.4) 
 
0.82 (0.28)1 
 
25.9 (10.2)4 
 
587/3,590 (16.4) 
1,490/4,510 (33.0) 
 
 
1,444/3,647 (39.6) 
1486/3,647 (40.8) 
717/3,647 (19.7) 
 
 
3,389/4,635 (73.1) 
948/4,635 (20.5) 
220/4,635 (4.8) 
78/4,635 (1.6) 
0.51 (1.08)7 
 
73.5 (6.2) 
- 
 
0.86 (0.27)2 
 
33.4 (8.9)5 
 
255/1,608 (15.9) 
568/1,997 (28.4) 
 
 
774/1,639 (47.2) 
629/1,639 (38.4) 
236/1,639 (14.4) 
 
 
1,560/2,070 (75.4) 
389/2,070 (18.8) 
95/2,070 (4.6) 
26/2,070 (1.3) 
0.47 (1.03)8 
 
74.3 (6.4) 
- 
 
0.78 (0.28)3 
 
19.6 (6.1)6 
 
332/1,982 (16.8) 
922/2,513 (36.7) 
 
 
670/2,008 (33.4) 
857/2,008 (42.7) 
481/2,008 (24.0) 
 
 
1,829/2,565 (71.3) 
559/2,565 (21.8) 
125/2,565 (4.9) 
52/2,565 (2.0) 
0.54 (1.11)9 
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Number of instrumental activities of 
daily living (IADL) items performed 
with difficulty, n/N (%):      0 
                                          1 or 2 
                                          3 or 4 
                                          5 to 7 
                                    mean, (SD) 
Quality of life: CASP score b, (SD) 
 
 
3,308/4,635 (71.4) 
991/4,635 (21.4) 
236/4,635 (5.1) 
100/4,635 (2.2) 
0.58 (1.20)7 
42.3 (8.7)10 
 
 
1,593/2,070 (77.0) 
358/2,070 (17.3) 
77/2,070 (3.7) 
42/2,070 (2.0) 
0.47 (1.13)8 
42.4 (8.5)11 
 
 
1,715/2,565 (66.9) 
633/2,565 (24.7) 
159/2,565 (6.2) 
58/2,565 (2.3) 
0.68 (1.25)9 
42.2 (8.9)12 
Outcomes (at wave 3): 
Death, n/N (%) 
Number of basic activities of daily 
living (BADL) items performed with 
difficulty, n (%):                 0 
                                          1 or 2 
                                          3 or 4 
                                          5 or 6 
                                     mean, (SD) 
Number of instrumental activities of 
daily living (IADL) items performed 
with difficulty, n (%):          0 
                                          1 or 2 
                                          3 or 4 
                                          5 to 7 
                                     mean, (SD) 
Quality of life: CASP score b, (SD) 
 
278/4,638) (6.0) 
 
 
2,694/3,671 (73.4) 
721/3,671 (19.6) 
195/3,671 (5.3) 
61/3,671 (1.7) 
0.52 (1.09)13 
 
 
2,643/3,671 (72.0) 
738/3,671 (20.1) 
190/3,671 (5.2) 
100/3,671 (2.7) 
0.61 (1.27)13 
40.3 (8.4)16 
 
147/2,070 (7.1) 
 
 
1,222/1,625 (75.2) 
297/1,625 (18.3) 
83/1,625 (5.1) 
23/1,625 (1.4) 
0.48 (1.04)14 
 
 
1,260/1,625 (77.5) 
267/1,625 (16.4) 
54/1,625 (3.3) 
44/1,625 (2.7) 
0.49 (1.21)14 
40.5 (8.2)17 
 
131/2,568 (5.1) 
 
 
1,472/2,046 (72.0) 
424/2,046 (20.7) 
112/2,046 (5.5) 
38/2,046 (1.9) 
0.55 (1.13)15 
 
 
1,383/2,046 (67.6) 
471/2,046 (23.0) 
136/2,046 (6.7) 
56/2,046 (2.7) 
0.70 (1.32)15 
40.2 (8.5)18 
 
a Frailty Index: 30 items (0 to 1); Not frail <0.08, Pre-frail >0.08 but <0.25, Frail >0.25; 
b CASP-19: Control, autonomy, self-realization, and pleasure (CASP) measure of quality of life (19 items) 
Unless indicated otherwise, N = 4,638 for all, 2,070 for male, and 2,568 for female. 
N = 14,092 21,826 32,266 43,869 51,760 62,109 74,635 82,070 92,565 103,305 111,534 121,771 133,671 
141,625 152,046162,834 171,300 181,534 
 
 
By two years, 6 percent of participants have died with this proportion being higher for men. 
Among survivors, there is a minimal increase in functional impairment judging from the 
proportions of those who have difficulty with three or more items of BADL and IADL at wave 3 
(7.0% and 7.9%) compared with wave 2 (6.4% and 7.3%). Mean BADL and IADL scores 
increase marginally by 0.01 and 0.03 respectively among survivors, with no differences across 
gender. Minor reduction in quality of life is observed in decrease in CASP-19 scores over the 
same period, again with no clear differences across gender. 
 
The results of CFA for the four physical frailty specifications are provided in Table 6 of the 
Appendix. Slowness contributes most to the physical frailty factor as judged by its factor loading 
values being largest among indicators, except in the case of the alternative specification with 
three indicators including weight loss. For the latter, weakness contributes the most. Where 
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included as an indicator, weight loss contributes by far the least with low standardized factor 
loading values of 0.3 or less. 
 
Prediction of death at two years by physical frailty specification factor scores and FI is 
summarized in Table 2. For the whole group, one unit of increase in physical frailty factor 
scores for the two candidate physical specifications increased the odds of death at two years 
by 50 to 57 percent holding age constant. Their corresponding c-statistics for prediction of 
death at two years range from 0.72 to 0.73, which indicates an intermediate level of model 
discrimination. This means that the probability that predicted risk is higher among those who 
experience the outcome than those who do not in 72 to 73% (Cook, 2007). 
 
 
Table 2. Prediction of death at two years by physical frailty factor scores of four 
specifications and by Frailty Index (FI) using logistic regression holding age constant: 
odds ratios and c-statistics 
 
 5 indicators 4 indicators 3 indicators 
(with 
exhaustion) 
3 indicators 
(with  
weight loss) 
Frailty 
Index 
All:  
Factor score/FI: OR 
C-statistic 
 
1.83* 
0.75 
 
1.57* 
0.73 
 
1.50* 
0.72 
 
1.39* 
0.71 
 
1.54* 
0.75 
Male: 
Factor score/FI: OR 
C-statistic 
 
2.22* 
0.77 
 
1.98* 
0.75 
 
1.92* 
0.75 
 
1.68* 
0.73 
 
1.73* 
0.77 
Female: 
Factor score/FI: OR 
C-statistic 
 
1.88* 
0.76 
 
1.66* 
0.75 
 
1.53* 
0.74 
 
1.62* 
0.74 
 
1.45* 
0.74 
 
OR: odds ratio 
* p-value <0.05 
N = 4,638 for all, 2,070 for male, and 2,568 for female (missing values handled by multiple imputation) 
Factor scores and Frailty Index are standardized. 
 
 
The alternative specification with three indicators has lower c-statistic (0.71). In contrast, the c-
statistic for the specification with five indicators and FI is marginally higher (0.75). Overall, c-
statistic is marginally higher for men than women or the same, except in the case of the 
alternative specification with three indicators where the converse is true. More importantly, the 
two candidate specifications have higher c-statistics for men than the alternative specification 
with three indicators does. However, the c-statistics for specification with five indicators and FI 
are higher than those for the two candidate specifications, albeit only in men in the case of FI. 
Thus, overall, the two candidate specifications predict death at two years slightly better than the 
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alternative specification with three indicators, but slightly worse than the specification with five 
indicators and FI. 
 
Prediction of functional impairment in terms of difficulty performing BADL at wave 3 among 
survivors is shown in Table 3. Since the analyses are adjusted for baseline BADL performance, 
the results are interpreted as reflecting change in BADL difficulty. One standard deviation of 
increase in physical frailty factor score for both specifications with three indicators including 
exhaustion, and with four indicators at wave 2 predicts 0.15 standard deviation increase of 
BADL items performed with difficulty, holding constant their corresponding performance at 
wave 2 and age. For the whole group and across gender, standardized coefficients for the two 
candidate physical frailty specifications are higher than those of the alternative specification 
with three indicators, but lower than those of the specification with five indicators. However, 
standardized coefficients for FI are higher. Variance of BADL difficulty at wave 3 explained by 
physical frailty, BADL difficulty at wave 2, and age, which is reflected by the r-squared values 
follows the same pattern as standardized coefficients across specifications, with the exception 
that those for the two candidate specifications and alternative specification with three indicators 
are equivalent for the whole group and among women. Overall, the two candidate physical 
frailty specifications predict change in BADL difficulty similarly. However, their predictive ability 
is better than the alternative specification with three indicators, but worse than those of the 
specification with five indicators and FI. 
 
 
Table 3. Prediction of basic activities of daily living (BADL) difficulty among survivors at 
wave 3 by physical frailty factor scores of four specifications and by Frailty Index (FI) 
holding constant BADL difficulty at wave 2 and age: standardized coefficients and r2 
 
Number BADL items 
performed with 
difficulty 
5 indicators 4 indicators 3 indicators 
(with 
exhaustion) 
3 indicators 
(with weight 
loss) 
Frailty 
Index 
All: 
Factor score/FI 
r2 
 
0.18* 
0.42 
 
0.15* 
0.41 
 
0.15* 
0.41 
 
0.10* 
0.41 
 
0.34* 
0.45 
Male: 
Factor score/FI 
r2 
 
0.20* 
0.41 
 
0.17* 
0.40 
 
0.18* 
0.41 
 
0.11* 
0.39 
 
0.39* 
0.44 
Female: 
Factor score/FI 
r2 
 
0.19* 
0.43 
 
0.15* 
0.42 
 
0.15* 
0.42 
 
0.12* 
0.42 
 
0.33* 
0.45 
 
* p-value <0.05 
N = 4,360 for all, 1,923 for male, and 2,437 for female (missing values handled by multiple imputation) 
 
 
97 
 
Prediction of functional impairment in terms of difficulty performing IADL at wave 3 among 
survivors is shown in Table 4. Here again, as the analyses are adjusted for baseline IADL 
performance, the results are interpreted as reflecting change in IADL difficulty. One standard 
deviation of increase in physical frailty factor score for both specifications with three indicators 
including exhaustion and with four indicators predicts 0.12 standard deviation increase in IADL 
items performed with difficulty, holding constant their performance at wave 2 and age. As with 
prediction of BADL difficulty, standardized coefficients for the two candidate physical frailty 
specifications are again higher than those of the alternative specification with three indicators, 
but lower than those of the specification with five indicators for the whole group and across 
gender. Again, standardized coefficients for FI are much higher. However, there are only 
marginal differences across specifications and FI in terms of variance of IADL difficulty 
explained by frailty reflected by r-squared values for the whole group and across gender. 
Overall, prediction of change in IADL difficulty by the two candidate physical frailty 
specifications is similar. Differences with other specifications and FI mirror those for prediction 
of BADL. 
 
 
Table 4. Prediction of instrumental activities of daily living (IADL) difficulty among 
survivors at wave 3 by physical frailty factor scores of four specifications and by Frailty 
Index (FI) holding constant IADL difficulty at wave 2 and age: standardized coefficients 
and r2 
 
Number IADL items 
performed with 
difficulty 
5 indicators 4 indicators 3 indicators 
(with 
exhaustion) 
3 indicators 
(with weight 
loss) 
Frailty 
Index 
All: 
Factor score/FI 
r2 
 
0.14* 
0.49 
 
0.12* 
0.49 
 
0.12* 
0.49 
 
0.09* 
0.49 
 
0.20* 
0.50 
Male: 
Factor score/FI 
r2 
 
0.12* 
0.50 
 
0.11* 
0.50 
 
0.11* 
0.50 
 
0.09* 
0.50 
 
0.16* 
0.51 
Female: 
Factor score/FI 
r2 
 
0.16* 
0.49 
 
0.13* 
0.48 
 
0.13* 
0.48 
 
0.11* 
0.48 
 
0.22* 
0.49 
 
* p-value <0.05 
N = 4,360 for all, 1,923 for male, and 2,437 for female (missing values handled by multiple imputation) 
 
 
Finally, prediction of poor quality of life measured by reverse of CASP-19 scores at wave 3 
among survivors is shown in Table 5. Yet again, as the analyses are adjusted for baseline poor 
quality of life, the results are interpreted as reflecting change in poor quality of life score. One 
standard deviation of increase in physical frailty factor score for the specification with three 
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indicators including exhaustion and with four indicators at wave 2 predicts 0.10 standard 
deviation increase in reverse of CASP-19 score, holding constant reverse of CASP-19 score at 
wave 2 and age. For the whole group and across gender, standardized coefficients for the two 
candidate physical frailty specifications are higher than those of the alternative specification 
with three indicators, but approximate those of the specification with five indicators. However, 
as for BADL and IADL, standardized coefficients for FI are higher. Nevertheless, variance of 
poor quality of life reflected by model r-squared values are almost equivalent across all frailty 
specifications and even FI, with minimal gender-specific differences. Thus, prediction of change 
in poor quality of life by the different physical frailty specifications is approximately equivalent, 
though possibly slightly worse than by FI. 
 
 
Table 5. Prediction of poor quality of life score (reverse of CASP-19a) among survivors at 
wave 3 by physical frailty specifications and by Frailty Index (FI) holding constant 
reverse of CASP-19 score at wave 2 and age: standardized coefficients and r2 
 
Reverse of 
CASP-19 score 
5 indicators 4 indicators 3 indicators 
(with 
exhaustion) 
3 indicators 
(with weight 
loss) 
Frailty 
Index 
All: 
Factor score/FI 
r2 
 
0.10* 
0.59 
 
0.10* 
0.59 
 
0.10* 
0.59 
 
0.06* 
0.59 
 
0.13* 
0.60 
Male: 
Factor score/FI 
r2 
 
0.12* 
0.58 
 
0.11* 
0.58 
 
0.11* 
0.58 
 
0.07* 
0.58 
 
0.15* 
0.59 
Female: 
Factor score/FI 
r2 
 
0.09* 
0.60 
 
0.10* 
0.60 
 
0.10* 
0.60 
 
0.07* 
0.60 
 
0.13* 
0.60 
 
* p-value <0.05 
a CASP-19: Control, autonomy, self-realization, and pleasure (CASP) measure of quality of life (19 items) 
N = 4,360 for all, 1,923 for male, and 2,437 for female (missing values handled by multiple imputation) 
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Discussion 
 
It is worth reiterating that this study represents an important segment of the process of 
developing suitable physical frailty specifications for investigating the relationship of frailty with 
multidimensional conditions within a framework of frailty pathways. The first research question 
is unequivocally answered by the finding that the two candidate physical frailty specifications 
significantly predict death, functional impairment, and quality of life two years later. Obtaining 
answers to the second and third research questions requires further evidence on the predictive 
performance of candidate frailty specifications. To this end, three sets of findings are relevant. 
 
The first set of findings relates to comparative performance of the four physical frailty 
specifications in their prediction of selected adverse outcomes, and answers in part the second 
research question. The two candidate specifications with three indicators (slowness, weakness 
and exhaustion) or four indicators (addition of weight loss) have approximately equivalent 
predictive ability for death, functional impairment, and poor quality of life two years on. They 
perform similarly or better than the alternative specification with three indicators including 
weight loss. On the other hand, their predictive ability is marginally worse that of the 
specification with five indicators including low physical activity, which mirrors the well-known 
CHS frailty phenotype. Together, these results demonstrate that the two candidate 
specifications have reasonable performance with respect to predicting these adverse 
outcomes, albeit not to the level that might be achieved when the fifth component of the CHS 
frailty phenotype, namely low physical activity, is included as an additional indicator. In a sense, 
this is expected given that low physical activity itself predicts death and functional impairment 
(McPhee et al., 2016; Nazroo et al., 2008; Stessman et al., 2009). That said, the difference 
between the predictive performance of the two candidate specifications and that with five 
indicators is marginal. Moreover, the argument against including low physical activity as a 
component of a physical frailty specification when investigating frailty pathways that has 
already been put forth. 
 
The next set of findings concern the predictive performance of the two candidate physical frailty 
specifications across the four adverse outcomes benchmarked against another established 
frailty instrument, and answers the remaining part the second research question. Their 
comparative performance is mixed in that prediction ability of the two candidate specifications 
with respect to death and poor quality of life is similar to that of FI, but worse for functional 
impairment. The latter finding is not surprising given that FI includes items including chronic 
illnesses, as well as psychological and social conditions. More crucially, FI also includes items 
on physical function, which would certainly boost its correlation with future functional 
impairment. Nevertheless, it may be argued that at least for prediction of IADL difficulty and 
poor quality of life, there is marginal or no improvement in variance explained by FI when 
already accounting for prior levels of these outcomes and age. Thus, the performance of the 
two candidate specifications is approximately equivalent to or worse than FI, depending on 
which adverse outcomes are being predicted. 
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The final set of findings provides insight on the predictive performance of the two candidate 
physical frailty specifications across gender and answers the third research question. In 
general, the predictive performance of the two candidate physical frailty specifications is 
broadly similar across gender, although minor differences in standardized coefficients and 
proportion of variance explained are observed. 
 
Given these findings, predictive validity of the two candidate physical frailty specifications with 
three indicators including slowness, weakness, and fatigue, and with four indicators with the 
addition of weight loss is arguably demonstrated. Their prediction of adverse outcomes that 
matter to older people such as death, functional impairment, and poor quality of life is only 
marginally inferior to the alternative specification that is equivalent of the CHS frailty phenotype, 
and mixed in comparison with another established frailty instrument, the FI. Notably, their 
predictive validity applies across gender. However, it is uncertain how they would compare with 
other frailty instruments that explicitly include multiple frailty domains such as the Tilburg Frailty 
Indicator (TFI). In the case of TFI, physical rather than psychological or social frailty contributes 
most to its predictive validity (Gobbens et al., 2012). This lends further support to the notion 
that despite lacking indicators drawn from other frailty domains, physical frailty specifications 
such as those evaluated in this study are unlikely to be significantly disadvantaged where 
predicting key adverse outcomes is concerned. While prediction of death and future disability 
with a physical frailty specification comprising four indicators was previously reported 
(Buchman et al., 2011; Buchman et al., 2009), this is, as far as the author is aware, the first 
report demonstrating the predictive validity of a physical frailty specification with only three out 
of five components of the CHS frailty phenotype as its indicators. 
 
The main strength of this study lies in the use of ELSA, which offers representative, reliable, 
and high quality data, that has produced a wealth of information on the experiences and 
consequences of ageing. In addition, the four selected outcomes are those that are important to 
most older people and their families, and comprise both objective and subjective measures. On 
the other hand, a number of study limitations are acknowledged. Firstly, secondary data is 
used, and the usual drawbacks of relying solely on retrospective information apply. Secondly, 
missing data are assumed to be missing at random (MAR) which may or may not be the case 
depending on the variable concerned. Data being missing not at random (MNAR) is not 
explored as doing so would unnecessarily complicate the predictive models. In any case, all 
frailty specifications being compared are subject to the same potential bias arising from the 
missing data on the outcomes examined. Thirdly, the large proportion of zero values for BADL 
and IADL difficulty raises the issue of whether use of zero-inflated negative binomial regression 
(ZINB) or negative binomial regression (NB) models would be more appropriate when 
predicting these two outcomes. While doing so would be ideal, the mibeta command used for 
these predictions does not accommodate ZINB and NB models. In any case, different 
specifications being compared would suffer from similar inefficiency and bias resulting from use 
of linear regression models to compare their predictive performance. Finally, data from a single 
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population is used. Consequently, the extent to which these findings may be generalized to 
other populations is at best uncertain. 
 
In conclusion, the evidence on predictive validity of the two candidate physical frailty 
specification gathered from this study builds on previous evidence of their construct and 
concurrent validity (Ding, 2016). This is achieved while employing a narrower definition of frailty 
that represents its physical domain. Taken together, they suggest that physical frailty 
specifications with three indicators (slowness, weakness and exhaustion) and four indicators 
(addition of weight loss) are suitable for employment in the investigation of frailty pathways. 
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Table 6. Measurement models for four specifications of physical frailty using 
confirmatory factor analysis (CFA)  
 
 
Physical frailty specification 
 
Standardized coefficient (Standard error) 
All By gender 
Male Female 
Five indicators: 
   Slowness a 
   Weakness b 
   Exhaustion c 
   Weight loss d 
   Low physical activity e 
 
0.80 (0.02) 
0.52 (0.02) 
0.56 (0.02) 
0.28 (0.03) 
0.76 (0.02) 
 
0.73 (0.03) 
0.53 (0.02) 
0.57 (0.04) 
0.22 (0.05) 
0.84 (0.03) 
 
0.76 (0.02) 
0.54 (0.02) 
0.56 (0.03) 
0.31 (0.04) 
0.73 (0.03) 
Four indicators: 
   Slowness a 
   Weakness b 
   Exhaustion c 
   Weight loss d 
 
0.76 (0.03) 
0.54 (0.02) 
0.55 (0.02) 
0.28 (0.03) 
 
0.67 (0.03) 
0.57 (0.03) 
0.53 (0.04) 
0.23 (0.06) 
 
0.71 (0.02) 
0.58 (0.03) 
0.55 (0.03) 
0.30 (0.04) 
Three indicators including 
exhaustion: 
   Slowness a 
   Weakness b 
   Exhaustion c 
 
 
0.78 (0.03) 
0.52 (0.02) 
0.54 (0.03) 
 
 
0.68 (0.03) 
0.56 (0.03) 
0.53 (0.04) 
 
 
0.72 (0.02) 
0.57 (0.03) 
0.55 (0.03) 
Three indicators including 
weight loss:   
   Slowness a 
   Weakness b 
   Weight loss d 
 
 
0.59 (0.05) 
0.68 (0.05) 
0.29 (0.03) 
 
 
0.48 (0.03) 
0.73 (0.04) 
0.22 (0.05) 
 
 
0.55 (0.03) 
0.75 (0.04) 
0.28 (0.04) 
 
P-values are <0.05 for all coefficients. 
a Slowness: mean gait speed multiplied by a factor of -1 
b Weakness: dominant hand grip strength reversed and for female gender, multiplied by a factor of 1.5 
c Exhaustion: positive response to either or both of two items of CES-D scale on “could not get going 
much of the time in the past week” and “felt everything they did during the past week was an effort” 
d Weight loss: decrease in weight of more than 5 kg from wave 0 to wave 2 
e Low physical activity: lowest (sedentary) of four categories of physical activity 
Full information maximum likelihood (FIML) is used to handle missing values. 
N for physical frailty specifications (whole group, men, women): 4,569, 2,033, 2,536 (5 indicators); 4,547, 
2019, 2,528 (4 indicators); 4,547, 2019, 2,528 (3 indicators including exhaustion); 4,440, 1985, 2455 (3 
indicators including weight loss);  
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6.3 Further thoughts 
 
In this paper, I demonstrate predictive validity of the two candidate specifications of physical 
frailty. Beyond confirming that their factor scores predict death, functional impairment, and poor 
quality of life, I show that they perform at levels that are almost equivalent to those of an 
alternative physical frailty specification based on five indicators. The latter reflects physical 
frailty based on the full complement of CHS frailty phenotype components. In addition, these 
two specifications are comparable with FI in prediction of death and poor quality of life.  
 
Together, the evidence gathered in the first two papers suggests that these two candidate 
physical frailty specifications are suitable for employment in the investigation of frailty 
pathways. Furthermore, the specification with three indicators namely, slowness, weakness, 
and exhaustion is probably more advantageous than the one with four indicators including 
weight loss, given that it is more parsimonious and requires less data. This is particularly 
relevant where serial weight data are not available to measure change when constructing the 
indicator on weight loss. Thus, I will use the specification with three indicators (slowness, 
weakness, and exhaustion) in the next three papers to investigate pathways to physical frailty 
and its adverse outcomes. 
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Part Three 
 
Frailty Pathways:  Exploring Predictors, Moderators, and Mediators 
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7 Preamble 
 
7.1 Substantive considerations 
  
I have described the development of suitable physical frailty specifications for investigation of 
frailty pathways in the first two papers. From here, I will now use the specification with three 
indicators, namely slowness, weakness, and exhaustion in favor of that with four indicators 
which has weight loss as the additional indicator. The reason for that there is little added value 
using four indicators in terms of construct, concurrent, and predictive validity, based on the 
results obtained in the first and second papers. Furthermore, the specification with three 
indicators is a more parsimonious option where data requirements and analyses are 
concerned. With the decision made on which physical frailty specification to use, the focus now 
shifts to the research questions I have set out to answer. 
 
To recap, the overarching research aim is to achieve a good understanding of conditions 
predicting frailty and those influencing the development of its adverse outcomes in older 
people. In the third paper, I will examine physical, psychological, and social conditions that 
predict physical frailty and explore their moderators and mediators. Following that in the fourth 
paper, I will investigate the effect of physical frailty on death, with particularly focus on 
moderation and mediation of this effect by selected conditions. Finally, in the fifth paper, I will 
investigate the effect of physical frailty on a key facet of functional impairment, namely activity 
limitation, while again focusing on conditions that moderate and mediate its effect. Throughout 
these papers, the working framework proposed by the Canadian Initiative on Frailty and Aging 
(Bergman et al., 2004) will be the conceptual model for frailty pathways. An adapted and 
simplified version of this working framework is provided in Figure 2.3 (page 34). 
 
7.2 Methodological considerations 
 
Given the availability of longitudinal data from ELSA, the opportunity arises to examine the 
progression of physical frailty across time for the individual older person (intra-individual 
change) as well as differences in progression over time across older persons (inter-individual 
differences). To take advantage of this opportunity, the measurement model for physical frailty 
first needs to be established. As mentioned, physical frailty is measured by its three indicators, 
namely slowness, weakness, and exhaustion. Given that slowness and weakness are 
measured by walking speed and hand grip strength respectively, and that data for these 
measures are only available at waves 2, 4, and 6 of ELSA, physical frailty will only be specified 
at these three time points. Figure 7.1 illustrates the measurement model for physical frailty 
across the three time points. 
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Figure 7.1. Measurement model for physical frailty over waves 2, 4, and 6 of the English 
Longitudinal Study of Ageing 
 
 
 
 
w2: wave 2   w4: wave 4   w6: wave 6 
Circle: latent variable 
Rectangle: observed variable 
Single-headed straight arrow: effect of one variable on another 
Double-headed curved arrow: covariance between two variables 
 
 
The next issue is that of measurement invariance across time points, or longitudinal invariance. 
This concerns whether the physical frailty construct is the same across time. A detailed 
discussion of measurement invariance is beyond the scope of this thesis. Nevertheless, it 
suffices to mention that for simplicity, I will assume and thus, adopt strong (or scalar) invariance 
for the physical frailty construct across waves 2, 4, and 6. Strong invariance imposes equality of 
loadings and intercepts across time. This is to avoid the situation where the operationalization 
of physical frailty changes across these three time points, which would not only be conceptually 
problematic, but would also complicate the interpretation of models that use a changing 
physical frailty measurement. Moreover, there is no substantive expectation of non-invariance 
across time points, each having a mixture of different ages of respondents, with only average 
age increasing. 
 
With the measurement model established, the structural model relating conditions and physical 
frailty is constructed. I will employ three different models for the next three papers, with the 
choice depending on the research question and whether the outcome variable is binary or 
continuous. For the third paper, I use latent growth curve models to estimate the effects of 
physical, psychological, and social conditions on physical frailty. Latent growth curve models 
are a flexible approach to investigating change in a variable over time. Here, linear latent 
growth curve models are constructed where change in physical frailty is assumed to be and 
thus, specified as constant over time. Given this, the measurement model is a linear latent 
growth model has physical frailty with multiple indicators as its “curve” portion. It also includes 
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an intercept factor, which represents initial physical frailty (at wave 2) and a slope factor, which 
represents physical frailty change over time (waves 2, 4, and 6). The structural part of the 
model incorporates time-invariant and time-varying predictors of physical frailty arising from 
physical, psychological, and social dimensions. 
 
For the fourth paper, I use discrete time survival analysis to estimate the effect of physical 
frailty at wave 2 on death across waves 3 to 5. Physical frailty is measured by factor scores 
derived from confirmatory factor analysis for physical frailty at wave 2. Given that death is a 
binary variable, the effect of physical frailty can be estimated by logistic regression, where 
regression coefficients are transformed to obtain the hazard rate for each time point using the 
formula: 
hti = 1 / (1 + e-βt) 
The discrete time survival model requires a series of binary repeated measures, which are 
coded as 0 if death has not occurred yet, 1 if death occurs during that period t, and missing if 
death has already occurred or censored. Physical frailty and a broad set of physical, 
psychological, and social conditions, all at wave 2, are predictors of death. 
 
Finally, for the fifth paper, I use autoregressive cross-lagged analysis to estimate the effect of 
lagged physical frailty factor scores on activity limitation (waves 4 and 6). Autoregressive cross-
lagged models are characterized by the outcome variable being regressed by its own lagged 
measure (auto-regression) as well as that of the lagged predictor (cross-lagged effect). The 
underlying concept is based on two rationales. Firstly, the inclusion of the lagged outcome 
controls for pre-existing differences in the outcome. This addresses the possibility that the 
existing relationship between the lagged predictor and lagged outcome explains the 
relationship between the lagged predictor and (non-lagged) outcome, where the latter 
relationship is the one of interest. Secondly, the stable aspects of the outcome variable are 
removed, so that the estimated cross-lagged effect represents the effect of the predictor on the 
change of the outcome (Newsom, 2015). The estimated effects are also controlled for those of 
a broad set of physical, psychological, and social conditions at wave 2. 
 
As mentioned, beyond estimating the effects of multidimensional predictors on physical frailty, 
and that of physical frailty on its outcomes, attention is paid to their moderated effects using 
stratified analyses, thereby answering questions concerning for whom the effects of predictors 
are stronger. In addition, their indirect effects are estimated through exploring mediated effects 
to answer questions on how predictors exert their effects. Furthermore, moderated mediation or 
moderation of these indirect effects (also known as conditional indirect effects) is also explored. 
 
Another methodological issue is the handling of missing values due to unit and item non-
response. Throughout the analyses, full information maximum likelihood (FIML) will be 
implemented for both types of missing values with the assumption that missing values are 
missing at random (MAR). FIML is analogous to multiple imputation although actual no 
imputation data are created. Rather, the missing data is handled within the analysis model 
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using maximum likelihood estimation, which identifies population parameters having the highest 
probability of producing the sample data. It uses all available data to generate their estimates 
and assumes multivariate normality (Enders, 2011). FIML handles item non-response for 
physical frailty indicators in the measurement model by using all observed values of indicators 
for the estimation, even for respondents with observed values in fewer than three indicators. 
Missing values for dependent variables are handled similarly. On the other hand, FIML handles 
item non-response in predictor variables by treating them as dependent variables through the 
procedure of estimating their sample means or variances, thereby using them for estimation of 
model parameters. 
 
I will not be applying sample weights for unit non-response given that description is not the 
focus of the three papers. Moreover, maximum likelihood is a reasonable option for handling 
attrition in longitudinal studies (Davis-Kean & Jager, 2012), including attrition due to mortality 
(Feng et al., 2006). In addition, to address the possibility that missing values for the outcome 
variable may be missing not at random (MNAR), I will also conduct sensitivity analyses 
including the use of a method of handling MNAR in the growth curve context, to observe 
whether the results have important differences from those obtained in the main analyses. 
 
Lastly, additional sensitivity analyses are conducted to explore whether the findings are robust 
to violations of specific key assumptions. These assumptions are: 
1) No unobserved confounding: To relax this assumption, the analyses are repeated while 
including a “phantom variable”, which is a latent variable that represents unmeasured 
confounders. The strength of its relationship with exposures and mediators is varied, 
while observing any important changes in the estimation of exposure-outcome 
relationship of interest. 
2) No exposure-mediator interaction: To relax this assumption, this interaction is included 
in the model, while observing for any important changes in the estimated mediated 
effect. 
3) Normal distribution of the outcome variable: Where right skewed distribution or count 
data with excess zero values are encountered, results of alternative analyses with 
negative binomial regression models are compared with those using standard linear 
regression. Zero-inflated models are not used given that interpretation of their results is 
less straightforward. 
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8 Third Paper 
 
8.1 Introduction 
 
For the third paper, the research aim is to explore the validity of a framework of pathways to 
frailty by quantifying the relationship of physical frailty with multidimensional conditions on these 
pathways. Specifically, I will seek to answer the research question: “What physical, 
psychological, and social conditions are predictors of physical frailty, and which are moderators 
and mediators of their effects in older people?”. Before that, I will outline the substantive and 
methodological considerations for the task. 
 
The foregoing literature review has identified that older age, female gender, chronic disease, 
allostatic load, low physical activity, being underweight, obesity, smoking, heavy drinking, 
poorer cognition, depression, having less education, lower income, being social isolated, 
financial strain, genetic influences, and poor social conditions in childhood all predict higher risk 
of developing frailty. In most instances, these conditions have been studied with only a limited 
set of control predictors. Given that these conditions are likely to be correlated to varying 
degrees with each other, it is not entirely clear which of them truly predict the development of 
frailty in older people after controlling for the effects of other predictors. Moreover, their inter-
relationships may be more complex. Specifically, it is possible that some of these conditions 
may moderate others, while some others may mediate the effects of others. A more precise 
understanding of the pathways from predictors to frailty is needed. To this end, a more detailed 
examination of these frailty pathways is a worthwhile endeavor. 
 
As mentioned, I will use the working framework proposed by the Canadian Initiative on Frailty 
and Aging (Bergman et al., 2004) as the conceptual model for investigating pathways to 
physical frailty. The left side of this working framework is the focus of this paper and is 
reproduced in Figure 8.1 (page 113). To reflect life course determinants (box on the left in 
Figure 8.1), physical, psychological, and social predictors will be included in the analyses. 
Genetic information and social conditions in early life may be relevant to the development of 
physical frailty in late life. However, given that data on social conditions in childhood are only 
available for a subset of respondents at wave 3 of the English Longitudinal Study of Ageing 
(ELSA) and that genetic influences are not the focus of this paper, they will not be included as 
predictors. Disease and decline in physiologic reserves (box in the center of Figure 8.1) are 
designated as mediators of the effects of predictors in this framework. As such, indirect effects 
of predictors through these two conditions will be included in the analyses in addition to their 
direct effects on physical frailty. In doing so, I seek to answer the question on how these 
predictors cause physical frailty by unpacking the “black box” of mechanisms through which 
they exert their effects on development of physical frailty. In addition, moderation of these 
predictors by selected conditions will also be explored to answer the question on for whom they 
exert their effects. As mentioned previously, physical frailty is specified with three indicators 
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(Ding, 2016) rather than with the seven components proposed in this framework (box on the 
right in Figure 8.1). 
 
 
Figure 8.1. Pathways to frailty adapted from the working framework of the proposed by 
the Canadian Initiative on Frailty and Aging (Bergman et al., 2004) 
 
 
 
 
 
Although a rich set of multidimensional predictors are included in the analyses, particular 
attention will be paid to the effects of those which are potentially modifiable such as lifestyle-
related, psychological, and social conditions. Other conditions including gender and age serve 
to control their estimated effects. Ultimately, the objective is to identify target conditions at 
which to direct population-wide interventions to prevent or delay physical frailty.  
 
As mentioned in the previous chapter, I will use latent growth curve analysis to examine 
pathways to physical frailty progression. To better handle measurement error, I will employ 
multiple indicators of physical frailty for the latent growth curve analysis. 
 
The following paper examines pathways to physical frailty to gain insight on their complex 
nature. Some of the foregoing key points are unavoidably repeated as this is a self-contained 
journal article. References specifically for this paper are again in a separate list just before the 
Supplementary Materials (pages 136 to 139). Relevant Mplus input files are provided in the 
Appendix. A version of this paper has been published in the journal, Biogerontology (Ding et al., 
2017).  
114 
 
 
8.2 Multidimensional predictors of physical frailty in older people: identifying how 
and for whom they exert their effects 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Joint work with Associate Professor Jouni Kuha (Departments of Statistics and Methodology, 
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Abstract 
 
Physical frailty in older people is an escalating health and social challenge. We investigate its 
physical, psychological, and social predictors, including how and for whom these conditions 
exert their effects. For 4,638 respondents aged 65 to 89 years from the English Longitudinal 
Study of Ageing, we examine prediction of physical frailty change over waves 2, 4 and 6 by 
physical, psychological, and social conditions using latent growth curve analysis with multiple 
indicators, and repeat the analyses after stratification by gender, age group, and selected 
conditions that are possible moderators. In addition, we explore their indirect effects through 
disease and physiologic decline, including the aforementioned stratified analyses. We find that 
chronic disease, allostatic load, low physical activity, depressive symptoms, cognitive 
impairment, and poor social support all predict future physical frailty. Furthermore, both chronic 
disease and allostatic load mediate the effects of low physical activity, depressive symptoms, 
and cognitive impairment on future physical frailty. Finally, although poor social integration is 
itself not a predictor of future physical frailty, this condition moderates the indirect effect of poor 
social support through chronic disease by rendering it stronger. By virtue of their roles as 
predictor, mediator, or moderator on pathways to physical frailty, chronic disease, allostatic 
load, low physical activity, cognitive impairment, depressive symptoms, poor social support, 
and perhaps, poor social integration are potentially modifiable target conditions for population-
level health and social interventions to reduce the risk of developing physical frailty or its 
worsening in older people. 
 
 
 
Key words: aged, mediators, moderators, growth curve, allostatic load, social support, social 
integration   
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Introduction 
 
Frailty denotes the multidimensional loss of an individual’s reserves that occurs with greater 
probability with advancing age. This loss results in vulnerability to developing adverse health 
outcomes (Lally & Crome, 2007). In biomedical circles, frailty is widely considered to be a 
clinical syndrome with an underlying biological basis, and is thought to be a transitional state 
between robustness and functional decline (Lang et al., 2009). Its prevalence from different 
studies that used a range of frailty instruments for its diagnostic categorization yielded an 
estimate of 10.7% among adults aged 65 years and older (Collard et al., 2012). From this, we 
can infer that one out of every 10 community-dwelling older people is frail. There is 
overwhelming evidence that frailty confers increased risk of adverse health outcomes that 
matter to older people. These include death (Buchman et al., 2009; Cawthon et al., 2007; Gu et 
al., 2009; Mitnitski et al., 2004; Rockwood et al., 2011), disability (Avila-Funes et al., 2008; 
Romero-Ortuno et al., 2011; Woo et al., 2006), falls (Bilotta et al., 2012; Samper-Ternent et al., 
2012), cognitive impairment and dementia (Auyeung et al., 2011; Boyle et al., 2010; Woo et al., 
2006), lower health-related quality of life (Kanauchi et al., 2008), hospitalization (Bilotta et al., 
2012), greater health services utilization (Rockwood et al., 2011), and institutionalization in 
long-term care facilities (Jones et al., 2005). In view of these consequences, frailty plays a 
central role in the well-being of older people at the individual and societal levels, and therefore 
has major public health importance. Moreover, with the projection of rapid growth in the number 
of older people living across the world, frailty presents a rapidly escalating societal challenge on 
a global scale (Conroy, 2009). Finally, given its impact, frailty has been described as the most 
problematic expression of ageing (Clegg et al., 2013). 
 
On a more positive note, accumulating evidence suggests that frailty is an addressable issue. 
For example, targeted interventions such as exercise have shown promise in reducing incident 
frailty in selected groups of older people (Mohandas et al., 2011). Without doubt, reducing 
frailty at the population level is a desirable goal. To this end, a more precise understanding of 
predictors of frailty holds the key to delaying its onset and slowing its progression. This 
knowledge can in turn assist in informing the formulation of health and social policies that 
address frailty in older people. 
 
Research on frailty over the past two decades has yielded important information on its 
predictors. To date, most of the available evidence concerns the physical domain. For example, 
older age (Fallah et al., 2011; Ottenbacher et al., 2009) and female gender increase the 
likelihood of developing frailty (Etman et al., 2012; Peek et al., 2012; Woods et al., 2005). 
Genetic factors play an important role with data from multi-generational families suggesting that 
its contribution is comparable with that of environmental factors (Garibotti et al., 2006). Chronic 
disease (Ottenbacher et al., 2009; Strawbridge et al., 1998; Syddall et al., 2010; Woods et al., 
2005), allostatic load (Gruenewald et al., 2009), and chronic systemic inflammation (Barzilay et 
al., 2007) are specific medical conditions associated with developing frailty. Low physical 
activity (Strawbridge et al., 1998), being underweight, overweight, or obese (Woods et al., 
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2005), smoking (Woods et al., 2005) and heavy drinking (Strawbridge et al., 1998) are lifestyle-
related conditions that also increase the risk of frailty. 
 
Beyond the physical domain, lower cognition and depression are psychological conditions that 
confer higher risk of incident frailty (Ottenbacher et al., 2009; Strawbridge et al., 1998; Woods 
et al., 2005). In the social realm, having less education and lower income, non-white collar 
occupation, living alone, and being social isolated are all associated with increased risk of 
developing frailty or worsening of frailty (Alvarado et al., 2008; Etman et al., 2012; Peek et al., 
2012; Strawbridge et al., 1998; Syddall et al., 2010; Woods et al., 2005). Financial strain also 
increases this risk (Alvarado et al., 2008; Peek et al., 2012). These findings are likely to reflect 
the effect of chronic stressors. From a life course perspective, poor social conditions in 
childhood such as experiencing hunger and having challenging socioeconomic circumstances 
also increases the risk of developing frailty (Alvarado et al., 2008). Conversely, social support 
characterized by perceived emotional support from family or friends protects against increasing 
degrees of frailty (Peek et al., 2012). Participation in group activities also confers lower risk of 
incident frailty in older persons (Fushiki et al., 2012). 
 
More recently, a life course epidemiological approach was proposed to offer a more 
comprehensive framework for investigating determinants and effects of frailty in older people. It 
attempts to integrate rather than segregate biological and social risk factors. In doing so, this 
approach can be valuable in conceptualizing multiple determinants that exert their dynamic 
effects across different age bands (Kuh, 2007). Typically, there is explicit temporal ordering of 
exposures and inter-relationships among these variables. Their effects are either direct or 
through intermediate conditions, also designated as mediators. A tangible output is a set of 
pathways for these conditions that serves as a suitable framework for the application of 
statistical modeling techniques such as structural equation modeling (Ben-Shlomo & Kuh, 
2002).  
 
Adopting a life course approach, Bergman developed the working framework of the Canadian 
Initiative for Frailty and Aging, which provides a graphical representation of multidimensional 
exposures across the life span in hypothesized pathways to frailty (Bergman et al., 2004). An 
adapted and simpler version of this framework is shown in Figure 1. Focusing on its left side, 
we see that life course determinants of frailty include physical, psychological, and social 
conditions. Their effects are mediated by disease and physiologic reserve decline. This 
framework offers a useful starting point for assembling a set of predictors on pathways to 
physical frailty in older people. To date however, empirical studies examining the concurrent 
and interacting effects of multidimensional predictors of frailty represented in this framework 
have not yet been reported.  
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Figure 1. Working framework of the Canadian Initiative for Frailty and Aging (adapted 
from Bergman, 2004 with modifications) 
 
 
 
 
Building on the Canadian framework, the integral conceptual model of frailty was subsequently 
proposed (Gobbens et al., 2010). In this model, frailty is explicitly specified as having distinct 
physical, psychological, and social domains. Doing so allows physical frailty to be 
disaggregated from the other two frailty domains. This in turn permits less constrained 
exploration of the relationship of frailty with its multidimensional predictors and effects. Adopting 
this approach to specifying frailty, a physical frailty specification with three indicators, namely, 
slowness, weakness and exhaustion was developed and its construct and concurrent validity 
demonstrated (Ding, 2016). 
 
Following this review, we study pathways to frailty as hypothesized in the working framework of 
the Canadian Initiative for Frailty and Aging with three research questions in mind. Our first 
question focuses on key multidimensional conditions that predict physical frailty. More 
specifically, what are the effect sizes of physical, psychological, and social predictors of 
physical frailty controlling for the effects of each other? Our second question concerns for 
whom these multidimensional predictors exert their effects. Particularly, to what extent are the 
effects of key predictors influenced by other predictors? Our third question examines how these 
predictors exert their effects. More precisely, are the effects of predictors mediated by disease 
and decline in physiological reserve as suggested by the working framework of the Canadian 
Initiative for Frailty and Aging? In answering these questions, we seek to advance beyond 
merely confirming that specific physical, psychological, and social conditions are indeed 
predictors of physical frailty, to further estimating their effects over and above each other. In 
addition, we examine the roles of key conditions in moderating the effects of other conditions 
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and in mediating indirect effects. To this end, we will operationalize the aforementioned 
physical frailty specification with three indicators and use it in the analysis of panel data of older 
people from the English Longitudinal Study of Ageing (ELSA). ELSA is a longitudinal survey of 
a representative sample of the English population aged 50 years and older living in their homes 
at baseline (Steptoe et al., 2013). It offers a broad range of reliable and multidimensional data 
across biennial waves beginning from 2002, and is currently still ongoing. 
.
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Methods 
 
Data 
 
Our study population comprises 4,638 respondents aged 65 to 89 years at wave 2 (2004) of 
ELSA (Marmot et al., 2015). Those aged 90 years and older are excluded because their age is 
uniformly coded as “90”. All respondents gave informed consent. Ethical approval for ELSA 
was granted by the Multicenter Research and Ethics Committee. Ethical oversight for this study 
is provided by procedures of the London School of Economics Ethics Policy. 
 
Physical frailty is specified by three indicators drawn from those of the Cardiovascular Health 
Study (CHS) frailty phenotype (Fried et al., 2001), namely slowness, weakness, and 
exhaustion. Slowness is operationalized as the average gait speed (in m/s) of two attempts at 
walking 2.4 m, but with values reversed through multiplication by -1. Weakness is measured by 
the dominant hand grip strength in kg, which is multiplied by 1.5 for women. The differential 
handling of raw grip strength values in men and women is based on gender-specific and 
population-independent values for grip strength proposed for the CHS frailty phenotype criteria 
(Saum et al., 2012). After that, values are reversed through multiplying them by -1. Exhaustion 
is a binary variable based on a positive response to at least one of two items in the Center for 
Epidemiologic Studies Depression Scale (CES-D scale) (Radloff, 1977) on whether the 
respondent “felt everything they did during the past week was an effort” and “could not get 
going much of the time in the past week” (Radloff, 1977). Data for gait speed and hand grip 
strength are only available at waves 2, 4, and 6. From among different permutations of the five 
components of the CHS frailty phenotype, the combination of these three indicators has been 
shown and argued to be preferred in representing the physical frailty construct for investigation 
of frailty pathways (Ding, 2016). Confirmatory factor analysis (CFA) with these three indicators 
for waves 2 (2004), 4 (2008), and 6 (2012) is performed while assuming and therefore, 
imposing scalar (strong) invariance over time where all loadings and intercepts are held 
constant across time. This measurement model is then incorporated in the full structural model. 
In addition, unique physical frailty factor scores for each respondent are derived at the three 
time points and then utilized to describe the study population. 
 
To further describe frailty status in our study population, a 30-item Frailty Index (FI) based on a 
deficit accumulation approach is constructed and represented as a scalar measure ranging 
from 0 to 1 (Rockwood & Mitnitski, 2007). In accordance with previous reports, FI values of at 
least 0.25 define frailty (Rockwood et al., 2007). 
  
Physical frailty is the outcome of interest that is specified at waves 2, 4, and 6 as factors with 
multiple indicators on a latent growth curve. Based on the Canadian working framework and 
evidence assembled from the literature, physical, psychological, and social conditions are 
shortlisted for inclusion as predictors in our models. Beyond age and gender, physical 
predictors include obesity (binary: body mass index (BMI) of 30 kg/m2 or more with reference to 
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BMI less than 30 kg/m2 but more than 20 kg/m2), being underweight (binary: BMI of 20 kg/m2 or 
less with reference to BMI less than 30 kg/m2 but more than 20 kg/m2), low physical activity 
(four levels of decreasing intensity activity related to occupation and exercise), chronic disease 
(count of conditions from 0 to 14), allostatic load (score of 0 to 9), smoking history ((binary: 
whether ever smoked), and high alcohol intake (binary: whether had alcohol drink almost every 
day in the past 12 months). Allostatic load reflects physiological dysregulation in multiple body 
systems and is specified by nine biomarkers including blood pressure readings, anthropometric 
measurements, and blood tests for cholesterol levels, glucose control, and inflammatory 
markers (Gruenewald et al., 2009). For each biomarker, a score of one is awarded for values 
beyond a cut-off level reflecting high risk, with a score of zero given if otherwise. 
 
Psychological predictors include depressive symptoms, which is based on a count of six out of 
eight items (score of 0 to 6) of the CESD Scale. The two omitted items are those already used 
to measure exhaustion as a physical frailty indicator. Cognitive impairment is measured by 
reversing a cognitive index based on the combined memory and executive function test 
performance (score of 0 to 49).  
 
Social predictors include low education (binary: no qualifications compared with any 
qualification), and low wealth (binary: lowest 2 deciles compared with highest 8 deciles of non-
pension wealth). Additionally, poor social integration reflecting social isolation is based on a 
combined score on five items (score of 0 to 14) concerning whether respondents have no 
spouse or partner living with them, had little contact with children, had little contact with other 
family members, had little contact with friends, and were not a member of any organization, 
club or society. Contact includes meeting, phoning, or writing or email. Its precise specification 
is adapted from that of a previous study (Banks et al., 2010). Finally, poor social support, in 
terms of deficient emotional support, and reflecting negative social interaction with family and 
friends is measured by the combined scores on three items each on whether there is lack 
positive support, and the occurrence of negative support (score of 0 to 54). Lack of positive 
support is measured by negative answers to questions on “understand the way you feel”, “can 
rely on if you had a serious problem”, and “can open up to them if you need to talk” with respect 
to children, other family members, and friends. Negative support is measured by positive 
answers to questions on whether children, other family members, and friends "criticizes the 
respondent", "lets the respondent down", and "gets on the nerves of respondent". This 
specification is again based on the aforementioned previous study (Banks et al., 2010). 
 
Statistical analyses: 
 
A series of structural equation models using latent growth curve analysis are developed to 
examine the effect of predictors on physical frailty. The growth curve is specified as linear and 
measured by multiple indicators for physical frailty at waves 2, 4, and 6. Random effects 
capture inter-individual differences in physical frailty development that are conceptualized as 
two growth factors. The first is the intercept growth factor, which reflects physical frailty at wave 
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2, and represents inter-individual differences in initial physical frailty at wave 2. The other is the 
slope growth factor, which reflects physical frailty change across waves 2 to 6, and represents 
inter-individual differences in physical frailty trajectory over time. 
 
Model 1 concerns prediction of initial physical frailty and its change over time. It comprises two 
parts. The first part is the regression of the intercept and slope factors for physical frailty on 
predictors that are designated as time-invariant variables, such as age (at wave 2) and gender. 
Other predictors such as smoking history, high alcohol intake, low education level, and low 
wealth are not expected to change over the three time points for the vast majority of 
respondents. Obesity is also designated as time-invariant, given that BMI data are not always 
available at the three time points. The second part is the regression of physical frailty factors at 
waves 2, 4, and 6 on their lagged time-varying predictors, namely chronic disease, allostatic 
load, low physical activity, depressive symptoms, cognitive impairment, poor social support, 
and poor social integration measured at waves 1, 2, and 4 respectively. Wave 1 is used given 
that data is not available for six out of seven of these variables at wave 0. In addition, stratified 
analyses according to gender and age group (below 75 years and at least 75 years) are 
performed. Model 2 extends Model 1 by examining moderation of the effects of predictors on 
physical frailty by low physical activity, depressive symptoms, low social support, and low social 
integration using stratified analyses of two subgroups defined by whether values are below or 
above their mean values. Equivalent effects across time are constrained to be equal. 
 
Model 3 extends Model 1 by including mediation of the effects of predictors on change in 
physical frailty. The indirect effects of time-varying predictors (waves 1, 2, and 4) on physical 
frailty factor (waves 2, 4, and 6) that are mediated by chronic disease and allostatic load 
(waves 2, 4, and 6) are estimated. These indirect effects are estimated by obtaining the product 
of the coefficients of the predictor-mediator and mediator-outcome effects, and then using 
Sobel’s test to test their significance (Sobel, 1982). Gender and age group-specific effects are 
also estimated with stratified analyses. Absence of predictor-mediator interaction is assumed. 
Finally, Model 4 extends Model 3 by including stratified analyses to explore moderation of these 
indirect effects (moderated mediation) by the four conditions examined in Model 2,  
 
Mathematical equations for Models 1 to 4, as well as graphical representations of Models 1 and 
3 are provided in the Supplementary Materials (Figures 3 and 4 respectively for the latter). The 
models are estimated using maximum likelihood with robust standard errors (MLR). Missing 
values for dependent variables due to both attrition and item non-response are handled by full 
information maximum likelihood (FIML) with the assumption of missing at random (MAR). FIML 
is a procedure that is analogous to multiple imputation, but without actual creation of imputation 
datasets. Rather, missing data is handled within the analysis model using maximum likelihood 
estimation, which identifies population parameters having the highest probability of producing 
the sample data. It uses all available data to generate estimates and assumes multivariate 
normality. It is also implemented for predictor variables by treating them as dependent variables 
through estimating their sample means.  
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Sensitivity analysis is explored in two ways. Firstly, the MAR assumption is relaxed to consider 
the possibility that missing values for the outcome variable are missing not at random (MNAR). 
This is particularly relevant given that missing values due to death or drop out may be MNAR. 
To perform this, Wu and Carroll’s selection model (Enders, 2011), which is a shared parameter 
model that is conditional on the latent factors, is incorporated in Model 1 to explore the extent to 
which results change when MNAR is considered. In this model, growth curve analysis is 
augmented with logistic regression equations that predict binary missing data indicators (at 
waves 4 and 6) using the two growth factors as well as time-invariant and time-varying 
predictors. In other words, initial physical frailty and its rate of change over time, as well as 
predictors of physical frailty all predict propensity for missing data. Graphical representation of 
Model 1 incorporating this selection model is shown in Figure 5 of the Supplementary Materials. 
Secondly, depressive symptoms are measured by the full set of eight items of the CESD 
instrument rather than just the six selected items. 
 
Mplus version 7.4 (Muthén & Muthén, 1998-2012) is used to perform structural equation 
modeling while STATA version 14.1 is used for all other analyses. Statistical significance is 
primarily assessed at the 5% level. However, for examination of moderation using four separate 
regression models, Bonferroni’s correction is implemented to adjust for multiple comparisons 
such that statistical significance is assessed at the 1.25% level.  
124 
 
 
Results 
 
Table 1 shows the characteristics of the study population at wave 2 (2004). The mean age is 74 
years, and women comprise 55% of respondents. Using the Frailty Index, almost 20% of them 
are classified as being frail at wave 2, with this proportion being higher among women and 
those aged 75 years and older. This proportion increases to almost 25% at wave 6, with 
corresponding increase over time observed across gender and age group. Among 
multidimensional conditions at baseline (wave 2), there are minor gender-specific differences in 
levels of chronic disease, allostatic load, low physical activity, cognitive impairment, and poor 
social integration. However, differences are more marked for obesity and depressive 
symptoms, which affect women more. As expected, women report less smoking, alcohol 
consumption, and poor social support, but have lower education and wealth. Those in the older 
age group have higher levels of chronic disease, allostatic load, depressive symptoms, 
cognitive impairment, and poor social integration, while having lower levels of physical activity, 
educational attainment, and wealth than those younger. For them, smoking is more common 
while obesity and heavy alcohol intake are less so. They also have better social support. 
 
 
Table 1. Characteristics of English Longitudinal Study of Ageing (ELSA) wave 2 
respondents aged 65 to 89 years included in analyses  
 
Variables All By gender By Age group 
Male Female < 75 years >= 75 years 
General: 
Mean age, years (SD) 
Female, n/N (%)             
 
 
74.0 (6.3) 
2,568/4,638  
(55.4) 
 
73.5 (6.2) 
- 
 
 
74.3 (6.4) 
- 
 
 
69.3 (2.8) 
1,399/2,643 
(52.9) 
 
80.2 (3.9) 
1,169/1,995 
(58.6) 
Physical frailty: 
Mean average walking 
speed, m/sec (SD): 
Hand grip strength,  
kg (SD) 
Exhaustion, n/N (%): 
 
Frailty by Frailty Index, 
n/N (%):            Wave 2 
 
                         Wave 4 
 
                         Wave 6 
 
0.8 (0.3)1 
 
25.9 (10.2)6 
 
1,490/4,510 
(33.0) 
 
717/3,647 
(19.7) 
507/2,371 
(21.4) 
438/1,774 
(24.7) 
 
0.9 (0.3)2 
 
33.4 (8.9)7 
 
568/1,997 
(28.4) 
 
236/1,639 
(14.4) 
158/1,051 
(15.0) 
145/768 
(18.9) 
 
0.8 (0.3)3 
 
19.6 (6.1)8 
 
922/2,513 
(36.7) 
 
481/2,008 
(24.0) 
349/1,320 
(26.4) 
293/1,006 
(29.1)  
 
0.9 (0.3)4 
 
28.4 (10.2)9 
 
728/2,596 
(28.0) 
 
322/2,207 
(14.6) 
279/1,571 
(17.8) 
285/1,325 
(21.5) 
 
0.7 (0.3)5 
 
22.2 (8.2)10 
 
762/1,914 
(39.8) 
 
395/1,440 
(27.4) 
228/800 
(28.5) 
153/449 
(34.1) 
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Physical: 
Obesity, n (%) 
 
Mean chronic disease 
count [out of 14] (SD) 
Mean allostatic load score 
[out of 8] (SD) 
Mean low physical activity 
level, [0 of 3] (SD)  
Smoking history, n (%) 
 
Heavy alcohol intake,  
n (%) 
 
1,018/3,976   
(25.6) 
1.9 (1.4)11 
 
2.0 (1.5)16 
 
1.2 (0.9)21 
 
2,963/4,634  
(63.9) 
1,249/3,871  
(32.3) 
 
400/1,783  
(22.4) 
1.8 (1.4)12 
 
1.9 (1.5)17 
 
1.1 (0.9)22 
 
1,567/2,069  
(75.7) 
720/1,742 
 (41.3) 
 
618/2,193  
(28.2) 
2.0 (1.4)13 
 
2.1 (1.5)18 
 
1.3 (0.9)23 
 
1,396/2,565 
(54.5) 
529/2,129 
 (24.9) 
 
662/2,328 
(28.4) 
1.8 (1.4)14 
 
1.9 (1.5)19 
 
1.0 (0.9)24 
 
1,649/2,639 
(62.5) 
792/2,344 
(33.8) 
 
356/1,648 
(21.6) 
2.1 (1.5)15 
 
2.1 (1.5)20 
 
1.4 (0.9)25 
 
681/1,995 
(65.9) 
457/1,527 
(29.9) 
Psychological: 
Mean CESD-8 score  
[0 to 8] (SD) 
Mean cognitive 
impairment score  
[0 to 49] (SD) 
 
1.7 (2.0)26 
 
27.5 (6.3)31 
 
 
1.3 (1.7)27 
 
26.3 (6.4)32 
 
 
1.9 (2.1)28 
 
25.5 (6.5)33 
 
 
1.5 (1.9)29 
 
24.1 (6.0)34 
 
 
1.9 (2.0)30 
 
28.4 (6.3)35 
 
Social: 
Low education, n (%) 
 
Low wealth, n (%) 
 
Mean poor social support 
score [0 to 54] (SD) 
Mean poor social 
interaction score  
[0 to 14] (SD) 
 
2,256/4,618 
(48.9) 
980/4,557 
(21.5) 
13.7 (7.0)36 
 
6.6 (2.5)41 
 
 
885/2,061 
(41.5) 
365/2,022 
(18.1) 
14.7 (7.0)37 
 
6.7 (2.6)42 
 
 
1,401/2,557 
(54.8) 
615/2,535 
(24.3) 
12.9 (6.8)38 
 
6.5 (2.5)43 
 
 
1,158/2,630 
(44.0) 
454/2,584 
(17.6) 
13.9 (7.0)39 
 
6.4 (2.5)44 
 
 
1,098/1,998 
(55.2) 
526/1,973 
(26.7) 
13.3 (6.8)40 
 
7.0 (2.6)45 
 
 
Frailty: Frailty Index >=0.25 
CESD-8: Center for Epidemiologic Studies Depression Scale (8 items) 
Unless indicated otherwise, N=4,638 (all), 2,070 (male), 2,568 (female), 2,643 (less than 75 years old), 
and 1,995 (at least 75 years old). 
N = 14,096 21,826 32,266 42,400 51,692 63,869 71,760 82,109 92,276 101,593 114,608 122,052 132,556 142,617 
151,991 162,319 171,064 181,255 191,436 20883 214,567 222,032 232,535 242,611 251,956 264,479 271,987 
282,492 292,586 301,893 314,349 321,946 332,403 342,546 351,803  363,339 371,529 381,810 392,068 401,271 
413,267 421,506 431,761 442,035 451,232 
 
 
Among the performance measures on which the three indicators for physical frailty are based, 
hand grip strength (weakness) clearly decreases at successive waves across gender and age 
group, while walking speed (slowness) does so very minimally or not at all. The trends are 
mixed for exhaustion with either increase or decrease in proportion reporting this across waves 
(Supplementary Materials, Table 6). Notably, missing values increase to 50 to 60% by wave 6. 
In addition, time-varying predictors show increased mean values across waves, with most also 
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doing so across gender and age group (Supplementary Materials, Table 7). Here, missing 
values occur in 30 to 40% of cases by wave 4. 
 
Graphical representation of derived physical frailty factor scores (unadjusted) at waves 2, 4, 
and 6 is provided in Figure 2. Over this period, mean physical frailty factor score increases by 
approximately 0.05. This is a relatively small increase considering that the standard deviation 
(SD) of factor scores at wave 2 is 0.81. Mean factor scores for women and those in the older 
group are higher. 
 
 
Figure 2. Trajectories of unadjusted physical frailty factor scores across wave 2, 4, and 6 
of the English Longitudinal Study of Ageing: mean values for whole group and 
subgroups  
 
 
 
N = 4,560 (all), 2,025 (male), 2,535 (female), 2,616 (less than 75 years old), and 1,944 (at least 75 years 
old) 
 
 
Table 2 shows that even after controlling for the effects of other predictors, older age, female 
gender, obesity, being underweight, low education, and low wealth are all associated with 
higher levels of initial physical frailty given their positive and significant coefficients in the first 
column. On the other hand, smoking is not significantly associated with initial physical frailty, 
while high alcohol intake has a negative and significant coefficient, and is therefore associated 
with lower levels of initial physical frailty. Coefficients in the second to fifth columns of Table 2 
indicate that the magnitude of effect for obesity is larger among women, while that for low 
education is larger among men. In addition, the magnitude of effect for older age is larger 
among those at least 75 years of age, while that for low wealth is larger among those below 75 
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years of age. However, all these differences across gender and age group are not statistically 
significant. 
 
 
Table 2. Predictors of initial physical frailty: standardized coefficients of latent growth 
curve models  
 
 All Gender Age 
Male Female < 75 years >= 75 
years 
Effects of time-invariant predictors (wave 2) on physical frailty intercept factor 
    Older age  0.563*  0.569*  0.584*  0.207*  0.443* 
    Female gender  0.419*  -  -  0.449*  0.484* 
    Obesity  0.101*  0.036  0.152*  0.132*  0.091* 
    Underweight  0.051*  0.085  0.033  0.064  0.048 
    Smoking history  0.038  0.032  0.043  0.059*  0.017 
    High alcohol intake -0.101* -0.078* -0.120* -0.129* -0.083* 
Low education  0.147*  0.189*  0.116*  0.177*  0.141* 
Low wealth  0.113*  0.112*  0.122*  0.163*  0.078* 
 
* Indicates p-value <0.05 
Standardized coefficients are interpreted as change in physical frailty intercept in standard deviation (SD) 
units for a one SD increase in continuous predictors, or from zero to one for binary predictors (female 
gender, obesity, underweight, smoking history, high alcohol intake, low education, and low wealth). 
N = 4,638 (all), 2,070 (male), 2,568 (female), 2,643 (less than 75 years old), and 1,995 (at least 75 years 
old) 
 
 
Of greater interest are those associations with future physical frailty across waves 2, 4, and 6, 
which better reflect their true predictive effects. Firstly, the correlation between the intercept 
(initial physical frailty) and slope (physical frailty change) factors is -0.206 (p-value>0.05), which 
indicates a non-significant trend towards higher levels of initial physical frailty being associated 
with less steep increase in physical frailty over time. This could be related in part to a ceiling 
effect. Next, none of the time-invariant predictors predict greater increase in physical frailty 
levels over time controlling for the effects of other predictors as shown by the non-significant 
coefficients in the first column in the upper section of Table 3. However, the predictive effect of 
older age is stronger and significant in men and those less than 75 years of age, although 
these differences across gender and age group are not statistically significant. Among time-
varying predictors, chronic disease, allostatic load, low physical activity, depressive symptoms, 
cognitive impairment, and poor social support all predict higher future physical frailty levels 
controlling for the effects of other time-varying predictors as well as those of time-invariant 
predictors on the physical frailty slope factor. The statistically significant coefficients in the first 
column in the lower section of Table 3 indicate that one SD increase in levels of these 
conditions predicts increase of 0.07 to 0.24 SD in physical frailty levels two years later. These 
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are non-trivial effects given that the mean physical frailty level of the study population only 
increases by 0.06 SD over two years. Judging by the coefficients in the second to fifth columns, 
the magnitude of effect is generally consistent across gender and age group except for those 
for depressive symptoms and poor social support, which are higher in the older age group, 
although these differences are also not significant. Notably, poor social integration did not 
predict higher physical frailty levels.  
 
 
Table 3. Predictors of future physical frailty (waves 2, 4, and 6): standardized coefficients 
from latent growth curve models  
 
 All Gender Age 
Male Female < 75 
years 
>= 75 
years 
Effects of time-invariant predictors (wave 2) on physical frailty slope factor 
    Older age  0.288  0.481*  0.132  0.226* -0.071 
    Female gender  0.062  -  -  0.294 -0.560 
    Obesity  0.156  0.210  0.114  0.104  0.214 
    Underweight -0.040 <0.001 -0.063 -0.058  0.029 
    Smoking history -0.058 -0.028 -0.089 -0.074 -0.003 
    High alcohol intake  0.019 -0.010  0.047  0.073 -0.101 
Low education -0.058  0.077 -0.139 -0.055 -0.030 
Low wealth  0.100 -0.039  0.174  0.090 -0.051 
Effects of lagged time-varying predictors (waves 1, 2, and 4) on physical frailty factor (waves 2, 4, and 
6) 
    Chronic disease  0.236*  0.264*  0.220*  0.259*  0.271* 
    Allostatic load  0.108*  0.132*  0.088*  0,118*  0.130* 
    Low physical activity  0.189*  0.191*  0.193*  0.205*  0.192* 
    Depressive symptoms  0.115*  0.130*  0.108*  0.108*  0.167* 
    Cognitive impairment  0.182*  0.222*  0.160*  0.181*  0.195* 
    Poor social support  0.067*  0.065*  0.074*  0.063*  0.109* 
    Poor social integration  0.007  0.029 -0.015  0.016 -0.024 
 
* Indicates p-value <0.05 
For time-invariant predictors, standardized coefficients are interpreted as change in physical frailty slope 
in standard deviation (SD) units for one SD increase in continuous predictors, or from zero to one for 
binary predictors (female gender, obesity, underweight, smoking history, high alcohol intake, low 
education, and low wealth). For time-varying predictors, standardized coefficients are interpreted as 
increase in physical frailty factor in SD units for their one SD increase. 
N = 4,638 (all), 2,070 (male), 2,568 (female), 2,643 (less than 75 years old), and 1,995 (at least 75 years 
old) 
 
 
Beyond gender- and age group-specific effects observed, effects of predictors in specific 
subgroups are of interest. For these, moderated effects are relevant and are shown in Table 4. 
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Table 4. Moderation of predictors of future physical frailty: standardized coefficients 
from latent growth curve models  
 
 Low physical 
activity 
Depressive 
symptoms 
Poor social 
support 
Poor social 
integration 
Below 
mean a 
Above 
mean b 
Below 
mean c 
Above 
mean d 
Below 
mean e 
Above 
mean f 
Below 
mean g 
Above 
mean h 
Effects of time-invariant predictors (wave 2) on physical frailty slope factor 
Older age  0.324**  0.117  0.246*  0.157  0.342*  0.198  0.514**  0.285 
Female gender  0.171 -0.174  0.106  0.012 -0.139  0.262  0.002  0.179 
Obesity  0.079  0.199*  0.112  0.112  0.026  0.220  0.069  0.407* 
Underweight -0.131  0.197 -0.081  0.041 -0.112  0.021 -0.110  0.047 
Smoking history -0.001 -0.087 -0.046  0.042 -0.091 -0.021 -0.204  0.046 
High alcohol intake -0.045  0.138 -0.014  0.093  0.002  0.020  0.009  0.054 
Low education -0.063  0.029 -0.018 -0.038 -0.047 -0.024 -0.014 -0.156 
Low wealth  0.171* -0.029  0.094  0.048  0.162  0.024  0.233  0.101 
Effects of lagged time-varying predictors (waves 1, 2, and 4) on physical frailty factor (waves 2, 4, and 
6) 
Chronic disease 0.233** 0.243** 0.240** 0.229** 0.261** 0.216** 0.247** 0.222** 
Allostatic load 0.078** 0.099** 0.108** 0.135** 0.109** 0.109** 0.095** 0.121** 
Low physical 
activity 
0.132** 0.140** 0.185** 0.189** 0.164** 0.208** 0.176** 0.191** 
Depressive 
symptoms 
0.098** 0.120** 0.054** 0.038* 0.127** 0.101** 0.111** 0.122** 
Cognitive 
impairment 
0.177** 0.207** 0.203** 0.164** 0.187** 0.181** 0.181** 0.180** 
Poor social  
support 
0.091** 0.058* 0.071** 0.009 0.068** 0.012 0.059** 0.072** 
Poor social 
integration 
-0.015 0.032 0.005 0.008 0.003 0.010 0.019 -0.011 
 
* Indicates p-value <0.05 but >=0.0125 
** Indicates p-value <0.0125 (to take into account Bonferroni’s correction for 4 comparison models) 
N = a2,819 b1,819 c3,324 d1,314 e2,275 f2,363 g2,244 h2,394 
For time-invariant predictors, standardized coefficients are interpreted as change in physical frailty slope 
in standard deviation (SD) units for one SD increase in continuous predictors, or from zero to one for 
binary predictors (female gender, obesity, underweight, smoking history, high alcohol intake, low 
education, and low wealth). For time-varying predictors, standardized coefficients are interpreted as 
increase in physical frailty factor in SD units for their one SD increase. 
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Among time-invariant predictors, female gender has a stronger effect on physical frailty change 
among those with poorer social support and poorer social integration, while obesity has a 
stronger effect on physical change among those with lower physical activity, poorer social 
support, and poorer social integration. However, all these differences do not reach statistical 
significant levels. Among time-varying predictors, allostatic load has a stronger effect on future 
physical frailty among those with more depressive symptoms and poorer social integration, 
while low physical activity has a stronger effect on those with poorer social support. Yet again, 
these differences are relatively small and not statistically significant. 
 
Indirect or mediated effects of time-varying predictors on physical frailty slope factor are shown 
in Table 5. Among these, the indirect effects of low physical activity, depressive symptoms, and 
cognitive impairment on physical frailty through chronic disease and allostatic load are 
significant given their respective coefficients in the first column. Indirect effects through chronic 
disease are stronger than those through allostatic load. Together, they account for at most one-
fifth of the total effects of these predictors (results not shown). The indirect effects through 
chronic disease are generally consistent across gender and age group. The exceptions are that 
of cognitive impairment, which is stronger among those in the younger age group, and poor 
social support, which are stronger among women and those in the older age group. The indirect 
effect of depressive symptoms through allostatic load is stronger in men. However, all these 
differences are not statistically significant. 
 
The results for moderation of indirect effects are provided in the Supplementary Materials 
(Table 8). Overall, there are minor and non-significant differences in indirect effects across 
categories of low physical activity, depressive symptoms, poor social support, and poor social 
integration. The exception is the stronger indirect effect of poor social support through chronic 
disease among those with poorer social integration, with the difference being statistically 
significant at the 5% level, but not at the 1.25% level. 
 
Sensitivity analyses that explore MNAR by incorporating the Wu and Carroll selection model in 
Model 1 indicate that there are only minor differences in predictor coefficients, with those 
predicting future physical frailty being smaller, when compared with those assuming MAR using 
FIML. Their comparative results are shown in the Supplementary Materials (Table 9) . Notably, 
age significantly predicts greater increase in physical frailty levels over time, while smoking 
predicts initial physical frailty levels, but being underweight does not in the selection model. 
Other than these differences, the list of significant predictors is identical to that for the original 
model assuming MAR. In other words, assuming the worst-case scenario that missing values 
due to dropout by death or other reasons are MNAR does not change the interpretation of the 
key results. Furthermore, specifying depressive symptoms with the full set of eight items of the 
CESD instrument rather than just six of them as we did only results in marginal changes in the 
coefficient for depressive symptoms (results not shown). It is also worth mentioning that most of 
the key findings on moderation are significant when accounting for multiple comparisons with 
Bonferroni’s correction. 
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Table 5. Effects of predictors (waves 1, 2, and 4) on future physical frailty (waves 2, 4, 
and 6) mediated by chronic disease and allostatic load (waves 2, 4, and 6): standardized 
coefficients from latent growth curve models  
 
 All Gender Age 
Male Female <75 years >=75 years 
Indirect effect on physical frailty through chronic disease: 
Low physical activity  0.052*  0.047*  0.054*  0.048*  0.065* 
Depressive symptoms  0.036*  0.041*  0.029*  0.038*  0.041* 
Cognitive impairment  0.015*  0.020*  0.014*  0.017*  0.004 
Poor social support  0.007  0.004  0.013*  0.013*  0.001 
Poor social integration -0.004 -0.001 -0.008 -0.003 -0.012 
Indirect effect on physical frailty through allostatic load: 
 Low physical activity  0.007*  0.009*  0.004  0.009*  0.004* 
 Depressive symptoms  0.002*  0.008* <0.001  0.002*  0.004* 
 Cognitive impairment  0.004*  0.002*  0.003  0.003*  0.006 
 Poor social support  0.001  0.003  0.001  0.003 -0.003 
 Poor social integration  0.001  0.002 <0.001 <0.001  0.002 
 
* Indicates p-value <0.05 
Standardized coefficients are interpreted as increase in physical frailty factor in SD units for one SD 
increase in the predictors. 
N = 4,638 (all), 2,070 (male), 2,568 (female), 2,643 (less than 75 years old), and 1,995 (at least 75 years 
old) 
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Discussion 
 
While much work has already done on predictors of physical frailty in older people, less is 
known on for whom and how they exert their effects. Thus, this study not only concerns the 
effects of multidimensional predictors, but also their moderators and indirect effects. We adopt 
a life course approach to the extent that we include candidate predictors of physical frailty that 
reflect conditions in earlier life such as allostatic load, smoking history, low education, and 
perhaps low wealth. However, genetic influences and childhood social conditions are not 
included although it will be ideal to do so. Although ELSA includes a life history interview 
conducted at wave 3, information on adverse circumstances in childhood is not available for 
about half of our study population, including those who died or dropped out by then. 
Furthermore, genetic influences are not the focus of this study. 
 
Observing associations between baseline physical frailty and conditions measured concurrently 
does not necessarily permit understanding of the direction of effect. Rather, these associations 
describe how physical frailty levels vary with a broad set of physical, psychological, and social 
conditions in older people. Nevertheless, obesity, low education, and low wealth may to an 
extent reflect prior health and social conditions in early to mid-life, and therefore, can arguably 
be considered predictors of initial physical frailty. In the case of smoking, its association with 
initial physical frailty may be attenuated and therefore, not significant due to selection effects in 
that smokers with more adverse health may have died and are not available for inclusion in the 
study at wave 2. However, the direction of effect is less certain for high alcohol intake. Indeed, 
the negative association between high alcohol intake and initial physical frailty may be 
explained by reverse causality where people with higher frailty levels are likely to consume less 
alcohol by reason of their ill health. 
 
On the other hand, we can be more confident of the predictive effects of those conditions 
associated with future physical frailty given their explicit temporal relationship. Here, we find 
that chronic disease, allostatic load, low physical activity, depressive symptoms, cognitive 
impairment, and poor social support all predict increase in future physical frailty levels after 
accounting for the effects of other measured predictors. In other words, these predictors 
adversely influence the trajectory of physical frailty over time. These findings provide some 
measure of evidence for their possible causal effects on physical frailty if we assume that the 
physical, psychological, and social predictors controlled for in our analyses are sufficient to 
account for important confounding due to omitted variables. In general, our findings are 
consistent those of previous studies that demonstrate the effects of specific predictors while 
addressing potential confounding to varying degrees. These include evidence that low physical 
activity increases the risk of developing frailty, with sedentary behavior being a distinct risk 
factor (Song et al., 2015). However, we did not observe that female gender, obesity, 
underweight, smoking, high alcohol intake, low education level, low wealth, and poor social 
interaction influence physical frailty progression as suggested by previous studies (Etman et al., 
2012; Gruenewald et al., 2009; Peek et al., 2012; Strawbridge et al., 1998; Syddall et al., 2010; 
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Woods et al., 2005). It is possible that female gender, low education, and low wealth may have 
already exerted a major part of their effects on initial physical frailty, and thus may not have any 
additional and significant impact during the follow-up years of our study. Furthermore, the 
effects of other predictors such as obesity, underweight, and poor social integration may 
overlap with those of stronger predictors and be subsumed under the effects of the latter. 
Finally, our choice for operationalization of predictors may not be optimal with respect to 
representing the intended constructs, thereby resulting in attenuation of any true effects. 
 
We could not demonstrate any significant gender- or age-specific effects of predictors of 
physical frailty. In addition, we did not find evidence of moderation by low physical activity, 
depressive symptoms, poor social support, and poor social integration, because observed 
differences in effects of predictors are not statistically significant across categories of these four 
conditions. 
 
However, we identify chronic disease and allostatic load as mediators of indirect effects on 
physical frailty, albeit only for selected predictors. Specifically, these two conditions mediate the 
effects of low physical activity, cognitive impairment, and depressive symptoms. To date, 
similar findings have not been reported. These findings answer in part the question on how 
predictors exert their effects. Another point worth highlighting is that we have restricted the 
choice of candidate mediators to those identified by the Canadian working framework 
(Bergman et al., 2004). It is quite possible that other lifestyle-related and psychological 
conditions may also have roles as mediators. This is a subject for further investigation. Finally, 
we demonstrate the moderating effect of poor social integration on the indirect effect of poor 
social support through chronic disease, which reflects the role of social conditions on pathways 
to physical frailty. To a limited extent, this finding answers the question of for whom the indirect 
effect of predictors of physical frailty is stronger. 
 
From a methodological perspective, our study has a few important limitations. Firstly, it is an 
observational investigation using secondary data. This imposes limits to which we are able to 
specify predictors especially those in the psychological and social domains. However, using the 
available data, we are able to operationalize established measurement instruments such as 
CESD for depressive symptoms, and implement composite measures devised by others to 
represent more complex constructs like poor social support and poor social integration (Banks 
et al., 2010). Beyond measurement, there is the possibility that unobserved confounding due to 
omitted variables exists, thereby introducing bias in our results. In the attempt to address this, 
we have carefully included a broad set of important physical, psychological, and social 
predictors based on the existing literature and have controlled for them in our analyses. As 
mentioned, genetic influences and early childhood social conditions are not included as 
predictors. Of interest, childhood socioeconomic position was found to be associated with 
relatively small reductions in gait speed and grip strength (Birnie et al., 2011). Nevertheless, 
unless the effects of omitted variables such as these are large and highly correlated with those 
of other predictors, it is not very likely that any residual confounding will be severe enough to 
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alter our study conclusions. Secondly, missing values which are inevitable in a longitudinal 
study such as ours pose challenges to validity. These are handled by FIML, which assumes 
that missing values are MAR. However, missing values due to dropout or death may be MNAR, 
given that their occurrence may be conditional on prior values of physical frailty. Thus, by way 
of sensitivity analyses, we incorporate more advanced modeling that takes into account that 
missing values may be MNAR. Indeed, these additional analyses using the shared parameter 
model which regresses binary missing data indicators on the two growth factors did not change 
the main results more than trivially, thus providing greater reassurance that our study 
conclusions are robust to missing values. Finally, our use of separate models for estimating 
moderating effects increases the risk of discovering significant effects purely by chance. To 
reduce this risk, we restrict our analyses to those investigating a limited set of pathways that 
are defined a priori, and use Bonferroni’s correction to account for multiple comparisons. 
Applying the latter procedure, most of our key results remain statistically significant. 
 
Our findings are relevant to health and social policy formulation. Particularly, knowledge of 
predictors of physical frailty progression as well as their mediators and moderators provides 
guidance on thinking about how physical frailty may be potentially modified by interventions. 
Based on the findings of our study, chronic disease, allostatic load, low physical activity, 
depressive symptoms, cognitive impairment, poor social support, and poor social integration 
represent potential target conditions for programs and policies directed at reducing physical 
frailty in older people. Moreover, obesity, low education, and low wealth probably represent 
prior conditions that could be better addressed in young and middle-aged people in the hope of 
reducing the risk of developing physical frailty as they transit to later life. While it might be 
argued that health and social care initiatives to address some of these issues may already exist 
in certain jurisdictions, focus on addressing specific components of allostatic load that have to 
date received less attention. For example, reducing chronic systemic inflammation from early 
life through lifestyle changes in diet, weight loss, and exercise is a specific area for attention 
(Nicklas et al., 2005). Equally important, population-level initiatives to identify depression and 
facilitate or encourage physical activity may need to be drawn up or may bear strengthening 
even if already in place. Poor social support is a more challenging issue to address at it occurs 
at the personal relationship level. Public education that highlights the importance of increasing 
social support, and particularly, that of providing emotional support should be explored. Poor 
social integration may be addressed by provision of interventions designed to reduce social 
isolation including social facilitation interventions involving group-based activities such as 
friendship clubs, day care centers, and social networking, Other useful interventions are health 
and social care in the form of community gatekeepers, geriatric rehabilitation, and visitation 
programs, as well as leisure and skill development activities such as gardening programs, 
computer use, and voluntary work (Gardiner et al., 2016).  
 
Although our findings are informative, they nevertheless point to specific gaps in our 
understanding of physical frailty in older people. To begin with, further research to identify 
specific subgroups for whom the predictive effects on physical frailty are stronger is needed. 
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Psychological deficits and adverse social conditions may define these subgroups. Finally, and 
as alluded to earlier, the possibility of alternative mediators including psychological conditions 
such as depression should be explored. 
 
In conclusion, our study validates at least in part the pathways to frailty put forth by the 
Canadian working framework (Bergman et al., 2004). Potentially modifiable predictors of future 
physical frailty in late life extend across more than one domain, and include low physical 
activity, cognitive impairment, depressive symptoms, and poor social support. In addition, 
obesity, low education, and low wealth may be addressable predictors in early or mid-life. 
Moreover, chronic disease and allostatic load are mediators, while poor social integration is a 
moderator on pathways to physical frailty. These findings provide supporting evidence for multi-
pronged population-level health and social interventions that target these conditions in broad 
strategies for minimizing the development or worsening of physical frailty in older people. 
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Mathematical equations for the statistical models 
 
Let yti denote physical frailty for individuals i = 1..., n at times t = 0, 1, and 2 corresponding to 
waves 2, 4, and 6 respectively, and let xi be a vector of time-invariant predictors and wt-1i be a 
vector of lagged time-varying predictors for yti. 
 
The latent growth curve model for yti (Model 1) is  
yti = η0i + η1it + γwt-1i + εti 
for subject i at times t = 0, 1, and 2, where εti is a normally distributed residual with mean 0 and 
variance σε, and where 
η0i = α0 + β0xi + ζ0i      (a) 
η1i = α1 + β1xi + ζ1i      (b) 
are referred to as the intercept growth factor and the slope growth factor (i.e. the coefficient of 
time t) respectively, and where ζ0i and ζ1i are normally distributed random effects with means 0 
and variances σζ0 and σζ1 and covariance σζ01. 
 
Here, the coefficients β0 describe the associations between the time-invariant predictors and 
physical frailty at wave t = 0, the coefficients β1 the effect of time-invariant predictors on the 
coefficient of t on physical frailty (the time slope), and the coefficients γ the association between 
time-varying predictors and within-person change in physical frailty, The estimated coefficients 
β0, β1, and γ for different predictors are shown in Table 2, and the upper and lower parts of 
Table 3 respectively. 
 
To estimate gender- and age-specific effects, we use the same latent growth curve model for 
yti, but stratified into two subgroups according to gender and age group. 
 
Moderation: Here, we use the latent growth curve model for yti (Model 1) again, but stratified 
into two subgroups according to four moderating variables, namely low physical activity, 
depressive symptoms, poor social support, and poor social integration (Model 2). 
 
Mediation: Here we use the results of standard linear path analysis, applied to model (b) for the 
slope factor. For simplicity of notation in introducing the idea, consider the case of two lagged 
time-varying predictors wt-1i = (vt-1i, mt-1i) (the extension to cases with more variables is also 
analogous), the latent growth curve model for yti is then 
yti = η0i + η1it + γ1vt-1i + γ2mt-1i + εti 
Again, suppose further that  
mt-1i = λ0 + λ1vt-1i + δt-1i. 
Then the model given vt-1i only, averaging over the distribution of mt-1i, is  
yti = η0i + η1it + γ*1vt-1i + ε*ti 
where ε*ti = (εti + γ2δt-1i) and γ∗1 = γ1 + γ2λ1. Here γ∗1 is the total effect of the variable vt-1i on yti, γ1 
is the direct effect of vt-1i, and γ2λ1 the indirect effect of vt-1i mediated via mi (Model 3). 
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Here, to estimate gender- and age-specific effects, we use the same mediation model, but 
stratified into two subgroups according to gender and age group. 
 
Moderated mediation: Here, we use the latent growth curve model for yti including mediated 
effects (Model 3) but stratified into two subgroups according for gender, age group, and four 
moderating variables, namely low physical activity, depressive symptoms, negative social 
interactions, and weak social network. 
 
Here, we use the same mediation model (Model 3) again, but stratified into two subgroups 
according to four moderating variables, namely low physical activity, depressive symptoms, 
poor social support, and poor social integration (Model 4). 
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Figure 3. Path diagram of Model 1: conditional latent growth curve model with time-
invariant and time-varying predictors 
 
 
 
 
 
 
w1: wave 1   w2: wave 2   w4: wave 4   w6: wave 6 
Circle: latent variable 
Rectangle: observed variable 
Single-headed straight arrow: effect of one variable on another 
Double-headed curved arrow: covariance between two variables 
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Figure 4. Path diagram of Model 3: conditional latent growth curve model with time-
invariant and time-varying predictors, and time-varying mediators 
 
 
 
 
 
 
w1: wave 1   w2: wave 2   w4: wave 4   w6: wave 6 
Circle: latent variable 
Rectangle: observed variable 
Single-headed straight arrow: effect of one variable on another 
Double-headed curved arrow: covariance between two variables 
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Figure 5. Path diagram of Model 1: conditional latent growth curve model with time-
invariant and time-varying predictors, and incorporating Wu and Carroll selection model 
(Enders, 2011) to handle missing not at random (MNAR) data 
 
 
 
 
 
 
 
w1: wave 1   w2: wave 2   w4: wave 4   w6: wave 6 
Circle: latent variable 
Rectangle: observed variable 
Single-headed straight arrow: effect of one variable on another 
Double-headed curved arrow: covariance between two variables 
Single-headed straight arrow (dashed): effect of one variable on another (for Wu and Carroll selection model) 
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Table 6. Characteristics of English Longitudinal Study of Ageing (ELSA) wave 2 
respondents aged 65 to 89 years included in analyses: physical frailty-related variables 
(waves 2, 4, and 6) 
 
Variables All By gender By Age group 
Male Female < 75 years >= 75 years 
Physical frailty: 
Mean average walking 
speed, m/sec (SD):  
                         Wave 2 
                         Wave 4 
                         Wave 6 
Hand grip strength, kg 
(SD):                Wave 2 
                         Wave 4 
                         Wave 6 
Exhaustion, n/N (%): 
                         Wave 2 
 
                         Wave 4 
 
                         Wave 6 
 
Frailty by Frailty Index 
n/N (%):           Wave 2 
 
                        Wave 4 
 
                        Wave 6 
 
 
 
 
0.8 (0.3)1 
0.8 (0.3)6 
0.8 (0.3)11 
 
25.9 (10.2)16 
24.3 (10.2)21 
22.8 (9.5)26 
 
1,490/4,510 
(33.0) 
955/2,977 
(32.1) 
632/1,962 
(32.2) 
 
717/3,647 
(19.7) 
507/2,371 
(21.4) 
438/1,774 
(24.7) 
 
 
 
0.9 (0.3)2 
0.8 (0.3)7 
0.8 (0.3)12 
 
33.4 (8.9)17 
32.0 (9.0)22 
29.6 (8.8)27 
 
568/1,997 
(28.4) 
327/1,290 
(25.4) 
218/848 
(25.7) 
 
236/1,639 
(14.4) 
158/1,051 
(15.0) 
145/768 
(18.9) 
 
 
 
0.8 (0.3)3 
0.7 (0.3)8 
0.7 (0.3)13 
 
19.6 (6.1)18 
18.2 (6.2)23 
17.5 (5.9)28 
 
922/2,513 
(36.7) 
628/1,687 
(37.2) 
414/1,114 
(37.2) 
 
481/2,008 
(24.0) 
349/1,320 
(26.4) 
293/1,006 
(29.1) 
 
 
 
0.9 (0.3)4 
0.8 (0.3)9 
0.8 (0.3)14 
 
28.4 (10.2)19 
26.6 (10.3)24 
24.4 (9.6)29 
 
728/2,596 
(28.0) 
518/1,868 
(27.7) 
401/1,402 
(28.6) 
 
322/2,207 
(14.6) 
279/1,571 
(17.8) 
285/1,325 
(21.5) 
 
 
 
0.7 (0.3)5 
0.7 (0.2)10 
0.6 (0.2)15 
 
22.2 (9.0)20 
20.4 (8.6)25 
18.9 (7.9)30 
 
762/1,914 
(39.8) 
437/1,109 
(39.4) 
231/560 
(41.3) 
 
395/1,440 
(27.4) 
228/800 
(28.5) 
153/449 
(34.1) 
 
Frailty: Frailty Index >=0.25 
N = 14,096 21,826 32,266 42,400 51,692 62,649 71,182 81,467 91,705 10944 111,688 12754 13934 141,254 15434 
163,869 171,760 182,109 192,276 201,593 212,531 221,115 231,416 241,621 25910 261,868 27820 281,048 291,339 
30529 
 
147 
 
Table 7. Characteristics of English Longitudinal Study of Ageing (ELSA) wave 2 
respondents aged 65 to 89 years included in analyses: time varying predictors and 
mediators across waves  
 
Variables All By gender By Age group 
Male Female < 75 years >= 75 years 
Physical: 
Mean chronic disease 
count [out of 14] (SD): 
                          Wave 2                                                  
                          Wave 4 
                          Wave 6 
Mean allostatic load 
score [out of 8] (SD):    
                         Wave 2 
                         Wave 4 
                         Wave 6 
Mean low physical 
activity level, n (%):                  
                         Wave 1 
                         Wave 2 
                         Wave 4 
 
 
 
1.9 (1.4)1 
2.2 (1.5)6 
2.1 (1.5)11 
 
 
2.0 (1.5)16 
2.2 (1.5)21 
2.6 (1.2)26 
 
1.1 (0.9)31 
1.2 (0.9)36 
1.3 (1.0)41 
 
 
 
1.8 (1.4)2 
2.1 (1.5)7 
1.9 (1.4)12 
 
 
1.9 (1.5)17 
2.0 (1.4)22 
2.5 (1.2)27 
 
 
1.0 (0.9)32 
1.1 (0.9)37 
1.2 (1.0)42 
 
 
 
2.0 (1.4)3 
2.4 (1.5)8 
2.2 (1.5)13 
 
 
2.1 (1.5)18 
2.3 (1.5)23 
2.6 (1.2)28 
 
 
1.2 (0.9)33 
1.3 (0.9)38 
1.4 (0.9)43 
 
 
 
1.8 (1.4)4 
2.1 (1.5)9 
2.0 (1.5)14 
 
 
1.9 (1.5)19 
2.1 (1.5)24 
2.6 (1.2)29 
 
 
1.0 (0.9)34 
1.0 (0.9)39 
1.1 (0.9)44 
 
 
 
2.1 (1.5)5 
2.5 (1.6)10 
2.3 (1.5)15 
 
 
2.1 (1.5)20 
2.4 (1.4)25 
2.5 (1.1)30 
 
 
1.3 (0.9)35 
1.4 (0.9)40 
1.7 (1.0)45 
Psychological: 
Mean CESD-8 score  
[0 to 8] (SD):      Wave 1 
                          Wave 2 
                          Wave 4 
Mean cognitive 
impairment score  
[0 to 49] (SD):   Wave 1 
                         Wave 2 
                         Wave 4 
 
 
1.5 (1.9)46 
1.7 (2.0)51 
1.5 (1.9)56 
 
 
25.0 (6.6)61 
27.5 (6.3)66 
25.6 (6.8)71 
 
 
1.2 (1.7)47 
1.3 (1.7)52 
1.1 (1.7)57 
 
 
25.2 (6.7)62 
26.3 (6.4)67 
25.8 (6.6)72 
 
 
1.8 (2.0)48 
1.9 (2.1)53 
1.8 (2.0)58 
 
 
24.7 (6.5)63 
25.5 (6.5)68 
25.5 (6.9)73 
 
 
1.4 (1.9)49 
1.5 (1.9)54 
1.3 (1.8)59 
 
 
23.1 (6.2)64 
24.1 (6.0)69 
24.0 (6.2)74 
 
 
1.7 (2.0)50 
1.9 (2.0)55 
1.8 (2.0)60 
 
 
27.5 (6.3)65 
28.4 (6.3)70 
28.6 (6.7)75 
Social: 
Mean poor social 
support score  
[0 to 54] (SD):   Wave 1 
                         Wave 2 
                         Wave 4 
Mean low poor social 
integration score  
[0 to 14] (SD):   Wave 1 
                         Wave 2 
                         Wave 4 
 
 
 
13.6 (7.1)76 
13.7 (7.0)81 
13.6 (6.9)86 
 
 
6.6 (2.5)91 
6.6 (2.5)96 
6.8 (2.5)101 
 
 
 
14.9 (7.1)77 
14.7 (7.0)82 
14.5 (7.1)87 
 
 
6.7 (2.6)92 
6.7 (2.6)97 
6.8 (2.6)102 
 
 
 
12.6 (6.8)78 
12.9 (6.8)83 
12.8 (6.6)88 
 
 
6.5 (2.5)93 
6.5 (2.5)98 
6.7 (2.4)103 
 
 
 
13.8 (7.1)79 
13.9 (7.0)84 
13.7 (7.0)89 
 
 
6.3 (2.5)94 
6.4 (2.5)99 
6.6 (2.4)104 
 
 
 
13.3 (7.0)80 
13.3 (6.8)85 
13.2 (6.6)90 
 
 
6.9 (2.6)95 
7.0 (2.6)100 
7.2 (2.6)105 
 
CESD-8: Center for Epidemiologic Studies Depression Scale (8 items) 
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N = 14,608 22,052 32,556 42,617 51,99163,115 71,350 81,765 91,909 101,206 112,400 121,022 131,378 141,642 
15758 162,319 171,064 181,255 191,436 20883 211,504 22668 23836 241,034 25470 26996 27440 28556 29763 30233 
314,572 322,036 332,536 342,597 351,975 364,567 372,032 382,535 392,611 401,956 413,125 421,355 431,770 
441,915 451,210 464,484 471,999 482,485 492,4557 501,927 514,479 521,987 532,492 542,586 551,893 562,960 
571,285 581,675 591,859 601,101 614,371 621,954 632,417 642,503 651,868 664,349 671,946 682,403 692,546 
701,803 712,605 721,145 731,460 741,680 75925 763,530 771,605 781,925 792,105 801,425 813,339 821,529 
831,810 842,068 851,271 862,236 871,000 881,236 891,473 90763 913,597 921,641 931,956 942,144 951,453 
963,267 971,506 981,761 992,035 1001,232 1012,184 102984 1031,200 1041,445 105739 
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Table 8. Moderation of mediated effects on future physical frailty: standardized 
coefficients from latent growth curve models implementing multiple groups  
 
 Low physical 
activity 
Depressive 
symptoms 
Poor social 
support 
Poor social 
integration 
Below 
mean a 
Above 
mean b 
Below 
mean c 
Above 
mean d 
Below 
mean e 
Above 
mean f 
Below 
mean g 
Above 
mean h 
Indirect effect on physical frailty through chronic disease: 
Low physical 
activity 
0.027** 0.053** 0.051** 0.052** 0.054** 0.052** 0.051** 0.054** 
Depressive 
symptoms 
0.039** 0.030** 0.037** 0.024** 0.042** 0.033** 0.042** 0.032** 
Cognitive 
impairment 
0.013** 0.012 0.016** 0.014 0.020** 0.012* 0.023** 0.014* 
Poor social 
support 
0.007 0.010 0.006 0.007 0.005 0.006 0.004Ɨ 0.016*Ɨ 
Poor social 
integration 
-0.004 -0.007 -0.002 -0.011 -0.004 -0.004 -0.003 -0.007 
Indirect effect on physical frailty through allostatic load: 
Low physical 
activity 
0.005* 0.003  0.008*  0.005  0.010*  0.006*  0.007  0.006* 
Depressive 
symptoms 
0.002* 0.001  0.003*  0.002  0.003*  0.002*  0.001  0.003* 
Cognitive 
impairment 
0.003 0.004  0.003*  0.005  0.007*  0.002  0.002  0.006* 
Poor social 
support 
0.002 -0.001  0.001  0.001  0.002  <0.001  0.002  0.001* 
Poor social 
integration 
<0.001 0.001 -0.001  0.004  0.000  0.001  0.001 <0.001 
 
* Indicates p-value <0.05 but >=0.0125 
** Indicates p-value <0.0125 (to take into account Bonferroni’s correction for 4 comparison models) 
Ɨ Indicates moderation with p-value <0.05 but >=0.0125 
N=4,638 (all), 2,070 (male), 2,568 (female), 2,643 (less than 75 years old), and 1,995 (at least 75 years 
old) 
For subgroups, N = a2,819 b1,819 c3,324 d1,314 e2,275 f2,363 g2,244 h2,394 
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Table 9. Sensitivity analyses to explore data being missing not at random (MNAR): 
standardized coefficients from latent growth curve models 
 
Predictor MAR: using FIML MNAR: using shared 
parameter model 
Effects of time-invariant predictors (wave 2) on physical frailty intercept factor 
    Older age  0.563*  0.586* 
    Female gender  0.419*  0.191* 
    Obesity  0.101*  0.126* 
    Underweight  0.051*  0.042 
    Smoking history  0.038  0.045* 
    High alcohol intake -0.101* -0.118* 
Low education  0.147*  0.167* 
Low wealth  0.113*  0.132* 
Effects of time-invariant predictors (wave 2) on physical frailty slope factor 
    Older age  0.288  0.367* 
    Female gender  0.062  0.059 
    Obesity  0.156  0.104 
    Underweight -0.040  0.053 
    Smoking history -0.058 -0.072 
    High alcohol intake  0.019  0.067 
Low education -0.058 -0.028 
Low wealth  0.100  0.063 
Effects of lagged time-varying predictors (waves 1, 2, and 4) on physical frailty factor (waves 2, 
4, and 6) 
    Chronic disease  0.236*  0.178* 
    Allostatic load  0.108*  0.067* 
    Low physical activity  0.189*  0.145* 
    Depressive symptoms  0.115*  0.099* 
    Cognitive impairment  0.182*  0.097* 
    Poor social support  0.067*  0.059* 
    Poor social integration  0.007 -0.016 
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8.3 Further Thoughts 
 
Although predictors of physical frailty with effects in early or mid-life such as obesity, low 
education, and wealth are identified in this study, the main purpose here is to uncover 
conditions that increase risk of developing physical frailty or its worsening when a person is 
already in late life. Gratifyingly, the effects of a number such conditions in lifestyle-related, 
psychological, and social domains have been identified. These include low physical activity, 
depressive symptoms, cognitive impairment, poor social support, and poor social integration. 
Given the potential for their modification by interventions in older people, these conditions 
deserve attention in the formulation of health and social strategies. While prevention of chronic 
disease is already an established component of these strategies in most places, allostatic load 
is more complex entity that requires a multi-pronged approach to address its different 
components. 
 
Notwithstanding efforts directed at preventing or slowing down the progression of physical 
frailty in older people, we can only expect reduction of physical frailty to be achieved in part. 
Even with the most appropriate health and social interventions, many older people will still 
continue to develop physical frailty with advancing age. Thus, it is imperative that we also turn 
our attention to examining the effects of physical frailty. Understanding the pathways from 
physical frailty to these adverse outcomes will be the focus of the rest of my thesis. 
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9 Fourth Paper 
 
9.1 Introduction 
 
Having identified the predictors of physical frailty and their moderated and indirect effects, I will 
now proceed to explore key adverse outcomes of physical frailty in older people, namely death 
and activity limitation. In the fourth paper, I will focus on its effect on death. We already know 
that frailty increases the risk of death (Buchman et al., 2009; Cawthon et al., 2007; Gu et al., 
2009; A. B. Mitnitski et al., 2004; Rockwood et al., 2011). What is less clear are for whom 
physical frailty has stronger effect on death, and how physical frailty leads to death. In other 
words, there is less evidence available on moderators and indirect effects of physical frailty on 
death. A good understanding of pathways from physical frailty to death can inform public health 
and social policy on appropriate strategies for improving longevity in older people. To this end, 
the fourth paper seeks to examine the negative effects of physical frailty on longevity, and pays 
attention to moderators and indirect effects. 
 
The research aim is to explore the validity of a framework of pathways from frailty to death by 
quantifying the relationship of physical frailty with multidimensional conditions on these 
pathways. I will seek to answer the research question: “Which physical, psychological, and 
social conditions moderate or mediate the effect of physical frailty on death in older people?” 
 
For the conceptual model for pathways from physical frailty to death, I will again adopt the 
working framework proposed by the Canadian Initiative on Frailty and Aging (Bergman et al., 
2004). The right side of the working framework on pathways to frailty is now the focus of this 
paper, and is reproduced in Figure 9.1 (page 153). As for the third paper, physical frailty is 
specified with three indicators rather than the seven components proposed in this framework 
(box on the left in Figure 9.1). That aside, the challenge is to identify the biological, 
psychological, and social conditions represented by the assets and deficits (lower right corner 
of Figure 9.1), which moderate the effect of physical frailty on death (arrow to that path).  The 
foregoing literature review identified that in the Canadian Study of Health and Aging, death 
rates for those aged over 75 years who exercised were similar to those aged from 65 to 75 
years who did not exercise. This effect was seen across gender and different degrees of frailty, 
but with the largest health benefits of exercise found among those participants who were more 
frail at baseline (Hubbard et al., 2009a). Apart from this, good evidence on specific conditions 
influencing the effect of frailty on death is not found.  
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Figure 9.1: Pathways from frailty to its adverse effects adapted from the working 
framework of the proposed by the Canadian Initiative on Frailty and Aging (Bergman et 
al., 2004) 
 
 
 
 
 
Guided by this limited evidence, I will examine the role of low physical activity as a moderator of 
the effect of physical frailty on death. In line with the categories of conditions put forth in Figure 
9.1, I will also explore the possibility that psychological and social conditions such as 
depressive symptoms, poor social support, and poor social integration assume roles as 
moderators. In addition, I will explore the possible mediating roles of physical and psychological 
conditions such as low physical activity, depressive symptoms, and cognitive impairment on 
these pathways. 
 
Physical frailty will again be measured by its three indicators, namely slowness, weakness, and 
exhaustion at wave 2. Unlike in the third paper and for the sake of simplicity, I will not 
incorporate the measurement model for physical frailty in the full model, but rather will use 
unique physical frailty factor scores for each respondent that are derived from confirmatory 
factor analysis. Death across waves 3 to 5 is the outcome of interest. Given that this is a binary 
outcome at three time intervals, I will use discrete time survival analysis to estimate the effect of 
physical frailty. A rich set of physical, psychological, and social predictors (wave 2) of death will 
be included as control variables in the model. In addition, and as mentioned, selected 
conditions will be included in the models as moderators and mediators of the effect of physical 
frailty. 
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To examine moderation, I will include interaction variables of physical frailty with other 
predictors, one at a time in successive models to screen for significant effects. Probing of 
significant moderated effects will be performed to estimate the effect of physical frailty on death 
at different levels of the moderating variable. 
 
For indirect effects, the methodological considerations are more complex. In the tradition of 
regression-based mediation analysis, I will use the product of coefficients to estimate the 
magnitude of these indirect effects. Sobel’s test will be used to test their statistical significiance 
(Sobel, 1982). Of note, these mediation analyses stand on five assumptions. The first three are 
the adequate control for physical frailty-death, physical frailty-mediator, and mediator-death 
confounding, which would apply to any observational study. To address test assumptions, I will 
employ a series of sensitivity analyses to explore the potential impact of residual unmeasured 
confounding. Parameters of an unmeasured confounder, represented by a “phantom” latent 
variable, that would be required to shift the estimated effect of physical frailty to a non-
significant level will be identified (VanderWeele, 2015). The idea is to estimate how sensitive 
the results are to unmeasured confounding. The fourth assumption is that there should not be 
any mediator-death confounder that is itself affected by physical frailty. However, testing for the 
violation of this assumption would require more complicated modeling (Daniel et al., 2013) that 
is beyond the ambit of this paper. The fifth assumption requires that there is no physical frailty-
mediator moderation. This is accounted for by inclusion of physical frailty-mediator interaction 
in the model. 
 
The following paper examines pathways from physical frailty to death. As before, some of the 
foregoing key points are unavoidably repeated as this is a self-contained journal article. 
References specifically for this paper are yet again provided in a separate list just before the 
Supplementary Materials (page 177 to 180). Relevant Mplus input files are provided in the 
Appendix. At the time of writing, this paper is being considered for publication in a gerontology 
journal. 
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9.2 Impact of physical frailty on longevity: identifying pathways in the English 
Longitudinal Study of Ageing 
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Abstract 
 
We seek to examine the negative impact of physical frailty on longevity in older people, and to 
identify for whom its effect is stronger, and understand how it exerts its effect. For 4,638 
respondents aged 65 to 89 years of the English Longitudinal Study of Ageing, confirmatory 
factor analysis for physical frailty using three indicators, namely slowness, weakness, and 
exhaustion is performed to obtain unique factor scores. Using discrete time survival analysis, 
we estimate the effect of physical frailty factor score on death over three waves (6 years), while 
exploring moderation and mediation by key physical, psychological, and social conditions. We 
confirm that higher levels of physical frailty significantly increase death risk, even after 
accounting for the effects of a rich set of multidimensional predictors. This effect extends 
across gender and age, except for those aged at least 75 years. However, it is significantly 
weaker among those with more cognitive impairment. Moreover, there are non-significant 
trends towards this effect being stronger among those with high consumption of alcohol and 
poor social integration, but weaker among those with obesity. More importantly, significant 
indirect effects of physical frailty on death act through low physical activity and cognitive 
impairment. Based on our findings, low physical activity and cognitive impairment are 
mediators, while high alcohol consumption and poor social integration are possible moderators 
on pathways from physical frailty to death. Efforts to address these conditions represent 
opportunities to mitigate at least in part the negative impact of physical frailty on longevity in 
older people. 
 
 
 
Key words: aged, death, mediators, moderators, discrete time survival analysis, physical 
activity, depression 
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Introduction 
 
Frailty is widely regarded as the multidimensional loss of an individual’s body system reserves 
that in turn results in vulnerability to developing adverse health-related outcomes (Espinoza & 
Walston, 2005; Lally & Crome, 2007; Pel-Littel et al., 2009). It is conceptualized as a 
transitional state between robustness and functional decline (Lang et al., 2009) that is 
associated with increased risk of death, disability, falls, hospitalization, and institutionalization 
(Daniels et al., 2012; Ensrud et al., 2009; Ensrud et al., 2008; Jones et al., 2005; Kiely et al., 
2009; Pilotto et al., 2012; Woo et al., 2012). Although long recognized as an important condition 
in older people, frailty has been defined in various ways ranging from a frailty phenotype with 
five components (Fried et al., 2001) to a frailty index that adopts a multiple deficit accumulation 
approach (Rockwood & Mitnitski, 2007). Some extent of consensus on its operational definition 
has only recently been achieved (Morley et al., 2013). Nonetheless, different definitions are 
probably best suited for different purposes (Martin & Brighton, 2008). 
 
Across a spectrum of definitions applied, the prevalence of frailty is estimated to be about 10% 
among people aged 65 years or older (Collard et al., 2012). In the United Kingdom alone, the 
number of those in this age group was 11.6 million in 2015 (ONS, 2016), suggesting that 
approximately 1.2 million older people across the country are frail. The potential adverse 
outcomes of frailty and the size of its problem combine to create significant health and social 
impact for ageing populations. Thus, frailty plays a central role in influencing the well-being of 
older people and holds major public health importance (Woo et al., 2006). 
 
Previous research indicates that frailty increases the risk of mortality in older people (Buchman 
et al., 2009; Cawthon et al., 2007; Gu et al., 2009; Mitnitski et al., 2004). However, the precise 
mechanisms by which frailty exerts this effect are unclear. There is sparse knowledge on 
precise pathways from frailty to eventual death. Better understanding of these pathways 
including identification of moderators and mediators on these pathways is needed to inform 
rational public health and social policy with respect to organizing effective population-level 
interventions that could potentially reduce the impact of frailty on premature death. 
 
To conceptualize pathways from frailty to mortality, a good starting point is the working 
framework proposed by the Canadian Initiative on Frailty and Aging (Bergman et al., 2004). An 
adapted and simpler version is shown in Figure 1. In the right half of this figure, biological, 
psychological, social, and societal assets and deficits are represented as moderators on the 
pathway from frailty to adverse outcomes including death. These assets and deficits represent 
potential targets for intervention to reduce the adverse impact of frailty. More recently, Gobbens 
et al proposed the integral concept of frailty (Gobbens et al., 2010) and developed a similar set 
of frailty pathways that were in essence adapted from those of the Canadian working 
framework. Other frailty pathways have been proposed but are largely restricted to the 
biological sphere, and are therefore less suitable for a broader investigation of the effects of 
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frailty. Thus, the Canadian working framework offers a useful foundation on which to build a 
conceptual model for pathways from frailty to death. 
 
 
Figure 1. Working framework of the Canadian Initiative for Frailty and Aging (adapted 
from Bergman, 2004 with modifications) 
 
 
 
 
 
With a conceptual model of frailty pathways available, the challenge then is to identify a frailty 
specification that is suitable for investigation of these pathways. In his seminal work, 
Strawbridge recognized the multidimensional nature of frailty and conceptualized frailty as 
involving problems in at least two from among physical, nutritive, cognitive, and sensory 
domains (Strawbridge et al., 1998). More recently, the view of frailty being multidimensional has 
been expressed in part by the development of frailty identifiers that measure deficits across 
more than a single domain (Bielderman et al., 2013; Gobbens et al., 2010; Rockwood, 2005). 
However, some of the multidimensional elements in these frailty specifications are themselves 
hypothesized to be key conditions on pathways from frailty to its adverse outcomes. Having 
these elements as part and parcel of the frailty specification complicates the task of teasing out 
important relationships between frailty and these conditions. As an alternative, the integral 
concept of frailty explicitly defines frailty as having three distinct domains, namely physical, 
psychological, and social (Gobbens et al., 2010). Being able to specify frailty based on a single 
domain facilitates its disentanglement from conditions related to its other two domains. This in 
turn facilitates less constrained exploration of the relationship of frailty with physical, 
psychological, and social conditions that may operate as mediators or moderators of its effect. 
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Among these three frailty domains, physical frailty offers the most promising choice as a frailty 
specification for investigation of its pathways. There are a few reasons for this. Firstly, physical 
frailty is far better understood and a more established concept than psychological or social 
frailty are. Secondly, physical frailty contributes most to prediction of adverse outcomes among 
these three frailty domains (Gobbens et al., 2012). Finally, there exists an excellent prototype 
for physical frailty in the Cardiovascular Health Study (CHS) frailty phenotype (Fried et al., 
2001). It conceptualizes physical frailty as having five components, namely, unintentional 
weight loss, weak hand grip strength, self-reported exhaustion, slow walking speed, and low 
physical activity level. 
 
Our conceptual model for investigating the effect of physical frailty on death is shown in Figure 
2. In this model, indirect effects through physical and psychological mediators are included in 
addition to the direct effect. Furthermore, the moderation of these direct and indirect effects by 
physical, psychological, and social conditions is also incorporated (dotted lines). Thus, we base 
these pathways on those of the Canadian working framework, but advance beyond to include 
indirect effects.  
 
 
Figure 2. Conceptual model for investigation of pathways from physical frailty to death 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Following on from the foregoing discussion, our study aims to identify moderators and 
mediators of the relationship between physical frailty and death. We ask the following research 
questions: 
1) Which physical, psychological, and social conditions moderate the effect of physical 
frailty on death? 
2) Which physical and psychological conditions mediate the effect of physical frailty on 
death? 
3) Do key psychological and social conditions moderate the mediated effects (moderated 
mediation) of physical frailty on death?  
Physical 
frailty 
 
 
Death 
 
 Physical and 
psychological 
conditions 
 
 
Physical, psychological 
and social conditions 
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In addition, we ask if there are any gender- and age-specific effects of physical frailty on death. 
 
To answer these questions, we use panel data from the English Longitudinal Study of Ageing 
(ELSA). ELSA is a longitudinal survey of a representative sample of the English population 
aged 50 years and older living in their homes at baseline (Steptoe et al., 2013). It offers a broad 
range of reliable and multidimensional data across biennial waves beginning from 2002, and is 
currently still ongoing. 
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Methods 
 
Data 
 
Our study population comprises 4,638 respondents aged 65 to 89 years at wave 2 (2004) of 
ELSA (Marmot et al., 2015). Those aged 90 years and above are excluded given that their age 
is uniformly coded as “90”, and that their number is small. All participants gave informed 
consent. Ethical approval for ELSA was granted by the Multicentre Research and Ethics 
Committee. Ethical oversight for this study is provided by procedures of the London School of 
Economics Ethics Policy. 
 
Physical frailty is specified by three indicators drawn from those of the CHS frailty phenotype 
(Fried et al., 2001), namely slowness, weakness, and exhaustion. Slowness is the average gait 
speed (in m/s) of two attempts at walking 2.4 m, but with values reversed through multiplication 
by -1. Weakness is derived from the dominant hand grip strength in kg, which is multiplied by 
1.5 in the case of women, and then reversed. The differential handling of raw grip strength 
values in men and women is based on gender-specific and population-independent cut-off 
values for grip strength previously proposed for the CHS frailty phenotype criteria (Saum et al., 
2012). Exhaustion is a binary variable based on a positive response to at least one of two items 
of the Center for Epidemiologic Studies Depression (CES-D) Scale on whether the respondent 
“felt everything they did during the past week was an effort” and “could not get going much of 
the time in the past week” (Radloff, 1977). It has been previously argued and demonstrated that 
the physical frailty specification with these three indicators has face, content, construct, and 
concurrent validity (Ding, 2016). Using confirmatory factor analysis (CFA) with these three 
indicators, unique physical frailty factor scores for wave 2 are derived for each respondent. 
These factor scores are then used for subsequent analyses. 
 
Death is the outcome of interest. It is represented by a set of three binary variables at waves 3 
to 5, each of which are assigned a value of one if death occurs in the time interval following the 
preceding wave, zero if still alive, and censored if death occurs at or prior to the preceding 
wave. Other predictors of death at wave 2 are drawn from deficit categories listed in the 
Canadian working framework. Beyond age and gender, physical predictors include obesity 
(binary: body mass index at least 30 kg/m2 compared with normal, defined as less than 30 
kg/m2 but more than 20 kg/m2), being underweight (binary: body mass index 20 kg/m2 or less 
compared with normal, defined as less than 30 kg/m2 but more than 20 kg/m2), low physical 
activity (four levels of increasing intensity activity related to occupation and exercise), chronic 
disease (count of conditions from 0 to 14), allostatic load (score of 0 to 9), smoking history 
(binary: whether ever smoked), and high alcohol intake (binary: whether had alcohol drink 
almost every day in the past 12 months). Allostatic load is a measure of the physiological 
dysregulation in multiple body systems (Gruenewald et al., 2009), and is specified by nine 
biomarkers including blood pressure readings, anthropometric measurements, and blood tests 
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for cholesterol levels, glucose control, and inflammatory markers. For each biomarker, a score 
of one is awarded for values beyond a cut-off level reflecting high risk, with a score of zero 
given if otherwise. The total score reflects the allostatic load. 
 
Psychological predictors include depressive symptoms, which is based on a count of six out of 
eight items (score of 0 to 6) of the CES-D Scale (Radloff, 1977). The two omitted items are 
those already used to measure exhaustion as a physical frailty indicator. Cognitive impairment 
is derived from a cognitive index based on the combined memory and executive function test 
performance (score of 0 to 49), which is then reversed.  
 
Social predictors include low education (binary: no qualifications compared with any 
qualification), and low wealth (binary: lowest 2 deciles compared with highest 8 deciles of non-
pension wealth). Additionally, poor social integration, reflecting social isolation, is based on the 
combined score on five items (score of 0 to 14) concerning whether participants have no 
spouse and partner living with them, had little contact with children, had little contact with other 
family members, had little contact with friends, and were not a member of any organization, 
club or society. Contact includes meeting, phoning, or writing or email. The composite scoring 
mode is adapted from previous work (Banks et al., 2010). Finally, poor social support, in terms 
of deficient emotional support, and reflecting negative social interaction with family and friends, 
is measured by the combined scores on whether there is lack of positive support, and 
occurrence of negative support (score of 0 to 54). Lack of positive support is measured by 
negative answers to questions on “understand the way you feel”, “can rely on if you had a 
serious problem”, and “can open up to them if you need to talk” with respect to children, other 
family members, and friends. Negative support is measured by positive answers to questions 
on whether children, other family members, and friends "criticizes the respondent", "lets the 
respondent down", and "gets on the nerves of respondent". The composite scoring mode is 
again based on that of the previous study mentioned (Banks et al., 2010).  
 
Statistical analyses: 
 
A series of structural equation models that examine the effect of physical frailty on death using 
discrete time survival analysis, and which include combinations of moderated and mediated 
effects, are constructed. The hazard of death h(t) is the probability of death occurring at time 
interval t given that death has not occurred before t, and is expressed as 
h(t) = 1 / (1+exp(Τt)) 
where Τ is the estimate of the linear predictor (“threshold” or intercept) for the binary event of 
death time interval t, obtained from logistic regression, and given a set of explanatory variables 
where their values are zero. To obtain this estimate for the average respondent, physical frailty 
factor score and all other variables are rescaled so that their zero values represent their means. 
To do so for respondents with physical frailty factor scores one standard deviation above or 
below the mean, their factor score values are similarly rescaled so that their zero values 
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represent these defined values. Their corresponding survival probability at time t or s(t) is given 
by 1 - h(t) multiplied by those in the previous time points (Newsom, 2015). Thus, 
s(t) = π(1 - h(t)) 
The discrete time survival model examines death at waves 3, 4, and 5. Physical frailty, 
moderators and mediators of its effect, as well as other predictors of death are all measured at 
wave 2. The mathematical formulas are provided in the Supplementary Materials. 
 
Model 1 concerns prediction of death by physical frailty factor scores at wave 2 controlled for 
gender, age, and multidimensional predictors, namely chronic disease, allostatic load, obesity, 
being underweight, low physical activity, smoking, high alcohol intake, depressive symptoms, 
cognitive impairment, low education, low wealth, poor social support, and poor social 
integration measured at the same wave. The regression coefficients represent the log odds of 
death for one standard deviation increase in continuous predictors, and from zero to one for 
binary predictors. Gender- and age-specific effects are estimated by including interactions of 
physical frailty with gender and age respectively in the model, and then probing these 
interactions. The latter procedure involves estimating the effect of physical frailty on death 
separately for men and women, and at specific ages, which are given by: 
 pf + (pf-g*Gender) 
 pf + (pf-a*Age) 
where pf is the coefficient for physical frailty, pf-g is the coefficient for the interaction of physical 
frailty with gender, Gender is the value assigned for male or female, pf-a is the coefficient for 
the interaction of physical frailty with age, and Age is the value for specific ages. Differences 
between effect estimates across gender and age are tested for statistical significance of 
moderation using the Wald test. Model 2 explores moderation of the effect of physical frailty on 
death by ten selected conditions at wave 2 namely, obesity, low physical activity, allostatic load, 
smoking, high alcohol intake, depressive symptoms, cognitive impairment, low wealth, poor 
social support, and poor social integration, by including in turn their respective interaction 
variables in the model. These lifestyle-related, psychological, and social variables are chosen a 
priori given that they represent potentially modifiable conditions. Probing of these interaction 
effects and tests for statistical significance of differences across categories of these potential 
moderators are then performed in the same way as for gender and age. 
 
Model 3 extends Model 1 by including indirect effects through low physical activity, depressive 
symptoms, and cognitive impairment measured at wave 2. Although it would be ideal to use 
values of these mediators at a subsequent time point (say, wave 3), doing so would place them 
within the time frame for the outcome, namely waves 3 to 5, which will be problematic. We 
included treatment-mediator interaction variables to relax the assumption of the absence of 
treatment-mediator interaction (Muthén & Asparouhov, 2015). Estimates of indirect effects are 
derived using the product of coefficients method. Since the logistic regression is used to predict 
the binary outcome, computing comparable coefficients for these two types of models to obtain 
the product of coefficients has been suggested (Mackinnon & Dwyer, 1993). However, where 
the mediator is continuous, which is the case here, it has been proposed that the indirect effect 
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can be obtained through the product of coefficient method using the physical frailty coefficient 
from linear regression where the mediator is the outcome, and the mediator coefficient from 
logistic regression where death is the outcome (MacKinnon et al., 2007). The latter procedure 
is adopted here. Sobel’s test for significance testing is applied (Sobel, 1982). As in Model 1, 
gender- and age-specific effects are also estimated by including interactions of physical frailty, 
and then probing these interaction effects. Estimates of the indirect effect of physical frailty on 
death according to gender and age are given by: 
 (pf + (pf-g*Gender))*m 
 (pf + (pf-a*Age))*m 
where pf is the coefficient for physical frailty, pf-g is the coefficient for the interaction of physical 
frailty with gender, and pf-a is the coefficient for the interaction of physical frailty with age, for 
the effect on the mediator. Gender is the value assigned for male or female, and Age is the 
value for specific ages. Finally, m is the coefficient for the mediator for its effect on death. 
Model 4 explores moderation of these indirect effects (moderated mediation) by poor social 
support, and poor social integration through including their respective interaction variables for 
the physical frailty-mediator and mediator-death effects, and then again probing the interaction 
effects as for gender and age. These two social variables are selected a priori on the basis that 
they may be potentially modifiable conditions that influence indirect effects of physical frailty. 
Yet again, tests for significance of moderation across gender, age, poor social support, and 
poor social integration are performed using the Wald test. 
 
Sensitivity analyses are conducted to explore the potential impact of residual confounding due 
to unmeasured variables including genetic influences and social conditions in early life. The 
adopted approach is that of identifying the parameters of an unmeasured confounder that 
would be required to shift the estimated effect of physical frailty to a non-significant level 
(VanderWeele, 2015). To implement these, we create and include a “phantom” latent variable 
in Model 1. Its correlation with physical frailty is fixed at 0.1 (low) and effect on death is varied 
starting from that equivalent to the effect of physical frailty on death, and then increasing this in 
turn by its multiples (that is, two times, three times, and so on). The point at which the effect of 
physical frailty on death is rendered non-significant is sought. The procedure is repeated with 
correlation of the “phantom” latent variable with physical frailty set to 0.3, and then finally to 0.5. 
For Model 3, the correlation of the “phantom” latent variable with the three mediators is added 
to the foregoing procedure and then varied accordingly. The end product of these analyses are 
tables of “corrected” estimates when implementing a range of sensitivity parameters 
(VanderWeele, 2015). 
 
Missing values are handled by full information maximum likelihood (FIML), which operates 
under the assumption of missing at random (MAR). It is analogous to multiple imputation, but 
without actual creation of imputation datasets. Rather, the missing data is handled within the 
analysis model using maximum likelihood estimation, which identifies population parameters 
having the highest probability of producing the sample data. It uses all available data to 
generate their estimates and assumes multivariate normality. To facilitate this procedure for 
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predictor variables, their means will be estimated. Mplus version 7.4 (Muthén & Muthén, 1998-
2012) is used to perform discrete time survival analysis, while STATA version 14.1 is used for 
all other analyses. Statistical significance is generally assessed at the 5% level. Where 
Bonferroni’s correction is implemented to account for multiple comparisons when testing ten 
separate moderated effects in Model 2, statistical significance is assessed at the 0.5% level. 
Similarly, to test two separate moderated effects in Model 4, statistical significance is assessed 
at the 2.5% level. 
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Results 
 
Table 1 describes the characteristics of our study population. There is complete data on death, 
age, and gender. Missing values due to death or loss to follow-up occur in less than 10% of 
cases for majority of other variables, with the highest proportion being about 50% for allostatic 
load. The mean age of respondents is 74 years, and approximately 55% are women. Physical 
frailty levels are on average higher in women and those aged 75 years and above. Death 
occurs by wave (year) 3 (2006), 4 (2008), and 5 (2010) among 6.0%, 12.8% and 20.1% of 
respondents respectively. This means that mortality is 6 to 7% within each successive wave 
with this figure being higher in men than women (7 to 8% vs. 5 to 6%) and in those aged 75 
years and above at baseline than those younger (10 to 11% vs. 3 to 4%). 
 
 
Table 1. Characteristics of English Longitudinal Study of Ageing (ELSA) wave 2 
respondents aged 65 to 89 years included in analyses  
 
Variables All By gender By Age group 
Male Female < 75 years >= 75 years 
General: 
Mean age,  
years (SD) 
Female, n/N (%)             
 
 
74.0 (6.3) 
 
2,568/4,638  
(55.4) 
 
73.5 (6.2) 
 
- 
 
 
74.3 (6.4) 
 
- 
 
 
69.3 (2.8) 
 
1,399/2,643 
(52.9) 
 
80.2 (3.9) 
 
1,169/1,995 
(58.6) 
Physical frailty: 
Mean average 
walking speed, 
m/sec (SD): 
Hand grip strength, 
kg (SD) 
Exhaustion, n/N (%): 
 
Mean physical frailty 
factor score (SD): 
 
0.8 (0.3)1 
 
 
25.9 (10.2)6 
 
1,490/4,510 
(33.0) 
0.01 (0.17)11 
 
0.9 (0.3)2 
 
 
33.4 (8.9)7 
 
568/1,997 
(28.4) 
-0.03 (0.16)12 
 
0.8 (0.3)3 
 
 
19.6 (6.1)8 
 
922/2,513 
(36.7) 
0.03 (0.17)13 
 
0.9 (0.3)4 
 
 
28.4 (10.2)9 
 
728/2,596 
(28.0) 
-0.05 (0.16)14 
 
0.7 (0.3)5 
 
 
22.2 (8.2)10 
 
762/1,914 
(39.8) 
0.08 (0.15)15 
Physical: 
Obesity, n/N (%) 
 
Mean chronic 
disease count  
[out of 14] (SD) 
Mean allostatic load 
score [out of 9] (SD) 
Mean low physical 
activity level,  
[0 of 3] (SD) 
 
1,018/3,976   
(25.6) 
1.9 (1.4)16 
 
 
2.1 (1.6)21 
 
1.4 (0.8)26 
 
 
 
400/1,783  
(22.4) 
1.8 (1.4)17 
 
 
2.3 (1.6)22 
 
1.3 (0.8)27 
 
 
 
618/2,193  
(28.2) 
2.0 (1.4)18 
 
 
2.0 (1.5)23 
 
1.4 (0.8)28 
 
 
 
662/2,328 
(28.4) 
1.8 (1.4)19  
 
 
2.0 (1.6)24 
 
1.2 (0.8)29 
 
 
 
356/1,648 
(21.6) 
2.1 (1.5)20  
 
 
2.3 (1.5)25 
 
1.6 (0.8)30 
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Smoking history,  
n/N (%) 
Heavy alcohol 
intake, n/N (%) 
2,963/4,634  
(63.9) 
1,249/3,871  
(32.3) 
1,567/2,069  
(75.7) 
720/1,742 
 (41.3) 
1,396/2,565 
(54.5) 
529/2,129 
 (24.9) 
1,649/2,639 
(62.5) 
792/2,344 
(33.8) 
681/1,995 
(65.9) 
457/1,527 
(29.9) 
Psychological: 
Mean CESD-8 score  
[0 to 8] (SD) 
Mean cognitive 
impairment score  
[0 to 49] (SD) 
 
1.7 (2.0)31 
 
18.9 (6.5)36 
 
1.3 (1.7)32 
 
19.3 (6.4)37 
 
1.9 (2.1)33 
 
18.5 (6.5)38 
 
1.5 (1.9)34 
 
17.1 (6.0)39 
 
1.9 (2.0)35 
 
21.4 (6.3)40 
Social: 
Low education,  
n (%) 
Low wealth, n (%) 
 
Mean poor social 
support score  
[0 to 54] (SD) 
Mean poor social 
integration score  
[0 to 14] (SD) 
 
2,256/4,618 
(48.9) 
980/4,557 
(21.5) 
13.7 (7.0)41 
 
 
6.6 (2.5)46 
 
885/2,061 
(41.5) 
365/2,022 
(18.1) 
14.7 (7.0)42 
 
 
6.7 (2.6)47 
 
1,401/2,557 
(54.8) 
615/2,535 
(24.3) 
12.9 (6.8)43 
 
 
6.5 (2.5)48 
 
1,158/2,630 
(44.0) 
454/2,584 
(17.6) 
13.9 (7.0)44 
 
 
6.4 (2.5)49 
 
1,098/1,998 
(55.2) 
526/1,973 
(26.7) 
13.3 (6.8)45 
 
 
7.0 (2.6)50 
Death: 
By wave 3 (2006), 
n/N (%) 
By wave 4 (2008), 
n/N (%) 
By wave 5 (2010), 
n/N (%) 
 
278/4,638 
(6.0) 
593/4,368 
(12.8) 
932/4,638 
(20.1) 
 
147/2,070 
(7.1) 
314/2,070 
(15.2) 
483/2,070 
(23.3) 
 
131/2,568 
(5.1) 
279/2,568 
(10.9) 
449/2,568 
(17.5) 
 
83/2,643  
(3.1) 
191/2,643 
(7.2) 
289/2,643 
(10.9) 
 
195/1,995 
(9.8) 
402/1,995 
(20.2) 
643/1,995 
(32.2) 
 
CESD-8: Center for Epidemiologic Studies Depression Scale (8 items) 
Unless indicated otherwise, N=4,638 (all), 2,070 (male), 2,568 (female), 2,643 (less than 75 years old), 
and 1,995 (at least 75 years old). 
N = 14,096 21,826 32,266 42,400 51,692 63,869 71,760 82,109 92,276 101,593 114,547 122,019 132,528 142,609 
151,938 164,608 172,052 182,556 192,617 201,991 212,264 221,043 231,221 241,414 25850 264,565 272,032 
282,533 292,610 301,955 314,479 321,987 332,492 342,586 351,893 364,348 371,945 382,403 392,545 401,803 
413,339 421,529 431,810 442,068 451,271 463,267 471,506 481,761 492,035 501,232 
 
 
 
Among multidimensional predictors at wave 2, there are minor gender-specific differences in 
levels of chronic disease, allostatic load, low physical activity, cognitive impairment, and weak 
social network. However, differences are more marked for obesity, depressive symptoms, low 
wealth, and low education, which are more common or have higher levels in women. In 
addition, women have lower prevalence of smoking and heavy alcohol consumption, and better 
social support. Those aged 75 years and older have more chronic disease, allostatic load, 
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depressive symptoms, and cognitive impairment, while having lower physical activity, 
education, and wealth, as well as poorer social integration than those younger. Fewer in this 
older age group have obesity and heavy alcohol intake, while more have smoked. 
 
Estimates for hazard of death are derived from the threshold values at the three time points and 
shown in the Supplementary Materials (Table 5). With mean physical frailty factor score and at 
mean values for other predictors, the hazard of death across the three time periods increases 
from 0.040 to 0.069, while the survival probability decreases from 0.960 to 0.845. However, 
when physical frailty factor score is one standard deviation below the mean, the corresponding 
hazard of death is lower (0.033 to 0.057), while the survival probability is correspondingly 
higher (0.967 to 0.871). In contrast, for physical frailty factor score at one standard deviation 
above the mean, the hazard of death is higher (0.050 to 0.084), while the survival probability is 
correspondingly lower (0.950 to 0.812). Hazard of death across time is graphically illustrated in 
Figure 3, while survival probability is shown in Figure 4. The interpretation of these findings is 
that with an increase of one standard deviation in physical frailty factor score from the mean 
value, the hazard of death is approximately 20% higher, when other predictors are held at their 
mean values. 
 
 
 
Figure 3. Death hazard estimates at waves 3 to 5 derived from discrete time survival 
analysis: comparison of different levels of physical frailty holding constant the effects of 
other predictors at their mean values 
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Figure 4. Survival probability estimates at waves 3 to 5 derived from discrete time 
survival analysis: comparison of different levels of physical frailty holding constant the 
effects of other predictors at their mean values 
 
 
 
 
 
 
Table 2 provides the standardized coefficients for prediction of death across waves 3 to 5 
obtained from discrete time survival analysis (Model 1). For the whole group, physical frailty 
significantly predicts hazard of death over the following 3 waves after controlling for other key 
multidimensional predictors. More precisely, one standard deviation increase of the physical 
factor score predicts 24% increase in the odds of death. Interestingly when standardized 
coefficients are compared in the Supplementary Materials (Table 6), the effect size of physical 
frailty on death is smaller than the corresponding effects of older age and female gender, 
similar in magnitude to those of smoking, being underweight, and low physical activity, but 
larger than those of other predictors. More precisely, the effect size of physical frailty is 
approximately 40% that of age, which has a standard deviation of approximately 6 years. Thus, 
in more concrete terms, the effect of one standard deviation increase in physical frailty factor 
score on death is approximately equivalent to the effect of increase in age of 2.5 years. This is 
stronger for women and those younger, with non-significant effects at 85 years of age as 
indicated by the coefficients in the second and third panels in Table 2. Given these findings, 
physical frailty is a significant and relatively strong predictor of death over the following 6 years, 
except among very old people. 
 
In addition, Table 2 shows that the effect of physical frailty decreases as the level of cognitive 
impairment increases as indicated by the coefficients in the fourth panel (Model 2). In fact, the 
difference in this effect is three-fold comparing that at level of cognitive impairment score one 
standard deviation above to that one standard deviation below the mean value. Thus, cognitive 
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impairment exerts a negative moderating influence on the effect of physical frailty on death, 
which is statistically significant at the 0.5% level when accounting for multiple comparisons. On 
the other hand, none of the other conditions have significant moderating influence on the effect 
of physical frailty. However, there are non-significant trends towards stronger effect of physical 
frailty among those having high alcohol intake and poor social integration, but weaker effect 
among those with obesity. Details of their effects are in the Supplementary Materials (Table 7).  
 
 
Table 2. Main and moderated effects of physical frailty (wave 2) on hazard of death 
(waves 3 to 5) while controlling for other predictors (wave 2) using discrete time survival 
analysis with interactions and probing of effects: coefficients for log odds and odds 
ratio of death  
 
 Log odds of death Odds ratio of death 
All  0.213* 1.237* 
Gender:                                                Men 
                                                             Women 
0.171* 
0.260* 
1.186* 
1.297* 
Age**                                                    65 years 
                                                             75 years 
                                                             85 years 
0.416* 
0.242* 
0.067 
1.516* 
1.274* 
1.070 
Cognitive impairment Ɨ                          Low 
                                                             Average 
                                                             High 
0.383*** 
0.256*** 
0.130**** 
1.467*** 
1.292*** 
1.139**** 
 
For cognitive impairment, values one standard deviation below the mean are designated as “low” and 
values one standard deviation above the mean as “high”. The mean value is designated as “average”. 
* Indicates p-value <0.05 
** Indicates that p-value <0.05 for moderation 
*** Indicates p-value <0.005 (Bonferroni’s correction for 10 multiple comparisons) 
**** Indicates p-value <0.05 but >=0.005  
Ɨ Indicates that p-value <0.005 for moderation  
Values of log odds and the odds ratio of death are for one standard deviation increase in physical frailty 
factor score. Estimated effects are controlled for age, gender, chronic disease, allostatic load, smoking, 
high alcohol intake, obesity, being underweight, low physical activity, depressive symptoms, cognitive 
impairment, low education level, low wealth, poor social support, and poor social integration. 
Missing values are handled by full information maximum likelihood (FIML). 
N = 4,638 
 
 
Mediation effects are inferred from the product of coefficients for physical frailty-mediator and 
mediator-death effects. In the first panel of Table 3, the coefficients for the mediated or indirect 
effects through low physical activity and cognitive impairment are positive and statistically 
significant, while that through depressive symptoms is not (Model 3). The interpretation is that 
the effect of physical frailty on death acts indirectly through low physical activity and cognitive 
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impairment. As indicated by coefficients in the second and third panels of Table 3, these 
indirect effects are stronger in the younger group. However, that through cognitive impairment 
is stronger in women, while those through the other two mediators are stronger in men. Only 
the difference in indirect effect through low physical activity across age is statistically 
significant. On the other hand, coefficients in the fourth and fifth panels of table 3 show minimal 
and non-significant differences across high and low levels of poor social support and poor 
social integration, indicating that these two conditions do not moderate these indirect effects 
(Model 4). 
 
 
Table 3. Mediation (indirect effects) of physical frailty on hazard of death (waves 3 to 5) 
by low physical activity, depressive symptoms, and cognitive impairment including 
moderated effects (moderated mediation) using discrete time survival analysis: 
coefficients for log odds and odds ratio of death  
 
 Mediator 
Low physical 
activity 
Depressive 
symptoms 
Cognitive 
impairment 
All 0.085* -0.008 0.053* 
Gender:                                              Men 
                                                           Women 
0.084* 
0.085* 
-0.007 
-0.009 
0.057* 
0.050* 
Age:                                                    65 years*** 
                                                           75 years 
                                                           85 years*** 
0.072* 
0.087* 
0.103* 
-0.008 
-0.009 
-0.009 
0.054* 
0.054* 
0.054* 
Poor social support:                           Low 
                                                           Average 
                                                           High 
0.084** 
0.085** 
0.085** 
-0.007 
-0.008 
-0.009 
0.049** 
0.053** 
0.057** 
Poor social integration:                      Low 
                                                           Average 
                                                           High 
0.080** 
0.084** 
0.089** 
-0.006 
-0.008 
-0.010 
0.048** 
0.053** 
0.059** 
 
* Indicates statistical significance at 5% level 
** Indicates statistical significance at 2.5% level (Bonferroni’s correction for multiple comparisons for 2 
separate models) 
*** Indicates statistically significance at the 5% level for moderation of indirect effects (only through low 
physical activity) 
Mean values are used as cut-off points for stratification of depressive symptoms, social support, and 
social integration into two categories.  
Missing values are handled by full information maximum likelihood (FIML). 
N = 4,638 
 
 
Finally, the results of sensitivity analyses that simulate the effect of unmeasured confounding 
(represented by a “phantom” variable) on the effect of physical frailty on hazard of death are 
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provided by “corrected” estimates in Table 4. When there is no unmeasured confounding, the 
log odds of death is 0.214 (first column of first row) which is consistent with Table 2. However, if 
correlation of an unmeasured confounder with physical frailty is 0.1, then the estimate remains 
significant, but decreases to 0.184 (second column of second row) when the effect of the 
unmeasured confounder on death is equivalent to that of physical frailty on death. The estimate 
remains significant, but further decreases to 0.151 and 0.122 (third and fourth columns of 
second row) when the effect of the unmeasured confounder on death is equivalent to two-fold 
and three-fold that of physical frailty on death respectively. When the latter increases to four-
fold, the estimate decreases to 0.095 (fifth column of second row), and is now not significant. 
Next, if correlation of the unmeasured confounder with physical frailty is increased to 0.2, then 
the estimate remains significant, but decreases to 0.145 (second column of third row) when the 
effect of the unmeasured confounder on death is equivalent to that of physical frailty on death. 
When the latter increases to two-fold, the estimate decreases to 0.072 (third column of third 
row) and is non-significant. Finally, if correlation of the unmeasured confounder with physical 
frailty is further increased to 0.3, then the estimate remains significant, but decreases to 0.105 
(second column of fourth row) when the effect of the unmeasured confounder on death is 
equivalent to that of physical frailty on death. When the latter increases to two-fold, the estimate 
decreases to -0.008 (third column of fourth row) and is clearly not significant. Together, these 
results indicate that for the effect of physical frailty on death to be rendered non-significant, an 
unmeasured confounder would either need to have between two to four times the effect of 
physical frailty, depending on whether its correlation with physical frailty is moderate (0.3) or 
very low (0.1) respectively. Thus, our estimated effect of physical frailty is relatively robust to 
unmeasured confounding. 
 
 
Table 4. “Corrected” estimates of the effect of physical frailty (wave 2) on hazard of 
death (waves 3 to 5) over different sensitivity parameters using discrete time survival 
analysis: coefficients for log odds of death  
 
Correlation of the 
unmeasured confounder 
with physical frailty 
Effect of the unmeasured confounder on death in terms of multiples of the 
uncorrected effect of physical frailty on death 
0X 1X 2X 3X 4X 
0 0.214* - - - - 
0.1 - 0.184* 0.151* 0.122* 0.095 
0.2 - 0.145* 0.072 - - 
0.3 - 0.105* -0.008 - - 
 
* Indicates statistical significance at 5% level 
Shaded cells indicate that “corrected” estimates for the effect of physical frailty on death remain positive 
and significant. 
Missing values are handled by full information maximum likelihood (FIML). 
N = 4.638 
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Similarly, “corrected” estimates of indirect effects for ranges of sensitivity parameters are 
provided in the Supplementary Materials (Table 8). For the indirect effect of physical frailty on 
death through low physical activity to be rendered non-significant, the effect of an unmeasured 
confounder on death would need to be three times that of physical frailty when its correlations 
with physical frailty and low physical activity are moderate (0.3). On the other hand, for the 
indirect effect through cognitive impairment to be rendered non-significant, the corresponding 
effect of an unmeasured confounder on death would need only need to be equivalent to two 
times that of physical frailty when its correlations with physical frailty and low physical activity 
are also moderate (0.3). These results suggest that the indirect effect through low physical 
activity is also relatively robust to unmeasured confounding, although it is less so for that 
through cognitive impairment. 
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Discussion 
 
For community-dwelling older people in England, increasing physical frailty levels 
independently predict death over the following six years. In other words, the risk of death from 
physical frailty remains even after accounting for other concurrent physical, psychological, and 
social predictors. Overall, its effect size ranks in the intermediate band among those of a rich 
set of multidimensional predictors. It is worth highlighting that we identify the incremental or 
marginal effects of physical frailty over and above those of other predictors of death. Notably, 
the effect of physical frailty is stronger among women and those who are younger. However, 
this effect is not significant among those who are very old. Our findings are consistent with 
previous work demonstrating that a frailty index had a greater negative effect on survival in 
women compared with men (Bartley et al., 2016; Mitnitski et al., 2004), and in lower compared 
higher age categories (Gu et al., 2009) among older people. For men and those very old, it is 
likely that conditions other than physical frailty have a larger role in predicting death. 
Nonetheless, we confirm that physical frailty has a distinct and sizeable impact on limiting 
longevity in older people, except those who are very old. 
 
To answer the question on for whom its effect is stronger, we observe that the effect of physical 
frailty on death is negatively moderated by cognitive impairment. Beyond this, we are unable to 
demonstrate significant moderation by other conditions in physical, psychological and social 
domains suggested in the Canadian working framework (Bergman et al., 2004). The latter 
finding parallels recent work demonstrating that psychosocial resources do not modify the 
effect of frailty on death (Hoogendijk et al., 2014). Despite this, it would be pertinent not to 
dismiss interesting trends observed even though they did not achieve statistical significance, 
given the greater statistical power typically needed to demonstrate moderation. Among these 
trends, physical frailty appears to have stronger effects in those who have high consumption of 
alcohol and poor social integration, but weaker effects among those with obesity. In the search 
for modifiers of the effect of physical frailty on longevity, our findings provide possible directions 
for future work, particularly in exploring the role of social integration. 
 
Returning to cognitive impairment, its negative moderation of the effect of physical frailty on 
death has not been reported previously. If replicated elsewhere, this finding may provide 
valuable insight on the complexity of pathways involved with respect to the relationship 
between physical frailty and other predictors. To explain this unexpected finding, we note that 
older people with more cognitive impairment are themselves at higher risk for death (see Table 
5 of the Supplementary Materials). It is possible that physical frailty adds less to the risk of 
death in situations where there already is more cognitive impairment. To an extent, the 
evidence on the stage of dementia being a stronger predictor of death than the frailty index 
supports this explanation (Kelaiditi et al., 2016). 
 
Equally interesting, the effect of physical frailty is weaker among those with obesity compared 
with those who are not, although this difference does not reach statistically significant levels. 
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However, in contrast to cognitive impairment, obesity itself predicts lower risk of death (see 
Table 2). The reduction of death risk among obese older people has been described as the 
“obesity paradox” (Strandberg et al., 2013), and is a vigorously debated subject. Placing our 
findings in this context, we deduce that the inter-relationships between weight, physical frailty, 
and death are likely to be more complex than those represented by the pathways we specified. 
Thus, until the evidence is clearer, obesity should certainly not be viewed in a positive light in 
terms of enhancing longevity in older persons with physical frailty. 
 
Beyond prediction and moderation, we demonstrate mediated effects of physical frailty and 
answer at least in part the question on how physical frailty exerts its effect on death. Its 
significant indirect effects on death through low physical activity and cognitive impairment are 
the major findings of our study. Given that low physical activity has a close relationship with 
frailty (Fried et al., 2001), and that it predicts lower life expectancy (Nazroo et al., 2008; 
Stessman et al., 2009), it is quite plausible that low physical activity could act as a mediator. In 
addition, we have already seen that cognitive impairment predicts death. Coupled with the 
knowledge that physical frailty predicts future cognitive impairment (Auyeung et al., 2011), it 
also seems quite plausible that cognitive impairment is a mediator. The implication of these 
findings is that low physical activity and cognitive impairment are possible target conditions for 
intervention for older people who are physically frail where enhancing longevity is concerned. 
 
Overall, our findings add to the existing body of evidence supporting health and social policies 
that promote greater physical activity and attempt to prevent cognitive decline in the bid to 
enhance longevity in older people through modifying the adverse impact of physical frailty. 
Given that participation in physical activity is low in older people despite public education on its 
benefits, implementation of multi-modal means of encouraging more physical activity need to 
be considered (McPhee et al., 2016). Preventing cognitive impairment is a more challenging 
endeavor. Current evidence suggests that cognitive training, and perhaps physical activity and 
dietary omega-3 tatty acids may have a role (Plassman et al., 2010). Beyond encouraging 
physical activity, advice on maintaining or boosting mental activity and encouraging fish 
consumption are common components of health promotion efforts directed at older people, 
although the extent of their take up has been less studied. In addition, our findings suggest that 
addressing high alcohol consumption and poor social integration among older people with 
physical frailty are potential areas of focus for further investigation. From a broader perspective, 
addressing these conditions may already be recognized as sensible objectives of health and 
social policies. In fact, initiatives that are consistent with these objectives may already been 
implemented in many settings. Nonetheless, frailty-specific evidence such as from this study 
may assist in bolstering support for the initiation, continuation, or even further expansion of 
such programs in the face of public resource constraints. 
 
There are a few methodological limitations of our study that are worth mentioning. Firstly, 
dependence on observational data imposes limits on the interpretation of findings. That said, 
the advantage of using longitudinal data allows us to ensure that cause precedes effect. 
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Moreover, inclusion of a broad range of physical, psychological, and social conditions in these 
models permits us to control for their effects and to argue that the influence of omitted variables 
is unlikely to be large enough to change our major conclusions. Indeed, our sensitivity analyses 
suggest that estimated effects of physical frailty on death are relatively robust to potential 
unmeasured confounding. Secondly, the use of secondary data restricts the way key variables 
are specified, particularly those concerning lifestyle habits or social conditions. However, this is 
compensated in part by the availability of rich and credible data available in ELSA. In addition, 
we benefit from the work of others who have elegantly operationalized the measurement of 
complex social constructs such as social support and integration (Banks et al., 2010), and then 
demonstrated the utility of these specifications. Thirdly, more than 20% of values are missing 
for allostatic load, low social support, and low social integration. We argue that handling on the 
MAR assumption is reasonable given that we include a broad range of predictors that provide 
information for the FIML procedure. Nonetheless, the potential influence of missing values 
needs to be borne in mind when interpreting negative findings for these three predictors. Lastly, 
five assumptions are needed if we are to inject any extent of causal interpretation into our 
mediation analysis (VanderWeele, 2016). The first three are adequate control for the physical 
frailty-death, physical frailty-mediator, and mediator-death confounding, which would apply to 
any observational study. As mentioned, controlling for a wide range of multidimensional 
predictors of death in our statistical models increases the possibility that these assumptions 
hold. In addition, our sensitivity analyses suggest that residual confounding is not likely to 
change our results in any important way. The fourth is that there should not be any mediator-
death confounder that is itself affected by physical frailty. Addressing any violation of this 
assumption would entail performing more complicated modeling (Daniel et al., 2013) that is 
beyond the ambit of our study. Thus, we acknowledge that our findings stand on this 
assumption. The fifth requires that there is no physical frailty-mediator moderation. To address 
this assumption, we include physical frailty-mediator interactions in our mediation models and 
thus, obtain estimates of indirect effects while taking these into account. Finally, we conduct 
multiple comparisons through performing separate models when exploring moderation, thereby 
increasing the risk of discovering significant effects purely by chance. To minimize this risk, we 
restrict our analyses to a reduced set of most plausible effects informed by the conceptual 
framework adopted, and use Bonferroni’s method of correction for multiple comparisons when 
testing for statistical significance of moderated effects. 
 
In summary, the evidence from ELSA confirms that physical frailty increases the risk of death in 
older people beyond that conferred by a rich set of multidimensional predictors. More 
importantly, it suggests that low physical activity and cognitive impairment are mediators, and 
high alcohol intake and poor social integration are possible moderators on pathways from 
physical frailty to death. Thus, in terms of mitigating the negative impact of physical frailty on 
longevity, implementation of interventions that address these conditions merit consideration as 
population health and social strategies. This is of course in addition to efforts directed at 
reducing physical frailty in the first place. 
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Mathematical equations for the statistical models 
 
Let yi denote the factor score of the continuous factor for death across wave 3 to 5 in the 
discrete time survival model, pi be the physical frailty factor score at wave 2, and xi represents 
a time-invariant predictor for individuals i = 1..., n. 
 
The discrete time survival model with continuous factor is  
yi = β0 + β1pi + β2xi + εi 
 
Here, the coefficient β1 describes the associations between physical frailty and death, while β2 
describes the associations between the time-invariant predictor and death. The estimated 
coefficients β1 and β2, are shown in Table 2. 
 
Moderation: Here, we consider the interaction between physical frailty and a time-invariant 
predictor. Thus, the corresponding discrete time survival model with continuous factor is  
yi = β0 + β1pi + β2xi + β3pi*xi + εi 
where pi*xi is the variable for interaction. The estimated coefficient β3 describes this interaction. 
 
Mediation: Here we use the results of standard linear path analysis applied to the discrete time 
survival model. For simplicity of notation in introducing the idea, consider the case where mi is 
a mediator of the effect of pi on yi, so that 
yi = β0 + β1pi + β2xi + β3mi + εi 
Suppose further that  
mi = λ0 + λ1pi + δi. 
Then the model given pi and xi only, averaging over the distribution of mi, is  
yi = β0 + β*1pi + β2xi + ε*i 
where ε*i = (εi + β3δi) and β∗1 = β1 + β3λ1. Here β∗1 is the total effect of the variable zi on the 
death factor, β1 is the direct effect of pi, and β3λ1 the indirect effect of pi mediated via mi. 
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Table 5. Estimated unstandardized thresholds (or intercepts) from discrete time survival 
analysis with corresponding hazard, and survival probability in the three time periods 
for different physical frailty factor score values and at mean values for other predictors 
 
 Thresholds Hazard Survival probability 
Physical frailty 
factor score 
- 1SD Mean + 1SD - 1SD Mean + 1SD - 1SD Mean + 1SD 
Wave 3 3.381 3.167 2.953 0.033 0.040 0.050 0.967 0.960 0.950 
Wave 4 3.083 2.869 2.654 0.044 0.054 0.066 0.924 0.908 0.887 
Wave 5 2.813 2.599 2.385 0.057 0.069 0.084 0.871 0.845 0.812 
 
N = 4.638  
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Table 6. Effects of physical frailty (wave 2) and other predictors (wave 2) on hazard of 
death (waves 3 to 5) while controlling for each other using discrete time survival 
analysis: standardized coefficients for log odds and odds ratio of death  
 
 Log odds of death Odds ratio of death 
Physical frailty*  0.214 1.239 
Age* 
Female gender* 
Chronic disease* 
Allostatic load* 
Smoking history* 
High alcohol intake 
Obesity* 
Underweight* 
Low physical activity* 
Depressive symptoms 
Cognitive impairment* 
Low education level 
Low wealth 
Poor social support 
Poor social integration 
 0.518 
-0.548 
 0.153 
 0.133 
 0.257 
 0.029  
-0.311 
 0.237 
 0.252 
-0.012 
 0.156 
 0.003 
 0.005 
-0.028 
 0.078 
1.679 
0.578 
1.165 
1.142 
1.293 
1.029 
0.733 
1.267 
1.287 
0.988 
1.169 
1.003 
1.005 
0.972 
1.081 
 
* Indicates statistical significance at 5% level 
Values of log odds or the odds ratio of death are for one standard deviation increase in continuous 
predictors or the increase from zero to one for the binary predictors (female gender, obesity, smoking, 
high alcohol intake, low educational level, and low wealth). 
Missing values are handled by full information maximum likelihood (FIML). 
N = 4.638 
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Table 7. Main and moderated effects of physical frailty (wave 2) on hazard of death 
(waves 3 to 5) while controlling for other predictors (wave 2) using discrete time survival 
analysis: coefficients for log odds and odds ratio of death  
 
  Log odds of death Odds ratio of death 
All  0.213* 1.239* 
Smoking                                                No                                                             
Yes 
0.184* 
0.227** 
1.202* 
1.255** 
High alcohol intake                                No                                                            
Yes 
0.168**
0.316** 
1.183** 
1.372** 
Low physical activity                              Less                                                            
Average                             
More 
0.299**
0.238** 
0.177** 
1.348** 
1.269** 
1.194** 
Obesity                                                   No                                                           
Yes 
0.250**
0.073 
1.284** 
1.076 
Allostatic load                                         Low                                                            
Average                                                     
High 
0.216* 
0.213**
0.210* 
1.242* 
1.237** 
1.233* 
Depressive symptoms                           Low                                                            
Average                                                         
High 
0.222**
0.214**
0.206** 
1.249** 
1.238** 
1.228** 
Cognitive impairment***                        Low                                                            
Average                                                           
High 
0.383**
0.256**
0.130* 
1.467** 
1.292** 
1.139* 
Poor social support                               Low                                                            
Average                                                           
High 
0.214**
0.213**
0.212** 
1.239** 
1.238** 
1.237** 
Poor social integration                          Low                                                            
Average                                                            
High 
0.170* 
0.218**
0.265** 
1.186* 
1.243** 
1.303** 
Low wealth                                            No                                                            
Yes 
0.222**
0.192* 
1.249** 
1.212* 
 
For continuous variables (depressive symptoms, cognitive impairment, low social support, low social 
integration, and low physical activity), values one standard deviation below the mean are designated as 
“low” and values one standard deviation above the mean as “high”. The exception is low wealth where 
lower 2 deciles of total non-pension wealth are designated as “Yes” and higher 8 deciles as “No”. Binary 
variables are obesity, underweight, smoking, high alcohol intake, and low wealth. 
* Indicates statistical significance at the 5% level but not at the 0.5% level 
** Indicates statistical significance at the 0.5% level (Bonferroni’s correction for 10 multiple comparisons) 
*** Indicates statistical significance at the 0.5% level for moderation (Bonferroni’s correction for 10 multiple 
comparisons)  
Values of log odds or the odds ratio of death are for one standard deviation increase (for continuous 
variables) or values from 0 to 1 (for binary variables) in the main or moderated effects. The estimated 
effects are controlled for age, gender, chronic disease, allostatic load, smoking history, high alcohol 
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intake, obesity, low physical activity, depressive symptoms, cognitive impairment, low education level, low 
wealth, poor social support, and poor social integration. 
Missing values are handled by full information maximum likelihood (FIML). 
N = 4.638 
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Table 8. “Corrected” estimates of the indirect effects of physical frailty (wave 2) on 
hazard of death (waves 3 to 5) over different sensitivity parameters using discrete time 
survival analysis: coefficients for log odds of death  
 
Mediator of 
indirect 
effect 
Correlation of 
unmeasured 
confounder 
with mediator 
Correlation of unmeasured confounder with physical frailty 
0 0.1 0.3 
Effect of the unmeasured confounder on death in terms of multiples 
of the uncorrected effect of physical frailty on death 
0X 1X 2X 3X 1X 2X 3X 
Low physical 
activity 
0 0.085* - - - - - - 
0.1 - 0.078* 0.072* 0.066* 0.077* 0.071* 0.065* 
0.3 - 0.061* 0.038* 0.016 0.061* 0.038* 0.015 
Depressive 
symptoms 
0 -0.008 - - - - - - 
0.1 - -0.015 -0.021 -0.027 -0.015 -0.021 -0.027* 
0.3 - -0.028 -0.047* -0.067* -0.028* -0.047* -0.067* 
Cognitive 
impairment 
0 0.053* - - - - - - 
0.1 - 0.044* 0.038* 0.032* 0.044* 0.038* 0.033* 
0.3 - 0.031* 0.012 -0.006 0.032* 0.013 -0.006 
 
* Indicates statistical significance at 5% level 
Shaded cells indicate that “corrected” estimates for the effect of physical frailty on death remain positive 
and significant. 
Missing values are handled by full information maximum likelihood (FIML). 
N = 4.638  
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9.3 Further Thoughts 
  
We have seen that pathways from physical frailty to death include indirect effects through low 
physical activity and cognitive impairment. This brings about opportunities for interventions to 
reduce the impact of physical frailty on death by modifying these two conditions in older people. 
However, besides longevity, other aspects of their lives matter to older people. Among the 
prominent themes from narratives on what older people view as most important is their desire 
for independence. This means having the ability to do activities are important to them (Redding 
et al., 2014). It also involves having good health and mobility to continue doing activities that 
enhance their quality of life (Gabriel & Bowling, 2004). This concerns the length of healthy life 
or healthspan, as opposed to mere length of life or lifespan. Increasing healthspan not only 
requires delaying the physiological decline that results in disease and disability (Crimmins, 
2015), but also involves mitigating their negative effects in older people. 
 
In view of the centrality of independence for older people, I will proceed to complete my thesis 
by examining the relationship between physical frailty and functional disability. Thus, the final 
paper focuses on pathways from physical frailty to activity limitation. 
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10 Fifth Paper 
 
10.1 Introduction 
 
As mentioned, being able to walk and perform self-care activities independently matters to 
older people. Functional disability certainly reduces the quality of life in older people (Murphy et 
al., 2007 ; Walker & Lowenstein, 2009). Unfortunately, being physical frail increases an older 
person’s risk of functional disability (Avila-Funes et al., 2008; Romero-Ortuno et al., 2011; Woo 
et al., 2006). While that may be the case, it is important to understand whether this risk is 
influenced by other physical, psychological, and social conditions. In other words, we need to 
identify moderators of the effect of physical frailty on functional disability. Furthermore, it is 
important to understand how physical frailty confers this risk by identifying mediators of its 
indirect effects. Where these moderators and mediators are potentially modifiable lifestyle-
related, psychological, and social conditions, they represent target conditions for interventions 
that aim to mitigate the negative effects of physical frailty on functional independence in older 
people. 
 
With these in mind, the research aim of the fifth paper is to explore pathways from physical 
frailty to functional disability. I will seek to answer the research question: “Which physical, 
psychological, and social conditions moderate or mediate the effect of physical frailty on 
functional disability in older people?” To this end, I will yet again adopt the working framework 
proposed by the Canadian Initiative on Frailty and Aging (Bergman et al., 2004) as the 
conceptual model. The right side of this working framework as illustrated in Figure 9.1 (page 
153) is relevant. Potential moderators and mediators will be drawn from the categories of 
conditions listed in the bottom right hand corner of this figure. Before that, a suitable definition 
of functional disability is required. 
 
In the latest WHO classification of disability, three levels of functioning are defined. They are 
impairment, activity limitation, and participation restriction (ICF, 2002). Typically, activity 
limitation is measured in terms of needing assistance in basic and instrumental activities of 
daily living (BADL and IADL). BADL items include bathing, dressing, toileting, transferring, 
feeding and walking (Katz et al., 1963), while those of instrumental IADL involve performance 
of more complex tasks ranging from preparing meals and taking medications to managing 
money and going shopping (Lawton & Brody, 1969). Activity limitation exerts a negative impact 
on older people. Those with increasing levels of activity limitation have lower levels of well-
being manifested by higher prevalence of depression, less life satisfaction, poorer quality of life, 
and more loneliness even after stratifying according to age (Demakakos et al., 2010). Thus, 
activity limitation defined by difficulty in performing BADL, is the outcome of interest for this 
paper. 
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As similar to the fourth paper, physical frailty is measured by its three indicators, namely 
slowness, weakness, and exhaustion, with unique physical frailty factor scores derived for each 
respondent. However, since examining change is the focus of this paper, physical frailty scores 
will be specified as a time-varying variable at waves 2, 4, and 6, instead of only at wave 2. 
Activity limitation at waves 2, 4, and 6 is the outcome. It is defined as the number out of six 
basic activities of daily living (BADL) items performed with difficulty (score of 0 to 6). As for the 
previous two papers, a rich set of physical, psychological, and social predictors of activity 
limitation will be included as control variables. In addition, selected conditions will also be 
specified as moderators or mediators of the effect of physical frailty. 
 
To estimate the effect of physical frailty on activity limitation across time, I will use 
autoregressive cross-lagged models (ACLM) over waves 2, 4, and 6 of ELSA data. ACLM is 
useful for examining whether one variable predicts another by taking advantage of temporal 
precedence of the first over the second variable. The fundamental idea of the lagged model is 
to estimate the effect of the cause (physical frailty) measured at an earlier time point on the 
effect (activity limitation) at a later point, while controlling for the earlier value of the effect 
variable (lagged activity limitation). Doing so allows control of pre-existing differences, as well 
as removal of stable aspects of the effect variable. Consequently, the cross-lagged effect 
represents the effect of the cause on change in the outcome (Newsom, 2015). Since interest is 
solely on the effect of physical frailty on change in activity limitation, and not on the opposite, a 
series of autoregressive cross-lagged models will be constructed where the attention is on 
unidirectional rather than bidirectional effects.  
 
The following paper examines pathways from physical frailty to activity limitation. Yet again, 
some of the foregoing key points are unavoidably repeated as this is a self-contained journal 
article. Its references are again in a separate list just before the Supplementary Materials 
(pages 211 to 214). Relevant Mplus input files are provided in the Appendix. At the time of 
writing, this paper is being considered for publication in a gerontology journal. 
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10.2 Pathways from physical frailty to activity limitation in older people: identifying 
moderators and mediators in the English Longitudinal Study of Ageing 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Joint work with Associate Professor Jouni Kuha (Departments of Statistics and Methodology, 
London School of Economics) and Professor Michael Murphy (Department of Social Policy, 
London School of Economics) 
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Abstract 
 
Physical frailty increases the risk of future activity limitation, which in turn compromises 
independent living of older people and limits their healthspan. Thus, we seek to identify 
moderators and mediators on pathways from physical frailty to activity limitation in older people, 
including gender- and age-specific effects. From data of the English Longitudinal Study of 
Ageing, unique physical frailty factor scores of 4,638 respondents aged 65 to 89 years are 
obtained from confirmatory factor analysis of physical frailty, which is specified by three 
indicators, namely slowness, weakness, and exhaustion. Using a series of autoregressive 
cross-lagged models, we estimate the effect of physical frailty factor score on activity limitation 
change, including its moderation by social conditions, and indirect effects through physical and 
psychological conditions. We find that physical frailty significantly worsens the activity limitation 
trajectory, and this effect is significantly stronger with older age. Physical frailty also has 
significant indirect effects through low physical activity, depressive symptoms, and cognitive 
impairment. In turn, the indirect effects of physical frailty through low physical activity and 
cognitive impairment are stronger with older age. Sensitivity analyses suggest that these 
effects vary in their robustness to unmeasured confounding. We conclude that low physical 
activity, depressive symptoms, and cognitive impairment are potentially modifiable mediators 
on pathways from physical frailty to activity limitation in older people, including those who are 
very old. This evidence offers support for population-level interventions that address these 
conditions to mitigate the effect of physical frailty on activity limitation, and thereby enhance 
healthspan. 
 
 
Key words: disability, pathways, physical activity, depression, cognition, cross-lagged  
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Introduction 
 
Frailty is widely regarded as the multidimensional loss of an individual’s body system reserves 
that results in vulnerability to developing adverse health-related outcomes (Espinoza & 
Walston, 2005; Lally & Crome, 2007; Pel-Littel et al., 2009). It is conceptualized as a 
transitional state between robustness and functional decline (Lang et al., 2009) that is 
associated with increased risk of death, disability, falls, hospitalization, and institutionalization 
(Daniels et al., 2012; Ensrud et al., 2009; Ensrud et al., 2008; Jones et al., 2005; Kiely et al., 
2009; Pilotto et al., 2012; Woo et al., 2012). Although long recognized as an important condition 
in older people, frailty has been defined in various ways ranging from a frailty phenotype with 
five components (Fried et al., 2001), to a frailty index that adopts a multiple deficit accumulation 
approach (Rockwood & Mitnitski, 2007). Some extent of consensus on its operational definition 
has only recently been achieved (Morley et al., 2013). Nonetheless, different definitions are 
probably best suited for different purposes (Martin & Brighton, 2008). 
 
Across a spectrum of definitions applied, the prevalence of frailty is estimated to be about 10% 
among people aged 65 years or older (Collard et al., 2012). In the United Kingdom alone, the 
number of those in this age group was 11.6 million in 2015 (ONS, 2016), permitting the 
estimation that approximately 1.2 million older people across the country are frail. The potential 
adverse outcomes of frailty and its size of problem combine to create significant health and 
social impact for ageing populations. Consequently, frailty plays a central role in influencing the 
well-being of older people and holds major public health importance (Woo et al., 2006). 
 
As an adverse outcome of frailty, functional disability reduces the quality of life in older people 
(Murphy et al., 2007 ; Walker & Lowenstein, 2009). The latest WHO classification of disability 
defined three levels of functioning. They are impairment, activity limitation, and participation 
restriction (ICF, 2002). Typically, activity limitation is measured in terms of needing assistance 
in basic and instrumental activities of daily living (BADL and IADL). BADL items include 
bathing, dressing, toileting, transferring, feeding and walking (Katz et al., 1963), while those of 
instrumental IADL involve performance of more complex tasks ranging from preparing meals 
and taking medications, to managing money and going shopping (Lawton & Brody, 1969). 
Activity limitation exerts a negative impact on older people. Those with increasing levels of 
activity limitation have lower levels of well-being, which manifests as higher prevalence of 
depression, less life satisfaction, poorer quality of life, and more loneliness, even after 
stratifying for age (Demakakos et al., 2010). Moreover, activity limitation compromises 
healthspan, which is measured by length of healthy life (Crimmins, 2015), and is equally if not 
more important than lifespan for many older people. 
 
Frailty and functional disability, represented here by activity limitation, are considered distinct 
entities with some degree of overlap (Fried et al., 2004). More importantly, frailty indicators 
predict future activity limitation in terms of BADL and IADL dependence among community-
dwelling older people (Avila-Funes et al., 2008; Gobbens et al., 2012b; Romero-Ortuno et al., 
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2011; Vermeulen et al., 2011). However, the precise mechanisms by which frailty exerts this 
effect are less clear. Particularly, there is sparse knowledge on pathways from frailty to 
eventual activity limitation. Better understanding of these pathways including the identification 
of moderators and mediators on them can inform public health and social policy with respect to 
organizing effective population-level interventions that could potentially minimize the impact of 
frailty where it already occurs. This may in turn slow down or even delay the onset of activity 
limitation in older people. 
 
To conceptualize pathways from frailty to activity limitation, a good starting point is the working 
framework proposed by the Canadian Initiative on Frailty and Aging (Bergman et al., 2004) 
which is simplified and shown in Figure 1. In the right half of this figure, biological, 
psychological, social, and societal assets and deficits are represented as moderators on the 
pathway from frailty to adverse outcomes which include disability. These assets and deficits 
represent potential target conditions for intervention to reduce the negative impact of frailty. 
More recently, the integral concept of frailty (Gobbens et al., 2010b) developed a similar set of 
frailty pathways adapted from those of the Canadian working framework. Other frailty pathways 
have also been proposed, but are largely restricted to the biological sphere, and are therefore 
less suitable for a broader investigation of the effects of frailty. Thus, the Canadian working 
framework offers a useful foundation on which to build a conceptual model for pathways from 
frailty to activity limitation.  
 
 
Figure 1. Working framework of the Canadian Initiative for Frailty and Aging (adapted 
from Bergman, 2004 with modifications) 
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With a conceptual model of frailty pathways available, the challenge is then to identify a frailty 
specification that is suitable for investigation of these pathways. In his seminal work, 
Strawbridge recognized the multidimensional nature of frailty and conceptualized frailty as 
involving problems in at least two from among physical, nutritive, cognitive, and sensory 
domains (Strawbridge et al., 1998), More recently, the view of frailty being multidimensional has 
been expressed in part through the development of frailty identifiers that measure deficits 
across more than a single domain (Bielderman et al., 2013; Gobbens et al., 2010b; Rockwood, 
2005). However, some of the multidimensional elements in these frailty specifications are also 
hypothesized to be key conditions on pathways from frailty to its adverse outcomes. Having 
these elements as part and parcel of the frailty specification complicates the task of teasing out 
the relationship between frailty and these key deficits. As an alternative, the integral concept of 
frailty explicitly specifies frailty as having three distinct domains namely physical, psychological, 
and social (Gobbens et al., 2010a). Being able to specify frailty based on a single domain 
facilitates its disentanglement from conditions related to the other two domains. This in turn 
facilitates less constrained exploration of the relationship of frailty with physical, psychological, 
and social conditions that may turn out to be mediators or moderators of its effect. 
 
Among these three frailty domains, physical frailty offers the most promising choice as a frailty 
specification for the investigation of related pathways. There are a number of reasons for this. 
Firstly, physical frailty is far better understood than psychological or social frailty.  Secondly, 
physical frailty contributes most to prediction of disability among the three frailty domains 
(Gobbens et al., 2012a). Finally, there exists an excellent prototype for physical frailty in the 
CHS frailty phenotype (Fried et al., 2001). It conceptualizes physical frailty has having five 
components. Our previous work argues that specifying physical frailty with three of the five 
indicators namely walking speed, grip strength, and report of exhaustion retains face and 
content validity. In addition, we demonstrate construct and concurrent validity for this physical 
frailty specification (Ding, 2016). In the light of these points, physical frailty specified by these 
three indicators holds promise for the investigation of pathways from frailty to activity limitation. 
 
Our conceptual model for investigating the relationship of physical frailty with activity limitation 
is shown in Figure 2. In this model, indirect or mediated effects through physical and 
psychological conditions are included in addition to the direct effect. Furthermore, moderation 
of these effects by social conditions is also incorporated (dotted lines). We base these 
hypothesized pathways in part on the Canadian working framework, while advancing beyond to 
also include indirect effects. These pathways are also consistent with current thinking that 
posits psychosocial resources as possible moderators and mediators of the effects of frailty 
(Dent & Hoogendijk, 2015). 
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Figure 2. Conceptual model for investigation of pathways from physical frailty to activity 
limitation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Thus, the overarching aim of our study is to identify and estimate the effects of physical, 
psychological, and social conditions that have roles as moderators and mediators of the 
relationship between physical frailty and future activity limitation in older people. Under this 
broad aim, we seek to answer three research questions: 
1) Does the effect of physical frailty on activity limitation vary across different levels of 
key social conditions? 
2) Does physical frailty have an indirect effect on activity limitation through key 
lifestyle and psychological conditions? 
3) Do the effects of physical frailty on activity limitation vary across gender and age? 
 
To answer these questions, we use longitudinal data from the English Longitudinal Study of 
Ageing (ELSA). ELSA is a longitudinal survey of a representative sample of the English 
population aged 50 years and older living in their homes at baseline (Steptoe et al., 2013). It 
offers a broad range of reliable and multidimensional data across biennial waves beginning 
from 2002, and is still ongoing. 
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Methods 
 
Data 
 
Our study population comprises 4,638 older respondents aged 65 to 89 years at wave 2 (2004) 
of ELSA (Marmot et al., 2015). Those aged 90 years and older are excluded given that their 
age is uniformly coded as “90”, and that their number is small. All participants gave informed 
consent. Ethical approval for ELSA was granted by the Multicentre Research and Ethics 
Committee. Ethical oversight for this study is provided by procedures of the London School of 
Economics Ethics Policy. 
 
Physical frailty is specified by three indicators drawn from those of the CHS frailty phenotype 
(Fried et al., 2001), namely slowness, weakness, and exhaustion. Slowness is the average gait 
speed (in m/s) of two attempts at walking 2.4 m, but with values reversed through multiplication 
by -1. Weakness is the dominant hand grip strength in kg, which is multiplied by 1.5 for women. 
The differential handling of raw grip strength values in men and women is based on gender-
specific and population-independent cut-off values for grip strength previously proposed for the 
CHS frailty phenotype criteria (Saum et al., 2012). After that, reversal of all values is achieved 
by multiplying them by -1. Exhaustion is a binary variable based on a positive response to at 
least one of two items in the Center for Epidemiologic Studies Depression Scale (CES-D) scale 
on whether the respondent “felt everything they did during the past week was an effort” and 
“could not get going much of the time in the past week” (Radloff, 1977). We have previously 
argued and demonstrated that the combination of these three indicators is preferred to 
represent the physical frailty construct from among other permutations of the five components 
of the CHS frailty phenotype (Ding, 2016). Given that measures for these indicators are only 
available at waves 2, 4, and 6, we measured physical frailty at these time points. Confirmatory 
factor analysis (CFA) with these three indicators across waves 2, 4, and 6 is performed, while 
assuming and thereby imposing scalar (strong) invariance, where all loadings and intercepts 
are held constant across time. From CFA, unique physical frailty factor scores for waves 2, 4, 
and 6 are obtained for each respondent, and then used for the subsequent regression 
analyses. 
 
Activity limitation is the outcome of interest and is defined by the number out of six BADL items 
performed with difficulty (score of 0 to 6). As we focus on physical function, IADL is not used 
because its performance requires additional cognitive competency. Other predictors of activity 
limitation are drawn from the multidimensional categories listed in the Canadian working 
framework (Bergman et al., 2004). Beyond age and gender, physical predictors, namely obesity 
(binary: body mass index (BMI) of 30 kg/m2 or more with reference to normal, defined by BMI 
less than 30 kg/m2 but more than 20 kg/m2), being underweight (binary: BMI of 20 kg/m2 or less 
with reference to normal, defined by BMI less than 30 kg/m2 but more than 20 kg/m2), low 
physical activity (four levels of decreasing intensity activity related to occupation and exercise), 
chronic disease (count of conditions from 0 to 14), allostatic load (score of 0 to 8), smoking 
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(binary: whether ever smoked), and high alcohol intake (binary: whether had alcohol drink 
almost every day in the past 12 months). Allostatic load is a measure of physiological 
dysregulation in multiple body systems (Gruenewald et al., 2009), and is specified by eight 
biomarkers including blood pressure readings, anthropometric measurements, and blood tests 
for cholesterol levels, glucose control, and inflammatory markers. For each biomarker, a score 
of one is awarded for values beyond a cut-off level reflecting high risk, with a score of zero 
given if otherwise. The total score defines allostatic load. 
 
Psychological predictors include depressive symptoms, which are measured by a count of six 
out of eight items (score of 0 to 6) of the CES-D Scale (Radloff, 1977). The two omitted items 
are those already used to specify exhaustion as a physical frailty indicator. Cognitive 
impairment is measured by reversing a cognitive index based on the combined memory and 
executive function test performance (score of 0 to 49). 
 
Social predictors include low education (binary: no qualifications compared with any 
qualification), and low wealth (binary: lowest 2 deciles compared with highest 8 deciles of non-
pension wealth). Additionally, low social integration, reflecting social isolation, is based on a 
combined score on five items (score of 0 to 14) concerning whether participants have no 
spouse and partner living with them, had little contact with children, had little contact with other 
family members, had little contact with friends, and were not a member of any organization, 
club or society. Contact includes meeting, phoning, or writing or email. Its composite scoring 
procedure is adapted from that of a previous study (Banks et al., 2010). Finally, poor social 
support, in terms of deficient emotional support, and reflecting negative social interaction with 
family and friends is measured by the combined scores on whether there is lack positive 
support, and the occurrence of negative support (score of 0 to 54). Lack of positive support is 
measured by negative answers to questions on “understand the way you feel”, “can rely on if 
you had a serious problem”, and “can open up to them if you need to talk” with respect to 
children, other family members, and friends. Negative support is measured by positive answers 
to questions on whether children, other family members, and friends "criticizes the respondent", 
"lets the respondent down", and "gets on the nerves of respondent". Its composite scoring 
procedure is again based on that of the aforementioned study (Banks et al., 2010). 
 
Statistical analyses: 
 
A series of autoregressive cross-lagged models over waves 2, 4, and 6 of ELSA data are 
created to examine the effect of physical frailty on activity limitation change, and include 
moderated and mediated effects. Details of models and their equations are provided in the 
Supplementary Materials. 
 
Model 1 predicts activity limitation change by physical frailty controlling for other predictors, 
namely gender, age, obesity, underweight state, chronic disease, allostatic load, smoking 
history, high alcohol intake, low educational level, low wealth, poor social integration, and poor 
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social support at wave 2. Both physical frailty and activity limitation are included at waves 2, 4, 
and 6 with auto-regressive effects for activity limitation (waves 2 and 4 predicting waves 4 and 
6 respectively) and physical frailty (wave 2 predicting wave 4). Cross-lagged effects of physical 
frailty at waves 2 and 4 predicting activity limitation change at waves 4 and 6 respectively are 
included. Equivalent effects are constrained to be equal across time. Here, the cross-lagged 
effect of physical frailty on activity limitation change is the focus of estimation. In addition, 
stratified analyses according to gender and age group (at least 75 years and less than 75 
years) are performed to obtain gender- and age group-specific estimates of the effect of 
physical frailty. Model 2 extends Model 1 by examining moderation of the effect of physical 
frailty by poor social support and poor social integration through stratified analyses according to 
values below the mean and those at least the mean. Differences between effect estimates 
across gender, age, poor social support, and poor social integration categories are tested for 
statistical significance of moderation using the Wald test. 
 
Model 3 extends Model 1 by including mediation of the indirect effects of physical frailty on 
activity limitation change by low physical activity, depressive symptoms, and cognitive 
impairment. For the indirect effect of physical frailty (wave 2) on activity limitation change (wave 
4), the mediators are either at wave 3 (cognitive impairment) or wave 4 (low physical activity 
and depressive symptoms). Correspondingly, for the indirect effect of physical frailty (wave 4) 
on activity limitation change (wave 6), the mediators are either at wave 4 (cognitive impairment) 
or wave 6 (low physical activity and depressive symptoms). Cognitive impairment at waves 3 
and 4 are used because the full cognitive index is not available at waves 5 and 6. Mediation 
effects are inferred from the product of coefficients for the physical frailty-mediator and 
mediator-activity limitation effects, using Sobel’s test to test for significance (Sobel, 1982). 
Absence of physical frailty-mediator interaction is assumed. Stratified analyses according to 
gender and age group are also performed. Finally, Model 4 is an extension of Model 3 with the 
addition of analyses for moderation of mediated effects (moderated mediation or conditional 
indirect effects) (Preacher et al., 2007) by poor social support, and poor social integration 
through stratified analyses as for Model 2. Yet again, differences between indirect effect 
estimates across gender, age, poor social support, and poor social integration categories are 
tested for statistical significance of moderation using the Wald test. Full details of the model 
specifications are given in the Supplementary Material. 
 
Sensitivity analyses are performed to relax three important assumptions in our analyses and 
then to observe whether there are important changes in the results. Firstly, physical frailty-
mediator interaction is also included in Model 3, relaxing the assumption of its absence. 
Secondly, we relax the assumption that there is no unmeasured confounding when estimating 
the physical frailty-mediator, mediator-activity limitation, and physical frailty-activity limitation 
effects. This is accomplished by including continuous latent variables (“phantom” variables) 
with varying magnitude of effect on physical frailty, activity limitation, and mediators in the 
model. This is to simulate the presence of unmeasured confounders and estimate the 
magnitude of their effects that would sufficient to cause the effects of physical frailty and 
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mediators to be non-significant (VanderWeele, 2016). Thirdly, we relax the assumption that the 
activity limitation has an approximately normal distribution, given that this variable is measured 
by number of BADL items performed with difficulty, which can be considered as count data. In 
anticipation that this distribution is right skewed with a large proportion of zero values, negative 
binomial regression will be also performed for its prediction to check if there are any important 
differences in the results in doing so (Zaninotto & Falaschetti, 2011). In addition, we restrict our 
analyses to respondents who have available values for activity limitation at wave 6, thereby 
excluding those contributing to attrition across time. The purpose is to provide alternative 
analyses to those implementing maximum likelihood for the whole study population, which in 
turn assumes that missing values are MAR. 
 
Missing values are handled under the assumption of missing at random (MAR) by full 
information maximum likelihood (FIML), which a procedure that is analogous to multiple 
imputation but without actual creation of imputation datasets. Rather, the missing data is 
handled within the analysis model using maximum likelihood estimation, which identifies 
population parameters having the highest probability of producing the sample data. It uses all 
available data to generate their estimates and assumes multivariate normality. It is also 
implemented for predictor variables by treating them as dependent variables through estimating 
their sample means. Mplus version 7.4 (Muthén & Muthén, 1998-2012) is used to perform the 
autoregressive cross-lagged analyses, while STATA version 14.1 is used for all other analyses. 
Statistical significance is assessed at the 5% level, except for examination of moderated effects 
by the two social predictors, where it is assessed at the 2.5% level on account of Bonferroni’s 
correction for multiple comparisons. 
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Results 
 
Table 1 describes the characteristics of the study population including physical frailty indicators, 
factor scores, frailty status, and activity limitation across waves 2, 4, and 6. In addition, 
predictors at wave 2 are also shown. Additional information on mediators at waves 2, 4, and 6 
is also provided by the Supplementary Materials (Table 4). The mean age is 74 years and 
women comprise approximately 55 percent. Activity limitation increases on over time with 27% 
needing assistance in one or more basic activities of living (BADL) item at wave 2 to 30% at 
wave 6. Correspondingly, the mean number of BADL items requiring assistance also increases 
from 0.51 to 0.70 from waves 2 to 6. There is more difficulty with BADL among women and 
those aged at least 75 years. Physical frailty increases over time as measured by factor scores 
(-0.02 to 0.02) and proportion categorized as having frailty (20% to 25%). Thus, increasing 
levels of activity limitation parallel increasing physical frailty in the study population. Moreover, 
physical frailty levels and proportions of respondents who are frail are higher among women 
and in the older group. Among physical, psychological, and social conditions at wave 2, there 
are minor gender-specific and age-specific differences with a few exceptions. Obesity is more 
common among women and in the younger group. Both history of smoking and high alcohol 
intake are more common among men. On the other hand, women and those in the older group 
have more depressive symptoms, while the latter also have more cognitive impairment. 
 
 
Table 1. Characteristics of English Longitudinal Study of Ageing (ELSA) wave 2 
respondents aged 65 to 89 years included in analyses 
 
Variables All By gender By Age group 
Male Female < 75 years >= 75 years 
General: 
Mean age, years 
(SD) 
Female, n/N (%)             
 
 
74.0 (6.3) 
 
2,568/4,638  
(55.4) 
 
73.5 (6.2) 
 
- 
 
 
74.3 (6.4) 
 
- 
 
 
69.3 (2.8) 
 
1,399/2,643 
(52.9) 
 
80.2 (3.9) 
 
1,169/1,995 
(58.6) 
Physical frailty: 
Mean average 
walking speed, 
m/sec (SD) 
Hand grip strength, 
kg (SD) 
Exhaustion,  
n/N (%) 
Frailty by Frailty 
Index, n/N (%):      
               Wave 2 
 
 
0.8 (0.3)1 
 
 
25.9 (10.2)6 
 
1,490/4,510 
(33.0) 
 
 
717/3,647 
(19.7) 
 
0.9 (0.3)2 
 
 
33.4 (8.9)7 
 
568/1,997 
(28.4) 
 
 
236/1,639 
(14.4) 
 
0.8 (0.3)3 
 
 
19.6 (6.1)8 
 
922/2,513 
(36.7) 
 
 
481/2,008 
(24.0) 
 
0.9 (0.3)4 
 
 
28.4 (10.2)9 
 
728/2,596 
(28.0) 
 
 
322/2,207 
(14.6) 
 
0.7 (0.3)5 
 
 
22.2 (8.2)10 
 
762/1,914 
(39.8) 
 
 
395/1,440 
(27.4) 
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               Wave 4 
 
               Wave 6 
 
Mean physical 
frailty factor score 
(SD):       Wave 2 
               Wave 4 
               Wave 6 
507/2,371 
(21.4) 
438/1,774 
(24.7) 
 
 
-0.02 (0.81)11 
0.01 (0.80)11 
0.02 (0.76)11 
158/1,051 
(15.0) 
145/768 
(18.9) 
 
 
-0.21 (0.76)12 
-0.18 (0.78)12 
-0.15 (0.74)12 
349/1,320 
(26.4) 
293/1,006 
(29.1) 
 
 
0.12 (0.80)13 
0.15 (0.78)13 
0.16 (0.74)13 
279/1,571 
(17.8) 
285/1,325 
(21.5) 
 
 
-0.28 (0.78)14 
-0.25 (0.78)14 
-0.22 (0.75)14 
228/800 
(28.5) 
153/449 
(34.1) 
 
 
0.32 (0.71)15 
0.35 (0.68)15 
0.35 (0.64)15 
Physical: 
Obesity, n/N (%) 
 
Underweight,  
n/N (%) 
Mean chronic 
disease count  
[0 to 14] (SD) 
Mean allostatic 
load score  
[0 to 8] (SD) 
Mean low physical 
activity level  
[0 to 3] (SD)  
Smoking history,  
n/N (%) 
Heavy alcohol 
intake, n (%) 
 
1,018/3,976   
(25.6) 
117/3,689 
(3.2) 
1.9 (1.4)16 
 
 
2.0 (1.5)21 
 
 
1.2 (0.9)26 
 
 
2,963/4,634  
(63.9) 
1,249/3,871  
(32.3) 
 
400/1,783  
(22.4) 
42/1,661  
(2.5) 
1.8 (1.4)17 
 
 
1.9 (1.5)22 
 
 
1.1 (0.9)27  
 
 
1,567/2,069  
(75.7) 
720/1,742 
 (41.3) 
 
618/2,193  
(28.2) 
75/2,028 
(3.7) 
2.0 (1.4)18 
 
 
2.1 (1.5)23 
 
 
1.3 (0.9)28  
 
 
1,396/2,565 
(54.5) 
529/2,129 
 (24.9) 
 
662/2,328 
(28.4) 
59/2,226  
(2.7) 
1.8 (1.4)19 
 
 
1.9 (1.5)24 
 
 
1.0 (0.9)29  
 
 
1,649/2,639 
(62.5) 
792/2,344 
(33.8) 
 
356/1,648 
(21.6) 
58/1,463 
(4.0) 
2.1 (1.5)20 
 
 
2.1 (1.5)25 
 
 
1.4 (0.9)30  
 
 
681/1,995 
(65.9) 
457/1,527 
(29.9) 
Psychological: 
Mean CESD-8 
score [0 to 8] (SD) 
Mean cognitive 
impairment score  
[0 to 49] (SD) 
 
1.7 (2.0)31 
 
27.5 (6.3)36 
 
1.3 (1.7)32 
 
26.3 (6.4)37 
 
1.9 (2.1)33 
 
25.5 (6.5)38 
 
1.5 (1.9)34 
 
24.1 (6.0)39 
 
1.9 (2.0)35 
 
28.4 (6.3)40 
Social: 
Low education,  
n (%) 
Low wealth, n (%) 
 
Mean poor social 
support score  
[0 to 54] (SD) 
Mean poor social 
integration score  
[0 to 14] (SD) 
 
 
2,256/4,618 
(48.9) 
980/4,557 
(21.5) 
13.7 (7.0)41 
 
 
6.6 (2.5)46 
 
885/2,061 
(41.5) 
365/2,022 
(18.1) 
14.7 (7.0)42 
 
 
6.7 (2.6)47 
 
1,401/2,557 
(54.8) 
615/2,535 
(24.3) 
12.9 (6.8)43 
 
 
6.5 (2.5)48 
 
1,158/2,630 
(44.0) 
454/2,584 
(17.6) 
13.9 (7.0)44 
 
 
6.4 (2.5)49 
 
1,098/1,998 
(55.2) 
526/1,973 
(26.7) 
13.3 (6.8)45 
 
 
7.0 (2.6)50 
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Activity limitation: 
Mean number of 
BADL items 
performed with 
difficulty  
[0 to 6] (SD): 
       Wave 2 (2004) 
       Wave 4 (2008) 
       Wave 6 (2012) 
At least one BADL 
item performed with 
difficulty, n (%): 
       Wave 2 (2004) 
 
       Wave 4 (2008) 
 
       Wave 6 (2012) 
 
 
 
 
 
 
0.51 (1.08)51 
0.58 (1.17)56 
0.70 (1.37)61 
 
 
 
1,246/4,635 
(26.9) 
917/3,127 
(29.3) 
730/2,402 
(30.4) 
 
 
 
 
 
 
0.47 (1.03)52 
0.52 (1.13)57 
0.63 (1.32)62 
 
 
 
510/2,070 
(24.6) 
336/1,356 
(27.0) 
280/1,023 
(27.4) 
 
 
 
 
 
 
0.55 (1.11)53 
0.63 (1.20)58 
0.75 (1.40)63 
 
 
 
736/2,565 
(28.7) 
551/1,771 
(31.1) 
450/1,379 
(32.6) 
 
 
 
 
 
 
0.40 (0.96)54 
0.45 (1.04)59 
0.53 (1.18)64 
 
 
 
563/2,641 
(21.3) 
457/1,916 
(23.8) 
408/1,642 
(24.9) 
 
 
 
 
 
 
0.66 (1.19)55 
0.79 (1.33)60 
1.07 (1.65)65 
 
 
 
683/1.994 
(34.3) 
460/1,211 
(38.0) 
322/760 
(42.4) 
 
Frail status by Frailty Index (FI): FI >=0.25 
CESD-8: Center for Epidemiologic Studies Depression Scale (8 items) 
BADL: basic activities of daily living 
Unless indicated otherwise, N = 4,638 (all), 2,070 (male), 2,568 (female), 2,643 (less than 75 years old), 
and 1,995 (at least 75 years old). 
N = 14,096 21,826 32,266 42,400 51,692 63,869 71,760 82,109 92,276 101,593 114,560 122,025 132,535 142,616 
152,025 164,608 172,052 182,556 192,617 201,991 212,319 221,064 231,255 241,436 25883 264,567 272,032 
282,535 292,611 301,956 314,479 321,987 332,492 342,586 351,893 364,349 371,946 382,403 392,546 401,803 
413,339 421,529 431,810 442,068 451,271 463,267 471,506 481,761 492,035 501,232 514,635 522,070 532,565 
542,641 551,994 563,127 571,356 581,771 591,916 601,211 612,402 621,023 631,379 641,642 65760 
 
 
Table 2 provides linear regression coefficients where physical frailty factor scores are 
standardized (Models 1 and 2). Physical frailty significantly predicts activity limitation change 
two years later controlling for other key predictors. More precisely, one standard deviation 
increase in physical frailty predicts increase in activity limitation change of almost 0.25 BADL 
items performed with difficulty (first panel of coefficients) over this time interval. Although this 
effect appears small in absolute terms, it is notable that physical frailty has by far the largest 
magnitude of effect on activity limitation change compared with other predictors when their 
standardized coefficients are compared in the Supplementary Materials (Table 5). In fact, the 
magnitude of effect for physical frailty is almost 2.5 times that of older age, which has the next 
largest significant effect. Viewed alternatively, one standard deviation increase in physical frailty 
predicts increase in activity limitation change that is equivalent to over two-fold that of the 
average increase observed in the study population, which is in the order of 0.1 BADL items 
performed with difficulty over two years (see Table 1). This effect of physical frailty is stronger 
for men compared with women, but not significantly so (second panel of coefficients). However, 
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this effect is significantly stronger among those in the older group compared with those younger 
(third panel of coefficients). Furthermore, the effect of physical frailty on activity limitation 
change has mild and non-significant differences across higher and lower levels of poor social 
support and poor social integration (fourth and fifth panels of coefficients).  
 
 
Table 2. Main and moderated effects of physical frailty on activity limitation change 
controlling for other predictors using the autoregressive cross-lagged model over waves 
2, 4, and 6 of the English Longitudinal Study of Ageing: standardized regression 
coefficients for physical frailty factor score and its interactions variables  
 
Outcome: activity limitation Coefficient estimate 
Physical frailty  0.234* 
Physical frailty - gender:                             Men 
                                                                                   Women 
 0.254* 
 0.219* 
Physical frailty - age**:                                <75 years 
                                                                    >=75 years 
 0.190* 
 0.312* 
Physical frailty - poor social support:          Low level 
                                                                                   High level 
 0.230*** 
 0.244*** 
Physical frailty - poor social integration:     Low level 
                                                                    High level 
 0.207*** 
 0.257*** 
 
Physical frailty: factor scores standardized according to standard deviation of wave 2 values 
Physical frailty - gender, Physical frailty - age, Physical frailty - poor social support, and Physical frailty - 
poor social integration: respective interactions with physical frailty factor scores 
Low level:  one standard deviation below the mean value  
High level:  one standard deviation above the mean value  
All effects are controlled for lagged activity limitation, gender, age, chronic disease, allostatic load, body 
mass index (BMI) category, smoking history, alcohol intake level, educational level, wealth level, social 
support level, and social integration level. 
* p-value <0.05 
** p-value <0.05 for difference between two groups 
*** p-value <0.025 (Bonferroni’s correction for multiple comparisons for 2 separate moderation models) 
Missing values are handled by full information maximum likelihood (FIML). 
N = 4,638 
 
 
Extension of the models to include mediation effects of physical frailty on activity limitation 
change (Model 3) yields interesting results which are shown in Table 3. Low physical activity, 
depressive symptoms, and cognitive impairment are all significant mediators (first panel), with 
their respective indirect effects being equivalent in magnitude to approximately 30%, 8%, and 
4% that of the total effect indicated in Table 2. There are no differences in these indirect effects 
across gender (second panel). On the other hand, indirect effects of physical frailty through low 
physical activity and cognitive impairment are significantly stronger with older age, whereas that 
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through depressive symptoms is not (third panel). In addition, indirect effects are not 
significantly different across strata defined by poor social support and poor social integration 
levels (fourth and fifth panels), indicating that there is no significant moderation of the indirect 
effects by these two conditions (Model 4). However, a trend in the indirect effect through 
depressive symptoms being more than 1.5 times stronger with higher compared with lower 
levels of poor social support is noted. 
 
 
Table 3. Mediation and moderated mediation of physical frailty on activity limitation 
controlling for other predictors using the autoregressive cross-lagged model over waves 
2, 4, and 6 of the English Longitudinal Study of Ageing: product of coefficients estimates  
 
Outcome: activity limitation Mediator 
Low physical 
activity 
Depressive 
symptoms 
Cognitive 
impairment 
All  0.070*  0.019*  0.009* 
Gender:                              Male 
                                           Female 
 0.079* 
 0.062* 
 0.019* 
 0.019* 
 0.012* 
 0.009* 
Age**:                                 <75 years 
                                           >=75 years 
 0.051* 
 0.086* 
 0.011* 
 0.030* 
 0.005* 
 0.017* 
Poor social support:           Low level 
                                           High level 
 0.068**** 
 0.073**** 
 0.015*** 
 0.024**** 
 0.013**** 
 0.006 
Poor social integration:      Low level 
                                           High level 
 0.067**** 
 0.073**** 
 0.022**** 
 0.017**** 
 0.010**** 
 0.009**** 
 
All effects are controlled for lagged activity limitation, gender, age, chronic disease, allostatic load, body 
mass index (BMI) category, smoking history, alcohol intake level, educational level, wealth level, social 
support level, and social integration level 
Low level:  one standard deviation below mean value  
High level:  one standard deviation above mean value  
Coefficients of physical frailty are standardized. 
* p-value <0.05 
** p-value <0.05 for difference between two groups (only where the mediator is low physical activity or 
cognitive impairment, but not depressive symptoms) 
*** p-value <0.05 but >=0.025 
**** p-value <0.025 (Bonferroni’s correction for multiple comparisons for 2 separate moderation models)  
Missing values are handled by full information maximum likelihood (FIML).                         
N = 4,638 
 
 
Sensitivity analyses yield informative results. Firstly, repeat analyses that include physical 
frailty-mediator interactions in the model obtain estimates of 0.075, 0.017, and 0.009 for the 
indirect effects mediated through low physical activity, depressive symptoms, and cognitive 
impairment respectively. These estimates are very similar to those obtained in models 
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excluding these interactions, indicating that including the latter only has trivial impact. Secondly, 
additional analyses that simulate the presence of an unmeasured confounder indicate that the 
magnitude of its effect on activity limitation change needs to be equivalent to three-fold that of 
the strongest among other predictors (age) for the effect of physical frailty on activity limitation 
change at a low level (0.3) of correlation between the unmeasured confounder and physical 
frailty to be rendered non-significant as shown in Table 4. This suggests that the estimated 
effect of physical frailty on activity limitation change is relatively robust to any unmeasured 
confounding.  
 
 
Table 4. Sensitivity analysis with simulation of unmeasured confounder of relationship 
between physical frailty and activity limitation using the autoregressive cross-lagged 
model over waves 2, 4, and 6 of the English Longitudinal Study of Ageing: linear 
regression coefficients  
 
Correlation between 
unmeasured 
confounder and 
physical frailty 
Effect size of unmeasured confounder on activity limitation  
(comparison with that of strongest predictor of activity limitation) 
0X 1X 2X 3X 
 
0 
 
 
0.234* 
 
- 
 
- 
 
- 
0.1 
(very low) 
- 0.182* 0.132* 0.083* 
0.3 
(low) 
- 0.172* 0.096* 0.015 
  
* p-value <0.05 
Coefficients are interpreted as change in activity limitation score for a one standard deviation increase in 
physical frailty factor score. 
Shaded areas indicate that the effect of physical frailty on activity limitation remains positive and 
significant. 
Missing values are handled by full information maximum likelihood (FIML). 
N = 4,638 
 
 
On the other hand, for indirect effects through low physical activity and depressive symptoms, 
correlation of an unmeasured confounder with mediators only needs to be 0.3 for them to be 
rendered non-significant, and in the opposite direction (for that through low physical activity), 
even at correlation with physical frailty of only 0.1 and effect on activity limitation just equivalent 
to that of the strongest among other predictors (chronic disease). Moreover, the indirect effect 
through cognitive impairment is rendered non-significant at correlation of an unmeasured 
confounder with the mediator and physical frailty of 0.1 and 0.3 respectively, and its effect on 
activity limitation again equivalent to that of the strongest among other predictors (chronic 
207 
 
diease). These results are shown in the Supplementary Materials (Table 7), and suggest that 
estimated indirect effects may be more sensitive to correlation of any unmeasured confounder 
with mediators. Thirdly, given the large proportion of zero values and right skewed distribution 
for activity limitation, negative binomial regression is also performed as an alternative to linear 
regression for Model 1. The results are approximately equivalent to those of linear regression 
(not shown). In view of this, the analyses for Models 1 to 4 represent our final findings. Lastly, 
repeat analyses for 2,402 respondents who have complete values for activity limitation at wave 
6 obtain similar and significant estimates of the main and indirect effects of physical frailty, 
albeit with slightly lower magnitudes compared those for the analysis of the whole study 
population that assume MAR for missing values (results not shown).  
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Discussion 
 
For community-dwelling older people in England, increasing levels of physical frailty 
independently predict more activity limitation change two years later. This means that the 
significantly worse activity limitation trajectory that is conferred by physical frailty remains even 
after taking into account the effects of a broad set of concurrent physical, psychological, and 
social predictors. This confirms previous work by others (Lang et al., 2007; Vermeulen et al., 
2011). In terms of magnitude, one standard deviation increase in physical frailty level predicts 
increase in activity limitation change over two years that is more than two-fold that of the 
population average. By any measure, this is a strong effect. However, our findings go beyond 
mere prediction. We find that this negative effect is mediated by low physical activity, 
depressive symptoms, and cognitive impairment. In addition, the effect of physical frailty is 
stronger with older age. Finally, the indirect effects of physical frailty on activity limitation 
through low physical activity and cognitive impairment are stronger with older age. In other 
words, the pathways from physical frailty to activity limitation appear to be more complex and 
involve mediation by physical and psychological conditions, which in turn is influenced by age. 
Notably, our findings add to the frailty pathways hypothesized in the Canadian working 
framework by identifying mediators on those pathways. To our knowledge, this is the first report 
concerning indirect effects of physical frailty on activity limitation trajectory in older people. 
 
The indirect effects we uncover provide insight on how physical frailty exerts its effect on 
activity limitation change. From our results, we infer that low physical activity mediates almost 
one third of the effect of physical frailty, whereas depressive symptoms and cognitive 
impairment do so much less. Low physical activity has previously been demonstrated to worsen 
activity limitation (Landi et al., 2007), with the exercise being shown to have the opposite 
desirable effect (Chou et al., 2012). Thus, the relatively large contribution of low physical 
activity to mediation is not surprising given that individuals who are physically frail are likely to 
have less physical activity, which in turn increases risk of activity limitation. However, the 
precise mechanism by which depressive symptoms and cognitive impairment mediate the 
effect of physical frailty on activity limitation change is less clear. Nevertheless, we know that 
physical frailty increases the risk of depression (Collard et al., 2015; Mezuk et al., 2012), which 
in turn increases the risk of activity limitation (Bruce et al., 1994). Furthermore, physical frailty 
predicts incident cognitive impairment (Canevelli et al., 2015). However, previous research 
yielded mixed results as to whether cognitive impairment had additional impact on disability for 
those who are already physically frail (Ament et al., 2014; Avila-Funes et al., 2009). 
 
On the other hand, our findings go only to a limited extent to indicate for whom the effect of 
physical frailty on activity limitation change is stronger. It is quite expected that the effect of 
physical frailty, including its indirect effects, would be stronger among those who are older, 
given the additional physiological decline that occurs with older age that is not captured by 
physical frailty and other predictors and are therefore subsumed under it. Nevertheless, this 
finding suggests that the effect of physical frailty on activity limitation, including those mediated 
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by low physical activity and cognitive impairment not only remains, but may even be strongerl in 
very old people.  Although previous research demonstrated that social support in the form of 
positive social interaction protects against functional decline in older people (Unger et al., 
1997), we did not observe this moderating effect. However, there is some suggestion that the 
indirect effect through depressive symptoms may be stronger with poorer social support. It is 
plausible that better social support, particularly in terms of emotional support through positive 
social interaction, may to some extent protect against activity limitation because of its 
psychological benefits, but we could not demonstrate a significant moderating effect. On the 
other hand, psychosocial resources may not protect against functional decline in physically frail 
older people to the degree as may be expected (Hoogendijk et al., 2014). That said, the 
relationship between these two conditions could be more complex, given that negative social 
exchanges have been shown to predict depression in ELSA respondents (Stafford et al., 2011). 
Nonetheless, alternative definitions of social support could be considered in further work 
investigating its influence on the effect of physical frailty on activity limitation. 
 
The described mediators on pathways from physical frailty to activity limitation may lend 
themselves to modification by population-level interventions that hold promise for addressing 
the larger public health implications of frailty on the healthspan of older people. Specifically, low 
physical activity, depressive symptoms, and cognitive impairment represent potential 
interventional opportunities for health and social programs that typically comprise behavioural 
and therapeutic components. At the very least, the evidence assembled here should go some 
distance in justifying the conduct of experimental or quasi-experimental trials testing 
interventions that encourage and facilitate physical activity, prevent depressive symptoms, 
delay the onset or slow down the progression of cognitive impairment, with the expressed 
objective of mitigating activity limitation resulting from physical frailty among older people. While 
it is possible that poor social support may have a moderating effect, addressing it is a more 
challenging task. Since social interactions are largely conducted at the personal level, it is hard 
to see how formal programs and policies can directly influence them. Instead, public education 
that raises awareness that positive interactions with frail older people may reduce the risk of 
activity limitation could be explored. 
 
From a broader perspective, addressing low physical activity, depressive symptoms, and 
cognitive impairment may already be recognized as sensible objectives of health and social 
policies. However, ongoing initiatives with these objectives may benefit from the additional 
frailty-specific evidence assembled here, in terms of bolstering support for their continuation or 
even expansion. 
 
We acknowledge two major limitations of our study. Firstly, dependence on observational data 
imposes limits on causal inference. That said, use of longitudinal data permits specification of 
cause preceding effect in our models. Moreover, inclusion of a broad range of multidimensional 
deficits in these models allows us to argue that the effects of any omitted variables are unlikely 
to be large and influential in changing the major conclusions of this study. In addition, our 
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sensitivity analyses suggest that at least some of our results relatively robust to model 
misspecification due to any unmeasured confounders. Notwithstanding this, our findings may 
offer the best available evidence on the possible mechanisms underlying the effect of physical 
frailty on activity limitation, in the absence of confirmation from experiments utilizing 
randomized or geographically-based treatment assignment. Next, the use of secondary data 
restricts the way key variables are specified, particularly those concerning lifestyle habits or 
social conditions. Fortunately, the availability of rich and credible data available in ELSA affords 
the opportunity to create these variables, or adopt the definitions developed by others. 
 
In conclusion, the evidence from ELSA suggests that low physical activity, depressive 
symptoms, and cognitive impairment have roles as mediators of the effect of physical frailty on 
activity limitation. Indirect effects through low physical activity and cognitive impairment are 
stronger with advancing age. Beyond these, poor social support may be a moderator on 
pathways from physical frailty to activity limitation. In terms of minimizing activity limitation 
resulting from physical frailty in older people, population health and social measures addressing 
these four conditions merit consideration for further investigation or even implementation. 
These measures can augment health promotion efforts directed at reducing physical frailty in 
the first place, thereby contributing to the wider effort of improving the healthspan of older 
people, including those who are very old.  
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Mathematical equations for the statistical models with corresponding graphical 
representation 
 
Model 1: 
 
Let yti denote activity limitation defined by number of items of basic activities of daily living 
performed with difficulty (score 0 to 6) across waves 2, 4, and 6, yt-1i be the lagged activity 
limitation, pti be the physical frailty factor score across waves 2, 4, and 6, and xi represents a 
time-invariant predictor at t =1 (wave 2) for individuals i = 1..., n at t = 2 and 3 (waves 4 and 6). 
 
The equation for the effect of interest in the autoregressive cross-lagged model is:  
yti = β0 + yt-1i + β1pt-1i + β2xi + εti 
 
The coefficient β1 describes the effect of lagged physical frailty factor score on activity 
limitation, while β2 describes the effect of time-invariant predictors on activity limitation and β0 is 
the intercept. The focus is on the estimated coefficient β1 which is shown in Table 2. A graphical 
representation of this model is: 
 
 
 
 
 
For gender- and age-specific effects, stratified analyses of two subgroups according to gender, 
age group use the same equation. 
 
 
Model 2: 
 
The equation for Model 1 applies for stratified analyses of two subgroups according to 
moderating variables, namely poor social support and poor social integration. 
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(wave 2) 
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Activity 
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(wave 2) 
Effect of interest 
Physical 
Frailty 
(wave 6) 
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Model 3: 
 
Suppose mi is a mediator of the effect of pt-1i on yti, so that: 
yti = β0 + yt-1i + β1pt-1i + β2xi + β4mti + εti 
Suppose further that  
mti = λ0 + λ1pt-1i + δti 
Then the model given pt-2i and xi only, averaging over the distribution of mti, is  
Yti = β0 + yt-1i + β*1pt-1i + β2xi + ε*ti 
where ε*ti = (εti + β4δti) and β*1 = β1 + β4λ1 
 
Here, β*1 is the total effect of pt-1i on activity limitation, β1 is the direct effect of pt-1i, and β4λ1 is 
the indirect effect of pt-1i mediated via mti. 
 
 
 
For gender- and age-specific effects, stratified analyses of two subgroups according to gender, 
age group use the same equation. 
 
 
Model 4: 
 
The equation for Model 3 applies for stratified analyses of two subgroups according to 
moderating variables, namely poor social support and poor social integration.  
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Table 5. Characteristics of English Longitudinal Study of Ageing (ELSA) wave 2 
respondents aged 65 to 89 years included in analyses: physical frailty-related and other 
time varying variables across different waves  
 
Variables All By gender By Age group 
Male Female < 75 years >= 75 years 
Physical frailty-related: 
Mean average walking speed, 
m/sec (SD):        Wave 2 
                           Wave 4 
                           Wave 6 
Hand grip strength (dominant 
hand), kg (SD):   Wave 2 
                           Wave 4 
                           Wave 6 
Exhaustion, n/N (%): 
                           Wave 2 
 
                           Wave 4 
 
                           Wave 6 
 
 
0.8 (0.3)1 
0.8 (0.3)6 
0.8 (0.3)11 
 
25.9 (10.2)16 
24.3 (10.2)21 
22.8 (9.5)26 
 
1,490/4,510 
(33.0) 
955/2,977 
(32.1) 
632/1,962 
(32.2) 
 
 
0.9 (0.3)2 
0.8 (0.3)7 
0.8 (0.3)12 
 
33.4 (8.9)17 
32.0 (9.0)22 
29.6 (8.8)27 
 
568/1,997 
(28.4) 
327/1,290 
(25.4) 
218/848 
(25.7) 
 
 
0.8 (0.3)3 
0.7 (0.3)8 
0.7 (0.3)13 
 
19.6 (6.1)18 
18.2 (6.2)23 
17.5 (5.9)28 
 
922/2,513 
(36.7) 
628/1,687 
(37.2) 
414/1,114 
(37.2) 
 
 
0.9 (0.3)4 
0.8 (0.3)9 
0.8 (0.3)14 
 
28.4 (10.2)19 
26.6 (10.3)24 
24.4 (9.6)29 
 
728/2,596 
(28.0) 
518/1,868 
(27.7) 
401/1,402 
(28.6) 
 
 
0.7 (0.3)5 
0.7 (0.2)10 
0.6 (0.2)15 
 
22.2 (9.0)20 
20.4 (8.6)25 
18.9 (7.9)30 
 
762/1,914 
(39.8) 
437/1,109 
(39.4) 
231/560 
(41.3) 
Physical: 
Mean low physical activity 
level, n (%):      Wave 2 
                         Wave 4 
                         Wave 6 
 
 
1.2 (0.9)31 
1.3 (1.0)36 
1.4 (1.0)41 
 
 
1.1 (0.9)32 
1.2 (1.0)37 
1.3 (1.0)42 
 
 
1.3 (0.9)33 
1.4 (0.9)38 
1.6 (0.9)43 
 
 
1.0 (0.9)34 
1.1 (0.9)39 
1.2 (0.9)44 
 
 
1.4 (0.9)35 
1.7 (1.0)40 
1.9 (0.9)45 
Psychological: 
Mean CESD-8 score  
[0 to 8] (SD):     Wave 2 
                         Wave 4 
                         Wave 6 
Mean cognitive impairment 
score [0 to 49] (SD): 
                         Wave 2 
                         Wave 3 
                         Wave 4 
 
 
1.7 (2.0)46 
1.5 (1.9)51 
1.0 (1.4)56 
 
 
27.5 (6.3)61 
25.7 (6.6)66 
25.6 (6.8)71 
 
 
1.3 (1.7)47 
1.1 (1.7)52 
0.8 (1.2)57 
 
 
26.3 (6.4)62 
26.0 (6.5)67 
25.8 (6.6)72 
 
 
1.9 (2.1)48 
1.8 (2.0)53 
1.2 (1.5)58 
 
 
25.5 (6.5)63 
25.5 (6.8)68 
25.5 (6.9)73 
 
 
1.5 (1.9)49 
1.3 (1.8)54 
0.9 (1.3)59 
 
 
24.1 (6.0)64 
24.0 (6.1)69 
24.0 (6.2)74 
 
 
1.9 (2.0)50 
1.8 (2.0)55 
1.2 (1.5)60 
 
 
28.4 (6.3)65 
28.4 (6.5)70 
28.6 (6.7)75 
 
Frail status: Frailty Index >=0.25 
CESD-8: Center for Epidemiologic Studies Depression Scale (8 items) 
N = 14,096 21,826 32,266 42,400 51,692 62,649 71,182 81,467 91,705 10944111,688 12754 13934 141,254 15434 
163,869 171,760 182,109 192,276 201,593 212,531 221,115 231,416 241,621 25910 261,868 27820 281,048 291,339 
30529 314,567 322,032 332,535 342,611 351,956 363,125 371,355 381,770 391,915 401,210 412,404 421,023 
431,381 441,643 45761 464,479 471,987 482,492 492,586 501,893 512,960 521,285 531,675 541,859 551,101 
562,215 57947 581,268 591,557 60658 614,349 621,946 632,403 642,546 651,803 662,605 671,145 681,460 691,680 
70925 713,375 721,492 731,883 742,041 751,334 
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Table 6. Effects of physical frailty on activity limitation controlling for other predictors 
using the autoregressive cross-lagged model over waves 2, 4, and 6 of the English 
Longitudinal Study of Ageing: standardized regression coefficients for predictors at 
wave 2  
 
Outcome: Activity Limitation Coefficient estimate 
Lagged activity limitation  0.572** 
Physical frailty  0.234** 
Female -0.085** 
Older age  0.097** 
Chronic disease  0.079** 
Allostatic load -0.007 
Obesity  0.043 
Underweight state  0.195 
Smoking history -0.021 
High alcoholic intake <0.001 
Low wealth  0.017 
Low educational level -0.004 
Poor social support  0.052* 
Poor social interaction -0.022 
 
Coefficients are standardized for continuous predictors. Thus, coefficients are interpreted as change in 
activity limitation score for a one standard deviation increase in continuous predictors, or from zero to one 
for binary predictors (female gender, obesity, underweight state, smoking, high alcohol intake, low wealth, 
and low educational level). 
* p-value <0.05 but >=0.01    
** p-value <0.01 
Missing values are handled by full information maximum likelihood (FIML). 
N = 4,638  
220 
 
Table 7. Sensitivity analysis with simulation of unmeasured confounder of indirect 
effects of physical frailty on activity limitation using the autoregressive cross-lagged 
model over waves 2, 4, and 6 of the English Longitudinal Study of Ageing: linear 
regression coefficients  
 
Mediator Correlation 
between 
unmeasured 
confounder and 
mediators 
Correlation 
between 
unmeasured 
confounder and 
physical frailty 
Effect size of unmeasured confounder on 
activity limitation (comparison with that of 
strongest predictor of activity limitation) 
 
0X 
 
1X 
 
3X 
 
 
Low 
physical 
activity 
0 0 0.70* - - 
 
0.1 
(very low) 
0.1 
(very low) 
 
- 
 
0.042* 
 
0.038* 
0.3 
(low) 
 
- 
 
0.026* 
 
0.024* 
 
0.3 
(low) 
0.1 
(very low) 
 
- 
 
-0.030* 
 
-0.024* 
0.3 
(low) 
 
- 
 
-0.074* 
 
-0.066* 
 
 
 
Depressive 
symptoms 
0 0 0.19* - - 
 
0.1 
(very low) 
0.1 
(very low) 
 
- 
 
0.014* 
 
0.013* 
0.3 
(low) 
 
- 
 
0.010* 
 
0.009* 
 
0.3 
(low) 
0.1 
(very low) 
 
- 
 
0.002 
 
0.001 
0.3 
(low) 
 
- 
 
-0.004* 
 
-0.003* 
 
 
 
Cognitive 
impairment 
0 0 0.09* - - 
 
0.1 
(very low) 
0.1 
(very low) 
 
- 
 
0.004* 
 
0.003* 
0.3 
(low) 
 
- 
 
0.001 
 
0.001 
 
0.3 
(low) 
0.1 
(very low)  
 
- 
 
-0.010* 
 
-0.004 
0.3 
(low) 
 
- 
 
-0.019* 
 
-0.015* 
  
* p-value <0.05 
Coefficients are interpreted as change in activity limitation score for a one standard deviation increase in 
physical frailty factor score. 
Shaded areas indicate that effect of physical frailty on activity limitation remains positive and significant. 
Missing values are handled by full information maximum likelihood (FIML). 
N = 4,638  
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10.3 Further Thoughts 
 
Based on the evidence from ELSA, pathways from physical frailty to activity limitation are not 
simple and merely direct, but involve indirect effects through three mediators, namely low 
physical activity, depressive symptoms, and cognitive impairment. Just as for pathways to 
physical frailty and death, these mediators pertain to the physical and psychological 
dimensions. Notably, these indirect effects extend to, and are even stronger among very old 
people, at least where low physical activity and cognitive impairment are mediators. More 
importantly, addressing these conditions through health and social interventions represent 
opportunities for influencing pathways from physical frailty to activity limitation 
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11 Closing Discussion 
 
11.1 Methodological Aspects 
 
Through examining pathways to frailty and its outcomes, I utilize three different techniques of 
analyzing longitudinal data from ELSA. In the third paper, latent growth curves allow estimation 
of both intra-individual change of physical frailty and inter-individual differences in that change. 
In the fourth paper, discrete time survival analysis permits estimation of the effects of physical 
frailty on death as a binary outcome measured at two-yearly intervals. Finally, in the fifth paper, 
autoregressive cross lagged models afford the opportunity to estimate the effect of physical 
frailty on activity limitation change. 
 
Further, I construct statistical models largely within the structural equation modeling framework. 
In doing so, latent variables with multiple indicators represent the physical frailty construct. 
These are either incorporated as the measurement component of the full statistical model 
(measurement model), or as manifest (or observed) variables of physical frailty factor scores 
derived from the measurement model. The major advantage of incorporating the measurement 
model in the third paper is that this handles measurement error better. This in turn translates to 
improved ability to detect any significant effects. On the other hand, doing so inevitably 
increases the complexity of the statistical models, resulting in longer computational time, and 
on occasion, non-convergence. In the light of this drawback, I elected to use physical frailty 
scores derived from the measurement model in the fourth and fifth papers. 
 
Finally, it is worth highlighting that for the core analyses throughout these three papers, I use 
standard regression methods and have largely not drawn on concepts from the potential 
outcomes framework for causal inference (Little & Rubin, 2000). Instead, I have only introduced 
limited ideas from the causal inference literature when performing mediation analyses in the 
fourth and fifth papers (Muthén & Asparouhov, 2015). Thus, I rely on temporal relationships in 
longitudinal data and a rich set of multidimensional conditions as control variable for qualified 
and cautious causal interpretation of findings in these three papers. Certainly, there is potential 
to extend the current work by using the potential outcomes framework. However, such an 
endeavor is worthy of a separate project well beyond this thesis. 
 
11.2 Substantive Implications 
  
I have investigated pathways to frailty and its adverse outcomes using an approach that is 
guided by the working framework proposed by the Canadian Initiative for Frailty and Aging 
(Bergman et al., 2004). The evidence from ELSA assembled from these three papers supports 
the validity of this framework of frailty pathways by confirming the roles of several physical, 
psychological, and social conditions as predictors on pathways to physical frailty. Beyond this, 
additional indirect effects on pathways from physical frailty to its adverse outcomes through key 
mediators are demonstrated. However, moderated effects on these pathways are observed to a 
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lesser extent. In the effort to construct a composite picture of these pathways, Figure 11.1 
summarizes the major positive effects on frailty pathways based on the evidence from ELSA, 
while using the working framework of the Canadian Initiative on Frailty and Aging as the 
template. 
 
 
 
Figure 11.1. Summary of evidence on frailty pathways from the English Longitudinal 
Study of Ageing using the working framework of the Canadian Initiative on Frailty and 
Aging as the template 
 
 
 
 
Direct and indirect effects 
Moderated effects 
 
 
 
It is worth highlighting that when attempting to unpack the complexity of these pathways, the 
picture that emerges is at times unexpected, thereby raising more questions. For example, on 
pathways to physical frailty, several conditions such as smoking, obesity, and low wealth did 
not predict physical frailty change as expected. As mentioned, it is likely that their major 
influence on physical frailty is exerted well before later life when ELSA respondents are eligible 
to enter our study. In support of this explanation, obesity, low education, and low wealth have 
significant effects on initial physical frailty measured at start of follow-up, but not on physical 
frailty change during the follow-up period. In addition, moderation by low physical activity, 
depressive symptoms, poor social support, and poor social integration is not statistically 
significant. As alluded to, higher statistical power needed for moderation may be at least in part 
a possible explanation for these negative findings, which is a common theme that extends 
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across the last three papers. In the case of pathways to adverse outcomes, negative 
moderation of the effect of physical frailty on death by cognitive impairment is unanticipated. As 
discussed, a possible explanation is that physical frailty adds less to the risk of death due to the 
competing effect of more severe cognitive impairment. In addition, lack of moderation of the 
effects of physical frailty on death and activity limitation change by social conditions is 
somewhat surprising. Besides the issue of statistical power required, this situation may be 
related in part to the way complex social constructs are operationalized. Alternatively, and as 
alluded to, it may be that these social conditions do not truly have significant impact on physical 
frailty and its adverse outcomes as has been widely assumed (Hoogendijk et al., 2014). 
 
Overall, the unexpected findings suggest that multiple mechanisms involving indirect pathways 
and moderators have yet to be discovered on frailty pathways. More poignantly, the findings 
from these three papers are likely to represent the “tip of the iceberg” where the relationship of 
physical frailty with physical, psychological, and social conditions is concerned. Indeed, the 
assembling of evidence from ELSA in this thesis should be viewed as the initial steps in the 
arguably intriguing process of understanding frailty pathways more precisely. There is certainly 
much more to learn by unravelling the mechanisms at work on these pathways. To this end, 
two aspects are relevant for future work. The first pertains to the identification of conditions on 
pathways that are yet unmeasured. The second involves the specification of additional 
relationships on frailty pathways, particularly those involving mediation and moderation. 
 
Given the findings of my thesis, I would like to offer some suggestions for further research. 
Firstly, where data permits, inclusion of other relevant lifestyle-related and environmental 
conditions would be helpful. Examples include dietary habits, and neighborhood characteristics 
(Lang et al., 2008). Secondly, revision of the measurement of key constructs such as cognition, 
social support, and social interaction is worth exploring. Thirdly, alternative specifications of 
relationships between key conditions on frailty pathways including additional indirect effects 
and moderation could be considered, as this may facilitate obtaining more complete answers to 
questions on for whom these effects are stronger and how they exert their effects. These are 
the most interesting and relevant questions with respect to better understanding complex frailty 
pathways. They, in turn, can inform more optimally the development of health and social 
strategies to address physical frailty at the population level. Fourthly, examination of the effect 
of physical frailty on other outcomes such as health care utilization and nursing home 
admission is needed to better comprehend how its wider negative impact may be mitigated. 
Finally, replication of our findings in other older populations would be helpful in providing 
assurance of their applicability beyond England, and indeed, if possible, across continents. 
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12 Final Conclusions 
  
In summary, pathways to frailty and its adverse effects are more complex than is immediately 
apparent. Overall, the evidence on frailty pathways from ELSA is broadly consistent with those 
proposed by the working framework of the Canadian Initiative for Frailty and Aging. Several key 
physical, psychological, and social conditions have different roles on these pathways. 
 
On pathways to physical frailty, low physical activity, depressive symptoms, cognitive 
impairment, and poor social support all predict future physical frailty during late life. In addition, 
obesity, low education, and low wealth are likely to be early to mid-life conditions that predict 
physical frailty in late life. Furthermore, chronic disease and allostatic load mediate the indirect 
effects of low physical activity, depressive symptoms, and cognitive impairment on future 
physical frailty. Finally, poor social integration moderates the indirect effect of poor social 
support through chronic disease. 
 
On pathways to its adverse outcomes, physical frailty increases the risk of death independent 
of a broad range of physical, psychological, and social predictors. This effect extends across 
gender and age, but not to those who are very old. There is suggestion that effect of physical 
frailty may be stronger among those with high consumption of alcohol and with poor social 
integration. More importantly, the effect of physical frailty on death is exerted indirectly through 
low physical activity and cognitive impairment. Furthermore, physical frailty worsens the activity 
limitation trajectory, with this effect being stronger with older age. This effect is also exerted 
indirectly through low physical activity, depressive symptoms, and cognitive impairment. In turn, 
the indirect effect of physical frailty through low physical activity is stronger with older age and 
possibly, poor social support. 
 
Thus, physical, psychological, and social conditions play key roles on frailty pathways, whether 
as predictors, moderators, mediators, or their combinations. More importantly, they represent 
potentially modifiable target conditions for population-level interventions that may not only slow 
the progression of physical frailty, but also mitigate its effects on death and activity limitation in 
older people. More detailed examination of their specific roles is warranted to achieve more 
precise understand frailty pathways. To this end, I hope that the findings of my thesis will serve 
as a springboard for further research on frailty pathways by others. Nevertheless, for certain 
conditions, such as low physical activity, depressive symptoms, cognitive impairment, and poor 
social support, the evidence of their influence on these pathways from ELSA is arguably strong 
enough to consider implementing programs to address them as part of broad efforts to enhance 
both the lifespan and healthspan of older people.  
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14 Appendix 
 
 
14.1 Literature search strategies 
 
Search Terms 
 
For MEDLINE using PubMed and then modified for other search portals: 
 
Frailty identifiers 
(frailty[Text Word]) AND (index*[Text Word] OR indices[Text Word] OR deficit*[Text Word] OR 
phenotyp*[Text Word] OR construct*[Text Word] OR concept*[Text Word] OR measure*[Text 
Word] OR identifi*[Text Word] OR indicator*[Text Word] OR instrument*[Text Word] OR 
score*[Text Word] OR scale*[Text Word] OR syndrom*[Text Word] OR state*[Text Word] OR 
component*[Text Word] OR diagnos*[Text Word] OR definition*[Text Word] OR model*[Text 
Word] OR framework*[Text Word]) AND (Humans[Mesh] AND aged[MeSH]) 
 
Frailty pathways 
(frailty[Text Word]) AND (chronic[Text Word] OR comorbidity[Text Word] OR 
socioeconomic[Text Word] OR social*[Text Word] OR support[Text Word] OR access*[Text 
Word] OR medical*[Text Word] OR "health care"[Text Word] OR healthcare[Text Word] OR 
diet*[Text Word] OR nutrition[Text Word] OR exercise*[Text Word] OR "physical activity"[Text 
Word] OR "physical inactivity"[Text Word] OR smoking[Text Word] OR lifestyle[Text Word] OR 
environment*[Text Word] OR biological*[Text Word] OR psychosocial*[Text Word] OR "life 
course"[Text Word] OR cogniti*[Text Word] OR dementi*[Text Word] OR mood[Text Word] OR 
depressi*[Text Word] OR caus*[Text word] OR path*[Text Word] OR mediat*[Text Word] OR 
moderat*[Text Word] OR modif*[Text Word] OR determinant*[Text Word]) AND (Humans[Mesh] 
AND aged[MeSH]) 
 
Sources of literature 
 
Electronic databases 
 
1) Health 
• MEDLINE via PubMed 
• Cochrane Library 
o Cochrane Database of Systematic Reviews (CDSR) 
o Cochrane Central Register of Controlled Trials (CENTRAL) 
 
2) Social sciences 
• Campbell Library 
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3) Multi-disciplinary 
• Web of Science 
 
Hand searched documents 
 
1) Identified from references of papers selected from electronic databases 
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14.2 Scoring systems for key variables 
 
 
Chronic disease 
 
 
Condition Definition 
Hypertension (High blood pressure) Whether ever reported high blood pressure 
Angina Whether ever reported angina 
Myocardial Infarction (Heart attack) Whether ever reported myocardial infarction 
Congestive Heart Failure Whether ever reported congestive heart failure 
Arrhythmia (Abnormal heart rhythm) Whether ever reported arrhythmia 
Diabetes Mellitus Whether ever reported diabetes 
Stroke Whether ever reported stroke 
Asthma Whether ever reported asthma 
Arthritis Whether ever reported arthritis 
Osteoporosis Whether ever reported osteoporosis 
Cancer Whether ever reported cancer 
Parkinson’s Disease Whether ever reported Parkinson’s Disease 
Psychiatric disorders Whether ever reported psychiatric disorders 
Dementia Whether ever reported dementia 
 
 Note: Presence of each comorbid condition is assigned a score of 1. The total score is from 0 to 14. 
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Allostatic load 
 
Allostatic load is the physiological dysregulation in multiple body systems and is specified by nine 
biomarkers including blood pressure readings, anthropometric measurements, and blood tests for 
cholesterol levels, glucose control, and inflammatory markers. These biomarkers are: 
 
 
Biomarker Definition 
Systolic blood pressure whether >150 mmHg or not 
Diastolic blood pressure whether >80 mmHg or not 
Glycosylated haemoglobin level whether >5.8% or not 
Serum triglyceride level whether >2.2 mmol/l or not 
Serum c-reactive protein level whether >4.7 mg/l or not 
Serum fibrinogen level whether >3.7 umol/l or not 
Peak expiratory flow rate whether <232 l/min or not 
Waist-hip ratio whether >0.9588534 or not 
 
Note: For each biomarker, a score of one is awarded for values beyond a cut-off level reflecting high risk 
(75th percentile), with a score of zero given if otherwise. 
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Low resilience 
 
Low resilience is measured in relation to three facets of adversity. 
1) Objective financial adversity: defined as being in the lowest quintile of total non-pension wealth. 
2) Self-perceived financial adversity is the report of sometimes or more often having too little money 
to spend on needs. 
3) Widowhood is the change of marital status from being married or single in wave 1 to being 
widowed in wave 2. 
The criterion for establishing resilience under these three facets of adversity is a Center for Epidemiologic 
Studies Depression Scale (CES-D) score of three or less. 
 
 
Facet Criterion for 
adversity satisfied 
Criterion for 
resilience satisfied 
Score 
Objective financial adversity Yes 
No 
No 
Yes 
Yes 
No 
Yes 
No 
-1 
0 
0 
1 
Self-perceived financial adversity Yes 
No 
No 
Yes 
Yes 
No 
Yes 
No 
-1 
0 
0 
1 
Widowhood Yes 
No 
No 
Yes 
Yes 
No 
Yes 
No 
-1 
0 
0 
1 
 
Note: Summing up separate scores for the three facets, a total score ranging from -3 to 3 is obtained 
where higher scores indicate lower resilience. 
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Poor social integration 
 
 
Item Scoring 
Living with spouse for partner Whether having no spouse or partner living with them (1) 
Little contact with children Whether contact by meeting, phoning, or email is: 
- at least once per week (0) 
- once or twice a month (1) 
- once every few months (2) 
- once or twice a year or less (3) 
Little contact with other family 
members 
Whether contact by meeting, phoning, or email is: 
- at least once per week (0) 
- once or twice a month (1) 
- once every few months (2) 
- once or twice a year or less (3) 
Little contact with friends Whether contact by meeting, phoning, or email is: 
- at least once per week (0) 
- once or twice a month (1) 
- once every few months (2) 
- once or twice a year or less (3) 
Low membership of non-religious 
organizations, clubs or societies 
Whether having membership of the following groups or 
organizations (number): 
1) Political party, trade union or environmental groups 
2) Tenants groups, resident groups, neighbourhood watch 
3) Charitable associations 
4) Education, arts or music groups or evening classes 
5) Social Clubs 
6) Sports clubs, gyms, exercise classes 
- 0 (0) 
- 1 or 2 (1) 
- 3 or 4 (2) 
- 5 or 6 (3) 
Not a member of a religious group Whether not a member of any church or other religious 
group (1) 
 
 
 
Note: Individual scores for each item are indicated in brackets. The total score (0 to 14) is a measure of 
the extent of social isolation. 
250 
 
Poor social support 
 
 
Item Scoring 
Lack of positive support Answers to questions on whether children:  
“understand the way you feel” 
- a lot (0) 
- some (1) 
- a little (2) 
- not at all (3) 
“can rely on if you had a serious problem” 
- a lot (0) 
- some (1) 
- a little (2) 
- not at all (3) 
“can open up to them if you need to talk” 
- a lot (0) 
- some (1) 
- a little (2) 
- not at all (3) 
In turn, answers for these questions are also sought with 
respect to other family members, and friends. 
Total score: 0 to 27 
Negative support Answers to questions on whether children:  
"criticizes the respondent" 
- a lot (3) 
- some (2) 
- a little (1) 
- not at all (0) 
"lets the respondent down" 
- a lot (3) 
- some (2) 
- a little (1) 
- not at all (0) 
"gets on the nerves of respondent" 
- a lot (3) 
- some (2) 
- a little (1) 
- not at all (0) 
In turn, answers for these questions are also sought with 
respect to other family members, and friends. 
Total score: 0 to 27 
 
 
Note: Individual scores for each item are indicated in brackets. The total score (0 to 54) is a measure of 
the extent of deficient emotional support or negative social interaction.  
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Frailty Index (30 items) 
 
Item Definition 
Chronic illness: Hypertension Whether ever reported high blood pressure 
Chronic illness: Myocardial 
Infarction 
Whether ever reported myocardial infarction 
Chronic illness: Congestive heart 
failure 
Whether ever reported congestive heart failure 
Chronic illness: Diabetes Mellitus Whether ever reported diabetes 
Chronic illness: Stroke Whether ever reported stroke 
Chronic illness: Arthritis Whether ever reported arthritis 
Chronic illness: Cancer Whether ever reported cancer 
Chronic illness: Obesity BMI: WHO definition of obesity (>=30) or underweight (<18.5) 
Psychological condition: Dementia Whether ever reported dementia 
Psychological condition: Feeling 
depressed (CESD) 
Whether…felt depressed much of the time during the past 
week 
Psychological condition: Feeling 
effortful (CESD) 
Whether…felt everything they did during the past week was 
an effort 
Psychological condition: Feeling 
happy (CESD): reverse 
Whether…happy much of the time during the past week 
(reverse) 
Psychological condition: Feeling 
lonely (CESD) 
Whether…felt lonely much of the time during the past week 
Psychological condition: Could not 
get going (CESD) 
Whether…could not get going much of the time during the 
past week 
Poor self-rated health Whether self-rated health reported as “poor” 
Mobility: walking 100 yards Difficulty walking 100 yards 
Mobility: getting up from chair Difficulty getting up from chair after sitting long periods 
Mobility: climbing stairs Difficulty climbing one flight stairs without resting 
Mobility: lifting weights Difficulty lifting or carrying weights over 10 pounds 
BADL: dressing Difficulty dressing, including putting on shoes and socks 
BADL: walking Difficulty walking across a room 
BADL: bathing Difficulty bathing or showering 
BADL: eating Difficulty eating, such as cutting up food 
BADL: toileting Difficulty using the toilet, including getting up or down 
IADL: shopping Difficulty shopping for groceries 
IADL: taking medication Difficulty taking medications 
IADL: doing housework Difficulty doing work around house and garden 
IADL: managing finances Difficulty managing money, eg paying bills, keeping track 
expenses 
Weak grip strength Weak grip strength (1st measurement dominant hand) using 
gender-specific cut-offs (male: <30kg female: <20 kg) 
 
Note: Positive response or finding for each item is assigned a score of 1. The total score is divided by 30 
to obtain the frailty Index (0 to 1). 
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14.3 Mplus input files 
 
Paper 1: 
   
Title: CFA for physical frailty with 4 indicators 
Data: File is physical frailty.dat; 
Variable: 
    Names are 
     id sex slow weak exhaust wtloss;        
    Usevariables are 
     slow weak exhaust wtloss; 
    Categorical are 
      exhaust wtloss; 
    Auxiliary = id; 
    Missing are ALL (-9999); 
  Analysis: 
    Estimator = mlr; 
  Model: 
    pffactor BY slow weak exhaust wtloss; 
  Output: 
    stand sampstat; 
  Savedata: 
    File is CFA.4indicators.dat; 
    Save = fscores; 
 
! id = identification number; sex = gender; slow = slowness; weak = weakness; exhaust = exhaustion; 
wtloss = weight loss; lowphyac = low physical activity; 
! An additional Variable command is inserted for separate analyses of men and women: 
    Useobservations are 
       sex EQ 1; and then sex EQ 2; 
where sex EQ 1 for men, and sex EQ 2 for women. 
 
! To use the wlsmv estimator instead of mlr, the Analysis command is omitted. 
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Title: CFA for physical frailty with three indicators (including exhaustion) 
Data: File is physical frailty.dat; 
Variable: 
    Names are 
     id sex slow weak exhaust wtloss;        
    Usevariables are 
     slow weak exhaust; 
    Categorical are 
      exhaust; 
    Auxiliary = id; 
    Missing are ALL (-9999); 
  Analysis: 
    Estimator = mlr; 
  Model: 
    pffactor BY slow weak exhaust; 
  Output: 
    stand sampstat; 
  Savedata: 
    File is CFA.3indicators.exhaust.dat; 
    Save = fscores; 
 
! id = identification number; sex = gender; slow = slowness; weak = weakness; exhaust = exhaustion; 
wtloss = weight loss; lowphyac = low physical activity; 
! An additional Variable command is inserted for separate analyses of men and women: 
    Useobservations are 
       sex EQ 1; and then sex EQ 2; 
where sex EQ 1 for men, and sex EQ 2 for women. 
 
! To use the wlsmv estimator instead of mlr, the Analysis command is omitted. 
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Title: CFA for physical frailty with three indicators (including weight loss) 
Data: File is physical frailty.dat; 
Variable: 
    Names are 
     id sex slow weak exhaust wtloss;        
    Usevariables are 
     slow weak wtloss; 
    Categorical are 
      wtloss; 
    Auxiliary = id; 
    Missing are ALL (-9999); 
  Analysis: 
    Estimator = mlr; 
  Model: 
    pffactor BY slow weak wtloss; 
  Output: 
    stand sampstat; 
  Savedata: 
    File is CFA.3indicators.wtloss.dat; 
    Save = fscores; 
 
! id = identification number; sex = gender; slow = slowness; weak = weakness; exhaust = exhaustion; 
wtloss = weight loss; lowphyac = low physical activity; 
! An additional Variable command is inserted for separate analyses of men and women: 
    Useobservations are 
       sex EQ 1; and then sex EQ 2; 
where sex EQ 1 for men, and sex EQ 2 for women. 
 
! To use the wlsmv estimator instead of mlr, the Analysis command is omitted. 
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Paper 2: 
 
! In addition to the input files for Paper 1, the following file is used. 
   
Title: CFA for physical frailty with 5 indicators 
Data: File is physical frailty.dat; 
Variable: 
    Names are 
     id sex slow weak exhaust wtloss lowphyac;        
    Usevariables are 
     slow weak exhaust wtloss lowphyac; 
    Categorical are 
      exhaust wtloss lowphyac; 
    Auxiliary = id; 
    Missing are ALL (-9999); 
  Analysis: 
    Estimator = mlr; 
  Model: 
    pffactor BY slow weak exhaust wtloss lowphyac; 
  Output: 
    stand sampstat; 
  Savedata: 
    File is CFA.5indicators.dat; 
    Save = fscores; 
 
! id = identification number; sex = gender; slow = slowness; weak = weakness; exhaust = exhaustion; 
wtloss = weight loss; lowphyac = low physical activity; 
! An additional Variable command is inserted for separate analyses of men and women: 
    Useobservations are 
       sex EQ 1; and then sex EQ 2; 
where sex EQ 1 for men, and sex EQ 2 for women. 
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Paper 3: 
 
! Model 1 
Title: Latent growth curve model for prediction of physical frailty with multiple indicators 
Data: File is physical frailty1.dat; 
Define: 
     age_c65 = age_w2 - 65; 
Variable: 
  Names are 
     id sex age_w2 sex slow_w2 weak_w2 exhau_w2 slow_w4 weak_w4 exhau_w4 slow_w6 weak_w6    
     exhau_w6 cd14_w2 cd14_w4 cd14_w6 allo8_w2 allo8_w4 allo8_w6 smo_w2 alc_w2 lowth_w2  
     loedu_w2 bmi_30 bmi_20 lowpa_w1 lowpa_w2 lowpa_w4 cesd6_w1 cesd6_w2 cesd6_w4 cogni_w1  
     cogni_w2 cogni_w4 pssu_w1 pssu_w2 pssu_w4 psin_w1 psin_w2 psin_w4 
  Usevariables are 
     slow_w2 weak_w2 exhau_w2 slow_w4 weak_w4 exhau_w4 slow_w6 weak_w6 exhau_w6 
     cd14_w2 cd14_w4 cd14_w6 allo8_w2 allo8_w4 allo8_w6 smo_w2 alc_w2 lowth_w2 loedu_w2  
     bmi30_w2 bmi20_w2 lowpa_w1 lowpa_w2 lowpa_w4 cesd6_w1 cesd6_w2 cesd6_w4 cogni_w1  
     cogni_w2 cogni_w4 pssu_w1 pssu_w2 pssu_w4 psin_w1 psin_w2 psin_w4 sex age_c65; 
  Categorical are 
     exhau_w2 exhau_w4 exhau_w6; 
  Missing are ALL (-9999); 
Analysis: 
  Algorithm = integration; 
  Integration = montecarlo; 
  Estimator = mlr; 
Model: 
  pffac_w2 BY slow_w2 (s)  
  weak_w2 (w)  
  exhau_w2 (e); 
  [slow_w2] (si); 
  [weak_w2] (wi); 
  [exhau_w2$1] (ei); 
  pffac_w4 BY slow_w4 (s)  
  weak_w4 (w)  
  exhau_w4 (e); 
  [slow_w4] (si); 
  [weak_w4] (wi); 
  [exhau_w4$1] (ei); 
  pffac_w6 BY slow_w6 (s)  
  weak_w6 (w)  
  exhau_w6 (e); 
  [slow_w6] (si); 
  [weak_w6] (wi); 
  [exhau_w6$1] (ei); 
  slow_w2 WITH slow_w4; 
  slow_w2 WITH slow_w6; 
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  slow_w4 WITH slow_w6; 
  weak_w2 WITH weak_w4; 
  weak_w2 WITH weak_w6; 
  weak_w4 WITH weak_w6; 
  i s | pffac_w2@0 pffac_w4@1 pffac_w6@2; 
  i WITH s; 
  i ON age_c65 sex bmi30_w2 bmi20_w2 smo_w2 alc_w2 loedu_w2 lowth_w2; 
  s ON age_c65 sex bmi30_w2 bmi20_w2 smo_w2 alc_w2 loedu_w2 lowth_w2; 
  pffac_w2 ON cesd6_w1 (ces) 
  lowpa_w1 (lop) 
  cogni_w1(cog) 
  pssu_w1 (pss) 
  psin_w1 (psi) 
  cd14_w2 (cd) 
  allo8_w2 (all); 
  pffac_w4 ON cesd6_w2 (ces) 
  lowpa_w2 (lop) 
  cogni_w2(cog) 
  pssu_w2 (pss) 
  psin_w2 (psi) 
  cd14_w4 (cd) 
  allo8_w4 (all); 
  pffac_w6 ON cesd6_w4 (ces) 
  lowpa_w4 (lop) 
  cogni_w4(cog) 
  pssu_w4 (pss) 
  psin_w4 (psi) 
  cd14_w6 (cd) 
  allo8_w6 (all);   
  [bmi30_w2 bmi20_w2 cd14_w2 cd14_w4 cd14_w6 allo8_w2 allo8_w4 allo8_w6 smo_w2 alc_w2  
  loedu_w2 lowth_w2 cesd6_w1 cesd6_w2 cesd6_w4 lowpa_w1 lowpa_w2 lowpa_w4 cogni_w1 cogni_w2  
  cogni_w4 pssu_w1 pssu_w2 pssu_w4 psin_w1 psin_w2 psin_w4]; 
Output: 
  stand sampstat cinterval; 
 
 
! The suffixes, _w1, _w2, _w4, and _w6 indicate that variables are measured at waves 1, 2, 4, and 6 
respectively. 
! id = identification number; age = age; sex = gender; slow = slowness; weak = weakness; exhaust = 
exhaustion; cd14 = chronic disease; allo8 = allostatic load; smo = smoking; alc = high alcohol intake; 
lowth = low wealth; loedu = low education; bmi30 = obesity; bmi20 = underweight; lowpa = low physical 
activity; cesd6 = depressive symptoms; cogni = cognitive impairment; pssu = poor social support; psin = 
poor social integration; pffac = physical frailty factor; 
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Title: Latent growth curve model for prediction of physical frailty with multiple indicators and stratified by 
gender 
Data: File is physical frailty1.dat; 
Define: 
     age_c65 = age - 65; 
Variable: 
  Names are 
     id sex age_w2 sex slow_w2 weak_w2 exhau_w2 slow_w4 weak_w4 exhau_w4 slow_w6 weak_w6    
     exhau_w6 cd14_w2 cd14_w4 cd14_w6 allo8_w2 allo8_w4 allo8_w6 smo_w2 alc_w2 lowth_w2  
     loedu_w2 bmi_30 bmi_20 lowpa_w1 lowpa_w2 lowpa_w4 cesd6_w1 cesd6_w2 cesd6_w4 cogni_w1  
     cogni_w2 cogni_w4 pssu_w1 pssu_w2 pssu_w4 psin_w1 psin_w2 psin_w4 
  Usevariables are 
     slow_w2 weak_w2 exhau_w2 slow_w4 weak_w4 exhau_w4 slow_w6 weak_w6 exhau_w6 
     cd14_w2 cd14_w4 cd14_w6 allo8_w2 allo8_w4 allo8_w6 smo_w2 alc_w2 lowth_w2 loedu_w2  
     bmi30_w2 bmi20_w2 lowpa_w1 lowpa_w2 lowpa_w4 cesd6_w1 cesd6_w2 cesd6_w4 cogni_w1  
     cogni_w2 cogni_w4 pssu_w1 pssu_w2 pssu_w4 psin_w1 psin_w2 psin_w4 age_c65; 
Categorical are 
     exhau_w2 exhau_w4 exhau_w6; 
     Classes = c(2); 
  Knownclass = c(sex = 1-2); 
  Missing are ALL (-9999); 
Analysis: 
  Type = mixture; 
  Algorithm = integration; 
  Integration = montecarlo; 
  Estimator = mlr; 
Model: 
  %overall% 
  pffac_w2 BY slow_w2 (s)  
  weak_w2 (w)  
  exhau_w2 (e); 
  [slow_w2] (si); 
  [weak_w2] (wi); 
  [exhau_w2$1] (ei); 
  pffac_w4 BY slow_w4 (s)  
  weak_w4 (w)  
  exhau_w4 (e); 
  [slow_w4] (si); 
  [weak_w4] (wi); 
  [exhau_w4$1] (ei); 
  pffac_w6 BY slow_w6 (s)  
  weak_w6 (w)  
  exhau_w6 (e); 
  [slow_w6] (si); 
  [weak_w6] (wi); 
  [exhau_w6$1] (ei); 
  slow_w2 WITH slow_w4; 
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  slow_w2 WITH slow_w6; 
  slow_w4 WITH slow_w6; 
  weak_w2 WITH weak_w4; 
  weak_w2 WITH weak_w6; 
  weak_w4 WITH weak_w6; 
  i s | pffac_w2@0 pffac_w4@1 pffac_w6@2; 
  i WITH s; 
  i ON age_c65 sex bmi30_w2 bmi20_w2 smo_w2 alc_w2 loedu_w2 lowth_w2; 
  s ON age_c65 sex bmi30_w2 bmi20_w2 smo_w2 alc_w2 loedu_w2 lowth_w2; 
  pffac_w2 ON cesd6_w1 (ces) 
  lowpa_w1 (lop) 
  cogni_w1(cog) 
  pssu_w1 (pss) 
  psin_w1 (psi) 
  cd14_w2 (cd) 
  allo8_w2 (all); 
  pffac_w4 ON cesd6_w2 (ces) 
  lowpa_w2 (lop) 
  cogni_w2(cog) 
  pssu_w2 (pss) 
  psin_w2 (psi) 
  cd14_w4 (cd) 
  allo8_w4 (all); 
  pffac_w6 ON cesd6_w4 (ces) 
  lowpa_w4 (lop) 
  cogni_w4(cog) 
  pssu_w4 (pss) 
  psin_w4 (psi) 
  cd14_w6 (cd) 
  allo8_w6 (all);   
  [bmi30_w2 bmi20_w2 cd14_w2 cd14_w4 cd14_w6 allo8_w2 allo8_w4 allo8_w6 smo_w2 alc_w2  
  loedu_w2 lowth_w2 cesd6_w1 cesd6_w2 cesd6_w4 lowpa_w1 lowpa_w2 lowpa_w4 cogni_w1 cogni_w2  
  cogni_w4 pssu_w1 pssu_w2 pssu_w4 psin_w1 psin_w2 psin_w4]; 
  %c#1% 
  pffac_w2 BY slow_w2 (s1)  
  weak_w2 (w1)  
  exhau_w2 (e1); 
  [slow_w2] (si1); 
  [weak_w2] (wi1); 
  [exhau_w2$1] (ei1); 
  pffac_w4 BY slow_w4 (s1)  
  weak_w4 (w1)  
  exhau_w4 (e1); 
  [slow_w4] (si1); 
  [weak_w4] (wi1); 
  [exhau_w4$1] (ei1); 
  pffac_w6 BY slow_w6 (s1)  
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  weak_w6 (w1)  
  exhau_w6 (e1); 
  [slow_w6] (si1); 
  [weak_w6] (wi1); 
  [exhau_w6$1] (ei1); 
  slow_w2 WITH slow_w4; 
  slow_w2 WITH slow_w6; 
  slow_w4 WITH slow_w6; 
  weak_w2 WITH weak_w4; 
  weak_w2 WITH weak_w6; 
  weak_w4 WITH weak_w6; 
  i s | pffac_w2@0 pffac_w4@1 pffac_w6@2; 
  i WITH s;   
  i ON age_c65 sex bmi30_w2 bmi20_w2 smo_w2 alc_w2 loedu_w2 lowth_w2; 
  s ON age_c65 sex bmi30_w2 bmi20_w2 smo_w2 alc_w2 loedu_w2 lowth_w2; 
  pffac_w2 ON cesd6_w1 (ces1) 
  lowpa_w1 (lop1) 
  cogni_w1(cog1) 
  pssu_w1 (pss1) 
  psin_w1 (psi1) 
  cd14_w2 (cd1) 
  allo8_w2 (all1); 
  pffac_w4 ON cesd6_w2 (ces1) 
  lowpa_w2 (lop1) 
  cogni_w2(cog1) 
  pssu_w2 (pss1) 
  psin_w2 (psi1) 
  cd14_w4 (cd1) 
  allo8_w4 (all1); 
  pffac_w6 ON cesd6_w4 (ces1) 
  lowpa_w4 (lop1) 
  cogni_w4(cog1) 
  pssu_w4 (pss1) 
  psin_w4 (psi1) 
  cd14_w6 (cd1) 
  allo8_w6 (all1);   
  [bmi30_w2 bmi20_w2 cd14_w2 cd14_w4 cd14_w6 allo8_w2 allo8_w4 allo8_w6 smo_w2 alc_w2  
  loedu_w2 lowth_w2 cesd6_w1 cesd6_w2 cesd6_w4 lowpa_w1 lowpa_w2 lowpa_w4 cogni_w1 cogni_w2  
  cogni_w4 pssu_w1 pssu_w2 pssu_w4 psin_w1 psin_w2 psin_w4]; 
  %c#2% 
  pffac_w2 BY slow_w2 (s1)  
  weak_w2 (w1)  
  exhau_w2 (e1); 
  [slow_w2] (si1); 
  [weak_w2] (wi1); 
  [exhau_w2$1] (ei1); 
  pffac_w4 BY slow_w4 (s1)  
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  weak_w4 (w1)  
  exhau_w4 (e1); 
  [slow_w4] (si1); 
  [weak_w4] (wi1); 
  [exhau_w4$1] (ei1); 
  pffac_w6 BY slow_w6 (s1)  
  weak_w6 (w1)  
  exhau_w6 (e1); 
  [slow_w6] (si1); 
  [weak_w6] (wi1); 
  [exhau_w6$1] (ei1); 
  slow_w2 WITH slow_w4; 
  slow_w2 WITH slow_w6; 
  slow_w4 WITH slow_w6; 
  weak_w2 WITH weak_w4; 
  weak_w2 WITH weak_w6; 
  weak_w4 WITH weak_w6; 
  i s | pffac_w2@0 pffac_w4@1 pffac_w6@2; 
  i WITH s;   
  i ON age_c65 sex bmi30_w2 bmi20_w2 smo_w2 alc_w2 loedu_w2 lowth_w2; 
  s ON age_c65 sex bmi30_w2 bmi20_w2 smo_w2 alc_w2 loedu_w2 lowth_w2; 
  pffac_w2 ON cesd6_w1 (ces1) 
  lowpa_w1 (lop1) 
  cogni_w1(cog1) 
  pssu_w1 (pss1) 
  psin_w1 (psi1) 
  cd14_w2 (cd1) 
  allo8_w2 (all1); 
  pffac_w4 ON cesd6_w2 (ces1) 
  lowpa_w2 (lop1) 
  cogni_w2(cog1) 
  pssu_w2 (pss1) 
  psin_w2 (psi1) 
  cd14_w4 (cd1) 
  allo8_w4 (all1); 
  pffac_w6 ON cesd6_w4 (ces1) 
  lowpa_w4 (lop1) 
  cogni_w4(cog1) 
  pssu_w4 (pss1) 
  psin_w4 (psi1) 
  cd14_w6 (cd1) 
  allo8_w6 (all1);   
  [bmi30_w2 bmi20_w2 cd14_w2 cd14_w4 cd14_w6 allo8_w2 allo8_w4 allo8_w6 smo_w2 alc_w2  
  loedu_w2 lowth_w2 cesd6_w1 cesd6_w2 cesd6_w4 lowpa_w1 lowpa_w2 lowpa_w4 cogni_w1 cogni_w2  
  cogni_w4 pssu_w1 pssu_w2 pssu_w4 psin_w1 psin_w2 psin_w4]; 
Output: 
  stand sampstat cinterval; 
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! The suffixes, _w1, _w2, _w4, and _w6 indicate that variables are measured at waves 1, 2, 4, and 6 
respectively. 
! id = identification number; age = age; sex = gender; slow = slowness; weak = weakness; exhaust = 
exhaustion; cd14 = chronic disease; allo8 = allostatic load; smo = smoking; alc = high alcohol intake; 
lowth = low wealth; loedu = low education; bmi30 = obesity; bmi20 = underweight; lowpa = low physical 
activity; cesd6 = depressive symptoms; cogni = cognitive impairment; pssu = poor social support; psin = 
poor social integration; pffac = physical frailty factor; 
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Title: Latent growth curve model for prediction of physical frailty with multiple indicators and stratified by 
age group 
Data: File is physical frailty1.dat; 
Define: 
     IF age GE 75 THEN age75 = 2; 
     IF age LT 75 THEN age75 = 1; 
     age_c65 = age - 65; 
Variable: 
  Names are 
     id sex age_w2 sex slow_w2 weak_w2 exhau_w2 slow_w4 weak_w4 exhau_w4 slow_w6 weak_w6    
     exhau_w6 cd14_w2 cd14_w4 cd14_w6 allo8_w2 allo8_w4 allo8_w6 smo_w2 alc_w2 lowth_w2  
     loedu_w2 bmi_30 bmi_20 lowpa_w1 lowpa_w2 lowpa_w4 cesd6_w1 cesd6_w2 cesd6_w4 cogni_w1  
     cogni_w2 cogni_w4 pssu_w1 pssu_w2 pssu_w4 psin_w1 psin_w2 psin_w4 
  Usevariables are 
     slow_w2 weak_w2 exhau_w2 slow_w4 weak_w4 exhau_w4 slow_w6 weak_w6 exhau_w6 
     cd14_w2 cd14_w4 cd14_w6 allo8_w2 allo8_w4 allo8_w6 smo_w2 alc_w2 lowth_w2 loedu_w2  
     bmi30_w2 bmi20_w2 lowpa_w1 lowpa_w2 lowpa_w4 cesd6_w1 cesd6_w2 cesd6_w4 cogni_w1  
     cogni_w2 cogni_w4 pssu_w1 pssu_w2 pssu_w4 psin_w1 psin_w2 psin_w4 sex age_c65; 
Categorical are 
     exhau_w2 exhau_w4 exhau_w6; 
     Classes = c(2); 
  Knownclass = c(age75 = 1-2); 
  Missing are ALL (-9999); 
Analysis: 
  Type = mixture; 
  Algorithm = integration; 
  Integration = montecarlo; 
  Estimator = mlr; 
Model: 
  %overall% 
  pffac_w2 BY slow_w2 (s)  
  weak_w2 (w)  
  exhau_w2 (e); 
  [slow_w2] (si); 
  [weak_w2] (wi); 
  [exhau_w2$1] (ei); 
  pffac_w4 BY slow_w4 (s)  
  weak_w4 (w)  
  exhau_w4 (e); 
  [slow_w4] (si); 
  [weak_w4] (wi); 
  [exhau_w4$1] (ei); 
  pffac_w6 BY slow_w6 (s)  
  weak_w6 (w)  
  exhau_w6 (e); 
  [slow_w6] (si); 
  [weak_w6] (wi); 
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  [exhau_w6$1] (ei); 
  slow_w2 WITH slow_w4; 
  slow_w2 WITH slow_w6; 
  slow_w4 WITH slow_w6; 
  weak_w2 WITH weak_w4; 
  weak_w2 WITH weak_w6; 
  weak_w4 WITH weak_w6; 
  i s | pffac_w2@0 pffac_w4@1 pffac_w6@2; 
  i WITH s;   
  i ON age_c65 sex bmi30_w2 bmi20_w2 smo_w2 alc_w2 loedu_w2 lowth_w2; 
  s ON age_c65 sex bmi30_w2 bmi20_w2 smo_w2 alc_w2 loedu_w2 lowth_w2; 
  pffac_w2 ON cesd6_w1 (ces) 
  lowpa_w1 (lop) 
  cogni_w1(cog) 
  pssu_w1 (pss) 
  psin_w1 (psi) 
  cd14_w2 (cd) 
  allo8_w2 (all); 
  pffac_w4 ON cesd6_w2 (ces) 
  lowpa_w2 (lop) 
  cogni_w2(cog) 
  pssu_w2 (pss) 
  psin_w2 (psi) 
  cd14_w4 (cd) 
  allo8_w4 (all); 
  pffac_w6 ON cesd6_w4 (ces) 
  lowpa_w4 (lop) 
  cogni_w4(cog) 
  pssu_w4 (pss) 
  psin_w4 (psi) 
  cd14_w6 (cd) 
  allo8_w6 (all);   
  [bmi30_w2 bmi20_w2 cd14_w2 cd14_w4 cd14_w6 allo8_w2 allo8_w4 allo8_w6 smo_w2 alc_w2  
  loedu_w2 lowth_w2 cesd6_w1 cesd6_w2 cesd6_w4 lowpa_w1 lowpa_w2 lowpa_w4 cogni_w1 cogni_w2  
  cogni_w4 pssu_w1 pssu_w2 pssu_w4 psin_w1 psin_w2 psin_w4]; 
  %c#1% 
  pffac_w2 BY slow_w2 (s)  
  weak_w2 (w)  
  exhau_w2 (e); 
  [slow_w2] (si); 
  [weak_w2] (wi); 
  [exhau_w2$1] (ei); 
  pffac_w4 BY slow_w4 (s)  
  weak_w4 (w)  
  exhau_w4 (e); 
  [slow_w4] (si); 
  [weak_w4] (wi); 
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  [exhau_w4$1] (ei); 
  pffac_w6 BY slow_w6 (s)  
  weak_w6 (w)  
  exhau_w6 (e); 
  [slow_w6] (si); 
  [weak_w6] (wi); 
  [exhau_w6$1] (ei); 
  slow_w2 WITH slow_w4; 
  slow_w2 WITH slow_w6; 
  slow_w4 WITH slow_w6; 
  weak_w2 WITH weak_w4; 
  weak_w2 WITH weak_w6; 
  weak_w4 WITH weak_w6; 
  i s | pffac_w2@0 pffac_w4@1 pffac_w6@2; 
  i WITH s;   
  i ON age_c65 sex bmi30_w2 bmi20_w2 smo_w2 alc_w2 loedu_w2 lowth_w2; 
  s ON age_c65 sex bmi30_w2 bmi20_w2 smo_w2 alc_w2 loedu_w2 lowth_w2; 
  pffac_w2 ON cesd6_w1 (ces) 
  lowpa_w1 (lop) 
  cogni_w1(cog) 
  pssu_w1 (pss) 
  psin_w1 (psi) 
  cd14_w2 (cd) 
  allo8_w2 (all); 
  pffac_w4 ON cesd6_w2 (ces) 
  lowpa_w2 (lop) 
  cogni_w2(cog) 
  pssu_w2 (pss) 
  psin_w2 (psi) 
  cd14_w4 (cd) 
  allo8_w4 (all); 
  pffac_w6 ON cesd6_w4 (ces) 
  lowpa_w4 (lop) 
  cogni_w4(cog) 
  pssu_w4 (pss) 
  psin_w4 (psi) 
  cd14_w6 (cd) 
  allo8_w6 (all);   
  [bmi30_w2 bmi20_w2 cd14_w2 cd14_w4 cd14_w6 allo8_w2 allo8_w4 allo8_w6 smo_w2 alc_w2  
  loedu_w2 lowth_w2 cesd6_w1 cesd6_w2 cesd6_w4 lowpa_w1 lowpa_w2 lowpa_w4 cogni_w1 cogni_w2  
  cogni_w4 pssu_w1 pssu_w2 pssu_w4 psin_w1 psin_w2 psin_w4]; 
  %c#2% 
  pffac_w2 BY slow_w2 (s1)  
  weak_w2 (w1)  
  exhau_w2 (e1); 
  [slow_w2] (si1); 
  [weak_w2] (wi1); 
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  [exhau_w2$1] (ei1); 
  pffac_w4 BY slow_w4 (s1)  
  weak_w4 (w1)  
  exhau_w4 (e1); 
  [slow_w4] (si1); 
  [weak_w4] (wi1); 
  [exhau_w4$1] (ei1); 
  pffac_w6 BY slow_w6 (s1)  
  weak_w6 (w1)  
  exhau_w6 (e1); 
  [slow_w6] (si1); 
  [weak_w6] (wi1); 
  [exhau_w6$1] (ei1); 
  slow_w2 WITH slow_w4; 
  slow_w2 WITH slow_w6; 
  slow_w4 WITH slow_w6; 
  weak_w2 WITH weak_w4; 
  weak_w2 WITH weak_w6; 
  weak_w4 WITH weak_w6; 
  i s | pffac_w2@0 pffac_w4@1 pffac_w6@2; 
  i WITH s; 
  i ON age_c65 sex bmi30_w2 bmi20_w2 smo_w2 alc_w2 loedu_w2 lowth_w2; 
  s ON age_c65 sex bmi30_w2 bmi20_w2 smo_w2 alc_w2 loedu_w2 lowth_w2; 
  pffac_w2 ON cesd6_w1 (ces1) 
  lowpa_w1 (lop1) 
  cogni_w1(cog1) 
  pssu_w1 (pss1) 
  psin_w1 (psi1) 
  cd14_w2 (cd1) 
  allo8_w2 (all1); 
  pffac_w4 ON cesd6_w2 (ces1) 
  lowpa_w2 (lop1) 
  cogni_w2(cog1) 
  pssu_w2 (pss1) 
  psin_w2 (psi1) 
  cd14_w4 (cd1) 
  allo8_w4 (all1); 
  pffac_w6 ON cesd6_w4 (ces1) 
  lowpa_w4 (lop1) 
  cogni_w4(cog1) 
  pssu_w4 (pss1) 
  psin_w4 (psi1) 
  cd14_w6 (cd1) 
  allo8_w6 (all1); 
  [bmi30_w2 bmi20_w2 cd14_w2 cd14_w4 cd14_w6 allo8_w2 allo8_w4 allo8_w6 smo_w2 alc_w2  
  loedu_w2 lowth_w2 cesd6_w1 cesd6_w2 cesd6_w4 lowpa_w1 lowpa_w2 lowpa_w4 cogni_w1 cogni_w2  
  cogni_w4 pssu_w1 pssu_w2 pssu_w4 psin_w1 psin_w2 psin_w4]; 
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Output: 
  stand sampstat cinterval; 
 
! The suffixes, _w1, _w2, _w4, and _w6 indicate that variables are measured at waves 1, 2, 4, and 6 
respectively. 
! id = identification number; age = age; sex = gender; slow = slowness; weak = weakness; exhaust = 
exhaustion; cd14 = chronic disease; allo8 = allostatic load; smo = smoking; alc = high alcohol intake; 
lowth = low wealth; loedu = low education; bmi30 = obesity; bmi20 = underweight; lowpa = low physical 
activity; cesd6 = depressive symptoms; cogni = cognitive impairment; pssu = poor social support; psin = 
poor social integration; pffac = physical frailty factor; 
 
 
! Model 2 
 
! For stratification by low physical activity, depressive symptoms, poor social support, and poor social 
integration, the corresponding binary variables (using means as the cut-off values) are created and used 
in place of age group (as in Model 1).  
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! Model 3 
 
Title: Latent growth curve model for prediction of physical frailty with multiple indicators and incorporating 
indirect effects 
Data: File is physical frailty1.dat; 
Define: 
     age_c65 = age_w2 - 65; 
Variable: 
  Names are 
     id sex age_w2 sex slow_w2 weak_w2 exhau_w2 slow_w4 weak_w4 exhau_w4 slow_w6 weak_w6    
     exhau_w6 cd14_w2 cd14_w4 cd14_w6 allo8_w2 allo8_w4 allo8_w6 smo_w2 alc_w2 lowth_w2  
     loedu_w2 bmi30_w2 bmi20_w2 lowpa_w1 lowpa_w2 lowpa_w4 cesd6_w1 cesd6_w2 cesd6_w4  
     cogni_w1 cogni_w2 cogni_w4 pssu_w1 pssu_w2 pssu_w4 psin_w1 psin_w2 psin_w4 
  Usevariables are 
     slow_w2 weak_w2 exhau_w2 slow_w4 weak_w4 exhau_w4 slow_w6 weak_w6 exhau_w6 
     cd14_w2 cd14_w4 cd14_w6 allo8_w2 allo8_w4 allo8_w6 smo_w2 alc_w2 lowth_w2 loedu_w2  
     bmi30_w2 bmi20_w2 lowpa_w1 lowpa_w2 lowpa_w4 cesd6_w1 cesd6_w2 cesd6_w4 cogni_w1  
     cogni_w2 cogni_w4 pssu_w1 pssu_w2 pssu_w4 psin_w1 psin_w2 psin_w4 sex age_c65; 
  Categorical are 
     exhau_w2 exhau_w4 exhau_w6; 
  Missing are ALL (-9999); 
Analysis: 
  Algorithm = integration; 
  Integration = montecarlo; 
  Estimator = mlr; 
Model: 
  pffac_w2 BY slow_w2 (s)  
  weak_w2 (w)  
  exhau_w2 (e); 
  [slow_w2] (si); 
  [weak_w2] (wi); 
  [exhau_w2$1] (ei); 
  pffac_w4 BY slow_w4 (s)  
  weak_w4 (w)  
  exhau_w4 (e); 
  [slow_w4] (si); 
  [weak_w4] (wi); 
  [exhau_w4$1] (ei); 
  pffac_w6 BY slow_w6 (s)  
  weak_w6 (w)  
  exhau_w6 (e); 
  [slow_w6] (si); 
  [weak_w6] (wi); 
  [exhau_w6$1] (ei); 
 
  slow_w2 WITH slow_w4; 
  slow_w2 WITH slow_w6; 
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  slow_w4 WITH slow_w6; 
  weak_w2 WITH weak_w4; 
  weak_w2 WITH weak_w6; 
  weak_w4 WITH weak_w6; 
  i s | pffac_w2@0 pffac_w4@1 pffac_w6@2; 
  i WITH s; 
  i ON age_c65 sex bmi30_w2 bmi20_w2 smo_e_w2 h_alc_w2 loedu_w2 lowth_w2; 
  s ON age_c65 sex bmi30_w2 bmi20_w2 smo_e_w2 h_alc_w2 loedu_w2 lowth_w2; 
  cd14_w2 ON 
  cesd6_w1 (cescd) 
  lowpa_w1 (lopcd) 
  cogni_w1(cogcd) 
  pssu_w1 (psscd) 
  psin_w1 (psicd); 
  allo8_w2 ON 
  cesd6_w1 (cesall) 
  lowpa_w1 (lopall) 
  cogni_w1(cogall) 
  pssu_w1 (pssall) 
  psin_w1 (psiall); 
  cd14_w4 ON 
  cesd6_w2 (cescd) 
  lowpa_w2 (lopcd) 
  cogni_w2(cogcd) 
  pssu_w2 (psscd) 
  psin_w2 (psicd); 
  allo8_w4 ON 
  cesd6_w2 (cesall) 
  lowpa_w2 (lopall) 
  cogni_w2(cogall) 
  pssu_w2 (pssall) 
  psin_w2 (psiall); 
  cd14_w6 ON 
  cesd6_w4 (cescd) 
  lowpa_w4 (lopcd) 
  cogni_w4(cogcd) 
  pssu_w4 (psscd) 
  psin_w4 (psicd); 
  allo8_w6 ON 
  cesd6_w4 (cesall) 
  lowpa_w4 (lopall) 
  cogni_w4(cogall) 
  pssu_w4 (pssall) 
  psin_w4 (psiall); 
  cd14_w2 WITH allo8_w2; 
  cd14_w4 WITH allo8_w4; 
  cd14_w6 WITH allo8_w6; 
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  pffac_w2 ON  
  cesd6_w1 (ces) 
  lowpa_w1 (lop) 
  cogni_w1(cog) 
  pssu_w1 (pss) 
  psin_w1 (psi) 
  cd14_w2 (cd) 
  allo8_w2 (all); 
  pffac_w4 ON  
  cesd6_w2 (ces) 
  lowpa_w2 (lop) 
  cogni_w2(cog) 
  pssu_w2 (pss) 
  psin_w2 (psi) 
  cd14_w4 (cd) 
  allo8_w4 (all); 
  pffac_w6 ON  
  cesd6_w4 (ces) 
  lowpa_w4 (lop) 
  cogni_w4(cog) 
  pssu_w4 (pss) 
  psin_w4 (psi) 
  cd14_w6 (cd) 
  allo8_w6 (all); 
  [bmi30_w2 bmi20_w2 smo_w2 alc_w2 loedu_w2 lowth_w2 cd14_w2 cd14_w4 cd14_w6 allo8_w2  
  allo8_w4 allo8_w6 lowpa_w1 lowpa_w2 lowpa_w4 cesd6_w1 cesd6_w2 cesd6_w4 cogni_w1 cogni_w2  
  cogni_w4 pssu_w1 pssu_w2 pssu_w4 psin_w1 psin_w2 psin_w4]; 
  Model constraint: 
  new (ind22 ind23 ind24 ind25 ind26 
  ind32 ind33 ind34 ind35 ind36);   
  ind22 = cescd*cd; 
  ind23 = lopcd*cd; 
  ind24 = cogcd*cd; 
  ind25 = psscd*cd; 
  ind26 = psicd*cd;   
  ind32 = cesall*all; 
  ind33 = lopall*all; 
  ind34 = cogall*all; 
  ind35 = pssall*all; 
  ind36 = psiall*all; 
Output: 
  stand sampstat cinterval; 
 
! The suffixes, _w1, _w2, _w4, and _w6 indicate that variables are measured at waves 1, 2, 4, and 6 
respectively. 
! id = identification number; age = age; sex = gender; slow = slowness; weak = weakness; exhaust = 
exhaustion; cd14 = chronic disease; allo8 = allostatic load; smo = smoking; alc = high alcohol intake; 
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lowth = low wealth; loedu = low education; bmi30 = obesity; bmi20 = underweight; lowpa = low physical 
activity; cesd6 = depressive symptoms; cogni = cognitive impairment; pssu = poor social support; psin = 
poor social integration; pffac = physical frailty factor; 
 
 
! Stratification by gender and age group are as for Model 1. 
 
 
 
 
! Model 4 
! For stratification by poor social support, and poor social integration, the corresponding binary variables 
(using means as the cut-off values) are created and used in place of age group (as in Model 3). 
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! Sensitivity analysis for Model 1 
 
Title: Latent growth curve model for prediction of physical frailty with multiple indicators incorporating the 
Wu-Carroll shared parameter model to account for missing data being MNAR  
Data: File is physical frailty1.dat; 
Define: 
     age_c65 = age_w2 - 65; 
Variable: 
  Names are 
     id sex age_w2 sex slow_w2 weak_w2 exhau_w2 slow_w4 weak_w4 exhau_w4 slow_w6 weak_w6    
     exhau_w6 cd14_w2 cd14_w4 cd14_w6 allo8_w2 allo8_w4 allo8_w6 smo_w2 alc_w2 lowth_w2  
     loedu_w2 bmi_30 bmi_20 lowpa_w1 lowpa_w2 lowpa_w4 cesd6_w1 cesd6_w2 cesd6_w4 cogni_w1  
     cogni_w2 cogni_w4 pssu_w1 pssu_w2 pssu_w4 psin_w1 psin_w2 psin_w4 ind2 ind4 ind6; 
  Usevariables are 
     slow_w2 weak_w2 exhau_w2 slow_w4 weak_w4 exhau_w4 slow_w6 weak_w6 exhau_w6 
     cd14_w2 cd14_w4 cd14_w6 allo8_w2 allo8_w4 allo8_w6 smo_w2 alc_w2 lowth_w2 loedu_w2  
     bmi30_w2 bmi20_w2 lowpa_w1 lowpa_w2 lowpa_w4 cesd6_w1 cesd6_w2 cesd6_w4 cogni_w1  
     cogni_w2 cogni_w4 pssu_w1 pssu_w2 pssu_w4 psin_w1 psin_w2 psin_w4 sex ind2 ind4 ind6  
     age_c65 d4 d6; 
  Categorical are 
     exhau_w2 exhau_w4 exhau_w6 d4 d6; 
  Missing are ALL (-9999); 
Analysis: 
  Algorithm = integration; 
  Integration = montecarlo; 
  Estimator = mlr; 
Data Missing: 
  Names are ind2 ind4 ind6; 
  Type = sdropout; 
  Binary = d4 d6; 
Model: 
  pffac_w2 BY slow_w2 (s)  
  weak_w2 (w)  
  exhau_w2 (e); 
  [slow_w2] (si); 
  [weak_w2] (wi); 
  [exhau_w2$1] (ei); 
  pffac_w4 BY slow_w4 (s)  
  weak_w4 (w)  
  exhau_w4 (e); 
  [slow_w4] (si); 
  [weak_w4] (wi); 
  [exhau_w4$1] (ei); 
  pffac_w6 BY slow_w6 (s)  
  weak_w6 (w)  
  exhau_w6 (e); 
  [slow_w6] (si); 
273 
 
  [weak_w6] (wi); 
  [exhau_w6$1] (ei); 
  slow_w2 WITH slow_w4; 
  slow_w2 WITH slow_w6; 
  slow_w4 WITH slow_w6; 
  weak_w2 WITH weak_w4; 
  weak_w2 WITH weak_w6; 
  weak_w4 WITH weak_w6; 
  i s | pffac_w2@0 pffac_w4@1 pffac_w6@2; 
  i WITH s; 
  i ON age_c65 sex bmi30_w2 bmi20_w2 smo_w2 alc_w2 loedu_w2 lowth_w2; 
  s ON age_c65 sex bmi30_w2 bmi20_w2 smo_w2 alc_w2 loedu_w2 lowth_w2; 
  pffac_w2 ON cesd6_w1 (ces) 
  lowpa_w1 (lop) 
  cogni_w1(cog) 
  pssu_w1 (pss) 
  psin_w1 (psi) 
  cd14_w2 (cd) 
  allo8_w2 (all); 
  pffac_w4 ON cesd6_w2 (ces) 
  lowpa_w2 (lop) 
  cogni_w2(cog) 
  pssu_w2 (pss) 
  psin_w2 (psi) 
  cd14_w4 (cd) 
  allo8_w4 (all); 
  pffac_w6 ON cesd6_w4 (ces) 
  lowpa_w4 (lop) 
  cogni_w4(cog) 
  pssu_w4 (pss) 
  psin_w4 (psi) 
  cd14_w6 (cd) 
  allo8_w6 (all); 
  d4 ON i (1) 
  s (2)  
  age_c65 (3)  
  sex (4)  
  bmi30_w2 (5)  
  bmi20_w2 (6)  
  smo_w2 (7)  
  alc_w2 (8)  
  loedu_w2 (9)  
  lowth_w2 (10)  
  cesd6_w2 (11)  
  lowpa_w2 (12) 
  cogni_w2 (13)  
  pssu_w2 (14)  
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  psin_w2 (15)  
  cd14_w4 (16)  
  allo8_w4 (17); 
  d6 ON i (1)  
  s (2)  
  age_c65 (3)  
  sex (4)  
  bmi30_w2 (5)  
  bmi20_w2 (6)  
  smo_w2 (7)  
  alc_w2 (8)  
  loedu_w2 (9)  
  lowth_w2 (10)  
  cesd6_w4 (11)  
  lowpa_w4 (12) 
  cogni_w4 (13)  
  pssu_w4 (14)  
  psin_w4 (15)  
  cd14_w6 (16)  
  allo8_w6 (17); 
  [bmi30_w2 bmi20_w2 cd14_w2 cd14_w4 cd14_w6 allo8_w2 allo8_w4 allo8_w6 smo_w2 alc_w2  
  loedu_w2 lowth_w2 cesd6_w1 cesd6_w2 cesd6_w4 lowpa_w1 lowpa_w2 lowpa_w4 cogni_w1 cogni_w2  
  cogni_w4 pssu_w1 pssu_w2 pssu_w4 psin_w1 psin_w2 psin_w4]; 
Output: 
  stand sampstat cinterval; 
 
 
! The suffixes, _w1, _w2, _w4, and _w6 indicate that variables are measured at waves 1, 2, 4, and 6 
respectively. 
! id = identification number; age = age; sex = gender; slow = slowness; weak = weakness; exhaust = 
exhaustion; cd14 = chronic disease; allo8 = allostatic load; smo = smoking; alc = high alcohol intake; 
lowth = low wealth; loedu = low education; bmi30 = obesity; bmi20 = underweight; lowpa = low physical 
activity; cesd6 = depressive symptoms; cogni = cognitive impairment; pssu = poor social support; psin = 
poor social integration; pffac = physical frailty factor; ind2, ind4, ind6 = represents physical frailty factor at 
waves 2, 4, and 6 respectively where missing occurs when all three indicators have missing values; d4, 
d6 = physical frailty missing value indicators at waves 4 and 6 respectively; 
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Paper 4: 
 
! Model 1 
  Title: Discrete time survival analysis for prediction of death by physical frailty   
  Data: File is physical frailty2.dat; 
  Define: 
    Center age_w2 sex bmi30_w2 bmi20_w2 lowpa_w2 cd14_w2 allo_w2 smo_w2 alc_w2 cesd6_w2  
    cogni_w2 lowth_w2 loedu_w2 psin_w2 pssu_w2 (grandmean); 
  Variable: 
    Names are 
       id dea_w3 dea_w4 dea_w5 age_w2 sex cd14_w2 allo_w2 bmi30_w2 bmi20_w2 lowpa_w2 smo_w2      
       alc_w2 cesd6_w2 cogni_w2 psin_w2 pssu_w2 loweq_w2 loebi_w2 pf_mean; 
    Usevariables are 
       dea_w3 dea_w4 dea_w5 age_w2 sex cd14_w2 allo_w2 bmi30_w2 bmi20_w2 lowpa_w2 smo_w2      
       alc_w2 cesd6_w2 cogni_w2 psin_w2 pssu_w2 loweq_w2 loebi_w2 pf_mean; 
    Categorical are 
       dea_w3 dea_w4 dea_w5; 
    Missing are ALL (-9999); 
  Analysis: 
    Algorithm = integration; 
    Integration = montecarlo; 
    Estimator = mlr; 
    Link = logit; 
  Model: 
    death BY dea_w3@1 dea_w4@1 dea_w5@1; 
    death@0; 
    death ON pf_mean age_w2 sex bmi30_w2 bmi20_w2 lowpa_w2 cd14_w2 allo_w2 
    smo_w2 alc_w2 cesd6_w2 cogni_w2 lowth_w2 loedu_w2 psin_w2 pssu_w2; 
    [pf_mean bmi30_w2 bmi20_w2 lowpa_w2 cd14_w2 allo_w2 smo_w2 alc_w2 cesd6_w2 cogni_w2  
    lowth_w2 loedu_w2 psin_w2 pssu_w2]; 
  Output: 
    stand sampstat cinterval tech4; 
 
! The suffixes, _w2, _w3, _w4, and _w5 indicate that variables are measured at waves 2, 3, 4, and 5 
respectively. 
! id = identification number; age = age; sex = gender; cd14 = chronic disease; allo8 = allostatic load; smo 
= smoking; alc = high alcohol intake; lowth = low wealth; loedu = low education; bmi30 = obesity; bmi20 = 
underweight; lowpa = low physical activity; cesd6 = depressive symptoms; cogni = cognitive impairment; 
pssu = poor social support; psin = poor social integration; pf_mean = physical frailty factor score 
(standardized and centred on mean);  
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Title: Discrete time survival analysis for prediction of death by physical frailty including interaction with 
gender  
  Data: File is physical frailty2.dat; 
  Define: 
    Center age_w2 sex bmi30_w2 bmi20_w2 lowpa_w2 cd14_w2 allo_w2 smo_w2 alc_w2 cesd6_w2 
cogni_w2 lowth_w2 loedu_w2 psin_w2 pssu_w2 (grandmean); 
    pfxsex = pf_mean*sex; 
  Variable: 
    Names are 
       id dea_w3 dea_w4 dea_w5 age_w2 sex cd14_w2 allo_w2 bmi30_w2 bmi20_w2 lowpa_w2 smo_w2      
       alc_w2 cesd6_w2 cogni_w2 psin_w2 pssu_w2 loweq_w2 loebi_w2 pf_mean; 
    Usevariables are 
       dea_w3 dea_w4 dea_w5 age_w2 sex cd14_w2 allo_w2 bmi30_w2 bmi20_w2 lowpa_w2 smo_w2      
       alc_w2 cesd6_w2 cogni_w2 psin_w2 pssu_w2 loweq_w2 loebi_w2 pf_mean; 
    Categorical are 
       dea_w3 dea_w4 dea_w5; 
    Missing are ALL (-9999); 
  Analysis: 
    Algorithm = integration; 
    Integration = montecarlo; 
    Estimator = mlr; 
    Link = logit; 
  Model: 
    death BY dea_w3@1 dea_w4@1 dea_w5@1; 
    death@0; 
    death ON pf_mean age_w2 sex bmi30_w2 bmi20_w2 lowpa_w2 cd14_w2 allo_w2 
    smo_w2 alc_w2 cesd6_w2 cogni_w2 lowth_w2 loedu_w2 psin_w2 pssu_w2 
    pfxsex (pfxsex); 
    [pf_mean bmi30_w2 bmi20_w2 lowpa_w2 cd14_w2 allo_w2 smo_w2 alc_w2 cesd6_w2 cogni_w2  
    lowth_w2 loedu_w2 psin_w2 pssu_w2 pfxsex]; 
    Model constraint: 
    New (male female pf_ma pf_fe); 
    male = 1; 
    female = 2; 
    pf_ma = pf + (pfxsex*male); 
    pf_fe = pf + (pfxsex*female); 
    Model test: 
    0 = pf_ma - pf_fe; 
  Output: 
    stand sampstat cinterval tech4; 
 
! The suffixes, _w2, _w3, _w4, and _w5 indicate that variables are measured at waves 2, 3, 4, and 5 
respectively. 
! id = identification number; age = age; sex = gender; cd14 = chronic disease; allo8 = allostatic load; smo 
= smoking; alc = high alcohol intake; lowth = low wealth; loedu = low education; bmi30 = obesity; bmi20 = 
underweight; lowpa = low physical activity; cesd6 = depressive symptoms; cogni = cognitive impairment; 
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pssu = poor social support; psin = poor social integration; pf_mean = physical frailty factor score 
(standardized and centred on mean); 
 
! For stratification by age, interaction of physical frailty with age (pfxage) is included instead of that with 
gender. In addition: 
    Model constraint: 
    New (loage meage hiage pf_loage pf_meage pf_hiage pflo_or pfme_or pfhi_or); 
    loage = 65; 
    meage = 75; 
    hiage = 85; 
    pf_loage = pf + (pfxage*loage); 
    pf_meage = pf + (pfxage*meage); 
    pf_hiage = pf + (pfxage*hiage); 
    Model test: 
    0 = pf_loage - pf_hiage;  
 
 
! Model 2 
 
! For stratification by obesity, smoking, and high alcohol intake, their binary variables are used in place of 
gender (as in Model 1). 
 
! For stratification by low physical activity, allostatic load, depressive symptoms, cognitive impairment, low 
wealth, poor social support, and poor social integration, their continuous variables are used in place of 
age (as in Model 1). However, the model constraint command estimates the effect of physical frailty factor 
score at the mean, as well as one standard deviation above and below the mean of these variables. 
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! Model 3 
  Title: Discrete time survival analysis for prediction of death by physical frailty with indiect effects through  
  low physical activity, depressive symptoms, and cognitive impairment 
  Data: File is physical frailty2.dat; 
  Define: 
    Center age_w2 sex bmi30_w2 bmi20_w2 lowpa_w2 cd14_w2 allo_w2 smo_w2 alc_w2 cesd6_w2  
    cogni_w2 lowth_w2 loedu_w2 psin_w2 pssu_w2 (grandmean); 
  Variable: 
    Names are 
       id dea_w3 dea_w4 dea_w5 age_w2 sex cd14_w2 allo_w2 bmi30_w2 bmi20_w2 lowpa_w2 smo_w2      
       alc_w2 cesd6_w2 cogni_w2 psin_w2 pssu_w2 loweq_w2 loebi_w2 pf_mean; 
    Usevariables are 
       dea_w3 dea_w4 dea_w5 age_w2 sex cd14_w2 allo_w2 bmi30_w2 bmi20_w2 lowpa_w2 smo_w2      
       alc_w2 cesd6_w2 cogni_w2 psin_w2 pssu_w2 loweq_w2 loebi_w2 pf_mean; 
    Categorical are 
       dea_w3 dea_w4 dea_w5; 
    Missing are ALL (-9999); 
  Analysis: 
    Algorithm = integration; 
    Integration = montecarlo; 
    Estimator = mlr; 
    Link = logit; 
  Model: 
    death BY dea_w3@1 dea_w4@1 dea_w5@1; 
    death@0; 
    death ON pf_mean age_w2 sex bmi30_w2 bmi20_w2 cd14_w2 allo_w2 smo_w2 alc_w2  
    lowpa_w2 (loptodea) 
    cesd6_w2 (cestodea) 
    cogni_w2 (cogtodea) 
    lowth_w2 loedu_w2 psin_w2 pssu_w2; 
    lowpa_w2 ON pf_mean (pftolop) 
    sex age_w2 cd14_w2 allo_w2 smo_w2 alc_w2 bmi30_w2 bmi20_w2 pssu_w2 psin_w2 loedu_w2  
    lowth_w2;     
    cesd6_w2 ON pf_mean (pftoces) 
    sex age_w2 cd14_w2 allo_w2 smo_w2 alc_w2 bmi30_w2 bmi20_w2 pssu_w2 psin_w2 loedu_w2  
    lowth_w2; 
    cogni_w2 ON pf_mean (pftocog) 
    sex age_w2 cd14_w2 allo_w2 smo_w2 alc_w2 bmi30_w2 bmi20_w2 pssu_w2 psin_w2 loedu_w2  
    lowth_w2; 
    lowpa_w2 WITH cesd6_w2 cogni_w2; 
    cesd6_w2 WITH cogni_w2; 
    [pf_mean bmi30_w2 bmi20_w2 lowpa_w2 cd14_w2 allo_w2 smo_w2 alc_w2 cesd6_w2 cogni_w2  
    lowth_w2 loedu_w2 psin_w2 pssu_w2]; 
    Model constraint: 
    new (indlop indces indcog); 
    indlop = pftolop*loptodea; 
    indces = pftoces*cestodea; 
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    indcog = pftocog*cogtodea; 
  Output: 
    stand sampstat cinterval tech4; 
 
! The suffixes, _w2, _w3, _w4, and _w5 indicate that variables are measured at waves 2, 3, 4, and 5 
respectively. 
! id = identification number; age = age; sex = gender; cd14 = chronic disease; allo8 = allostatic load; smo 
= smoking; alc = high alcohol intake; lowth = low wealth; loedu = low education; bmi30 = obesity; bmi20 = 
underweight; lowpa = low physical activity; cesd6 = depressive symptoms; cogni = cognitive impairment; 
pssu = poor social support; psin = poor social integration; pf_mean = physical frailty factor score 
(standardized and centred on mean);  
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  Title: Discrete time survival analysis for prediction of death by physical frailty with indiect effects through  
  low physical activity, depressive symptoms, and cognitive impairment, and including interaction of    
  physical frailty with gender 
  Data: File is physical frailty2.dat; 
  Define: 
    Center age_w2 sex bmi30_w2 bmi20_w2 lowpa_w2 cd14_w2 allo_w2 smo_w2 alc_w2 cesd6_w2  
    cogni_w2 lowth_w2 loedu_w2 psin_w2 pssu_w2 (grandmean); 
    pfxlop = pf_mean*lowpa_w2; 
    pfxces = pf_mean *cesd6_w2; 
    pfxcog = pf_mean *cogni_w2; 
    pfxsex = pf_mean *sex; 
  Variable: 
    Names are 
       id dea_w3 dea_w4 dea_w5 age_w2 sex cd14_w2 allo_w2 bmi30_w2 bmi20_w2 lowpa_w2 smo_w2      
       alc_w2 cesd6_w2 cogni_w2 psin_w2 pssu_w2 loweq_w2 loebi_w2 pf_mean; 
    Usevariables are 
       dea_w3 dea_w4 dea_w5 age_w2 sex cd14_w2 allo_w2 bmi30_w2 bmi20_w2 lowpa_w2 smo_w2      
       alc_w2 cesd6_w2 cogni_w2 psin_w2 pssu_w2 loweq_w2 loebi_w2 pf_mean pfxlop pfxces pfxcog   
       pfxsex; 
    Categorical are 
       dea_w3 dea_w4 dea_w5; 
    Missing are ALL (-9999); 
  Analysis: 
    Algorithm = integration; 
    Integration = montecarlo; 
    Estimator = mlr; 
    Link = logit; 
    Bootstrap = 1000; 
  Model: 
    death BY dea_w3@1 dea_w4@1 dea_w5@1; 
    death@0; 
    death ON pf_mean age_w2 sex bmi30_w2 bmi20_w2 cd14_w2 allo_w2 smo_w2 alc_w2  
    lowpa_w2 (loptodea) 
    cesd6_w2 (cestodea) 
    cogni_w2 (cogtodea) 
    lowth_w2 loedu_w2 psin_w2 pssu_w2 
    pfxlop pfxces pfxcog; 
    lowpa_w2 ON pf_mean (pftolop) 
    sex age_w2 cd14_w2 allo_w2 smo_w2 alc_w2 bmi30_w2 bmi20_w2 pssu_w2 psin_w2 loedu_w2  
    lowth_w2 pfxsex (pfsexlop);     
    cesd6_w2 ON pf_mean (pftoces) 
    sex age_w2 cd14_w2 allo_w2 smo_w2 alc_w2 bmi30_w2 bmi20_w2 pssu_w2 psin_w2 loedu_w2  
    lowth_w2 pfxsex (pfsexces); 
    cogni_w2 ON pf_mean (pftocog) 
    sex age_w2 cd14_w2 allo_w2 smo_w2 alc_w2 bmi30_w2 bmi20_w2 pssu_w2 psin_w2 loedu_w2  
    lowth_w2 pfxsex (pfsexcog); 
    lowpa_w2 WITH cesd6_w2 cogni_w2; 
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    cesd6_w2 WITH cogni_w2; 
    [pf_mean bmi30_w2 bmi20_w2 lowpa_w2 cd14_w2 allo_w2 smo_w2 alc_w2 cesd6_w2 cogni_w2  
    lowth_w2 loedu_w2 psin_w2 pssu_w2 pfxlop pfxces pfxcog pfxsex]; 
    Model constraint: 
    new (m f indlop_m indlop_f indces_m indces_f indcog_m indcog_f); 
    m = 1; 
    f = 2; 
    indlop_m = (pftolop + pfsexlop*m)*(loptodea); 
    indlop_f = (pftolop + pfsexlop*f)*(loptodea); 
    indces_m = (pftoces + pfsexces*m)*(cestodea); 
    indces_f = (pftoces + pfsexces*f)*(cestodea); 
    indcog_m = (pftocog + pfsexcog*m)*(cogtodea); 
    indcog_f = (pftocog + pfsexcog*f)*(cogtodea); 
    Model test: 
    0 = indlop_m – indlop_f;  
  Output: 
    stand sampstat cinterval (bcbootstrap) tech4; 
 
! The suffixes, _w2, _w3, _w4, and _w5 indicate that variables are measured at waves 2, 3, 4, and 5 
respectively. 
! id = identification number; age = age; sex = gender; cd14 = chronic disease; allo8 = allostatic load; smo 
= smoking; alc = high alcohol intake; lowth = low wealth; loedu = low education; bmi30 = obesity; bmi20 = 
underweight; lowpa = low physical activity; cesd6 = depressive symptoms; cogni = cognitive impairment; 
pssu = poor social support; psin = poor social integration; pf_mean = physical frailty factor score 
(standardized and centred on mean); 
! The Model test command is implemented to test significance for differences in indirect effects through 
low physical activity, depressive symptoms, and cognitive impairment in turn across gender. 
 
! For stratification by age, interaction of physical frailty with age (pfxage) is included instead of that with 
gender. In addition: 
Model constraint: 
    new (indlop65 indlop75 indlop85 indces65 indces75 indces85 
    indcog65 indcog75 indcog85); 
    indlop65 = (pftolop + pfagelop*65)*(loptodea); 
    indlop75 = (pftolop + pfagelop*75)*(loptodea); 
    indlop85 = (pftolop + pfagelop*85)*(loptodea); 
    indces65 = (pftoces + pfageces*65)*(cestodea); 
    indces75 = (pftoces + pfageces*75)*(cestodea); 
    indces85 = (pftoces + pfageces*85)*(cestodea); 
    indcog65 = (pftocog + pfagecog*65)*(cogtodea); 
    indcog75 = (pftocog + pfagecog*75)*(cogtodea); 
    indcog85 = (pftocog + pfagecog*85)*(cogtodea); 
where pfagelop, pfageces, and pfagecog are coefficients for the effect of interactions of physical frailty 
factor score with age, on low physical activity, depressive symptoms, and cognitive impairment 
respectively. 
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! Model 4 
! For stratification by poor social support and poor social integration, their continuous variables are used in 
place of age (as in Model 3). However, the model constraint command estimates the effect of physical 
frailty factor score at the mean, as well as one standard deviation above and below the mean of these 
variables.  
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! Sensitivity analyses using phantom variables 
  Title: Discrete time survival analysis for prediction of death by physical frailty, while implementing  
  sensitivity analyses using phantom variables  
  Data: File is physical frailty2.dat; 
  Define: 
    Center age_w2 sex bmi30_w2 bmi20_w2 lowpa_w2 cd14_w2 allo_w2 smo_w2 alc_w2 cesd6_w2  
    cogni_w2 lowth_w2 loedu_w2 psin_w2 pssu_w2 (grandmean); 
  Variable: 
    Names are 
       id dea_w3 dea_w4 dea_w5 age_w2 sex cd14_w2 allo_w2 bmi30_w2 bmi20_w2 lowpa_w2 smo_w2      
       alc_w2 cesd6_w2 cogni_w2 psin_w2 pssu_w2 loweq_w2 loebi_w2 pf_mean; 
    Usevariables are 
       dea_w3 dea_w4 dea_w5 age_w2 sex cd14_w2 allo_w2 bmi30_w2 bmi20_w2 lowpa_w2 smo_w2      
       alc_w2 cesd6_w2 cogni_w2 psin_w2 pssu_w2 loweq_w2 loebi_w2 pf_mean; 
    Categorical are 
       dea_w3 dea_w4 dea_w5; 
    Missing are ALL (-9999); 
  Analysis: 
    Algorithm = integration; 
    Integration = montecarlo; 
    Estimator = mlr; 
    Link = logit; 
  Model: 
    death BY dea_w3@1 dea_w4@1 dea_w5@1; 
    death@0; 
    death ON pf_mean age_w2 sex bmi30_w2 bmi20_w2 lowpa_w2 cd14_w2 allo_w2 
    smo_w2 alc_w2 cesd6_w2 cogni_w2 lowth_w2 loedu_w2 psin_w2 pssu_w2 
    u@x; 
    u BY; 
    u@1;   
    u WITH pf_mean@y  
    sex@0 age_w2@0 cd14_w2@0 allo_w2@0 smo_w2@0 alc_w2@0 bmi30_w2@0 bmi20_w2@0   
    lowpa_w2@0 cesd6_w2@0 cogni_w2@0 pssu_w2@0 psin_w2@0 loedu_w2@0 lowth_w2@0; 
    [pf_mean bmi30_w2 bmi20_w2 lowpa_w2 cd14_w2 allo_w2 smo_w2 alc_w2 cesd6_w2 cogni_w2  
    lowth_w2 loedu_w2 psin_w2 pssu_w2]; 
  Output: 
    stand sampstat cinterval tech4; 
 
! The suffixes, _w2, _w3, _w4, and _w5 indicate that variables are measured at waves 2, 3, 4, and 5 
respectively. 
! id = identification number; age = age; sex = gender; cd14 = chronic disease; allo8 = allostatic load; smo 
= smoking; alc = high alcohol intake; lowth = low wealth; loedu = low education; bmi30 = obesity; bmi20 = 
underweight; lowpa = low physical activity; cesd6 = depressive symptoms; cogni = cognitive impairment; 
pssu = poor social support; psin = poor social integration; pf_mean = physical frailty factor score 
(standardized and centred on mean); u = phantom variable; 
! x = equivalent to multiples of the effect of physical frailty on death; y = correlation between u and 
physical frailty;  
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  Title: Discrete time survival analysis for prediction of death by physical frailty with indiect effects through  
  low physical activity, depressive symptoms, and cognitive impairment, while implementing sensitivity  
  analyses using phantom variables 
  Data: File is physical frailty2.dat; 
  Define: 
    Center age_w2 sex bmi30_w2 bmi20_w2 lowpa_w2 cd14_w2 allo_w2 smo_w2 alc_w2 cesd6_w2  
    cogni_w2 lowth_w2 loedu_w2 psin_w2 pssu_w2 (grandmean); 
  Variable: 
    Names are 
       id dea_w3 dea_w4 dea_w5 age_w2 sex cd14_w2 allo_w2 bmi30_w2 bmi20_w2 lowpa_w2 smo_w2      
       alc_w2 cesd6_w2 cogni_w2 psin_w2 pssu_w2 loweq_w2 loebi_w2 pf_mean; 
    Usevariables are 
       dea_w3 dea_w4 dea_w5 age_w2 sex cd14_w2 allo_w2 bmi30_w2 bmi20_w2 lowpa_w2 smo_w2      
       alc_w2 cesd6_w2 cogni_w2 psin_w2 pssu_w2 loweq_w2 loebi_w2 pf_mean; 
    Categorical are 
       dea_w3 dea_w4 dea_w5; 
    Missing are ALL (-9999); 
  Analysis: 
    Algorithm = integration; 
    Integration = montecarlo; 
    Estimator = mlr; 
    Link = logit; 
  Model: 
    death BY dea_w3@1 dea_w4@1 dea_w5@1; 
    death@0; 
    death ON pf_mean age_w2 sex bmi30_w2 bmi20_w2 cd14_w2 allo_w2 smo_w2 alc_w2  
    lowpa_w2 (loptodea) 
    cesd6_w2 (cestodea) 
    cogni_w2 (cogtodea) 
    lowth_w2 loedu_w2 psin_w2 pssu_w2 
    u@x; 
    lowpa_w2 ON pf_mean (pftolop) 
    sex age_w2 cd14_w2 allo_w2 smo_w2 alc_w2 bmi30_w2 bmi20_w2 pssu_w2 psin_w2 loedu_w2  
    lowth_w2;     
    cesd6_w2 ON pf_mean (pftoces) 
    sex age_w2 cd14_w2 allo_w2 smo_w2 alc_w2 bmi30_w2 bmi20_w2 pssu_w2 psin_w2 loedu_w2  
    lowth_w2; 
    cogni_w2 ON pf_mean (pftocog) 
    sex age_w2 cd14_w2 allo_w2 smo_w2 alc_w2 bmi30_w2 bmi20_w2 pssu_w2 psin_w2 loedu_w2  
    lowth_w2; 
    lowpa_w2 WITH cesd6_w2 cogni_w2; 
    cesd6_w2 WITH cogni_w2; 
    u BY; 
    u@1; 
    u WITH pf_mean@y lowpa_w2@z1 cesd6_w2@z2 cogni_w2@z3  
    sex@0 age_w2@0 cd14_w2@0 allo_w2@0 smo_w2@0 alc_w2@0 bmi30_w2@0 bmi20_w2@0      
    pssu_w2@0 psin_w2@0 loedu_w2@0 lowth_w2@0; 
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    [pf_mean bmi30_w2 bmi20_w2 lowpa_w2 cd14_w2 allo_w2 smo_w2 alc_w2 cesd6_w2 cogni_w2  
    lowth_w2 loedu_w2 psin_w2 pssu_w2]; 
    Model constraint: 
    new (indlop indces indcog); 
    indlop = pftolop*loptodea; 
    indces = pftoces*cestodea; 
    indcog = pftocog*cogtodea; 
  Output: 
    stand sampstat cinterval tech4; 
 
! The suffixes, _w2, _w3, _w4, and _w5 indicate that variables are measured at waves 2, 3, 4, and 5 
respectively. 
! id = identification number; age = age; sex = gender; cd14 = chronic disease; allo8 = allostatic load; smo 
= smoking; alc = high alcohol intake; lowth = low wealth; loedu = low education; bmi30 = obesity; bmi20 = 
underweight; lowpa = low physical activity; cesd6 = depressive symptoms; cogni = cognitive impairment; 
pssu = poor social support; psin = poor social integration; pf_mean = physical frailty factor score 
(standardized and centred on mean); u = phantom variable; 
! x = equivalent to multiples of the effect of physical frailty on death; y = correlation between u and 
physical frailty; z1 = correlation between u and low physical activity; z2 = correlation between u and 
depressive symptoms; z3 = correlation between u and cognitive impairment; 
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Paper 5: 
 
! Model 1 
Title: Autoregressive cross-lagged model for prediction of activity limitation by physical frailty   
Data: File is physical frailty3.dat; 
Variable: 
  Names are 
     id badl6_w2 badl6_w4 badl6_w6 age_w2 sex cd14_w2 allo_w2 bmi30_w2 bmi20_w2 smo_w2 alc_w2  
     lowth_w2 loedu_w2 pssu_w2 psin_w2 pf_w2 pf_w4 pf_w6; 
  Usevariables are 
     badl6_w2 badl6_w4 badl6_w6 age_w2 sex cd14_w2 allo_w2 bmi30_w2 bmi20_w2 smo_w2 alc_w2  
     lowth_w2 loedu_w2 pssu_w2 psin_w2 pf_w2 pf_w4 pf_w6; 
  Missing are ALL (-9999); 
Analysis: 
  Algorithm = integration; 
  Integration = montecarlo; 
  Estimator = mlr; 
Model: 
  badl6_w4 ON badl6_w2 (adladl) 
  pf_w2 (pfadl) 
  sex (sexadl) 
  age_w2 (ageadl) 
  cd14 (cdadl) 
  allo (alladl) 
  bmi30_w2 (b30adl) 
  bmi20_w2 (b20adl) 
  smo_w2 (smoadl) 
  alc_w2 (alcadl)   
  lowth_w2 (lowadl) 
  loedu_w2 (loeadl) 
  pssu_w2 (pssadl) 
  psin_w2 (psiadl); 
  badl6_w6 ON badl6_w4 (adladl) 
  pf_w4 (pfadl) 
  sex (sexadl) 
  age_w2 (ageadl) 
  cd14 (cdadl) 
  allo (alladl) 
  bmi30_w2 (b30adl) 
  bmi20_w2 (b20adl) 
  smo_w2 (smoadl) 
  alc_w2 (alcadl)   
  lowth_w2 (lowadl) 
  loedu_w2 (loeadl) 
  pssu_w2 (pssadl) 
  psin_w2 (psiadl); 
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  pf_w4 ON pf_w2 (pfpf) 
  badl6_w2 (adlpf) 
  sex (sexpf) 
  age_w2 (agepf) 
  cd14 (cdpf) 
  allo (allpf) 
  bmi30_w2 (b30pf) 
  bmi20_w2 (b20pf) 
  smo_w2 (smopf) 
  alc_w2 (alcpf)   
  lowth_w2 (lowpf) 
  loedu_w2 (loepf) 
  pssu_w2 (psspf) 
  psin_w2 (psipf); 
  pf_w6 ON pf_w4 (pfpf) 
  badl6_w4 (adlpf) 
  sex (sexpf) 
  age_w2 (agepf) 
  cd14 (cdpf) 
  allo (allpf) 
  bmi30_w2 (b30pf) 
  bmi20_w2 (b20pf) 
  smo_w2 (smopf) 
  alc_w2 (alcpf)   
  lowth_w2 (lowpf) 
  loedu_w2 (loepf) 
  pssu_w2 (psspf) 
  psin_w2 (psipf); 
  badl6_w4 WITH badl6_w6 pf_w4; 
  pf_w6 WITH pf_w4 badl6_w6; 
  [cd14_w2 allo_w2 bmi30_w2 bmi20_w2 smo_w2 alc_w2 lowth_w2 loedu_w2 pssu_w2 psin_w2]; 
Output: 
  stand sampstat cinterval tech4; 
 
! The suffixes, _w2, _w4, and _w6 indicate that variables are measured at waves 2, 4, and 6 respectively. 
! id = identification number; age = age (standardized); sex = gender; cd14 = chronic disease 
(standardized); allo = allostatic load (standardized); smo = smoking; alc = high alcohol intake; lowth = low 
wealth; loedu = low education; bmi30 = obesity; bmi20 = underweight; pssu = poor social support 
(standardized); psin = poor social integration (standardized); pf = physical frailty factor score 
(standardized); badl6 = number of basic activities of daily living items performed with difficulty;   
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Title: Autoregressive cross-lagged model for prediction of activity limitation by physical frailty with 
stratification by gender 
Data: File is physical frailty3.dat; 
Variable: 
  Names are 
     id badl6_w2 badl6_w4 badl6_w6 age_w2 sex cd14_w2 allo_w2 bmi30_w2 bmi20_w2 smo_w2 alc_w2  
     lowth_w2 loedu_w2 pssu_w2 psin_w2 pf_w2 pf_w4 pf_w6; 
  Usevariables are 
     badl6_w2 badl6_w4 badl6_w6 age_w2 cd14_w2 allo_w2 bmi30_w2 bmi20_w2 smo_w2 alc_w2  
     lowth_w2 loedu_w2 pssu_w2 psin_w2 pf_w2 pf_w4 pf_w6; 
  Classes = c(2); 
  Knownclass = c(sex = 1-2); 
  Missing are ALL (-9999); 
Analysis: 
  Type = mixture; 
  Algorithm = integration; 
  Integration = montecarlo; 
  Estimator = mlr; 
Model: 
  %overall% 
  badl6_w4 ON badl6_w2 (adladl) 
  pf_w2 (pfadl) 
  age_w2 (ageadl) 
  cd14 (cdadl) 
  allo (alladl) 
  bmi30_w2 (b30adl) 
  bmi20_w2 (b20adl) 
  smo_w2 (smoadl) 
  alc_w2 (alcadl)   
  lowth_w2 (lowadl) 
  loedu_w2 (loeadl) 
  pssu_w2 (pssadl) 
  psin_w2 (psiadl); 
  badl6_w6 ON badl6_w4 (adladl) 
  pf_w4 (pfadl) 
  age_w2 (ageadl) 
  cd14 (cdadl) 
  allo (alladl) 
  bmi30_w2 (b30adl) 
  bmi20_w2 (b20adl) 
  smo_w2 (smoadl) 
  alc_w2 (alcadl)   
  lowth_w2 (lowadl) 
  loedu_w2 (loeadl) 
  pssu_w2 (pssadl) 
  psin_w2 (psiadl); 
  pf_w4 ON pf_w2 (pfpf) 
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  badl6_w2 (adlpf) 
  age_w2 (agepf) 
  cd14 (cdpf) 
  allo (allpf) 
  bmi30_w2 (b30pf) 
  bmi20_w2 (b20pf) 
  smo_w2 (smopf) 
  alc_w2 (alcpf)   
  lowth_w2 (lowpf) 
  loedu_w2 (loepf) 
  pssu_w2 (psspf) 
  psin_w2 (psipf); 
  pf_w6 ON pf_w4 (pfpf) 
  badl6_w4 (adlpf) 
  age_w2 (agepf) 
  cd14 (cdpf) 
  allo (allpf) 
  bmi30_w2 (b30pf) 
  bmi20_w2 (b20pf) 
  smo_w2 (smopf) 
  alc_w2 (alcpf)   
  lowth_w2 (lowpf) 
  loedu_w2 (loepf) 
  pssu_w2 (psspf) 
  psin_w2 (psipf); 
  badl6_w4 WITH badl6_w6 pf_w4; 
  pf_w6 WITH pf_w4 badl6_w6; 
  [cd14_w2 allo_w2 bmi30_w2 bmi20_w2 smo_w2 alc_w2 lowth_w2 loedu_w2 pssu_w2 psin_w2]; 
  %c#1% 
  badl6_w4 ON badl6_w2 (adladl1) 
  pf_w2 (pfadl1) 
  age_w2 (agead1l) 
  cd14 (cdadl1) 
  allo (alladl) 
  bmi30_w2 (b30adl1) 
  bmi20_w2 (b20adl1) 
  smo_w2 (smoadl1) 
  alc_w2 (alcadl1)   
  lowth_w2 (lowadl1) 
  loedu_w2 (loeadl1) 
  pssu_w2 (pssadl1) 
  psin_w2 (psiadl1); 
  badl6_w6 ON badl6_w4 (adladl1) 
  pf_w4 (pfadl1) 
  age_w2 (ageadl1) 
  cd14 (cdadl1) 
  allo (alladl1) 
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  bmi30_w2 (b30adl1) 
  bmi20_w2 (b20adl1) 
  smo_w2 (smoadl1) 
  alc_w2 (alcadl)1   
  lowth_w2 (lowadl1) 
  loedu_w2 (loeadl1) 
  pssu_w2 (pssadl1) 
  psin_w2 (psiadl1); 
  pf_w4 ON pf_w2 (pfpf1) 
  badl6_w2 (adlpf1) 
  age_w2 (agepf1) 
  cd14 (cdpf1) 
  allo (allpf1) 
  bmi30_w2 (b30pf1) 
  bmi20_w2 (b20pf1) 
  smo_w2 (smopf1) 
  alc_w2 (alcpf1)   
  lowth_w2 (lowpf1) 
  loedu_w2 (loepf1) 
  pssu_w2 (psspf1) 
  psin_w2 (psipf1); 
  pf_w6 ON pf_w4 (pfpf1) 
  badl6_w4 (adlpf1) 
  age_w2 (agepf1) 
  cd14 (cdpf1) 
  allo (allpf1) 
  bmi30_w2 (b30pf1) 
  bmi20_w2 (b20pf1) 
  smo_w2 (smopf1) 
  alc_w2 (alcpf1)   
  lowth_w2 (lowpf1) 
  loedu_w2 (loepf1) 
  pssu_w2 (psspf1) 
  psin_w2 (psipf1); 
  badl6_w4 WITH badl6_w6 pf_w4; 
  pf_w6 WITH pf_w4 badl6_w6; 
  [cd14_w2 allo_w2 bmi30_w2 bmi20_w2 smo_w2 alc_w2 lowth_w2 loedu_w2 pssu_w2 psin_w2]; 
  %c#2% 
  badl6_w4 ON badl6_w2 (adladl2) 
  pf_w2 (pfadl2) 
  age_w2 (ageadl2) 
  cd14 (cdadl2) 
  allo (alladl2) 
  bmi30_w2 (b30adl2) 
  bmi20_w2 (b20adl2) 
  smo_w2 (smoadl2) 
  alc_w2 (alcadl2)   
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  lowth_w2 (lowadl2) 
  loedu_w2 (loeadl2) 
  pssu_w2 (pssadl2) 
  psin_w2 (psiadl2); 
  badl6_w6 ON badl6_w4 (adladl2) 
  pf_w4 (pfadl2) 
  age_w2 (ageadl2) 
  cd14 (cdadl2) 
  allo (alladl2) 
  bmi30_w2 (b30adl2) 
  bmi20_w2 (b20adl2) 
  smo_w2 (smoadl2) 
  alc_w2 (alcadl2)   
  lowth_w2 (lowadl2) 
  loedu_w2 (loeadl2) 
  pssu_w2 (pssadl2) 
  psin_w2 (psiadl2); 
  pf_w4 ON pf_w2 (pfpf2) 
  badl6_w2 (adlpf2) 
  age_w2 (agepf2) 
  cd14 (cdpf2) 
  allo (allpf2) 
  bmi30_w2 (b30pf2) 
  bmi20_w2 (b20pf2) 
  smo_w2 (smopf2) 
  alc_w2 (alcpf2)   
  lowth_w2 (lowpf2) 
  loedu_w2 (loepf2) 
  pssu_w2 (psspf2) 
  psin_w2 (psipf2); 
  pf_w6 ON pf_w4 (pfpf2) 
  badl6_w4 (adlpf2) 
  age_w2 (agepf2) 
  cd14 (cdpf2) 
  allo (allpf2) 
  bmi30_w2 (b30pf2) 
  bmi20_w2 (b20pf2) 
  smo_w2 (smopf2) 
  alc_w2 (alcpf2)   
  lowth_w2 (lowpf2) 
  loedu_w2 (loepf2) 
  pssu_w2 (psspf2) 
  psin_w2 (psipf2); 
  badl6_w4 WITH badl6_w6 pf_w4; 
  pf_w6 WITH pf_w4 badl6_w6; 
  [cd14_w2 allo_w2 bmi30_w2 bmi20_w2 smo_w2 alc_w2 lowth_w2 loedu_w2 pssu_w2 psin_w2]; 
  Model test: 
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  0 = pfadl1 - pfadl2; 
Output: 
  stand sampstat cinterval tech4; 
 
! The suffixes, _w2, _w4, and _w6 indicate that variables are measured at waves 2, 4, and 6 respectively. 
! id = identification number; age = age (standardized); sex = gender; cd14 = chronic disease 
(standardized); allo = allostatic load (standardized); smo = smoking; alc = high alcohol intake; lowth = low 
wealth; loedu = low education; bmi30 = obesity; bmi20 = underweight; pssu = poor social support 
(standardized); psin = poor social integration (standardized); pf = physical frailty factor score 
(standardized); badl6 = number of basic activities of daily living items performed with difficulty;  
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Title: Autoregressive cross-lagged model for prediction of activity limitation by physical frailty with 
stratification by age group 
Data: File is physical frailty3.dat; 
Define: 
  IF age_w2 GE 75 THEN age75_w2 = 2; 
  IF age_w2 LT 75 THEN age75_w2 = 1; 
Variable: 
  Names are 
     id badl6_w2 badl6_w4 badl6_w6 age_w2 sex cd14_w2 allo_w2 bmi30_w2 bmi20_w2 smo_w2 alc_w2  
     lowth_w2 loedu_w2 pssu_w2 psin_w2 pf_w2 pf_w4 pf_w6; 
  Usevariables are 
     badl6_w2 badl6_w4 badl6_w6 age_w2 sex cd14_w2 allo_w2 bmi30_w2 bmi20_w2 smo_w2 alc_w2  
     lowth_w2 loedu_w2 pssu_w2 psin_w2 pf_w2 pf_w4 pf_w6; 
  Classes = c(2); 
  Knownclass = c(age75_w2 = 1-2); 
  Missing are ALL (-9999); 
Analysis: 
  Type = mixture; 
  Algorithm = integration; 
  Integration = montecarlo; 
  Estimator = mlr; 
Model: 
  %overall% 
  badl6_w4 ON badl6_w2 (adladl) 
  pf_w2 (pfadl) 
  age_w2 (ageadl) 
  sex (sexadl) 
  cd14 (cdadl) 
  allo (alladl) 
  bmi30_w2 (b30adl) 
  bmi20_w2 (b20adl) 
  smo_w2 (smoadl) 
  alc_w2 (alcadl)   
  lowth_w2 (lowadl) 
  loedu_w2 (loeadl) 
  pssu_w2 (pssadl) 
  psin_w2 (psiadl); 
  badl6_w6 ON badl6_w4 (adladl) 
  pf_w4 (pfadl) 
  age_w2 (ageadl)  
  sex (sexadl) 
  cd14 (cdadl) 
  allo (alladl) 
  bmi30_w2 (b30adl) 
  bmi20_w2 (b20adl) 
  smo_w2 (smoadl) 
  alc_w2 (alcadl)   
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  lowth_w2 (lowadl) 
  loedu_w2 (loeadl) 
  pssu_w2 (pssadl) 
  psin_w2 (psiadl); 
  pf_w4 ON pf_w2 (pfpf) 
  badl6_w2 (adlpf) 
  age_w2 (agepf) 
  sex (sexpf) 
  cd14 (cdpf) 
  allo (allpf) 
  bmi30_w2 (b30pf) 
  bmi20_w2 (b20pf) 
  smo_w2 (smopf) 
  alc_w2 (alcpf)   
  lowth_w2 (lowpf) 
  loedu_w2 (loepf) 
  pssu_w2 (psspf) 
  psin_w2 (psipf); 
  pf_w6 ON pf_w4 (pfpf) 
  badl6_w4 (adlpf) 
  age_w2 (agepf)  
  sex (sexpf) 
  cd14 (cdpf) 
  allo (allpf) 
  bmi30_w2 (b30pf) 
  bmi20_w2 (b20pf) 
  smo_w2 (smopf) 
  alc_w2 (alcpf)   
  lowth_w2 (lowpf) 
  loedu_w2 (loepf) 
  pssu_w2 (psspf) 
  psin_w2 (psipf); 
  badl6_w4 WITH badl6_w6 pf_w4; 
  pf_w6 WITH pf_w4 badl6_w6; 
  [cd14_w2 allo_w2 bmi30_w2 bmi20_w2 smo_w2 alc_w2 lowth_w2 loedu_w2 pssu_w2 psin_w2]; 
  %c#1% 
  badl6_w4 ON badl6_w2 (adladl1) 
  pf_w2 (pfadl1) 
  age_w2 (agead1l)  
  sex (sexadl1) 
  cd14 (cdadl1) 
  allo (alladl) 
  bmi30_w2 (b30adl1) 
  bmi20_w2 (b20adl1) 
  smo_w2 (smoadl1) 
  alc_w2 (alcadl1)   
  lowth_w2 (lowadl1) 
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  loedu_w2 (loeadl1) 
  pssu_w2 (pssadl1) 
  psin_w2 (psiadl1); 
  badl6_w6 ON badl6_w4 (adladl1) 
  pf_w4 (pfadl1) 
  age_w2 (ageadl1)  
  sex (sexadl1) 
  cd14 (cdadl1) 
  allo (alladl1) 
  bmi30_w2 (b30adl1) 
  bmi20_w2 (b20adl1) 
  smo_w2 (smoadl1) 
  alc_w2 (alcadl)1   
  lowth_w2 (lowadl1) 
  loedu_w2 (loeadl1) 
  pssu_w2 (pssadl1) 
  psin_w2 (psiadl1); 
  pf_w4 ON pf_w2 (pfpf1) 
  badl6_w2 (adlpf1) 
  age_w2 (agepf1)  
  sex (sexpf1) 
  cd14 (cdpf1) 
  allo (allpf1) 
  bmi30_w2 (b30pf1) 
  bmi20_w2 (b20pf1) 
  smo_w2 (smopf1) 
  alc_w2 (alcpf1)   
  lowth_w2 (lowpf1) 
  loedu_w2 (loepf1) 
  pssu_w2 (psspf1) 
  psin_w2 (psipf1); 
  pf_w6 ON pf_w4 (pfpf1) 
  badl6_w4 (adlpf1) 
  age_w2 (agepf1)  
  sex (sexpf1) 
  cd14 (cdpf1) 
  allo (allpf1) 
  bmi30_w2 (b30pf1) 
  bmi20_w2 (b20pf1) 
  smo_w2 (smopf1) 
  alc_w2 (alcpf1)   
  lowth_w2 (lowpf1) 
  loedu_w2 (loepf1) 
  pssu_w2 (psspf1) 
  psin_w2 (psipf1); 
  badl6_w4 WITH badl6_w6 pf_w4; 
  pf_w6 WITH pf_w4 badl6_w6; 
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  [cd14_w2 allo_w2 bmi30_w2 bmi20_w2 smo_w2 alc_w2 lowth_w2 loedu_w2 pssu_w2 psin_w2]; 
  %c#2% 
  badl6_w4 ON badl6_w2 (adladl2) 
  pf_w2 (pfadl2) 
  age_w2 (ageadl2)  
  sex (sexadl2) 
  cd14 (cdadl2) 
  allo (alladl2) 
  bmi30_w2 (b30adl2) 
  bmi20_w2 (b20adl2) 
  smo_w2 (smoadl2) 
  alc_w2 (alcadl2)   
  lowth_w2 (lowadl2) 
  loedu_w2 (loeadl2) 
  pssu_w2 (pssadl2) 
  psin_w2 (psiadl2); 
  badl6_w6 ON badl6_w4 (adladl2) 
  pf_w4 (pfadl2) 
  age_w2 (ageadl2)  
  sex (sexadl2) 
  cd14 (cdadl2) 
  allo (alladl2) 
  bmi30_w2 (b30adl2) 
  bmi20_w2 (b20adl2) 
  smo_w2 (smoadl2) 
  alc_w2 (alcadl2)   
  lowth_w2 (lowadl2) 
  loedu_w2 (loeadl2) 
  pssu_w2 (pssadl2) 
  psin_w2 (psiadl2); 
  pf_w4 ON pf_w2 (pfpf2) 
  badl6_w2 (adlpf2) 
  age_w2 (agepf2)  
  sex (sexpf2) 
  cd14 (cdpf2) 
  allo (allpf2) 
  bmi30_w2 (b30pf2) 
  bmi20_w2 (b20pf2) 
  smo_w2 (smopf2) 
  alc_w2 (alcpf2)   
  lowth_w2 (lowpf2) 
  loedu_w2 (loepf2) 
  pssu_w2 (psspf2) 
  psin_w2 (psipf2); 
  pf_w6 ON pf_w4 (pfpf2) 
  badl6_w4 (adlpf2) 
  age_w2 (agepf2)  
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  sex (sexpf2) 
  cd14 (cdpf2) 
  allo (allpf2) 
  bmi30_w2 (b30pf2) 
  bmi20_w2 (b20pf2) 
  smo_w2 (smopf2) 
  alc_w2 (alcpf2)   
  lowth_w2 (lowpf2) 
  loedu_w2 (loepf2) 
  pssu_w2 (psspf2) 
  psin_w2 (psipf2); 
  badl6_w4 WITH badl6_w6 pf_w4; 
  pf_w6 WITH pf_w4 badl6_w6; 
  [cd14_w2 allo_w2 bmi30_w2 bmi20_w2 smo_w2 alc_w2 lowth_w2 loedu_w2 pssu_w2 psin_w2]; 
  Model test: 
  0 = pfadl1 - pfadl2; 
Output: 
  stand sampstat cinterval tech4; 
 
! The suffixes, _w2, _w4, and _w6 indicate that variables are measured at waves 2, 4, and 6 respectively. 
! id = identification number; age = age (standardized); sex = gender; cd14 = chronic disease 
(standardized); allo = allostatic load (standardized); smo = smoking; alc = high alcohol intake; lowth = low 
wealth; loedu = low education; bmi30 = obesity; bmi20 = underweight; pssu = poor social support 
(standardized); psin = poor social integration (standardized); pf = physical frailty factor score 
(standardized); badl6 = number of basic activities of daily living items performed with difficulty; 
 
 
! Model 2 
 
! For stratification by poor social support and poor social integration, the corresponding binary variables 
(using means as the cut-off values) are created and used in place of age group (as in Model 1).  
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! Model 3 
Title: Autoregressive cross-lagged model for prediction of activity limitation by physical frailty with indiect 
effects through low physical activity, depressive symptoms, and cognitive impairment  
Data: File is physical frailty3.dat; 
Variable: 
  Names are 
     id badl6_w2 badl6_w4 badl6_w6 age_w2 sex cd14_w2 allo_w2 bmi30_w2 bmi20_w2 smo_w2 alc_w2  
     lowth_w2 loedu_w2 pssu_w2 psin_w2 pf_w2 pf_w4 pf_w6 lowpa_w2 lowpa_w4 lowpa_w6 cesd6_w2    
     cesd6_w4 cesd6_w6 cogni_w2 cogni_w3 cogni_w4; 
  Usevariables are 
     badl6_w2 badl6_w4 badl6_w6 age_w2 sex cd14_w2 allo_w2 bmi30_w2 bmi20_w2 smo_w2 alc_w2  
     lowth_w2 loedu_w2 pssu_w2 psin_w2 pf_w2 pf_w4 pf_w6 lowpa_w2 lowpa_w4 lowpa_w6 cesd6_w2    
     cesd6_w4 cesd6_w6 cogni_w2 cogni_w3 cogni_w4; 
  Missing are ALL (-9999); 
Analysis: 
  Algorithm = integration; 
  Integration = montecarlo; 
  Estimator = mlr; 
Model: 
  badl6_w4 ON badl6_w2 (adladl) 
  pf_w2 (pfadl) 
  age_w2 (ageadl) 
  sex (sexadl) 
  cd14 (cdadl) 
  allo (alladl) 
  bmi30_w2 (b30adl) 
  bmi20_w2 (b20adl) 
  smo_w2 (smoadl) 
  alc_w2 (alcadl)   
  lowth_w2 (lowadl) 
  loedu_w2 (loeadl) 
  pssu_w2 (pssadl) 
  psin_w2 (psiadl); 
  badl6_w6 ON badl6_w4 (adladl) 
  pf_w4 (pfadl) 
  age_w2 (ageadl)  
  sex (sexadl) 
  cd14 (cdadl) 
  allo (alladl) 
  bmi30_w2 (b30adl) 
  bmi20_w2 (b20adl) 
  smo_w2 (smoadl) 
  alc_w2 (alcadl)   
  lowth_w2 (lowadl) 
  loedu_w2 (loeadl) 
  pssu_w2 (pssadl) 
  psin_w2 (psiadl); 
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  pf_w4 ON pf_w2 (pfpf) 
  badl6_w2 (adlpf) 
  age_w2 (agepf) 
  sex (sexpf) 
  cd14 (cdpf) 
  allo (allpf) 
  bmi30_w2 (b30pf) 
  bmi20_w2 (b20pf) 
  smo_w2 (smopf) 
  alc_w2 (alcpf)   
  lowth_w2 (lowpf) 
  loedu_w2 (loepf) 
  pssu_w2 (psspf) 
  psin_w2 (psipf); 
  pf_w6 ON pf_w4 (pfpf) 
  badl6_w4 (adlpf) 
  age_w2 (agepf)  
  sex (sexpf) 
  cd14 (cdpf) 
  allo (allpf) 
  bmi30_w2 (b30pf) 
  bmi20_w2 (b20pf) 
  smo_w2 (smopf) 
  alc_w2 (alcpf)   
  lowth_w2 (lowpf) 
  loedu_w2 (loepf) 
  pssu_w2 (psspf) 
  psin_w2 (psipf); 
  badl6_w4 WITH badl6_w6 pf_w4; 
  pf_w6 WITH pf_w4 badl6_w6; 
  lowpa_w4 ON lowpa_w2 (loplop) 
  pf_w2 (pflop) 
  sex (sexlop) 
  age_w2 (agelop) 
  cd14_w2 (cdlop) 
  allo_w2 (alllop) 
  smo_w2 (smolop) 
  alc_w2 (alclop) 
  pssu_w2 (psslop) 
  psin_w2 (psilop) 
  lowth_w2 (lowlop) 
  loedu_w2 (loelop) 
  bmi30_w2 (b30lop) 
  bmi20_w2 (b20lop); 
  lowpa_w6 ON lowpa_w4 (loplop) 
  pf_w4 (pflop) 
  sex (sexlop) 
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  age_w2 (agelop) 
  cd14_w2 (cdlop) 
  allo_w2 (alllop) 
  smo_w2 (smolop) 
  alc_w2 (alclop) 
  pssu_w2 (psslop) 
  psin_w2 (psilop) 
  lowth_w2 (lowlop) 
  loedu_w2 (loelop) 
  bmi30_w2 (b30lop) 
  bmi20_w2 (b20lop); 
  cesd6_w4 ON cesd6_w2 (cesces) 
  pf_w2 (pfces) 
  sex (sexces) 
  age_w2 (ageces) 
  cd14_w2 (cdces) 
  allo_w2 (allces) 
  smo_w2 (smoces) 
  alc_w2 (alcces) 
  pssu_w2 (pssces) 
  psin_w2 (psices) 
  lowth_w2 (lowces) 
  loedu_w2 (loeces) 
  bmi30_w2 (b30ces) 
  bmi20_w2 (b20ces); 
  cesd6_w6 ON cesd6_w4 (cesces) 
  pf_w4 (pfces) 
  sex (sexces) 
  age_w2 (ageces) 
  cd14_w2 (cdces) 
  allo_w2 (allces) 
  smo_w2 (smoces) 
  alc_w2 (alcces) 
  pssu_w2 (pssces) 
  psin_w2 (psices) 
  lowth_w2 (lowces) 
  loedu_w2 (loeces) 
  bmi30_w2 (b30ces) 
  bmi20_w2 (b20ces); 
  cogni_w3 ON cogni_w2 (cogcog) 
  pf_w2 (pfcog) 
  sex (sexcog) 
  age_w2 (agecog) 
  cd14_w2 (cdcog) 
  allo_w2 (allcog) 
  smo_w2 (smocog) 
  alc_w2 (alccog) 
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  pssu_w2 (psscog) 
  psin_w2 (psicog) 
  lowth_w2 (lowcog) 
  loedu_w2 (loecog) 
  bmi30_w2 (b30cog) 
  bmi20_w2 (b20cog); 
  cogni_w4 ON cogni_w3 (cogcog) 
  pf_w4 (pfcog) 
  sex (sexcog) 
  age_w2 (agecog) 
  cd14_w2 (cdcog) 
  allo_w2 (allcog) 
  smo_w2 (smocog) 
  alc_w2 (alccog) 
  pssu_w2 (psscog) 
  psin_w2 (psicog) 
  lowth_w2 (lowcog) 
  loedu_w2 (loecog) 
  bmi30_w2 (b30cog) 
  bmi20_w2 (b20cog); 
  lowpa_w2 WITH cesd6_w2 cogni_w2; 
  cesd6_w2 WITH cogni_w2; 
  lowpa_w4 WITH cesd6_w4 cogni_w3; 
  cesd6_w4 WITH cogni_w3; 
  lowpa_w6 WITH cesd6_w6 cogni_w4; 
  cesd6_w6 WITH cogni_w4; 
  [cd14_w2 allo_w2 bmi30_w2 bmi20_w2 smo_w2 alc_w2 lowth_w2 loedu_w2 pssu_w2 psin_w2 
  lowpa_w2 lowpa_w4 lowpa_w6 cesd6_w2 cesd6_w4 cesd6_w6 cogni_w2 cogni_w3 cogni_w4]; 
  Model constraint: 
  new (IND1 IND2 IND3); 
  IND1 = (pflop*lopadl); 
  IND2 = (pfces*cesadl); 
  IND3 = (pfcog*cogadl); 
Output: 
  stand sampstat cinterval tech4; 
 
! The suffixes, _w2, _w3, _w4, and _w6 indicate that variables are measured at waves 2, 3, 4, and 6 
respectively. 
! id = identification number; age = age (standardized); sex = gender; cd14 = chronic disease 
(standardized); allo = allostatic load (standardized); smo = smoking; alc = high alcohol intake; lowth = low 
wealth; loedu = low education; bmi30 = obesity; bmi20 = underweight; pssu = poor social support 
(standardized); psin = poor social integration (standardized); lowpa = low physical activity (standardized); 
cesd6 = depressive symptoms (standardized); cogni = cognitive impairment (standardized); pf = physical 
frailty factor score (standardized); badl6 = number of basic activities of daily living items performed with 
difficulty;    
 
! Stratification by gender and age group are as for Model 1. 
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! Model 4 
! For stratification by poor social support, and poor social integration, the corresponding binary variables 
(using means as the cut-off values) are created and used in place of age group (as in Model 3). 
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! Sensitivity analyses including exposure-mediator interaction 
 
! Additional variables for interaction of physical frailty with mediators (low physical activity, depressive 
symptoms, and cognitive impairment) are created and included in the prediction of activity limitation.  
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! Sensitivity analyses using phantom variables 
 
Title: Autoregressive cross-lagged model for prediction of activity limitation by physical frailty, while 
implementing sensitivity analyses using phantom variables 
Data: File is physical frailty3.dat; 
Variable: 
  Names are 
     id badl6_w2 badl6_w4 badl6_w6 age_w2 sex cd14_w2 allo_w2 bmi30_w2 bmi20_w2 smo_w2 alc_w2  
     lowth_w2 loedu_w2 pssu_w2 psin_w2 pf_w2 pf_w4 pf_w6; 
  Usevariables are 
     badl6_w2 badl6_w4 badl6_w6 age_w2 sex cd14_w2 allo_w2 bmi30_w2 bmi20_w2 smo_w2 alc_w2  
     lowth_w2 loedu_w2 pssu_w2 psin_w2 pf_w2 pf_w4 pf_w6; 
  Missing are ALL (-9999); 
Analysis: 
  Algorithm = integration; 
  Integration = montecarlo; 
  Estimator = mlr; 
Model: 
  badl6_w4 ON badl6_w2 (adladl) 
  pf_w2 (pfadl) 
  sex (sexadl) 
  age_w2 (ageadl) 
  cd14 (cdadl) 
  allo (alladl) 
  bmi30_w2 (b30adl) 
  bmi20_w2 (b20adl) 
  smo_w2 (smoadl) 
  alc_w2 (alcadl)   
  lowth_w2 (lowadl) 
  loedu_w2 (loeadl) 
  pssu_w2 (pssadl) 
  psin_w2 (psiadl) 
  u1@x; 
  badl6_w6 ON badl6_w4 (adladl) 
  pf_w4 (pfadl) 
  sex (sexadl) 
  age_w2 (ageadl) 
  cd14 (cdadl) 
  allo (alladl) 
  bmi30_w2 (b30adl) 
  bmi20_w2 (b20adl) 
  smo_w2 (smoadl) 
  alc_w2 (alcadl)   
  lowth_w2 (lowadl) 
  loedu_w2 (loeadl) 
  pssu_w2 (pssadl) 
  psin_w2 (psiadl) 
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  u2@x; 
  pf_w4 ON pf_w2 (pfpf) 
  badl6_w2 (adlpf) 
  sex (sexpf) 
  age_w2 (agepf) 
  cd14 (cdpf) 
  allo (allpf) 
  bmi30_w2 (b30pf) 
  bmi20_w2 (b20pf) 
  smo_w2 (smopf) 
  alc_w2 (alcpf)   
  lowth_w2 (lowpf) 
  loedu_w2 (loepf) 
  pssu_w2 (psspf) 
  psin_w2 (psipf) 
  u1@y; 
  pf_w6 ON pf_w4 (pfpf) 
  badl6_w4 (adlpf) 
  sex (sexpf) 
  age_w2 (agepf) 
  cd14 (cdpf) 
  allo (allpf) 
  bmi30_w2 (b30pf) 
  bmi20_w2 (b20pf) 
  smo_w2 (smopf) 
  alc_w2 (alcpf)   
  lowth_w2 (lowpf) 
  loedu_w2 (loepf) 
  pssu_w2 (psspf) 
  psin_w2 (psipf) 
  u2@y; 
  badl6_w4 WITH badl6_w6 pf_w4; 
  pf_w6 WITH pf_w4 badl6_w6; 
  u1 BY; 
  u1@1; 
  u2 BY; 
  u2@1; 
  u2 ON u1; 
  u1 WITH age_w2@0 sex@0 cd14_w2@0 allo_w2@0 smo_w2@0 alc_w2@0 pssu_w2@0 psin_w2@0  
  lowth_w2@0 loedu_w2@0 bmi30_w2@0 bmi20_w2@0; 
  u2 WITH age_w2@0 sex@0 cd14_w2@0 allo_w2@0 smo_w2@0 alc_w2@0 pssu_w2@0 psin_w2@0  
  lowth_w2@0 loedu_w2@0 bmi30_w2@0 bmi20_w2@0; 
  [cd14_w2 allo_w2 bmi30_w2 bmi20_w2 smo_w2 alc_w2 lowth_w2 loedu_w2 pssu_w2 psin_w2]; 
Output: 
  stand sampstat cinterval tech4; 
 
! The suffixes, _w2, _w4, and _w6 indicate that variables are measured at waves 2, 4, and 6 respectively. 
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! id = identification number; age = age (standardized); sex = gender; cd14 = chronic disease 
(standardized); allo = allostatic load (standardized); smo = smoking; alc = high alcohol intake; lowth = low 
wealth; loedu = low education; bmi30 = obesity; bmi20 = underweight; pssu = poor social support 
(standardized); psin = poor social integration (standardized); pf = physical frailty factor score 
(standardized); badl6 = number of basic activities of daily living items performed with difficulty; u1, u2 = 
phantom variables; 
 
! x = equivalent to multiples of the effect of the strongest predictor (other than physical frailty) on activity 
limitation; y = correlation between u and physical frailty;  
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Title: Autoregressive cross-lagged model for prediction of activity limitation by physical frailty with indiect 
effects through low physical activity, depressive symptoms, and cognitive impairment, while implementing 
sensitivity analyses using phantom variables  
Data: File is physical frailty3.dat; 
Variable: 
  Names are 
     id badl6_w2 badl6_w4 badl6_w6 age_w2 sex cd14_w2 allo_w2 bmi30_w2 bmi20_w2 smo_w2 alc_w2  
     lowth_w2 loedu_w2 pssu_w2 psin_w2 pf_w2 pf_w4 pf_w6 lowpa_w2 lowpa_w4 lowpa_w6 cesd6_w2    
     cesd6_w4 cesd6_w6 cogni_w2 cogni_w3 cogni_w4; 
  Usevariables are 
     badl6_w2 badl6_w4 badl6_w6 age_w2 sex cd14_w2 allo_w2 bmi30_w2 bmi20_w2 smo_w2 alc_w2  
     lowth_w2 loedu_w2 pssu_w2 psin_w2 pf_w2 pf_w4 pf_w6 lowpa_w2 lowpa_w4 lowpa_w6 cesd6_w2    
     cesd6_w4 cesd6_w6 cogni_w2 cogni_w3 cogni_w4; 
  Missing are ALL (-9999); 
Analysis: 
  Algorithm = integration; 
  Integration = montecarlo; 
  Estimator = mlr; 
Model: 
  badl6_w4 ON badl6_w2 (adladl) 
  pf_w2 (pfadl) 
  age_w2 (ageadl) 
  sex (sexadl) 
  cd14 (cdadl) 
  allo (alladl) 
  bmi30_w2 (b30adl) 
  bmi20_w2 (b20adl) 
  smo_w2 (smoadl) 
  alc_w2 (alcadl)   
  lowth_w2 (lowadl) 
  loedu_w2 (loeadl) 
  pssu_w2 (pssadl) 
  psin_w2 (psiadl) 
  u1@x; 
  badl6_w6 ON badl6_w4 (adladl) 
  pf_w4 (pfadl) 
  age_w2 (ageadl)  
  sex (sexadl) 
  cd14 (cdadl) 
  allo (alladl) 
  bmi30_w2 (b30adl) 
  bmi20_w2 (b20adl) 
  smo_w2 (smoadl) 
  alc_w2 (alcadl)   
  lowth_w2 (lowadl) 
  loedu_w2 (loeadl) 
  pssu_w2 (pssadl) 
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  psin_w2 (psiadl); 
  u2@x; 
  pf_w4 ON pf_w2 (pfpf) 
  badl6_w2 (adlpf) 
  age_w2 (agepf) 
  sex (sexpf) 
  cd14 (cdpf) 
  allo (allpf) 
  bmi30_w2 (b30pf) 
  bmi20_w2 (b20pf) 
  smo_w2 (smopf) 
  alc_w2 (alcpf)   
  lowth_w2 (lowpf) 
  loedu_w2 (loepf) 
  pssu_w2 (psspf) 
  psin_w2 (psipf) 
  u1@y; 
  pf_w6 ON pf_w4 (pfpf) 
  badl6_w4 (adlpf) 
  age_w2 (agepf)  
  sex (sexpf) 
  cd14 (cdpf) 
  allo (allpf) 
  bmi30_w2 (b30pf) 
  bmi20_w2 (b20pf) 
  smo_w2 (smopf) 
  alc_w2 (alcpf)   
  lowth_w2 (lowpf) 
  loedu_w2 (loepf) 
  pssu_w2 (psspf) 
  psin_w2 (psipf) 
  u2@y; 
  badl6_w4 WITH badl6_w6 pf_w4; 
  pf_w6 WITH pf_w4 badl6_w6; 
  lowpa_w4 ON lowpa_w2 (loplop) 
  pf_w2 (pflop) 
  sex (sexlop) 
  age_w2 (agelop) 
  cd14_w2 (cdlop) 
  allo_w2 (alllop) 
  smo_w2 (smolop) 
  alc_w2 (alclop) 
  pssu_w2 (psslop) 
  psin_w2 (psilop) 
  lowth_w2 (lowlop) 
  loedu_w2 (loelop) 
  bmi30_w2 (b30lop) 
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  bmi20_w2 (b20lop) 
  u1@z1; 
  lowpa_w6 ON lowpa_w4 (loplop) 
  pf_w4 (pflop) 
  sex (sexlop) 
  age_w2 (agelop) 
  cd14_w2 (cdlop) 
  allo_w2 (alllop) 
  smo_w2 (smolop) 
  alc_w2 (alclop) 
  pssu_w2 (psslop) 
  psin_w2 (psilop) 
  lowth_w2 (lowlop) 
  loedu_w2 (loelop) 
  bmi30_w2 (b30lop) 
  bmi20_w2 (b20lop) 
  u2@z1; 
  cesd6_w4 ON cesd6_w2 (cesces) 
  pf_w2 (pfces) 
  sex (sexces) 
  age_w2 (ageces) 
  cd14_w2 (cdces) 
  allo_w2 (allces) 
  smo_w2 (smoces) 
  alc_w2 (alcces) 
  pssu_w2 (pssces) 
  psin_w2 (psices) 
  lowth_w2 (lowces) 
  loedu_w2 (loeces) 
  bmi30_w2 (b30ces) 
  bmi20_w2 (b20ces) 
  u1@z2; 
  cesd6_w6 ON cesd6_w4 (cesces) 
  pf_w4 (pfces) 
  sex (sexces) 
  age_w2 (ageces) 
  cd14_w2 (cdces) 
  allo_w2 (allces) 
  smo_w2 (smoces) 
  alc_w2 (alcces) 
  pssu_w2 (pssces) 
  psin_w2 (psices) 
  lowth_w2 (lowces) 
  loedu_w2 (loeces) 
  bmi30_w2 (b30ces) 
  bmi20_w2 (b20ces) 
  u2@z2; 
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  cogni_w3 ON cogni_w2 (cogcog) 
  pf_w2 (pfcog) 
  sex (sexcog) 
  age_w2 (agecog) 
  cd14_w2 (cdcog) 
  allo_w2 (allcog) 
  smo_w2 (smocog) 
  alc_w2 (alccog) 
  pssu_w2 (psscog) 
  psin_w2 (psicog) 
  lowth_w2 (lowcog) 
  loedu_w2 (loecog) 
  bmi30_w2 (b30cog) 
  bmi20_w2 (b20cog) 
  u1@z3; 
  cogni_w4 ON cogni_w3 (cogcog) 
  pf_w4 (pfcog) 
  sex (sexcog) 
  age_w2 (agecog) 
  cd14_w2 (cdcog) 
  allo_w2 (allcog) 
  smo_w2 (smocog) 
  alc_w2 (alccog) 
  pssu_w2 (psscog) 
  psin_w2 (psicog) 
  lowth_w2 (lowcog) 
  loedu_w2 (loecog) 
  bmi30_w2 (b30cog) 
  bmi20_w2 (b20cog) 
  u2@z3; 
  lowpa_w2 WITH cesd6_w2 cogni_w2; 
  cesd6_w2 WITH cogni_w2; 
  lowpa_w4 WITH cesd6_w4 cogni_w3; 
  cesd6_w4 WITH cogni_w3; 
  lowpa_w6 WITH cesd6_w6 cogni_w4; 
  cesd6_w6 WITH cogni_w4; 
  u1 BY; 
  u1@1; 
  u2 BY; 
  u2@1; 
  u1 WITH age_w2@0 sex@0 cd14_w2@0 allo_w2@0 smo_w2@0 alc_w2@0 pssu_w2@0 psin_w2@0  
  lowth_w2@0 loedu_w2@0 bmi30_w2@0 bmi20_w2@0; 
  u2 WITH age_w2@0 sex@0 cd14_w2@0 allo_w2@0 smo_w2@0 alc_w2@0 pssu_w2@0 psin_w2@0  
  lowth_w2@0 loedu_w2@0 bmi30_w2@0 bmi20_w2@0; 
  u2 ON u1; 
  [cd14_w2 allo_w2 bmi30_w2 bmi20_w2 smo_w2 alc_w2 lowth_w2 loedu_w2 pssu_w2 psin_w2 
  lowpa_w2 lowpa_w4 lowpa_w6 cesd6_w2 cesd6_w4 cesd6_w6 cogni_w2 cogni_w3 cogni_w4]; 
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  Model constraint: 
  new (IND1 IND2 IND3); 
  IND1 = (pflop*lopadl); 
  IND2 = (pfces*cesadl); 
  IND3 = (pfcog*cogadl); 
Output: 
  stand sampstat cinterval tech4; 
 
! The suffixes, _w2, _w3, _w4, and _w6 indicate that variables are measured at waves 2, 3, 4, and 6 
respectively. 
! id = identification number; age = age (standardized); sex = gender; cd14 = chronic disease 
(standardized); allo = allostatic load (standardized); smo = smoking; alc = high alcohol intake; lowth = low 
wealth; loedu = low education; bmi30 = obesity; bmi20 = underweight; pssu = poor social support 
(standardized); psin = poor social integration (standardized); lowpa = low physical activity (standardized); 
cesd6 = depressive symptoms (standardized); cogni = cognitive impairment (standardized); pf = physical 
frailty factor score (standardized); badl6 = number of basic activities of daily living items performed with 
difficulty; u1, u2 = phantom variables; 
 
! x = equivalent to multiples of the effect of the strongest predictor (other than physical frailty) on activity 
limitation; y = correlation between u and physical frailty; z1 = equivalent to multiples of the effect of the 
strongest predictor (other than physical frailty) on low physical activity; z2 = equivalent to multiples of the 
effect of the strongest predictor (other than physical frailty) on depressive symptoms; z3 = equivalent to 
multiples of the effect of the strongest predictor (other than physical frailty) cognitive impairment; 
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! Sensitivity analyses using negative binomial regression 
Title: Autoregressive cross-lagged model for prediction of activity limitation by physical frailty using 
negative binomial regression  
Data: File is physical frailty3.dat; 
Variable: 
  Names are 
     id badl6_w2 badl6_w4 badl6_w6 age_w2 sex cd14_w2 allo_w2 bmi30_w2 bmi20_w2 smo_w2 alc_w2  
     lowth_w2 loedu_w2 pssu_w2 psin_w2 pf_w2 pf_w4 pf_w6; 
  Usevariables are 
     badl6_w2 badl6_w4 badl6_w6 age_w2 sex cd14_w2 allo_w2 bmi30_w2 bmi20_w2 smo_w2 alc_w2  
     lowth_w2 loedu_w2 pssu_w2 psin_w2 pf_w2 pf_w4 pf_w6; 
  Count are 
     badl6_w2 (nbi) badl6_w4 (nbi) badl6_w6 (nbi); 
  Missing are ALL (-9999); 
Analysis: 
  Algorithm = integration; 
  Integration = montecarlo; 
  Estimator = mlr; 
Model: 
  badl6_w4 ON badl6_w2 (adladl) 
  pf_w2 (pfadl) 
  sex (sexadl) 
  age_w2 (ageadl) 
  cd14 (cdadl) 
  allo (alladl) 
  bmi30_w2 (b30adl) 
  bmi20_w2 (b20adl) 
  smo_w2 (smoadl) 
  alc_w2 (alcadl)   
  lowth_w2 (lowadl) 
  loedu_w2 (loeadl) 
  pssu_w2 (pssadl) 
  psin_w2 (psiadl); 
  badl6_w4#1 ON badl6_w2 (adladl1) 
  pf_w2 (pfadl1) 
  sex (sexadl1) 
  age_w2 (ageadl1) 
  cd14 (cdadl1) 
  allo (alladl1) 
  bmi30_w2 (b30adl1) 
  bmi20_w2 (b20adl1) 
  smo_w2 (smoadl1) 
  alc_w2 (alcadl1)   
  lowth_w2 (lowadl1) 
  loedu_w2 (loeadl1) 
  pssu_w2 (pssadl1) 
  psin_w2 (psiadl1); 
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  badl6_w6 ON badl6_w4 (adladl) 
  pf_w4 (pfadl) 
  sex (sexadl) 
  age_w2 (ageadl) 
  cd14 (cdadl) 
  allo (alladl) 
  bmi30_w2 (b30adl) 
  bmi20_w2 (b20adl) 
  smo_w2 (smoadl) 
  alc_w2 (alcadl)   
  lowth_w2 (lowadl) 
  loedu_w2 (loeadl) 
  pssu_w2 (pssadl) 
  psin_w2 (psiadl); 
  badl6_w6#1 ON badl6_w4 (adladl1) 
  pf_w4 (pfadl1) 
  sex (sexadl1) 
  age_w2 (ageadl1) 
  cd14 (cdadl1) 
  allo (alladl1) 
  bmi30_w2 (b30adl1) 
  bmi20_w2 (b20adl1) 
  smo_w2 (smoadl1) 
  alc_w2 (alcadl1)   
  lowth_w2 (lowadl1) 
  loedu_w2 (loeadl1) 
  pssu_w2 (pssadl1) 
  psin_w2 (psiadl1); 
  pf_w4 ON pf_w2 (pfpf) 
  badl6_w2 (adlpf) 
  sex (sexpf) 
  age_w2 (agepf) 
  cd14 (cdpf) 
  allo (allpf) 
  bmi30_w2 (b30pf) 
  bmi20_w2 (b20pf) 
  smo_w2 (smopf) 
  alc_w2 (alcpf)   
  lowth_w2 (lowpf) 
  loedu_w2 (loepf) 
  pssu_w2 (psspf) 
  psin_w2 (psipf); 
  pf_w6 ON pf_w4 (pfpf) 
  badl6_w4 (adlpf) 
  sex (sexpf) 
  age_w2 (agepf) 
  cd14 (cdpf) 
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  allo (allpf) 
  bmi30_w2 (b30pf) 
  bmi20_w2 (b20pf) 
  smo_w2 (smopf) 
  alc_w2 (alcpf)   
  lowth_w2 (lowpf) 
  loedu_w2 (loepf) 
  pssu_w2 (psspf) 
  psin_w2 (psipf); 
  badl6_w4 WITH badl6_w6 pf_w4; 
  pf_w6 WITH pf_w4 badl6_w6; 
  [cd14_w2 allo_w2 bmi30_w2 bmi20_w2 smo_w2 alc_w2 lowth_w2 loedu_w2 pssu_w2 psin_w2]; 
Output: 
  stand sampstat cinterval tech4; 
 
! The suffixes, _w2, _w4, and _w6 indicate that variables are measured at waves 2, 4, and 6 respectively. 
! id = identification number; age = age (standardized); sex = gender; cd14 = chronic disease 
(standardized); allo = allostatic load (standardized); smo = smoking; alc = high alcohol intake; lowth = low 
wealth; loedu = low education; bmi30 = obesity; bmi20 = underweight; pssu = poor social support 
(standardized); psin = poor social integration(standardized); pf = physical frailty factor score 
(standardized); badl6 = number of basic activities of daily living items performed with difficulty; 
